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ABSTRACT 
Transcriptomics and the introduction of bioinformatics approaches over the last couple of 
decades have had a large impact on the current revolutions in dairy welfare and the economics 
and structure of dairy industries. The etiology of disease e.g. endomeritits, metabolic dis-
comforts and optimal calving BCS are major challenges for future advances in dairy cow 
management. The current research conducted five different studies to investigate the effects of 
nutrition, infection, disease and different calving BCS on cows’ hepatic transcriptomes and 
metabolic profiles using mRNA gene expression profiles, biochemical parameters, and the latest 
bioinformatics tools. 
The first study investigated the expression and regulatory mechanism of FGF21 under 
early postpartal ketosis, L-carnitine infusion, a prepartal high energy diet and inflammatory 
mediators. Ketosis increased the expression and serum level of FGF2; however, a high plasma 
concentration of carnitine decreased hepatic expression of FGF21. Prepartal high energy diet 
increased FGF21 expression and intra mammary LPS challenge further increased hepatic 
expression of FGF21.  The decrease in hepatic KLB expression may suggest adipose as a target 
tissue for FGF21 in these cows. The findings from this study revealed that, like rodents and other 
mammals, bovine hepatic FGF21 is also regulated by changes in nutrition, metabolism, and 
inflammatory conditions through different mechanisms. This study will help to clarify the role of 
FGF21 as a nutrition adaptation factor in dairy cows (For details see chapter 2). 
The liver has a precise role in lipid metabolism; any change in dietary lipid 
supplementation can affect hepatic cell function through modulating the expression of an array 
of genes from different networks. The second project uncovered the change in phospholipids 
(PL) and triacylglycerol (TAG) LCFA profiles and expression of genes associated PPARα 
 
 
iii 
 
signaling, metabolism, growth, energy and immune responses in transitional cows supplemented 
with saturated fatty acids or polyunsaturated fatty acids (PUFA). Preliminary findings revealed 
that both diets affected the LCFA profile of hepatic LP and TAG. However, saturated fatty acids 
were more effective than PUFA in eliciting hepatic transcriptional changes; PUFA showed a 
greater decrease in fatty acid oxidation, gluconeogenesis, intraocular energy and inflammation 
(For details see chapter 3). 
In the third set of experiments, bovine specific microarray and related bioinformatics 
tools were used to study the transcriptomic changes of peripheral tissues in response to sub 
clinical endometritis (SCE). Milk production, blood metabolites, and disease biomarkers did not 
differ greatly between healthy and SCE cows. However, transcriptomic analysis of hepatic and 
subcutaneous adipocytes from cows with SCE revealed a marked effect on the complement and 
coagulation cascade, steroid hormone biosynthesis, apoptosis, inflammation and oxidative stress. 
Other effects included the hepatic inhibition of vitamin B3 and B6 metabolism in cows with 
SCE. The findings from this study uncovered that SCE in dairy cattle during early lactation 
induces molecular alterations in liver and adipose tissues, indicative of immune activation and 
cellular stress. (For details see chapter 4). 
Calving body condition score (BCS) management is a key contributing factor to cow 
welfare subsequent to calving. The fourth and fifth sets of experiments aimed to investigate the 
metabolic and molecular changes induced by change in BCS using blood biomarkers, hepatic 
TAG concentrations, and hepatic gene expression profiling. For this purpose, a group of cows 
with mixed ages and breeds managed from the second half of the previous lactation to achieve 
mean group BCS that were high (H, 5.5 BCS), medium (M, 4.5 BCS), or low (L, 3.5 BCS) BCS 
(10-point scale). In the fourth study, blood and hepatic biomarkers as well as gene expression 
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data revealed that both high and medium BCS at calving benefit milk production. However, high 
BCS cows may be more prone to accumulating fat in the liver. All cows underwent an 
inflammatory response around calving, but cows with medium BCS seemed to recover faster. 
The biomarker data suggested that a low BCS induced some degree of liver dysfunction. 
Different measures of production, inflammatory state, and metabolism indicate that cows calving 
at BCS 3.5 or 5.5 (1-10 scale) are suboptimal in comparison to a calving BCS of 4.5. (For details 
see chapter 5). 
The fifth study used hepatic transcriptome and bioinformatics tools to uncover the most 
impacted functional categories and top transcriptional regulators in response to changes	in calving BCS. 
The study revealed carbohydrates, lipid terpenoids and polyketides, and vitamin metabolism as 
the most impacted categories affected by changes in BCS. An increase in BCS induced pathways 
supports milk production but also predisposes cows to health problems associated with fatty 
liver, biosynthesis of inflammatory precursors and oxidative stress. In cows with a low BCS, the 
liver adapts a glucose sparing effect for lactogenesis, but regulates the pathways associated with 
the biosynthesis of unsaturated fatty acids, antioxidant systems, and immune responses. Overall, 
the results indicate that subtle changes in cow adiposity at calving can have significant effects on 
health and production and provide support for an optimum calving BCS of 4.5-5.0 (i.e. 2.75-3.0 
in a 5-point scale). Furthermore, the study uncovered TP53 to be a central hub regulating a large 
spectrum of genes altered by BCS. The interaction effect of BCS and time relative to parturition 
(BCS  wk) revealed HNF4A had the greatest number of targets (For details see chapter 6). 
Findings from these experiments are based around biochemical and gene expression 
profiling techniques that will have a positive impact on future strategic developments for bovine 
welfare and the dairy industry. 
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CHAPTER 1: LITERATURE REVIEW 
 
Transition period in dairy cows 
The transition period is the time between the pregnant non-lactating stage to non-
pregnant early lactation stage in dairy cows, also called the peripartum period (Drackley, 1999). 
This period can range between three weeks prepartum to three weeks postpartum (Mulligan and 
Doherty, 2008). It involves numerous metabolic, physiological, and nutritional changes, which 
constitute a crucial point in cows’ productive cycle between lactations (Grummer et al., 2004). 
The understanding and management of these changes is very important, as they are linked to 
lactation, postpartal diseases, and reproductive performance that can significantly affect 
profitability (Drackley, 1999). 
The transition period is also marked by major hormonal changes that cause a decrease in 
DMI, while there is an increase in energy demand to sustenance fetal growth, and lactation (Bell, 
1995, Drackley, 1999, Grummer, 1995). The greater nutrient demand, the severe variations in 
endocrine status, and the reduction in DMI during late pregnancy affect metabolism, specifically, 
lipid metabolism (Grummer, 1995). To attain the required balance for the onset of lactation, 
liver, adipose tissue, mammary glands, and the gut are the major body components that 
experience more drastic changes (Drackley, 1999).  
Nutrition and energy demand of dairy cows  
Nutrition influences the supply of nutrients to tissues and alters the metabolic status and 
animal’s susceptibility to metabolic and infectious diseases. The energy requirements of dairy 
cows fluctuate with stage of lactation, and highest energy requirements have been detected in 
early lactation (NRC, 2001). This increase in energy demand for the initiation of lactation might 
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be associated with decrease in DMI, as dairy cows often experience a decrease in DMI 18 d 
before parturition (VanSaun and Sniffen, 1996). In terms of net nutrient intake, a 2 to 4 kg 
decline in DMI is significant. 
Peripartum energy status in dairy cows 
Peripartum is the most challenging period for dairy cows because a marked change in 
hormonal status occurs to support calving and lactogenesis (Bell, 1995, Grummer, 1995). Pre-
partum fed energy may play a determining role in the success of the transition period (Drackley, 
1999). Research on dairy cattle has demonstrated whether dry period energy consumption may 
aid the transition in dairy cows (Douglas et al., 2006, Janovick and Drackley, 2010). Generally, a 
decrease in DMI occurs 7 to 10 days before calving, but at the same time, an increase in nutrient 
demand for the growing fetus and lactogenesis (Grummer, 1995) lead to a stage of negative 
energy balance (NEB). To meet the energy requirements of this period, dairy cattle rely on 
mobilization of adipose and muscle tissue (Drackley, 1999). This period of NEB lasts until the 
yield of milk starts to decline (7 – 10 wk after parturition) and the energy from the DMI becomes 
sufficient to meet the cow’s requirements (Roche et al., 2009). Consequentially, the gap in 
demand and supply of nutrients, and the associated alteration in metabolic activity predispose the 
cow to various metabolic and infectious diseases. 
A high incidence of metabolic diseases such as ketosis, as well as other infectious 
diseases like mastitis and endometritis, have been seen in early lactation (Rukkwamsuk et al., 
1999b, Stabel et al., 2003). Hammon et al (2006), observed by an association between a lower 
feed intake at 3 wks prepartum and a decrease in neutrophil killing capacity from 1 to 3 wks 
postpartum (Hammon et al., 2006). Thus, careful monitoring of factors such as management, 
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balanced feed composition and routine feed intake during the transition period is necessary to 
ensure a smooth transition from the dry to the lactating stage. 
Higher incidence of diseases has been reported in both over and under-conditioned dairy 
cows as compared with normal conditioned animals (Rukkwamsuk et al., 1999b). Cows with a 
restricted energy intake prepartum maintained DMI and NEL as parturition approached and had 
higher DMI and NEL intakes the first 21 DIM (Douglas et al., 2006). Serious effects on 
reproductive parameters such as postpartum interval to first oestrus and pregnancy rate have 
been observed in cows with insufficient energy intake during late pregnancy to meet the required 
energy demand (Randel, 1990). Overfed (high) energy prepartum diet leads to lower postpartum 
DMI and severe metabolic burden (Drackley et al., 2005). Oboes animals suffer from a longer, 
more prominent depression in DMI after calving, resulting in a more severe NEB than cows with 
normal body conditions (Agenas et al., 2003, Grummer, 1995, Hayirli et al., 2002). 
Early lactating cows depend on endogenous substrates (mainly glucogenic amino acids 
and glycerol), to fulfill their high demand of glucose for lactogenesis (Bell and Bauman, 1997). 
As a consequence of the large-scale mobilization of adipose tissue in early lactation, there is a 
considerable rise in plasma concentration of NEFA (Loor et al., 2007). The liver has very 
important role in fat metabolism, particularly during early lactation when NEFA influx is 
comparatively very high than other stages of lactation.  In early lactating cows, about 50% of 
NEFA are oxidized to ketone bodies or re-esterified to triglycerides in the liver (Bell, 1995). 
However, as ruminants cannot proficiently export triglycerides as part of VLDL (very low 
density lipoproteins), significant amounts of these triglycerides are stored in the liver 
(Rukkwamsuk et al., 1999b).  
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Fatty liver develops as a result of increase esterification of NEFA to tryglyceride (TG) 
due to suboptimal hepatic oxidation of fatty acid and TG transport. This predispose the cows to 
other metabolic and immunological disorders such as ketosis, displaced abomasum, metritis, 
immune suppression, and decreased reproductive performance (Bobe et al., 2004). In addition, 
Hammon et al. (2006) reported an association between increased NEFA concentration and 
reduced neutrophil myeloperoxidase activity, particularly in the week before calving. Recently, 
Galvao et al, (2010) observed an association of increased concentration of BHBA and NEFA 
with the risk of metritis and cytological endometritisnear calving. Preventative measures against 
fatty liver to alter hepatic metabolism have been made by reducing NEFA mobilization from 
adipose tissue, enhancing hepatic fatty acid oxidation, or increasing TG export from the liver 
through manipulation of pre or postpartum nutrition (Bobe et al., 2004). However, a definitive 
approach for prevention of fatty liver remains to be found. 
Dietary L-carnitine supplementation and transition cows 
L-Carnitine, which is required for mitochondrial long-chain fatty acid oxidation, has been 
shown to dramatically decrease or prevent liver lipid accumulation in laboratory animals (Bykov 
et al., 2003, Spaniol et al., 2003). The activity and expression of carnitine palmitoyltransferase-I 
(CPT-I), the mitochondrial enzyme for which carnitine serves as a cofactor, increases around 
parturition to facilitate the oxidation of mobilized non-esterified fatty acids (NEFA) (Dann and 
Drackley, 2005, Loor et al., 2005). In vitro studies have shown that carnitine addition to 
incubation media increased palmitate oxidation by bovine liver slices (Drackley et al., 1991, 
Jesse et al., 1986), bovine hepatocytes (Knapp et al., 1992), and sheep hepatocytes (Lomax et al., 
1983). This suggests that supplemental carnitine may alter in vivo hepatic fatty acid metabolism. 
Our research group at the University of Illinois previously demonstrated that abomasal carnitine 
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infusion increased in vitro hepatic fatty acid oxidation and had a tendency to prevent hepatic 
triglyceride (TG) accumulation during feed restriction in mid-lactating cows (Carlson et al., 
2006). Data obtained from non-ruminants indicates that carnitine supplementation increases 
hepatic gluconeogenesis (Ji et al., 1996, Owen et al., 2001); similar responses in dairy cows 
would provide additional benefits considering the extreme glucose demand imposed by lactation 
(Drackley, 2001).  
Lipopolysaccharide (LPS) and transition cows 
Postpartum bacterial contaminations of the uterine lumen are ubiquitous in dairy cattle 
(Sheldon et al., 2002, Williams et al., 2008). The E coli release an endotoxin called 
lipopolysaccharide (LPS), which can pass to the peripheral circulation from the uterine lumen, 
and higher concentration of LPS has been reported in cows with uterine infection (Williams et 
al., 2005). Infusion of E. coli LPS into the uterine lumen suppresses the pre-ovulatory luteinizing 
hormone surge and disrupts ovulation in heifers (Williams et al., 2008). Intrauterine application 
of E. coli LPS as a uterine defense stimulator has been used to increase the influx and phagocytic 
activities of neutrophil in to the uterine lumen in apparently healthy mares (Williamson et al., 
1987), cows (Hussain and Daniel, 1992) and also in cows suffering from endometritis (Singh et 
al., 2000). 
In transitional cows, decreased DMI is well reported and is associated with increased 
NEFA levels (Drackley, 1999), which contribute to fatty liver, and  in turn are associated with 
impaired neutrophil function (LeBlanc et al., 2011). Fibroblast growth factor 21 (FGF21) 
regulates lipid metabolism (Kharitonenkov and Larsen, 2011, Kliewer and Mangelsdorf, 2010); 
its plasma consternation is found to dramatically increase during parturition and early lactation, 
and liver is major contributor for this effect (Schoenberg et al., 2011). In mice, LPS treatment 
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increased serum FGF21 levels, while it decreased the hepatic expression of FGF21. However, an 
increase was observed in adipose and muscles tissue, indicating that the liver cannot be the 
source of the increase in serum FGF21 during the APR (Feingold et al., 2012). 
Dietary fatty acid and transition cows 
Feeding lipid supplements in dairy cow management has been an important practice to 
minimize transition problems (Drackley, 1999). Supplemental lipids increase the energy density 
of the diet, might improve the energy balance of early lactating cows (Ballou et al., 2009), and 
may also modulate metabolism influencing enzyme activities (Jump, 2002).  Dietary fatty acids 
(FA) can regulate production and assembly of cytokines and other molecules involved in 
immune responses (Lessard et al., 2003). Omega-3 and omega-6 polyunsaturated FA (PUFA) are 
important immune-modulators of immune reactions (Miles and Calder, 1998). Long-chain n–3 
PUFAs has been reported to replace inflammatory precursor (e.g. arachidonic acid metabolism 
inhibition) or alter the expression of inflammatory genes (modulating transcription factor 
activation) (Calder, 2006). 
Long chain fatty acids (LCFA), mainlyphospholipids, make up a significant component 
of cell membranes. These fatty acids act as filters that control what goes in and out of the cell, 
and can affect membrane fluidity (Yaqoob, 2003). Changing the LCFA profile of the diet 
influences the hepatic fatty acid profile of phospholipids (PL) and TAG, which affects cell 
fluidity and function (Douglas et al., 2007, Rukkwamsuk et al., 1999a). Macrophages enriched 
with polyunsaturated fatty acids phagocytized at a faster rate (126-148% of control) compared to 
macrophages enriched in saturated fats or oleic acid (72 to 89% of controls). This improvement 
and influence on receptor number and affinity was likely due to the increased fluidity of the 
membrane. 
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Prostaglandins are inflammation mediators produced by macrophages thought to be 
attractants for neutrophils to the site of an infection (Hoedemaker et al., 1992). At the time of 
parturition, the uterus produces PGF2α, and the linoleic acid (precursor for is arachidonic acid 
(C20:4)) intake increases more; its concentration is measured as its metabolite (PGFM) in 
plasma. Higher concentrations of circulating PGFM have been measured in cows with uterine 
infections. Dairy cows (n=14) diagnosed with severe endometritis (fetid sanguine-purulent 
lochia) had greater concentrations of plasma PGFM and uterine fluid PGE2 than cows with 
moderate endometritis (mucopurulent to purulent lochia) (Mateus et al., 2003). Replacing uterine 
linoleic acid with ω -3 fatty acids was likely to have reduced the production of PGF2α by the 
uterus (Mattos et al., 2004). Higher proportions of ω-3 fatty acids were found in the uterine 
endometrium of beef cows fed fish meal (Burns et al., 2003), in the caruncles of dairy cows fed 
fish oil (Mattos et al., 2004) and in the plasma and liver of dairy cows fed linseed oil (Amaral, 
2006).  
Importance of liver 
The liver, the chief metabolic organ, plays a vital role in integrating several biochemical 
pathways such as glycogen syntheses, gluconeogenesis, liponeogenesis, ketogenesis, 
detoxification and glucose, vitamins, amino acids, lipid and cholesterol  metabolism(Jungermann 
and Katz, 1989, Loor et al., 2005, Sanchez and Aranda-Michel, 2006). It regulates numerous 
genes to perform these metabolic functions in order to maintain energy homeostasis within an 
organism (Spear et al., 2006). As discussed above, the transition from gestation to lactation is 
generally associated with a decrease in DMI, negative energy balance and large scale 
mobilization of body nutrient stores (Drackley, 1999).  During the transitional period, fatty acid 
released from adipose tissue circulate as non-esterified fatty acids (NEFA); acts as a major 
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source of energy during this period. The concentration of NEFA increases during parturition and 
negative energy balance, due to increase in lipolysis (Drackley, 1999, Loor et al., 2007). Serum 
NEFA concentrations can also be the result of dietary FA absorbed from gut. After absorption, 
dietary FAs are packaged into lipoproteins, which deliver dietary FA to peripheral tissues. 
Normally, a substantial proportion of the NEFA arriving at the liver is oxidized to 
support the cow’s energy requirements. Conversely, NEFA may export from the liver as very 
low-density lipoproteins (VLDL), to be metabolized in other tissues; this being the method by 
which mobilized body fat is integrated into milk fat. On the other hand, when the amount of fat 
presented to the liver goes beyond its normal oxidative or transport capacities, partial oxidation 
will occur, resulting in an increased production of ketone bodies, including β-OH butyrate 
(BHB) (Drackley, 2001). Consequently, dietary FAs result in elevation of NEFA concentration 
due to LPL action in peripheral tissues. Remnant lipoproteins and HDL are cleared by the liver, 
thereby delivering FA to the liver (Drackley, 1999).  
Serum NEFA is an essential indicator of the energy status of an animal.  From the 
bloodstream, NEFA can be utilized as an energy source by other tissues (Drackley, 1999), but 
the liver is the most important site for removal of NEFA (Bell, 1979). In the liver, NEFA can be 
converted into acyl-CoA by the activity of acyl-CoA synthetase (ACS), after which carnitine acyl 
transferase (CPT) transports acyl-CoA into the mitochondria matrix where β-oxidation occurs 
(Zammit, 1984). Acetyl Co A, which is the product of β -oxidation, can be oxidized for energy in 
the citric acid (TCA) cycle. Long chain fatty acids (LCFA) β-oxidation also occurs in hepatic 
peroxisomes that may provide an oxidative pathway to utilize excess uptake of NEFA around 
parturition (Douglas et al., 2006, Drackley et al., 2001). Parallel β-oxidation in mitochondria and 
peroxisome might have reduced hepatic accumulation of TG in cows restricted fed during the dry 
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period (Douglas et al., 2006). In the meantime, synthesis of ketone bodies (acetoacetate, β-
oxidation of hydroxybutyrate and acetone) may occur if the oxidation capacity of acetyl CoA 
decreases due to the reduced capacity of TCA metabolites (Drackley, 1999). Ketone bodies can 
be released into blood from liver (Bell, 1979) and used as an alternate water-soluble fuel source 
by many tissues (e.g., heart and skeletal muscle) when glucose is limited. However, if the rate of 
lipid mobilization exceeds the rate of ketone body utilization, then ketones accumulate and may 
adversely affect the health and productivity of the cow (Ingvartsen and Andersen, 2000). The 
greater than normal levels of ketone bodies in the blood may cause ketosis.    
Non-esterified fatty acids (NEFA) can be esterified and exported from the liver as TGs 
with VLD to other tissues such as the mammary gland, where the fatty acids are incorporated 
into milk fat TG (Smith et al., 1997). If the rate of esterification exceeds the rate of TG export 
from liver then metabolic disorder of fatty liver can occur (Drackley, 1999). Morrow (1976) 
reported that if NEB increases, then the ability of the hepatic cells to utilize NEFA and secrete 
triglycerides decreases in transition dairy cows. Therefore, TGs can build up in the liver, 
decreasing liver function and eventually causing liver lipidosis (Drackley, 1999). The severe 
lipid infiltration in the liver of dairy cows is susceptible to other pathologies (Herdt, 1988). 
Importance of fibroblast growth factor 21 
Fibroblast growth factor 21 (FGF21) is a metabolic regulator from the FGF family, 
produced by the liver that regulates glucose and lipid metabolism (Murata et al., 2011). 
Specifically, an increase in FGF21 is negatively correlated with serum triglyceride and glucose 
levels (Feingold et al., 2012). This decrease may be due to lower levels of hepatic lipogenesis 
and an induced hepatic oxidation of fatty acid and ketone production (Domouzoglou and 
Maratos-Flier, 2011). The enzymes involved in these processes are increased by FGF21, 
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including Carnitine palmitoyltransferase 1 (CPT-1), acyl-Coenzyme A oxidase (ACO), and 
hydroxymethylglutaryl-CoA synthase 2 (HMGCS2) (Badman et al., 2007, Inagaki et al., 2007). 
In mice, FGF21 is induced in the liver by fasting through a mechanism that requires the nuclear 
fatty acid receptor, peroxisome proliferator-activated receptor α (PPARα) (Inagaki et al., 2007).  
Moreover, in many species, early lactation is a physiological state in which the use of 
lipids is substantial and dependent on coordinated activities between white adipose tissue (WAT) 
and liver. These relationships are well understood in high-yielding dairy cows (Vernon et al., 
2002). Mobilization of NEFA from WAT is both intensive and extensive after parturition and 
sustained at sufficient rates over the first month of lactation to cover 30% of the total energy 
requirement (Drackley, 2001). However, higher level of NEFA contributes to the fatty liver, 
which in turn with an increased risk of ketosis, immune suppression, displaced abomasum, 
metritis, and decreased reproductive performance (Bobe et al., 2004, LeBlanc et al., 2011).  
In the liver, the genetic program underpinning lipid oxidation is turned on by peroxisome 
proliferator-activated receptor (PPAR)-α in response to incoming NEFA. Less attention, 
however, has been given to mechanisms responsible for matching WAT mobilization to 
oxidative capacity in liver. Failure of this coordination is thought to be a root cause of the cluster 
of diseases associated with excessive lipolysis and hepatic TG accumulation in early lactating 
dairy cows. A significant development in this context is the discovery of the fibroblast growth 
factor (FGF)-21 as a novel and potent regulator of metabolism (Kliewer and Mangelsdorf, 2010). 
Endocrine FGF have the distinctive ability to circulate in significant concentration in plasma and 
to act only in tissues expressing the co-receptor proteins Klotho or β-Klotho (Itoh, 2010). In the 
case of FGF21, increased plasma concentrations occur in mice subject to conditions associated 
with increased lipid use such as fasting and consumption of ketogenic diets and target β-Klotho-
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expressing tissues such as liver and WAT. Recently, Schoenberg et al., (2011), observed increase 
in FGF21 expression during parturition and early lactation, and the liver was major contributor 
for this effect. 
Immune system in dairy cows 
The immune system is integrated by a diversity of cells and molecules that are capable of 
recognizing and eliminating, in a specific manner, invading foreign microorganisms. In 
ruminants, the immune system can be divided into innate and acquired immune system. The 
innate immunity is the prime defense during early stages of infections; initiated in response to a 
pathogen (antigens), and the response will not be amplified by repeated exposure to the same 
pathogen. Whereas, the acquired, or adaptive, immune system recognizes specific antigen 
markers and is facilitated by antigen presenting cells (APC); repeated exposure to the same 
antigen enhances immune reactivity due to immunological memory (Janeway, 2005, Sordillo and 
Streicher, 2002).  
Both Innate and acquired systems have the  ability to recognize specific and conserved 
components of pathogens called pathogen-associated molecular patterns (PAMPs): 
lipopolysaccharide (LPS), peptidoglycan and bacterial DNA (Hornef et al., 2002). Toll-like 
receptors (TLRs) are mainly responsible for recognizing these molecules, and provide signaling 
during the initiation of an immune response (Janeway, 2005, Medzhitov et al., 1997). Leukocytes 
(white blood cells) and numerous soluble factors play important roles in the immune response. 
The innate immune responses are mediated by neutrophils, macrophages, natural killer (NK) 
cells and soluble factors such as complement and lysozyme, whereas an acquired system is 
composed of lymphocytes, macrophages and soluble components such as immunoglobulins 
(Sordillo and Streicher, 2002). 
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Immune system alterations during periparturient period. 
Diseases may occur when the immune system is not able to respond competently to the 
type of pathogens. In dairy cows, the peripartum is a time of significant stress on immune 
responses (Goff and Horst, 1997),  so much so, her immune system is suppressed to a point 
where there is an increase in incidences of infection (Carlson et al., 2006). Rapid migration of 
the neutrophil (also known as polymorphonuclear (PMN)) to the site of infection is one of the 
key factors in the control and eradication of an infection (Burton and Erskine, 2003, Heyneman 
et al., 1990). During an infection, PMN migrate from blood to tissue in response to 
chemoattractants secreted from either macrophages or epithelial cells within the tissue (Goldsby 
et al., 2000). During diapedesis (migration from blood into the tissue), chemoattractants 
stimulate endothelial cells to express specific molecules (i.e., E-selectin and P-selectin) that 
allow the PMN to adhere to the endothelial cell surface.   
The number of neutrophil increases during parturition (Gilbert et al., 1993, Saad and 
Astrom, 1988), however their functional capacity would be impaired. The adhesion of neutrophil 
to endothelium cease its rolling, whereas, around calving the down regulation and shedding of 
CD62L molecules from neutrophils have been observed; consequently not as many cells are able 
to migrate into nearby tissues(Lee and Kehrli, 1998, Paape et al., 2002). Additionally, the ability 
for neutrophils to phagocytize and kill is compromised during parturition (Mehrzad et al., 2001, 
Saad and Astrom, 1988). 
The proportion and functional activities (cloning expansion and antibody) of blood 
lymphocytes decreases as parturition approach and nadir during the days of parturition (Detilleux 
et al., 1995, Ishikawa et al., 1994, Kimura et al., 1999). In addition, the functions of certain 
subpopulations change; around parturition the blood CD4+ T-cells preferentially produces IL-4 
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and IL-10 while during mid to late lactation, they shift to produce IFN-γ and IL-2 (ShaferWeaver 
et al., 1996). On the other hand, CD8+ suppressor cells predominate, which may also contribute 
to  different sets of cytokines such as IL-10 and transforming growth factor beta (TGF-β) with 
suppressive activity on the immune response (Janeway, 2005). The changes in leukocytes and 
cytokine production around calving make the animal more susceptible to infection due to 
suppression of the cellular immunity activity. Despite the changes detected in the different T-
cells subsets, the percentage of B-lymphocytes seems to remain fairly constant as parturition 
approaches (ShaferWeaver et al., 1996). In contrast, a higher proportion of blood B-cells has 
been reported before and at calving than after parturition (Van Kampen and Mallard, 1997). A 
diminished antibody production with regards to the functional activity of B-cells during 
parturition has been observed (Detilleux et al., 1995, Nagahata et al., 1992). 
Uterine infections in dairy cows 
Uterine infections indicateuterine contamination with a pathogen, which negatively 
affects the reproductive efficiency of dairy cows, increases culling and economic losses due to 
reduced milk production and cost of treatment (Gunduz et al., 2010, Sheldon et al., 2009, 
Sheldon, 2004). Uterine infections and the associated inflammatory and immune responses 
compromise animal welfare, causing sub-fertility and infertility (Sheldon, 2004, Williams et al., 
2008). Majority of these infections are being with bacterial contamination of the uterine lumen 
after parturition, which remains sterile during pregnancy while almost contaminated with a wide 
range of bacteria after parturition (Sheldon et al., 2009, Sheldon, 2004).  Although, many cows 
get rid of these pathogens within first five weeks after parturition, in 10-17% of cows, the 
persistence causes uterine disease depending on the cows’ immune response and species and 
load of bacteria (Sheldon et al., 2006). These infections have been reported to reduce dairy cow 
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fertility (McDougall, 2001), with vaginal discharge associated with reduced submission (61% 
versus 80%), conception (34% versus 53%) and pregnancy rates (76% versus 91%; (Parkinson et 
al., 2007). In dairy cows, uterine diseases are classified in five categories according to clinical 
and degree of severity: puerperal metritis, clinical metritis, clinical endometritis, sub clinical 
endometritis and Pyometra (Gunduz et al., 2010, Sheldon et al., 2008,Thurmond et al., 1993). 
Metritis. Metritis involves the inflammation of the entire thickness of the uterine wall 
such as edema, infiltration by leukocytes, and myometrium degeneration (Gunduz et al., 2010, 
Sheldon et al., 2006). Whereas, endometritis involves superficial inflammation of the 
endometrium, extending no deeper than the stratum spongiosum (Sheldon et al., 2006). 
However, both conditions show mucosal congestion and prominent leukocytes infiltration in 
response to the common pathogen A. pyogenes, FusobacteriumNecrophorum, Prevotella species 
and E. coli (Sheldon et al., 2006).  Metritis occurs within 3 weeks and is most common with 10 
days of parturition; It is characterized by an enlarged uterus and a watery red-brown fluid to 
viscous off-white purulent uterine discharge, which often has a fetid odor (Sheldon et al., 2009). 
The disease is further categorized based on signs and animal health.  
Puerperal metritis. Puerperal metritis is an acute systemic illness caused by a bacterial 
infection in the uterus and usually occurs within 10 days after parturition. The condition is  
characterized by the presence of an abnormally enlarged uterus, a fetid red-brown watery uterine 
discharge associated systemic illness and, usually, pyrexia (Sheldon et al., 2009, Sheldon et al., 
2008); Reduced milk yield, dullness, inappetance or anorexia, elevated heart rate, and apparent 
dehydration have also been observed in severe cases (Sheldon et al., 2006).  
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Clinical metritis. Without systemic signs but with abnormally enlarged uterus and a fetid 
uterine discharge within 21 days postpartum, the animal may be classified as having clinical 
metritis (Sheldon et al., 2006, Welchman et al., 2012).  Incidence of clinical metritis ranges from 
25-40% in the first week after calving, and up 20% animal persists to clinical endometritis 
(Sheldon et al., 2008). Clinical metritis has the same negative effect on fertility as puerperal 
metritis (Benzaquen et al., 2007).   
Endometritis. In dairy cows endometritis has been defined as endometrial 
inflammation occurring 21 Days in milk (DIM) or, more after calving without systemic signs of 
illness (Sheldon et al., 2006). Histologically, it is the disruption of the epithelium with presence 
of inflammatory cells (Bondurant, 1999). Postpartum endometritis reduces the reproductive 
productivity of animals by extending the interval between calving to the conception, affecting  
the number of inseminations per conception, and increasing culling rates (Gautam et al., 2010). 
In 43 studies, the incidence of endometritis ranged from 2.2% to 37.3%, with a median of 10.1% 
(Kelton et al., 1998). 
Clinical endometritis. The signs associated with clinical endometritis include the 
detectable presence of purulent (>50% pus) in the vagina after 21 or more days post calving, or 
presence of mucopurulent (approximately 50% pus, 50% mucus) discharge in the vagina after 26 
days and is not accompanied by systemic illness (Sheldon et al., 2006, Sheldon et al., 2008). The 
presence of mucopurulent, or worse (purulent or foul) vaginal discharge during the postpartum 
period, was also found to be detrimental to subsequent reproductive performance (McDougall et 
al., 2007, Runciman et al., 2009).  
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Subclinical endometritis. Subclinical endometritis refers to cows showing no clinical 
signs of endometritis but having an increased percentage PMN in endometrial cytology that is 
associated with reduced reproductive performance (Kasimanickam et al., 2004). A cow with 
subclinical endometritis is defined by >18% neutrophils in uterine cytology samples collected 
21–33 days after calving, or >10% neutrophils at 34–47 days. The condition is prevalent in dairy 
cows and has a severe negative impact on reproductive performance (Hammon et al., 2006). In 
comparison with healthy cows, subclinical endometritis reduces conception rates and increases 
reproductive failure (Gilbert et al., 2005, Kasimanickam et al., 2004).  
Decreased DMI prior to parturition has been well documented, and is associated with the 
mobilization of NEFA released from adipose tissue (Grummer et al., 2004). Peripheral blood 
neutrophil (PMN) function begins to decline preceding parturition and aborts after calving and 
rivets back prepartum levels by about 4 weeks postpartum (Kehrli et al., 1989). Elevated NEFA 
and decrease DMI in cows with peripartum significantly impairs neutrophil function, which is 
associated with periparturient immune function suppression and uterine health disorders 
(Hammon et al., 2006, Rukkwamsuk et al., 1999b). Furthermore, elevated levels of BHBA and 
other ketones have been shown to affect the functions of immune cells and predispose the cows 
to  postpartal systemic infections(Hammon et al., 2006). 
Body condition score (BCS) 
In dairy management, assessment of the body fat content of a cow via use of BCS is an 
excellent indicator of the nutritional status. (Roche et al., 2009). BCS is a subjective 
measurement of the energy status of the animals, and an inferred risk to animal welfare. Several 
factors such as genetic selection, parity, age with parity, season of calving, level of feeding, and 
diet type have been reported to affect cows BCS (Roche et al., 2009, Roche et al., 2007b). The 
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scale used to measure BCS differs from country to country, but respectively low values reflect 
emaciation and high values quantify obesity (Roche et al., 2009). 
During lactation, mammals convert the body’s stored energy, namely lipids, to milk; 
some species like whales and polar bears, exclusively rely on body reserves for producing milk, 
while the dairy cows rely on a combination of available feed  and body reserves to meet the 
demands of lactogenesis (Bewley, 2008). In most mammals, characteristic changes in lipid 
metabolism occur during pregnancy and lactation; endocrine profile changes and lipolysis and 
lipogenesis are regulated to increase lipid reserves. Changes in BCS during calving and lactation 
influence animal health and reproduction.  
Body condition and peripartum period. The transition period is crucial for the health and 
performance of dairy cows, which are exposed to large-scale physiological changes and severe 
metabolic stress (Drackley, 1999, Grummer, 1995). Calving BCS is probably the most influential 
time point in the cow’s lactation calendar, as it affects early lactation DMI, post-calving BCS 
loss, milk yield, cow immunity and, although it does not directly affect pregnancy rate, it does 
influence reproduction through its effect on nadir BCS and BCS loss. BCS at breeding and the 
loss of BCS between parturition and breeding have recently gained notoriety because of their 
negative impact on reproductive performance (Beam and Butler, 1999, Roche et al., 
2007a,Roche et al., 2009). 
The ideal calving BCS ranges between 3.0 and 3.25 (5-point; equivalent to 5.0 to 5.25 on 
an 8-point scale and 5.0 to 5.5 on a 10-point scale), whereas, cows that calve thinner than this 
produce less milk, are less likely to get pregnant, and are more likely to present themselves in an 
animal welfare-risk category. In contrast, cows that calve in a greater BCS will have a reduced 
DMI, will produce less milk, and are more likely to succumb to periparturient metabolic 
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disorders. Correlations between BCS and the incidence of metabolic diseases have been 
extensively reported (Bewley, 2008). Generally, the rate of metabolic diseases increases with 
milk production (Oetzel, 2004); there were considerably more incidents of periparturient disease 
experienced in fat cows than thin in cows (Bewley, 2008). 
Calving and early lactation BCS are associated with a higher incidence of several 
metabolic disorders, most importantly ketosis (Duffield, 2000, Gillund et al., 2001) and milk 
fever (Roche and Berry, 2006), but also displaced abomasum (Bewley, 2008) and, probably, 
fatty liver (Drackley, 1999). Among the earlier research, the most consistent relationship has 
been the high incidence of ketosis for cows with high BCS at calving (Duffield, 2000, Ferguson, 
2002). Similarly, Gillund et al. (2001) reported a high risk of ketosis in cows with a calving BCS 
of >3.5 as compared with those with a calving BCS of 3.25. The continued efforts for increasing 
milk yields in dairy herds will predispose to ketosis (Duffield, 2000). Roche and Berry (2006) 
described a nonlinear relation concerning BCS and the incidence of milk fever. The odds of a 
cow succumbing to milk fever was 13 and 30% greater at a calving BCS less than 2.5 and greater 
than 3.5, respectively, in comparison to a calving BCS of 3.0. 
Body condition and feed intake. Significant energy loss in the body happens during early 
lactation when food consumption levels do not satisfy the needs of the cow to sustain 
lactogenesis (Beever, 2006). During early lactation, the energy consumption is the primary issue 
in causing energy loss in the body (Villa-Godoy et al., 1988).However, some report that 
augmented milk yield is a more distinct cause of higher body condition loss(Beever, 2006). 
Beam and Butler (1999) demonstrated howa growing follicle is affected by a decrease in the 
pulse frequency of luteinizing hormone caused by a severe negative energy balance (Beam and 
Butler, 1999). Buckley et al. (2003), based on data obtained with pasture-fed cows, resolved that 
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‘reproductive performance, particularly the probability of conception, may be negatively 
associated with the magnitude and duration of negative energy balance in early lactation’. Based 
on this evidence (Buckley et al., 2003), Mee (2004) recommended improved cow reproductive 
performance through improvement in feeding systems to reduce negative energy balance and 
maintain body condition (Mee, 2004). 
The research largely shows that DMI deceases as BCS increases at calving (Broster and 
Broster, 1998). Usually DMI is larger in cows with less condition. Increased levels of body fat 
cause a decrease in DMI in a negative feedback impact (Bewley, 2008). The decline in DMI for 
cows that have a larger BCS starts during the close-up period (Hayirli et al., 2002).  
Body condition and uterine infection. Uterine infections have been associated with both pre-
calving and early lactation BCS loss (Butler and Smith, 1989, Kim and Suh, 2003, Markusfeld et 
al., 1997). A greater risk of metritis has been observed in thin cows (Heuer et al., 1999, 
Hoedemaker et al., 2009), and high incidence was observed in cows that lost 0.5-1.0 BCS (22%) 
unit or >1.0 BCS units (47%) in comparison to cows that lost<0.5 BCS unit (6%) during calving 
(Butler and Smith, 1989).  
Kim and Suh (2003) witnessed a considerably higher occurrence of metritis in cows that 
lost ≥1 units of BCS between dry-off and near calving than in cows that lost <1 units of BCS 
during the dry period. It was shown in a German study that cows with BCS at calving <3.0 were 
more likely to have metritis than cows with a higher BCS at calving (Hoedemaker et al., 2009). 
Recently, a study conducted in New Zealand identified increased numbers of polymorphonuclear 
cells (PMNCs) in uterine samples (28 and 42 DIM) from young cows with low postpartum BCS 
(Roche et al., 2009). The timing of the BCS state and BCS change (precalving or very early 
postcalving) indicates that low BCS scores or BCS loss are risk factors for uterine infections, 
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whereas, periparturient metabolic disorders appear to be associated with elevated periparturient 
BCS, probably a result of reduced DMI post-calving because of over conditioning (Roche et al., 
2009). 
Gene expression and bioinformatics  
The latest generation of microarray based technology offers a high resolution and 
accurate screenshot (Zahurak et al., 2007) and has become an appealing choice for the scientific 
community to screen the expression of thousands genes at the same time (Naidooa et al., 2005). 
In particular, they allow the global assessment of gene expression. It is therefore possible to 
asses not only the expression status of a particular gene, but also the expression pattern of that 
gene relative to others, which clearly represents an useful approach for understanding polygenic 
regulation of complex processes.  
There are a variety of microarray platforms that have been developed: spotted 
microarrays, such as cDNA microarrays and oligonucleotide arrays, and the Affymetrix 
GeneChip® system, which involves synthesis of oligonucleotides directly onto the microarray 
support (Glonek and Solomon, 2004). Basically, a glass slide or membrane is spotted or arrayed 
with DNA fragments or oligonucleotides that represent specific coding regions of genes. These 
oligonucleotides are made to encode specific regions of the genes in the genome of a species. 
Microarrays can be constructed by using the information from genome sequencing or EST 
(expressed sequence tag) projects that provide large sets of annotated clones and sequences 
(Rimm et al., 2001). These oligonucleotides are attached to glass chip through covalent bonds 
via surface engineering. A cDNA is prepared from RNA isolated form samples, radio-labeled, 
and hybridized to the oligonucleotides on chip. Signal intensity data for each spot on a 
microarray is obtained by laser scanning or autoradiographic imaging. At this point, the data may 
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then be entered into a database and analyzed. Recently, Agilent corporation used two-sample 
hybridization array with long (60-mer) oligonucleotides, and gained wide spread acceptance as a 
result. These arrays are also hybridized with two different fluorescent samples and measurements 
of differential expression obtained from the relative abundance of hybridized mRNA.  
The University of Illinois has developed 13,257-oligonucleotide bovine microarray, 
which essentially represents an expansion of the 7,000 cDNA micro array platforms developed 
originally (Everts et al., 2005). Details of the development of the micro array platform used can 
be found in the Supplementary Materials and Methods from Loor et al. (2007). Briefly, an 
embryonic bovine cDNA library and 38,732 high-quality expressed sequence tag (EST) 
sequences based on the cattle 7,872 cDNA array (Everts et al., 2005) were filtered for repeats as 
well as sequences of viral, bacterial, or mitochondrial origin using Repeat Marker. Subsequently, 
seventy-base long (i.e., 70-mers) oligos from the unique cluster and singlet sequences were 
designed. Sequence alignments of designed oligos were done by BLASTN similarity searches 
against human RefSeq, mouse RefSeq, bovine RefSeq, human UniGene, mouse UniGene, bovine 
UniGene, bovine TIGR and the bovine genome using an E-value cut-off of E ≤ e-5 and scoring 
threshold of 40 bp (Everts et al., 2005). Best hits were used to annotate the cattle sequences. 
NCBI UniGene and Gene databases were used for functional annotation (e.g., gene symbol, gene 
name, function, OMIM number, and PubMed identification numbers) and Gene Ontology (GO) 
annotation (Everts et al., 2005). This microarray contains ca. 97% unique elements.   
Recently, Agilent, in cooperation with Rosetta, has combined some of the best features of 
cDNA microarrays and Affymetrix GeneChip® system and gained wide spread acceptance. 
Their array involves two-sample hybridization with the use of long (60-mer) oligonucleotides, 
 
 
22 
 
and with two different fluorescent dyes, and measurements of differential expression obtained 
from the relative abundance of hybridized mRNA (Zahurak et al., 2007). 
Our laboratory has explored the large-scale genomic data for bovine liver (Loor et al., 
2005, Loor et al., 2006,Loor et al., 2007). The microarray data from these studies has been used 
to explain the differences in gene expression observed in experimental and control groups in 
above studies. The gene expression data along with blood metabolite, growth and performance 
data to study tissue function under different physiological conditions is a promising approach to 
study unexplored mechanisms in calves (Drackley et al., 2006). In this thesis proposal, the use of 
the current microarray technology has been applied to study the alterations in hepatic expression 
profile in response to uterine infection and body condition score in transition dairy cows. The 
microarray data with qPCR verification of more important genes along with BCS data has helped 
uncover the hepatic adaptation at the mRNA level, and can help us in determining new targets 
and nutritional adaptation factors to treat cows with uterine infection. 
Data mining. The primary goal of the microarray studies is to determine deferentially 
expressed genes (DEGs), which distinguished biological conditions like disease from healthy. In 
addition, scientific research demands for reproducibility, whereas some of the most prestigious 
journals criticized and showed concerns about the microarray credibility and hence reliability 
(Frantz, 2005, Ioannidis, 2005, Marshall, 2004).  To address this lack of reproducibility some 
explanations have been offered. Recently, Shi et al (2008) demonstrated that previously reported 
discordance between DEG lists could simply result from ranking and selecting DEGs solely by 
statistical significance (P) derived from widely used simple t-tests. They examined six different 
genes raking method and found that DEG lists become much more reproducible with using fold 
change (FC) as the ranking criterion with a non-stringent P-value cutoff filtering. Based on their 
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observation they recommended that P-value cutoff should not be stringent (too small) and FC 
should be as large as possible (Shi et al., 2008). Similarly, a couple years before this study, Guo 
et al (2006), also reported more reproducibility and increase consistency in gene ontology terms 
and pathways, with gene list generated by fold change raking with non-stringent cutoff (Guo et 
al., 2006).  
Bioinformatics tools. Bioinformatics analysis plays an important part in processing the 
information generated in large-scale expression profiling studies and for laying the foundation 
for biological interpretation. Over the past years, numerous bioinformatics tools have emerged 
for microarray data analysis (Zhang et al., 2009).  In this project we have used Dynamic Impact 
Approach (DIA), Kyoto Encyclopedia of Genes and Genomes (KEGG) or Database for 
Annotation, Visualization, and Integrated Discovery (DAVID) v6.7. Dynamic Impact Approach 
(DIA), is a novel method for functional enrichment analysis introduced by our lab (Bionaz et al., 
2012). The rationale of this approach lies on the fact that in a cell change in transcription is non-
random. The DIA was implemented using MS Excel and its formulae functions using the FDR, P 
value and fold change associated with biological terms obtained from different databases.  The 
DIA reveals information about most affected gene ontology terms by the experimental conditions 
given in the database. The impact shows the proportion of DEGs in a pathway while flux shows 
the direction of the expression.  
The KEGG database was initiated in 1995 under the Human Genome Project of Ministry 
of Education Science Support and Culture in Japan. There are three main databases given in 
KEGG: pathways, genes, and ligand. The KEGG database provides information about main 
functions associated with the network of molecules. KEGG GENES have all the information 
about all the genes of genomes that have completely or partially sequenced (Kanehisa and Goto, 
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2000). DAVID is a web based functional annotation tool, for large gene list or dataset. The first 
version of DAVID was publicly available in 2003 that was continually approved and more tools 
became available in version 6 (Huang da et al., 2007). Several questions associated with large list 
of genes can be answered. For instance, what genes and gene families are in a given gene list or 
what annotation terms or groups are enriched for any given gene list (Huang da et al., 2007). 
REFERENCES 
 
Agenas, S., E. Burstedt, and K. Holtenius. 2003. Effects of feeding intensity during the dry 
period. 1. Feed intake, body weight, and milk production. J Dairy Sci 86(3):870-882. 
Amaral, e. a. B. C., C.R. Staples, S.C. Kim, L. Badinga and W.W. Thatcher. . 2006. Effect of 
diets enriched in oleic (cis or trans), linoleic, or linolenic acids on concentrations of blood 
and liver fatty acids of Holstein cows. J. Dairy Sci. 84:E100-E112. 
Badman, M. K., P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier. 2007. 
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of 
hepatic lipid metabolism in ketotic states. Cell Metab 5(6):426-437. 
Ballou, M. A., R. C. Gomes, S. O. Juchem, and E. J. DePeters. 2009. Effects of dietary 
supplemental fish oil during the peripartum period on blood metabolites and hepatic fatty 
acid compositions and total triacylglycerol concentrations of multiparous Holstein cows. 
J Dairy Sci 92(2):657-669. 
Beam, S. W. and W. R. Butler. 1999. Effects of energy balance on follicular development and 
first ovulation in postpartum dairy cows. J Reprod Fertil Suppl 54:411-424. 
Beever, D. E. 2006. The impact of controlled nutrition during the dry period on dairy cow health, 
fertility and performance. Anim Reprod Sci 96(3-4):212-226. 
 
 
25 
 
Bell, A. W. 1979. Lipid metabolism in liver and selected tissues and in the whole body of 
ruminant animals. Prog Lipid Res 18(3):117-164. 
Bell, A. W. 1995. Regulation of organic nutrient metabolism during transition from late 
pregnancy to early lactation. J Anim Sci 73(9):2804-2819. 
Bell, A. W. and D. E. Bauman. 1997. Adaptations of glucose metabolism during pregnancy and 
lactation. J Mammary Gland Biol Neoplasia 2(3):265-278. 
Benzaquen, M. E., C. A. Risco, L. F. Archbald, P. Melendez, M. J. Thatcher, and W. W. 
Thatcher. 2007. Rectal temperature, calving-related factors, and the incidence of 
puerperal metritis in postpartum dairy cows. J Dairy Sci 90(6):2804-2814. 
Bewley, J. M. a. S. 2008. R eview: An Interdisciplinary Review of Body Condition Scoring for 
Dairy Cattle. The Professional Animal Scientist 24 507–529. 
Bionaz, M., K. Periasamy, S. L. Rodriguez-Zas, W. L. Hurley, and J. J. Loor. 2012. A novel 
dynamic impact approach (DIA) for functional analysis of time-course omics studies: 
validation using the bovine mammary transcriptome. PLoS One 7(3):e32455. 
Bobe, G., J. W. Young, and D. C. Beitz. 2004. Invited review: Pathology, etiology, prevention, 
and treatment of fatty liver in dairy cows. J Dairy Sci 87(10):3105-3124. 
Broster, W. H. and V. J. Broster. 1998. Body score of dairy cows. J Dairy Res 65(1):155-173. 
Buckley, F., K. O'Sullivan, J. F. Mee, R. D. Evans, and P. Dillon. 2003. Relationships among 
milk yield, body condition, cow weight, and reproduction in spring-calved Holstein-
Friesians. J Dairy Sci 86(7):2308-2319. 
Burns, P. D., T. E. Engle, M. A. Harris, R. M. Enns, and J. C. Whittier. 2003. Effect of fish meal 
supplementation on plasma and endometrial fatty acid composition in nonlactating beef 
cows. J Anim Sci 81(11):2840-2846. 
 
 
26 
 
Burton, J. L. and R. J. Erskine. 2003. Immunity and mastitis - Some new ideas for an old disease. 
Vet Clin N Am-Food A 19(1):1-+. 
Butler, W. R. and R. D. Smith. 1989. Interrelationships between energy balance and postpartum 
reproductive function in dairy cattle. J Dairy Sci 72(3):767-783. 
Bykov, I., H. Jarvelainen, and K. Lindros. 2003. L-carnitine alleviates alcohol-induced liver 
damage in rats: Role of tumour necrosis factor-alpha. Alcohol Alcoholism 38(5):400-406. 
Calder, P. C. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. 
Am J Clin Nutr 83(6):1505s-1519s. 
Carlson, D. B., N. B. Litherland, H. M. Dann, J. C. Woodworth, and J. K. Drackley. 2006. 
Metabolic effects of abomasal L-carnitine infusion and feed restriction in lactating 
Holstein cows. J Dairy Sci 89(12):4819-4834. 
Dann, H. M. and J. K. Drackley. 2005. Carnitine palmitoyltransferase I in liver of periparturient 
dairy cows: effects of prepartum intake, postpartum induction of ketosis, and 
periparturient disorders. J Dairy Sci 88(11):3851-3859. 
Detilleux, J. C., M. E. Kehrli, Jr., J. R. Stabel, A. E. Freeman, and D. H. Kelley. 1995. Study of 
immunological dysfunction in periparturient Holstein cattle selected for high and average 
milk production. Vet Immunol Immunopathol 44(3-4):251-267. 
Domouzoglou, E. M. and E. Maratos-Flier. 2011. Fibroblast growth factor 21 is a metabolic 
regulator that plays a role in the adaptation to ketosis. Am J Clin Nutr 93(4):901S-905. 
Douglas, G. N., T. R. Overton, H. G. Bateman, 2nd, H. M. Dann, and J. K. Drackley. 2006. 
Prepartal plane of nutrition, regardless of dietary energy source, affects periparturient 
metabolism and dry matter intake in Holstein cows. J Dairy Sci 89(6):2141-2157. 
 
 
27 
 
Douglas, G. N., J. Rehage, A. D. Beaulieu, A. O. Bahaa, and J. K. Drackley. 2007. Prepartum 
nutrition alters fatty acid composition in plasma, adipose tissue, and liver lipids of 
periparturient dairy cows. J Dairy Sci 90(6):2941-2959. 
Drackley, J. K. 1999. ADSA Foundation Scholar Award. Biology of dairy cows during the 
transition period: the final frontier? J Dairy Sci 82(11):2259-2273. 
Drackley, J. K., A. D. Beaulieu, and J. P. Elliott. 2001. Responses of milk fat composition to 
dietary fat or nonstructural carbohydrates in Holstein and Jersey cows. J Dairy Sci 
84(5):1231-1237. 
Drackley, J. K., D. C. Beitz, and J. W. Young. 1991. Regulation of Invitro Metabolism of 
Palmitate by Carnitine and Propionate in Liver from Dairy-Cows. J Dairy Sci 
74(9):3014-3024. 
Drackley, J. K., S. S. Donkin, and C. K. Reynolds. 2006. Major advances in fundamental dairy 
cattle nutrition. J Dairy Sci 89(4):1324-1336. 
Drackley, J. K., et al. . 2001. Adaptations of glucose and long-chain fatty acid metabolism in 
liver of dairy cows during the periparturient period. J. Dairy Sci. 84:E100-E112. 
Drackley, J. K., H. M.; Douglas, G. N.; Guretzky, N. A. J.; Litherland, N. B.; Underwood, and J. 
J. Loor. 2005. Physiological and pathological adaptations in dairy cows that may increase 
susceptibility to periparturient diseases and disorders. Italian Journal of Animal Science 
4:323-344. 
Duffield, T. 2000. Subclinical ketosis in lactating dairy cattle. Vet Clin N Am-Food A 16(2):231-
251. 
 
 
28 
 
Everts, R. E., M. R. Band, Z. L. Liu, C. G. Kumar, L. Liu, J. J. Loor, R. Oliveira, and H. A. 
Lewin. 2005. A 7872 cDNA microarray and its use in bovine functional genomics. Vet 
Immunol Immunopathol 105(3-4):235-245. 
Feingold, K. R., C. Grunfeld, J. G. Heuer, A. Gupta, M. Cramer, T. Zhang, J. K. Shigenaga, S. 
M. Patzek, Z. W. Chan, A. Moser, H. Bina, and A. Kharitonenkov. 2012. FGF21 Is 
Increased by Inflammatory Stimuli and Protects Leptin-Deficient ob/ob Mice from the 
Toxicity of Sepsis. Endocrinology. 
Frantz, S. 2005. An array of problems. Nat Rev Drug Discov 4(5):362-363. 
Gautam, G., T. Nakao, K. Koike, S. T. Long, M. Yusuf, R. M. Ranasinghe, and A. Hayashi. 
2010. Spontaneous recovery or persistence of postpartum endometritis and risk factors 
for its persistence in Holstein cows. Theriogenology 73(2):168-179. 
Gilbert, R. O., Y. T. Grohn, P. M. Miller, and D. J. Hoffman. 1993. Effect of Parity on 
Periparturient Neutrophil Function in Dairy-Cows. Vet Immunol Immunop 36(1):75-82. 
Gilbert, R. O., S. T. Shin, C. L. Guard, H. N. Erb, and M. Frajblat. 2005. Prevalence of 
endometritis and its effects on reproductive performance of dairy cows. Theriogenology 
64(9):1879-1888. 
Gillund, P., O. Reksen, Y. T. Grohn, and K. Karlberg. 2001. Body condition related to ketosis 
and reproductive performance in Norwegian dairy cows. J Dairy Sci 84(6):1390-1396. 
Glonek, G. F. and P. J. Solomon. 2004. Factorial and time course designs for cDNA microarray 
experiments. Biostatistics 5(1):89-111. 
Goff, J. P. and R. L. Horst. 1997. Physiological changes at parturition and their relationship to 
metabolic disorders. J Dairy Sci 80(7):1260-1268. 
 
 
29 
 
Grummer, R. R. 1995. Impact of changes in organic nutrient metabolism on feeding the 
transition dairy cow. J Anim Sci 73(9):2820-2833. 
Grummer, R. R., D. G. Mashek, and A. Hayirli. 2004. Dry matter intake and energy balance in 
the transition period. Vet Clin N Am-Food A 20(3):447-+. 
Gunduz, M. C., A. Sabuncu, M. Ucmak, G. Kasikci, and C. Tek. 2010. Postpartum Reproductive 
Problems and Therapy in Dairy Cows. J Anim Vet Adv 9(14):1952-1954. 
Guo, L., E. K. Lobenhofer, C. Wang, R. Shippy, S. C. Harris, L. Zhang, N. Mei, T. Chen, D. 
Herman, F. M. Goodsaid, P. Hurban, K. L. Phillips, J. Xu, X. Deng, Y. A. Sun, W. Tong, 
Y. P. Dragan, and L. Shi. 2006. Rat toxicogenomic study reveals analytical consistency 
across microarray platforms. Nat Biotechnol 24(9):1162-1169. 
Hammon, D. S., I. M. Evjen, T. R. Dhiman, J. P. Goff, and J. L. Walters. 2006. Neutrophil 
function and energy status in Holstein cows with uterine health disorders. Vet Immunol 
Immunopathol 113(1-2):21-29. 
Hayirli, A., R. R. Grummer, E. V. Nordheim, and P. M. Crump. 2002. Animal and dietary 
factors affecting feed intake during the prefresh transition period in Holsteins. J Dairy Sci 
85(12):3430-3443. 
Herdt, T. H. 1988. Fatty liver in dairy cows. Vet Clin North Am Food Anim Pract 4(2):269-287. 
Heuer, C., Y. H. Schukken, and P. Dobbelaar. 1999. Postpartum body condition score and results 
from the first test day milk as predictors of disease, fertility, yield, and culling in 
commercial dairy herds. J Dairy Sci 82(2):295-304. 
Heyneman, R., C. Burvenich, and R. Vercauteren. 1990. Interaction between the Respiratory 
Burst Activity of Neutrophil Leukocytes and Experimentally Induced Escherichia-Coli 
Mastitis in Cows. J Dairy Sci 73(4):985-994. 
 
 
30 
 
Hoedemaker, M., L. A. Lund, and W. C. Wagner. 1992. Influence of arachidonic acid 
metabolites and steroids on function of bovine polymorphonuclear neutrophils. Am J Vet 
Res 53(9):1534-1539. 
Hoedemaker, M., D. Prange, and Y. Gundelach. 2009. Body condition change ante- and 
postpartum, health and reproductive performance in German Holstein cows. Reprod 
Domest Anim 44(2):167-173. 
Hornef, M. W., M. J. Wick, M. Rhen, and S. Normark. 2002. Bacterial strategies for overcoming 
host innate and adaptive immune responses. Nat Immunol 3(11):1033-1040. 
Huang da, W., B. T. Sherman, Q. Tan, J. Kir, D. Liu, D. Bryant, Y. Guo, R. Stephens, M. W. 
Baseler, H. C. Lane, and R. A. Lempicki. 2007. DAVID Bioinformatics Resources: 
expanded annotation database and novel algorithms to better extract biology from large 
gene lists. Nucleic Acids Res 35(Web Server issue):W169-175. 
Hussain, A. M. and R. C. Daniel. 1992. Effects of intrauterine infusion of Escherichia coli 
endotoxin in normal cows and in cows with endometritis induced by experimental 
infection with Streptococcus agalactiae. Theriogenology 37(4):791-810. 
Inagaki, T., P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. 
Mohammadi, V. Esser, J. K. Elmquist, R. D. Gerard, S. C. Burgess, R. E. Hammer, D. J. 
Mangelsdorf, and S. A. Kliewer. 2007. Endocrine regulation of the fasting response by 
PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5(6):415-425. 
Ingvartsen, K. L. and J. B. Andersen. 2000. Integration of metabolism and intake regulation: a 
review focusing on periparturient animals. J Dairy Sci 83(7):1573-1597. 
Ioannidis, J. P. 2005. Microarrays and molecular research: noise discovery? Lancet 
365(9458):454-455. 
 
 
31 
 
Ishikawa, H., T. Shirahata, and K. Hasegawa. 1994. Interferon-Gamma Production of Mitogen-
Stimulated Peripheral Lymphocytes in Perinatal Cows. J Vet Med Sci 56(4):735-738. 
Itoh, N. 2010. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in 
development, metabolism, and disease. Cell Tissue Res 342::1-11. 
Janeway, C. 2005. Immunobiology : the immune system in health and disease. 6th ed. Garland 
Science, New York. 
Janovick, N. A. and J. K. Drackley. 2010. Prepartum dietary management of energy intake 
affects postpartum intake and lactation performance by primiparous and multiparous 
Holstein cows. J Dairy Sci 93(7):3086-3102. 
Jesse, B. W., R. S. Emery, and J. W. Thomas. 1986. Control of Bovine Hepatic Fatty-Acid 
Oxidation. J Dairy Sci 69(9):2290-2297. 
Ji, H., T. M. Bradley, and G. C. Tremblay. 1996. Atlantic salmon (Salmo salar) fed L-carnitine 
exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth 
rate. J Nutr 126(8):1937-1950. 
Jump, D. B. 2002. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr 
Opin Lipidol 13(2):155-164. 
Jungermann, K. and N. Katz. 1989. Functional Specialization of Different Hepatocyte 
Populations. Physiol Rev 69(3):708-764. 
Kanehisa, M. and S. Goto. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic 
Acids Res 28(1):27-30. 
Kasimanickam, R., T. F. Duffield, R. A. Foster, C. J. Gartley, K. E. Leslie, J. S. Walton, and W. 
H. Johnson. 2004. Endometrial cytology and ultrasonography for the detection of 
subclinical endometritis in postpartum dairy cows. Theriogenology 62(1-2):9-23. 
 
 
32 
 
Kehrli, M. E., Jr., B. J. Nonnecke, and J. A. Roth. 1989. Alterations in bovine neutrophil 
function during the periparturient period. Am J Vet Res 50(2):207-214. 
Kelton, D. F., K. D. Lissemore, and R. E. Martin. 1998. Recommendations for recording and 
calculating the incidence of selected clinical diseases of dairy cattle. J Dairy Sci 
81(9):2502-2509. 
Kharitonenkov, A. and P. Larsen. 2011. FGF21 reloaded: challenges of a rapidly growing field. 
Trends Endocrin Met 22(3):81-86. 
Kim, I. H. and G. H. Suh. 2003. Effect of the amount of body condition loss from the dry to near 
calving periods on the subsequent body condition change, occurrence of postpartum 
diseases, metabolic parameters and reproductive performance in Holstein dairy cows. 
Theriogenology 60(8):1445-1456. 
Kimura, K., J. P. Goff, M. E. Kehrli, and J. A. Harp. 1999. Phenotype analysis of peripheral 
blood mononuclear cells in periparturient dairy cows. J Dairy Sci 82(2):315-319. 
Kliewer, S. A. and D. J. Mangelsdorf. 2010. Fibroblast growth factor 21: from pharmacology to 
physiology. Am J Clin Nutr 91(1):254S-257S. 
Knapp, J. R., H. C. Freetly, B. L. Reis, C. C. Calvert, and R. L. Baldwin. 1992. Effects of 
Somatotropin and Substrates on Patterns of Liver-Metabolism in Lactating Dairy-Cattle. 
J Dairy Sci 75(4):1025-1035. 
LeBlanc, S. J., T. Osawa, and J. Dubuc. 2011. Reproductive tract defense and disease in 
postpartum dairy cows. Theriogenology 76(9):1610-1618. 
Lee, E. K. and M. E. Kehrli. 1998. Expression of adhesion molecules on neutrophils of 
periparturient cows and neonatal calves. Am J Vet Res 59(1):37-43. 
 
 
33 
 
Lessard, M., N. Gagnon, and H. V. Petit. 2003. Immune response of postpartum dairy cows fed 
flaxseed. J Dairy Sci 86(8):2647-2657. 
Lomax, M. A., I. A. Donaldson, and C. I. Pogson. 1983. The Control of Fatty-Acid Metabolism 
in Liver-Cells from Fed and Starved Sheep. Biochem J 214(2):553-560. 
Loor, J. J., H. M. Dann, R. E. Everts, R. Oliveira, C. A. Green, N. A. Guretzky, S. L. Rodriguez-
Zas, H. A. Lewin, and J. K. Drackley. 2005. Temporal gene expression profiling of liver 
from periparturient dairy cows reveals complex adaptive mechanisms in hepatic function. 
Physiol Genomics 23(2):217-226. 
Loor, J. J., H. M. Dann, N. A. Guretzky, R. E. Everts, R. Oliveira, C. A. Green, N. B. Litherland, 
S. L. Rodriguez-Zas, H. A. Lewin, and J. K. Drackley. 2006. Plane of nutrition prepartum 
alters hepatic gene expression and function in dairy cows as assessed by longitudinal 
transcript and metabolic profiling. Physiol Genomics 27(1):29-41. 
Loor, J. J., R. E. Everts, M. Bionaz, H. M. Dann, D. E. Morin, R. Oliveira, S. L. Rodriguez-Zas, 
J. K. Drackley, and H. A. Lewin. 2007. Nutrition-induced ketosis alters metabolic and 
signaling gene networks in liver of periparturient dairy cows. Physiol Genomics 
32(1):105-116. 
Markusfeld, O., N. Galon, and E. Ezra. 1997. Body condition score, health, yield and fertility in 
diary cows. Vet Rec 141(3):67-72. 
Marshall, E. 2004. Getting the noise out of gene arrays. Science 306(5696):630-631. 
Mateus, L., L. Lopes da Costa, P. Diniz, and A. J. Ziecik. 2003. Relationship between endotoxin 
and prostaglandin (PGE2 and PGFM) concentrations and ovarian function in dairy cows 
with puerperal endometritis. Anim Reprod Sci 76(3-4):143-154. 
 
 
34 
 
Mattos, R., C. R. Staples, A. Arteche, M. C. Wiltbank, F. J. Diaz, T. C. Jenkins, and W. W. 
Thatcher. 2004. The effects of feeding fish oil on uterine secretion of PGF2alpha, milk 
composition, and metabolic status of periparturient Holstein cows. J Dairy Sci 87(4):921-
932. 
McDougall, S., R. Macaulay, and C. Compton. 2007. Association between endometritis 
diagnosis using a novel intravaginal device and reproductive performance in dairy cattle. 
Anim Reprod Sci 99(1-2):9-23. 
Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the 
Drosophila Toll protein signals activation of adaptive immunity. Nature 388(6640):394-
397. 
Mee, J. F. 2004. Temporal trends in reproductive performance in Irish dairy herds and associated 
risk factors. Ir Vet J 57(3):158-166. 
Mehrzad, J., H. Dosogne, E. Meyer, R. Heyneman, and C. Burvenich. 2001. Respiratory burst 
activity of blood and milk neutrophils in dairy cows during different stages of lactation. J 
Dairy Res 68(3):399-415. 
Miles, E. A. and P. C. Calder. 1998. Modulation of immune function by dietary fatty acids. P 
Nutr Soc 57(2):277-292. 
Mulligan, F. J. and M. L. Doherty. 2008. Production diseases of the transition cow. Vet J 
176(1):3-9. 
Murata, Y., M. Konishi, and N. Itoh. 2011. FGF21 as an Endocrine Regulator in Lipid 
Metabolism: From Molecular Evolution to Physiology and Pathophysiology. J Nutr 
Metab 2011:981315. 
 
 
35 
 
Nagahata, H., A. Ogawa, Y. Sanada, H. Noda, and S. Yamamoto. 1992. Peripartum Changes in 
Antibody-Producing Capability of Lymphocytes from Dairy-Cows. Vet Quart 14(1):39-
40. 
Naidooa et al., D. a. D. K. B. 2005. Microarray experiments: considerations for experimental 
design. South African Journal of Science (101). 
Oetzel, G. R. 2004. Monitoring and testing dairy herds for metabolic disease. Vet Clin North Am 
Food Anim Pract 20(3):651-674. 
Owen, K. Q., H. Ji, C. V. Maxwell, J. L. Nelssen, R. D. Goodband, M. D. Tokach, G. C. 
Tremblay, and S. I. Koo. 2001. Dietary L-carnitine suppresses mitochondrial branched-
chain keto acid dehydrogenase activity and enhances protein accretion and carcass 
characteristics of swine. J Anim Sci 79(12):3104-3112. 
Paape, M., J. Mehrzad, X. Zhao, J. Detilleux, and C. Burvenich. 2002. Defense of the bovine 
mammary gland by polymorphonuclear neutrophil leukocytes. J Mammary Gland Biol 
7(2):109-121. 
Parkinson, T. J., J. J. Vermunt, and J. Malmo. 2007. Uterine infections: Causes, Management 
and Sequelae. Pages 139-153 in Proc. Society of Dairy Cattle Veterinarians of the New 
Zealand Veterinary Association, Palmerston North. 
Randel, R. D. 1990. Nutrition and Postpartum Rebreeding in Cattle. J Anim Sci 68(3):853-862. 
Rimm, D. L., R. L. Camp, L. A. Charette, J. Costa, D. A. Olsen, and M. Reiss. 2001. Tissue 
microarray: a new technology for amplification of tissue resources. Cancer J 7(1):24-31. 
Roche, J. R. and D. P. Berry. 2006. Periparturient climatic, animal, and management factors 
influencing the incidence of milk Fever in grazing systems. J Dairy Sci 89(7):2775-2783. 
 
 
36 
 
Roche, J. R., D. P. Berry, J. M. Lee, K. A. Macdonald, and R. C. Boston. 2007a. Describing the 
body condition score change between successive calvings: A novel strategy generalizable 
to diverse cohorts. J Dairy Sci 90(9):4378-4396. 
Roche, J. R., N. C. Friggens, J. K. Kay, M. W. Fisher, K. J. Stafford, and D. P. Berry. 2009. 
Invited review: Body condition score and its association with dairy cow productivity, 
health, and welfare. J Dairy Sci 92(12):5769-5801. 
Roche, J. R., K. A. Macdonald, C. R. Burke, J. M. Lee, and D. P. Berry. 2007b. Associations 
among body condition score, body weight, and reproductive performance in seasonal-
calving dairy cattle. J Dairy Sci 90(1):376-391. 
Rukkwamsuk, T., T. A. M. Kruip, G. A. L. Meijer, and T. Wensing. 1999a. Hepatic fatty acid 
composition in periparturient dairy cows with fatty liver induced by intake of a high 
energy diet in the dry period. J Dairy Sci 82(2):280-287. 
Rukkwamsuk, T., T. A. M. Kruip, and T. Wensing. 1999b. Relationship between overfeeding 
and overconditioning in the dry period and the problems of high producing dairy cows 
during the postparturient period. Vet Quart 21(3):71-77. 
Runciman, D. J., G. A. Anderson, and J. Malmo. 2009. Comparison of two methods of detecting 
purulent vaginal discharge in postpartum dairy cows and effect of intrauterine cephapirin 
on reproductive performance. Aust Vet J 87(9):369-378. 
Saad, A. M. and G. Astrom. 1988. Effects of Exogenous Estrogen Administration to 
Ovariectomized Cows on the Blood and Milk-Leukocyte Counts and Milk-Neutrophil 
Phagocytosis Measured by Flow-Cytometry. J Vet Med B 35(9):654-663. 
Sanchez, A. J. and J. Aranda-Michel. 2006. Nutrition for the liver transplant patient. Liver 
Transpl 12(9):1310-1316. 
 
 
37 
 
Schoenberg, K. M., S. L. Giesy, K. J. Harvatine, M. R. Waldron, C. Cheng, A. Kharitonenkov, 
and Y. R. Boisclair. 2011. Plasma FGF21 Is Elevated by the Intense Lipid Mobilization 
of Lactation. Endocrinology 152(12):4652-4661. 
ShaferWeaver, K. A., G. M. Pighetti, and L. M. Sordillo. 1996. Diminished mammary gland 
lymphocyte functions parallel shifts in trafficking patterns during the postpartum period. 
P Soc Exp Biol Med 212(3):271-279. 
Sheldon, I. M., J. Cronin, L. Goetze, G. Donofrio, and H. J. Schuberth. 2009. Defining 
Postpartum Uterine Disease and the Mechanisms of Infection and Immunity in the 
Female Reproductive Tract in Cattle. Biol Reprod 81(6):1025-1032. 
Sheldon, I. M., G. S. Lewis, S. LeBlanc, and R. O. Gilbert. 2006. Defining postpartum uterine 
disease in cattle. Theriogenology 65(8):1516-1530. 
Sheldon, I. M., D. E. Noakes, A. N. Rycroft, D. U. Pfeiffer, and H. Dobson. 2002. Influence of 
uterine bacterial contamination after parturition on ovarian dominant follicle selection 
and follicle growth and function in cattle. Reproduction 123(6):837-845. 
Sheldon, I. M., E. J. Williams, A. N. A. Miller, D. M. Nash, and S. Herath. 2008. Uterine 
diseases in cattle after parturition. Vet J 176(1):115-121. 
Sheldon, M. 2004. The postpartum uterus. Vet Clin N Am-Food A 20(3):569-+. 
Shi, L., W. D. Jones, R. V. Jensen, S. C. Harris, R. G. Perkins, F. M. Goodsaid, L. Guo, L. J. 
Croner, C. Boysen, H. Fang, F. Qian, S. Amur, W. Bao, C. C. Barbacioru, V. Bertholet, 
X. M. Cao, T. M. Chu, P. J. Collins, X. H. Fan, F. W. Frueh, J. C. Fuscoe, X. Guo, J. 
Han, D. Herman, H. Hong, E. S. Kawasaki, Q. Z. Li, Y. Luo, Y. Ma, N. Mei, R. L. 
Peterson, R. K. Puri, R. Shippy, Z. Su, Y. A. Sun, H. Sun, B. Thorn, Y. Turpaz, C. Wang, 
S. J. Wang, J. A. Warrington, J. C. Willey, J. Wu, Q. Xie, L. Zhang, S. Zhong, R. D. 
 
 
38 
 
Wolfinger, and W. Tong. 2008. The balance of reproducibility, sensitivity, and specificity 
of lists of differentially expressed genes in microarray studies. Bmc Bioinformatics 9 
Suppl 9:S10. 
Singh, J., S. S. Sidhu, G. S. Dhaliwal, G. R. Pangaonkar, A. S. Nanda, and A. S. Grewal. 2000. 
Effectiveness of lipopolysaccharide as an intrauterine immunomodulator in curing 
bacterial endometritis in repeat breeding cross-bred cows. Anim Reprod Sci 59(3-4):159-
166. 
Smith, T. R., A. R. Hippen, D. C. Beitz, and J. W. Young. 1997. Metabolic characteristics of 
induced ketosis in normal and obese dairy cows. J Dairy Sci 80(8):1569-1581. 
Sordillo, L. M. and K. L. Streicher. 2002. Mammary gland immunity and mastitis susceptibility. 
J Mammary Gland Biol Neoplasia 7(2):135-146. 
Spaniol, M., P. Kaufmann, K. Beier, J. Wuthrich, M. Torok, H. Scharnagl, W. Marz, and S. 
Krahenbuhl. 2003. Mechanisms of liver steatosis in rats with systemic carnitine 
deficiency due to treatment with trimethylhydraziniumpropionate. J Lipid Res 44(1):144-
153. 
Spear, B. T., L. Jin, S. Ramasamy, and A. Dobierzewska. 2006. Transcriptional control in the 
mammalian liver: liver development, perinatal repression, and zonal gene regulation. Cell 
Mol Life Sci 63(24):2922-2938. 
Stabel, J. R., J. P. Goff, and K. Kimura. 2003. Effects of supplemental energy on metabolic and 
immune measurements in periparturient dairy cows with Johne's disease. J Dairy Sci 
86(11):3527-3535. 
 
 
39 
 
Thurmond, M. C., C. M. Jameson, and J. P. Picanso. 1993. Effect of Intrauterine Antimicrobial 
Treatment in Reducing Calving-to-Conception Interval in Cows with Endometritis. J Am 
Vet Med Assoc 203(11):1576-1578. 
Van Kampen, C. and B. A. Mallard. 1997. Effects of peripartum stress and health on circulating 
bovine lymphocyte subsets. Vet Immunol Immunop 59(1-2):79-91. 
VanSaun, R. J. and C. J. Sniffen. 1996. Nutritional management of the pregnant dairy cow to 
optimize health, lactation and reproductive performance. Anim Feed Sci Tech 59(1-
3):13-26. 
Vernon, R. G., R. G. Denis, A. Sorensen, and G. Williams. 2002. Leptin and the adaptations of 
lactation in rodents and ruminants. Horm Metab Res 34(11-12):678-685. 
Villa-Godoy, A., T. L. Hughes, R. S. Emery, L. T. Chapin, and R. L. Fogwell. 1988. Association 
between energy balance and luteal function in lactating dairy cows. J Dairy Sci 
71(4):1063-1072. 
Welchman, D. D., A. M. Verkuijl, W. J. Pepper, G. Ibata, S. A. King, H. M. Davidson, I. C. 
Mawhinney, and M. Banks. 2012. Association of gammaherpesviruses and bacteria with 
clinical metritis in a dairy herd. Vet Rec 170(8):207b-U262. 
Williams, E. J., D. P. Fischer, D. U. Pfeiffer, G. C. England, D. E. Noakes, H. Dobson, and I. M. 
Sheldon. 2005. Clinical evaluation of postpartum vaginal mucus reflects uterine bacterial 
infection and the immune response in cattle. Theriogenology 63(1):102-117. 
Williams, E. J., S. Herath, G. C. England, H. Dobson, C. E. Bryant, and I. M. Sheldon. 2008. 
Effect of Escherichia coli infection of the bovine uterus from the whole animal to the cell. 
Animal 2(8):1153-1157. 
 
 
40 
 
Williamson, P., S. Munyua, R. Martin, and W. J. Penhale. 1987. Dynamics of the acute uterine 
response to infection, endotoxin infusion and physical manipulation of the reproductive 
tract in the mare. J Reprod Fertil Suppl 35:317-325. 
Yaqoob, P. 2003. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol 
24(12):639-645. 
Zahurak, M., G. Parmigiani, W. Yu, R. B. Scharpf, D. Berman, E. Schaeffer, S. Shabbeer, and L. 
Cope. 2007. Pre-processing Agilent microarray data. Bmc Bioinformatics 8. 
Zammit, V. A. 1984. Mechanisms of regulation of the partition of fatty acids between oxidation 
and esterification in the liver. Prog Lipid Res 23(1):39-67. 
Zhang, Y., J. Szustakowski, and M. Schinke. 2009. Bioinformatics analysis of microarray data. 
Methods Mol Biol 573:259-284. 
  
 
 
41 
 
CHAPTER 2: Hepatic adaptation of hepatic FGF21 under the effect of nutrition, ketosis and 
inflammation in peripartal Holstein dairy cows 
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ABSTRACT 
In rodents, fibroblast growth factors 21 (FGF21) has emerged as a metabolic regulator 
produced by liver in response to different physiological conditions that regulate glucose and lipid 
metabolism. Its up-regulation induces glucose uptake in adipose tissue and skeletal muscle; 
whereas in liver it increases hepatic fatty acid oxidation, reduces triacylglycerol accumulation, 
and stimulates ketogenesis. The regulatory mechanism and action of FGF21 in ruminants remain 
unclear. We sought to investigate the regulatory mechanism of hepatic FGF21 in dairy cows 
under different nutritional conditions including early postpartal ketosis (KET), peripartal dietary 
L-carnitine supplementation, and prepartal level of dietary energy. We also examined hepatic 
FGF21 in response to intramammary lipopolysaccharide (LPS) challenge at 7 days postpartum.  
In KET, liver biopsies were obtained at d 14 postpartum from control (n = 7) and feed-restricted 
induced ketotic (n = 7) cows. In carnitine supplemented study, the liver biopsies were harvested 
at d 2 and d 10 postpartum in cows assigned to control (n = 5), 100 g CAR/d (C100, n = 5), and 
200 g CAR/d (C200, n = 4). In the LPS study, cows (n = 6/treatment) were fed during the dry 
period either moderate-energy (OVE) or control energy (CON) and received 0 (OVE:N, CON:N) 
or 200 Î¼g LPS (OVE:Y, CON:Y) at 7 d postpartum. Liver biopsies were harvested at d 7 and d 
14 postpartum. The hepatic mRNA expression and serum concentration of FGF21, and mRNA 
level of other genes associated fatty acid oxidation (CPT1A, PPARA), the hepatokine ANGPTL4, 
the circadian rhythm (ARNTL, CLOCK, NFIL3) and insulin signaling (AKT1) were measured. 
Ketosis induced the expression of FGF21 (P< 0.05) and KLB (P < 0.05); whereas, numerical 
increase (P > 0.05) was observed with serum concentration of FGF21. There was an interaction 
effect (P < 0.05) of carnitine for FGF21 expression due primarily to lower expression at d 10 
with C100 and C200 vs. control. The opposite effect was observed for ANGPTL4 expression (a 
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hepatokine) at d 2 which was greater with C100 and C200 vs. control. Subsequently, a marked 
decrease by d 10 was observed with C200 at which point ANGPTL4 was lower than C100 and 
controls. The significant interaction (P < 0.05) for PPARA expression was due to a marked 
increase at d 10 with C100. A similar response to C100 was observed for CPT1A and KLB 
expression. In the LPS study, expression of FGF21 was induced (P < 0.05) with both at d7 and 
14 in OVE:N compared with CON:N and LPS further increased its expression but response was 
more marked with OVE:Y at 14. The serum FGF21 was higher in OVE:Y while lower in 
CON:Y compared with OVE:N and CON:N, receptively. Prepartal OVE led to greater (P = 0.06) 
overall ANGPTL4 postpartum. Overall, results indicate that in dairy cows, Ketosis could up-
regulate the expression of FGF21 likely via incoming non-esterified fatty acids and potentially 
via PPARα whereas, the increased KLB further supports the hepatic paracrine role of FGF21 in 
dairy cows under feed restriction. The down regulation of FGF21 at d10 in C200 could be 
associated with feedback inhibition of FGF21 with high carnitine level. Inflammatory challenge 
regulates FGF21 expression but the down regulation of hepatic KLB may suggest adipose as the 
target tissue. This study will be helpful in developing further understanding about the role of 
FGF21 in dairy cows. 
Keywords: FGF21, ketosis, LPS, dairy cows  
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INTRODUCTION 
In mammals, the liver is the most import metabolic organ, and has a pivotal role in 
mediating physiological adaptations under different nutritional and disease conditions. It has a 
central role in whole-body metabolism by regulating lipid, glucose homeostasis as well as 
protein synthesis (Sanchez and Aranda-Michel, 2006, Spear et al., 2006). The periparturient 
period is generally accompanied by negative energy balance (NEB) that leads to glucogenolysis. 
However, when energy deprivation progresses, the glycogen stores are quickly depleted, and β-
oxidation of fatty acids derived from lipolysis increases (Drackley, 1999, Schlegel et al., 2012). 
Furthermore, the elevated level of NEFA and hydroxybutyrate (BHBA) due to extensive 
mobilization of fat stored in adipose tissues contributes to immune suppression and predisposes 
the animal to many metabolic disorders and infectious diseases (Bertoni et al., 2009, Burvenich 
et al., 2003, Dann et al., 2006). Altering the degree of adipose tissue lipolysis and hepatic 
capacity for fatty acid oxidation are both of considerable interest for the prevention and 
alleviation of fatty liver  (Bobe et al., 2004, Reddy and Rao, 2006). 
Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator of the FGF family 
that is produced by the liver and in rodents has an important role in the regulation of glucose and 
lipid metabolism (Inagaki et al., 2007, Potthoff et al., 2009). The induction of expression of 
hepatic FGF21 stimulates glucose uptake in adipocytes and skeletal muscle, thus, improving 
insulin sensitivity and reducing serum triacylglycerol (TAG) levels (Kharitonenkov et al., 2005, 
Mashili et al., 2011). In response to fasting and during consumption of a ketogenic diet in 
rodents, FGF21 also has an important role in the regulation of hepatic oxidation of fatty acids 
and gluconeogenesis (Domouzoglou and Maratos-Flier, 2011). The importance of FGF21 has 
been partly demonstarted by the observation of higher rates of lypolysis with fasting and greater 
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deposition of liver TAG in FGF21-null mice fed a ketogenic diet (Badman et al., 2009, Hotta et 
al., 2009). Schoenberg and colleagues (2011) working with periparturient cows found that the 
onset of NEB after calving was associated with increased plasma FGF21 concentration, and with 
greater mRNA expression in liver (Schoenberg et al., 2011).  
Carnitine has an important role in various metabolic functions including mitochondrial 
long-chain fatty acid oxidation, and has been shown to dramatically decrease or prevent liver 
lipid accumulation in laboratory animals (Bykov et al., 2003, Spaniol et al., 2003). Recently, 
Schlegel et al (2012) working with periparturient cows observed a positive correlation between 
FGF21 expression and genes involved in carnitine synthesis (Schlegel et al., 2012). Moreover, in 
rodents the onset of infection, inflammation, trauma, and malignancy induce the acute phase 
response (APR), which leads to decreased hepatic oxidation of fatty acids and ketogenesis 
(Gabay and Kushner, 1999, Kim et al., 2007). Feingold et al., (2012) proposed that FGF21 is a 
positive APR protein that could help protect animals from the toxic effects of LPS and sepsis 
(Feingold et al., 2012). 
The above data led us to hypothesize that FGF21 has a central role in the adaptations to 
NEB, ketosis, carnitine supplementation, and inflammatory challenge. Thus, the aim of the 
present study was to develop a better understanding about the role of hepatic FGF21 in early 
postpartal dairy cows. To achieve that aim we used liver and serum samples from previous 
experiments dealing with early postpartal ketosis (Loor et al., 2007), peripartal dietary L-
carnitine supplementation (Carlson et al., 2007), and prepartal level of dietary energy and 
postpartal intra-mammary LPS challenge (Graugnard et al., 2013). The data generated were used 
to develop a hypothetical model of FGF21 action in liver and adipose tissue. 
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MATERIALS AND METHODS 
Experimental design and treatments  
The present study was performed using samples from three different experiments, i.e. 
early postpartum ketosis (Loor et al., 2007), peripartal dietary L-carnitine supplementation 
(Carlson et al. 2007), and prepartal dietary energy level and postpartal inflammatory challenge 
(Graugnard et al., 2013). 
Early postpartum ketosis cows 
The details of the animal management and sample collection were presented earlier (Loor 
et al 2007). Briefly, on d 5 postpartum Holstein cows were randomly assigned to control (n=7) or 
ketosis induction (n=7) groups based on a thorough physical examination on d 4 postpartum. 
Cows in the control group were fed ad libitum throughout the treatment period while cows in the 
ketosis-induction group were fed at 50% of d 4 intake until they developed signs of clinical 
ketosis. Liver biopsy for gene expression profiling was performed at 9-14 d postpartum (ketosis) 
or 14 d postpartum (Control). The serum samples for FGF21 analysis were from the same d of 
the biopsy. 
Dietary carnitine supplemented cows  
Detailed information of the animal management and sample collection was presented by 
Carlson et al. (2007). Briefly, Holstein cows were assigned to treatments at d −25 relative to 
expected calving date and remained on the experiment until 56 d in milk. Treatments were 4 
amounts of supplemental dietary carnitine: control (0 g/d of L-carnitine; n = 14); low carnitine (6 
g/d; n = 11); medium carnitine (C100, 50 g/d; n = 12); and high carnitine (C200, 100 g/d; n = 
12). Carnitine supplementation began on d −14 relative to expected calving and continued until 
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21 d in milk. Hepatic concentration of free carnitine was increased by C100 and C200 on d 2 and 
10 (treatment × time, P < 0.01); whereas, low carnitine did not increase free carnitine relative to 
the control. Furthermore, at d 2 and 10, comparatively higher total lipid and TAG concentrations 
were observed in liver from control cows compared with C100 and C200. Therefore, the liver 
tissue samples from d 2 and 10 from control (n=5), C100 (n = 4), and C200 (n = 4) were used for 
the present study. 
Prepartal high energy diet and postpartal intramammary lipopolysaccharide (LPS) challenge 
Detailed information of the animal management and sample collection was presented 
recently (Graugnard et al., 2013). Briefly, Holstein cows were assigned randomly (n = 20 per 
diet) to a control diet (controlled energy, high-fiber; 1.34 Mcal/kg diet DM), which was fed for 
ad libitum intake to provide approximately 100% of calculated NEL requirements (control group 
= CON), or were fed a diet to provide at least 150% of calculated NEL requirements (1.62 
Mcal/kg DM, overfed group =OVE moderate energy diet) during the entire 45-d dry period 
(NRC, 2001). After parturition, cows were moved to a tie-stall barn, fed a common lactation diet 
(NEL = 1.69 Mcal/kg DM), and milked twice daily (0400 and 1600 h).  
At ~7 DIM, each group (i.e. CON and OVE) were further divided into two additional 
groups (total of 4) based on whether they received an intramammary E. coli LPS challenge (200 
μg, strain 0111:B4, cat. # L2630, Sigma Aldrich, St. Louis, MO) or not, i.e. 0 (OVE:N,CON:N) 
or 200 μg LPS (OVE:Y, CON:Y) at 7 d postpartum.  Liver was sampled at ~0800 h on d -14, 7, 
14, and 30 relative to parturition. However, only liver and serum samples from d 7 and 14 were 
used for hepatic gene expression analysis and serum concentration of FGF21. 
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RNA extraction, primer designing and qPCR analysis 
The complete procedures of RNA extraction and qPCR analysis have been published 
previously (Akbar et al., 2013, Graugnard et al., 2013).  Briefly, approximately 0.2-0.3 g of liver 
tissue was homogenized in 1-2 mL ice-cold TRIzol reagent (Invitrogen, Carlsbad, CA, USA, 
Cat.No. 15596-026) and RNA extraction was performed as described previously (Loor et al., 
2005). RNA concentration was measured using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA), while the RNA quality was assessed using a 
2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, USA). The average RNA 
integrity number (RIN) value for adipose samples was 8  0.4. Total RNA was purified with the 
RNeasy Mini Kit and residual DNA removed using the RNase-Free DNase Set (Qiagen, 
Valencia, CA, USA). The extracted and clean RNA was re-suspended in RNase free water 
(Qiagen, Cat No. 74104) and stored at -80°C until microarray or qPCR analysis. 
Genes selected for transcript profiling in this study were associated with fatty acid 
oxidation (CPT1A, PPARA), FGF21 and other hepatokines (ANGPLT4, KLB). In addition, it has 
been recently determined that the BMAL1 (ARNTL)-CLOCK complex also activates the rodent 
Fgf21 promoter, whereas, another circadian gene E4bp4 (NFIL3) suppresses it. Furthermore the 
down regulation of FGF21 with insulin is mediated through NFIL3 (Tong et al., 2010). 
Therefore, the expression of genes associated with circadian rhythms (ARNTL, CLOCK, NFIL3) 
and insulin signaling (AKT1) were also investigated. The final data were normalized using the 
geometric mean (V2/3 = 0.20) of ubiquitously-expressed transcript (UXT), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), and ribosomal protein S9 (RPS9). Details of the primers 
and sequences are presented in Appendix–A Suppl. table A.1 and table A.2. Information of 
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qPCR efficiency and % relative RNA abundance can be found in Appendix–A Suppl. table A.3 
and A.4. 
Serum concentration of FGF21 
FGF21 is a secreted protein therefore ELISA was performed to investigate the serum 
concentration of FGF21 using a Mouse and Rat FGF-21 ELISA (BioVendor –dignotic 
Laboratorní , Brno,  Czech Republic, Cat.No.  RD291108200R) validated for bovine. The serum 
samples from the dietary carnitine study were not available. In the ketosis study the analysis was 
performed on samples collected on the day of ketosis diagnosis or 14 DIM (control). In the 
prepartal level of energy and postpartal intramammary LPS challenge study, the serum 
concentrations of FGF21 were investigated on day 7 and 14 relative to parturition. 
Statistical analysis 
The MIXED procedure of SAS (SAS Institute, Inc., Cary, NC, USA) was used for 
statistical analysis. The fixed effects included diet, time (days relative to parturition), and 
interaction diet  time. Data were normalized by logarithmic transformation prior to statistical 
analysis. All means were compared using the PDIFF statement of SAS (SAS Institute, Inc., Cary, 
NC, USA). Statistical significance was declared at P  0.05. 
RESULTS 
Hepatic gene expression by qPCR 
Early postpartal ketosis. The present study revealed greater FGF21 and KLB expression 
(T, P<0.05) in cows with ketosis; whereas, no significant change was observed for the expression 
of NFIL3, ARNTL, CLOCK and AKT1 (Table 2.1).  
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Dietary L-carnitine supplementation. The expression of FGF21 was affected by the 
interaction of diet (T) × day (D) (P<0.05); no main effect of diet or day was observed (Table 
2.2). The interaction of diet  day occurred because of the marked decrease in mRNA expression 
of FGF21 between d 2 and 10 in the C200 group. There also was an interaction effect (P < 0.01) 
for the expression of KLB, an essential component of the FGF21 signaling pathway in rodents, 
such that feeding C200 led to a marked decrease between d 2 and 10 (Table 2.2). 
Peroxisome proliferator-activated receptor α (PPARα) expression was affected by the 
interaction effect (P<0.01), a crucial transcription factor regulating expression of FGF21 under 
different nutritional condition. In the present study, carnitine showed tendency (T, P<0.07) to 
decrease PPARα, and the numerically lower expression was observed in C200 at d10 (Table 2.2). 
However, significant increase (T×D, P<0.05) was observed from d2 to d10 in C100 group.  
Interaction effect (T×D, P=0.05) was observed for CPT1A because of greater expression between 
d2 and d10 in C100. The expression of ANGPTL4 decreased from d2 to d10 with carnitine 
supplementation (T×D, P<0.05) and the lower expression was observed at d10 in C200, whereas, 
increase was observed in control between 2 and day 10 relative to parturition (Table 2.2). 
Our results revealed interaction effect (T×D, P<0.05) for all the three genes (NFIL3, 
ARNTL, CLOCK) under study, but, the diet effect (T, P<0.05) was only observed in NFIL3, 
whereas, CLOCK showed tendency with diet (T, P=0.06) and significant effect with days relative 
to parturition (D, P<0.05). The expression of NFIL3 increased between d2 and d10 in both 
control and C100 group, but, no change was observed in C200. The group supplemented with 
high carnitine (C200) showed significant decrease in ARNTL expression between d2 to d10 while 
numerical increase in CLOCK expression. However, C100 showed significant increase in the 
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expression of CLOCK at d10. No main effect of carnitine or interaction (T×D, P<0.05) was 
observed for a gene associated with insulin signaling (AKT1). 
Prepartal high energy diet and intramammary lipopolysaccharide (LPS) challenge. The third 
set of experiment was performed to investigate the expression of FGF21 and related gene in LPS 
challenged cows. Our results revealed interaction effect of diet (T) ×LPS (L) and day (D) 
(T×L×D, P<0.05) for FGF21, PPARA, NFIL3, and CLOCK, whereas, day and LPS interaction 
(L×D, P<0.05) was observed for ANGPTL, NFIL3, CLOCK, ARNTL, and AKT1 (Table 2.3). 
Except FGF21 (T×L, P=0.07), no other gene under the study showed interaction effect of diet 
and LPS, whereas, the diet and day interaction effect was only observed in AKT1 (T×D, P<0.05) 
(Table 2.3).  
The expression of FGF21 increased (P<0.05) with moderated diet (OVE:N) compared to 
control (CON:N), whereas LPS challenge showed tendency of further increase (L, P=0.07) 
(Table 2.3). The expression of FGF21 was high (T×L×D, P<0.05) at day 7 in OVE:Y and 
CON:Y compared with its control groups, whereas, decrease was observed at d14 and maximum 
decrease was observed in OVE:Y and CON:N (Table 2.3). However, PPARA showed high 
expression at d14 in CON:N and CON:Y groups, whereas no significant change was in the 
expression of CPT1A. The expression of AGPTL4 was high (D, P<0.05) at d7, and compared 
with control (CON:N) the mRNA value was high (T, P=0.06)  in moderate diet (OVE:N) group 
(Table 2.3). Furthermore, LPS increased the expression of ANGPTL4 in both OVE:Y and 
CON:Y and like controls (OVE:N and CON:N) mRNA expression was decreased towards d14 
(L×D, P<0.05) (Table 2.3). LPS significantly decreased (L, P<0.05) KLB expression, irrespective 
of prepartal energy state (Table 2.3).  
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The expression of gene associated with circadian rhythm was significantly affected (L, 
P<0.05) with LPS challenged; NFIL3 increased while decrease was observed in ARNTL and 
CLOCK expression. Furthermore, results revealed an increase (D×L, P<0.05) in NFIL3 
expression due to LPS challenge (OVE:Y, CON:Y) at d7, however,  decrease was observed at 
d14. The expression of ARNTL was higher in OVE:N at d7 but decrease was observed at d14 (D, 
P<0.05), whereas, LPS challenge decreased its expression in both groups, but CON:Y showed  
increase (D×L, P<0.05) between d7 and d14. Furthermore, the LPS treatment decreased (L, 
P<0.05) the expression of CLOCK irrespective of diet (T×L, P>0.05) and further decrease was 
observed in OVE:Y at d14 (D×L, P<0.05).  The expression of AKT1 increased at d14 in CON:N 
compared with other groups, however, a decrease was observed in LPS challenged groups (D×L, 
P>0.05) (Table 2.3). 
Serum concentration of FGF21  
In the absence of serum sample from dietary carnitine experiment (Carlson et al., 2007), 
we only measured the blood serum concentration of FGF21 from the ketosis (Loor et al., 2007) 
and prepartal high energy intake and LPS challenged study (Graugnard et al., 2013). The cows 
under clinical ketosis had numerical increase (P>0.05) in the serum concentration of FGF21 
(Figure 2.1). However, intramammary LPS challenge increased (L, P<0.05) the blood 
concentration of FGF21 in OVE:Y but decreased (L, P<0.05) in CON:Y. Furthermore, OVE:Y 
and CON:N groups showed a significant decrease (T×L, P<0.05) was in FGF21 concentration 
between d7 and 14, whereas, OVE:N and CON:Y showed a numerical decrease (Figure 2.2). 
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DISCUSSION 
Ketosis induced the expression of FGF21 
The ketotic cows under study for this expresment were under severe negative energy 
balance that lead to increases in NEFA, BHBA, and hepatic TG concentration (Loor et al., 2007). 
Furthermore, these cows had greater hepatic expression of PPARA, ANGPTL4 and genes 
associated with ketogenesis and gluconeogeneis (Loor et al., 2007). The 3-fold increase in 
FGF21mRNA expression and the numerical increase in its serum conceration in ketotic cows 
(Table 2.1 and Figure 2.1) support previous observations with transition cows (Schlegel et al., 
2012, Schoenberg et al., 2011). Overall, the response of dairy cows to negative energy balance 
and ketosis is similar to what is observed in feed-deprived rodents and humans (Domouzoglou 
and Maratos-Flier, 2011, Galman et al., 2008).  
The somatotropic axis controls many aspects of growth and lactation; calving and 
negative energy balance are associated with upcoupling of the somatotropic axis (Lucy, 2008). 
Calving increases blood concenration of growth hormone (GH), which further augments blood 
NEFA during negative energy balance (Adewuyi et al., 2005, Akers, 2006, Bradford and Allen, 
2008). It was recently observed in beef cattles that GH injection regulates the hepatic expression 
of FGF21 via STAT5 dependent manner by increasing STAT5 binding to it’s putative sites on 
FGF21 promotor (Yu et al., 2012). This inloves the binding of GH to its hapatic recepotors 
(GHR) that commence JAK2-STAT5 signaling to regulate target genes e.g. FGF21, IGF1 and 
SOCS2.   However, the downregulation of GHR, STAT5b, IGF1, and SOCS2 in cows under 
ketosis (Loor et al., 2007)  do not support the Yu et al (2012) model of FGF21 regulation in 
angus cattle, which can be explained by the fact that GHR declines during parturition but doesn’t 
change in beef cattle (Jiang et al., 2005).  
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In non-ruminants, it is well-established that PPAR regulates FGF21 during feed 
restriction (Uebanso et al., 2011). Another recent study with mice demonstrated that GH 
regulates hepatic expression of FGF21 via PPARα activation in response to the high NEFA level 
from GH stimulated lipolysis (Chen et al., 2011). The above discussion about GH level and the 
observed increase in NEFA and PPARA and its target genes ANGPTL4 (Loor et al., 2007) suport 
the speculation that an increase in lipolysis was necessary to upregulate FGF21 via PPARA 
during ketosis (Figure 2.3). The observation of  a parallel increase in PPARA and FGF21 during 
ketosis supports the proposal by Schlegel et al. (Schlegel et al., 2012) with early lactation cows.  
FGF21 is a secretory protein and the specificity of its action in peripheral tissues is 
determined to a large extent by the expression of β klotho (KLB) (Fisher et al., 2011). The fact 
that ketosis increased the hepatic expression of KLB, in a similar fashion as the onset of lactation 
(Schoenberg et al., 2011), suggests that  FGF21 may exert a paracrine/autocrine action on liver 
during ketosis (Figure 2.3). As such, FGF21 may lead to a decrease in the hepatic expression of 
IGF-1 by increasing the expression of IGFBP1(Fisher et al., 2011, Inagaki et al., 2008), which 
was observed previously (Loor et al., 2007).  
In mammals, the PPAR-mediated acitivation of FGF21 in liver appears to play a central 
role in the stimulation of genes involved in fatty acid oxidation and ketogenesis (Inagaki et al., 
2007).  The study of Badman (2007) and Inagaki et al. (2007) provided evidence that activation 
of PPARA induced FGF21, leading to an increase in the protein concentration of CPT1A and 
HMGCS2 in the liver via a posttranscriptional mechanism without affecting mRNA expression 
(Badman et al., 2007, Inagaki et al., 2007). The lack of change in the expression of CPT1A with 
ketosis (Loor et al., 2007) suggests the existence of a similar paracrine role for FGF21 on 
CPT1A (Figure 2.3).  
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Dietery carnitine downregulates the hepatic expression of FGF21 
The cows fed C100 and C200 had higher hepatic acyl, free and total carnitine 
concentrations on d2; whereas, on d10 the cows fed C200 had the peak concentrations (Carlson 
et al., 2007). Furthermore, on d 2 and 10 the control group had higher hepatic lipid and TAG 
concentration. Moreover, there was an increase in serum insulin concentration in the cows 
supplemented with carnitine regardless of the intake amount (Carlson et al., 2007). FGF21 
regulates the hepatic expression of key genes involved in lipid metabolism in response to high 
NEFA level (Badman et al., 2009, Hotta et al., 2009, Schoenberg et al., 2011) whereas, dietary 
carnitine has been reported to increase lipid oxidation (Bykov et al., 2003, Spaniol et al., 2003). 
The positive correlation in FGF21 expression and genes associated with carnitine synthesis and 
hepatic uptake in cow (Schlegel et al., 2012)  and also in sows during lactation in response to low 
blood and hepatic carnitine level than non-lactating sows (Rosenbaum et al., 2013); leads to 
speculate that FGF21regulates carnitine synthesis and hepatic uptake in response to high flux of 
NEFA that may lead to increased hepatic oxidation and transport to milk as a milk fat (Calson et 
al 2007). The decrease in Fgf21 expression with carnitine administration indicates that excess 
carnitine influx into liver actually might feedback-inhibit the transcriptional activation of FGF21 
(Figure 2.4) and more potently when C200 than C100, compared with control. Moreover, the 
lower expression of PPARA and circadian clock gene (ARNTL) (that has been reported to 
activate FGF21expression in hematoma cell line) (Tong et al., 2010), with C200 further supports 
our statement. Although speculative, the decrease in KLB on d10 in cows fed C200 would seem 
to argue against extra hepatic sources of FGF21 that may act on the liver in the carnitine 
supplemented cows. The protein encoded by KLB determines the target specificity of FGF21 and 
its hepatic expression increases during early lactation in dairy cows (Schoenberg et al., 2011).   
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Dietary carnitine decreased hepatic concentration of TAG and the maximum decrease 
was observed on d10 in cows fed C200; whereas, cows fed control increased hepatic TAG 
content after d10 (Carlson et al., 2007). The observed increase in the hepatic concentration of 
FGF21 on d10 in controls and the decrease in C200, along with the pattern of TAG concentration 
in liver, suggest a mechanistic link between FGF21 and hepatic TAG content. There is evidence 
in monogastrics that FGF21 decreases hepatic TAG concentration by inhibiting hepatic 
lipogenic gene expression (Seo and Kim, 2012, Xu et al., 2009). In dairy cows, however, the 
liver is not a lipogenic tissue, but many studies have observed a positive correlation between 
hepatic FGF21 expression and hepatic triacylglycerols (TAG) and  triglyceride (TG) 
concentration in dairy cows (Carriquiry et al., 2009, Schlegel et al., 2012, Schoenberg et al., 
2011). It is notable that none of the previously mentioned studies has examined the FGF21 
expression under dietary carnitine, which might be helpful to uncover the triglyceride-lowering 
role of FGF21 with increased carnitine metabolism in response to high NEFA to prevent fatty 
liver, supported by previous observation in both ruminants and non-ruminants (Rosenbaum et al., 
2013, Schlegel et al., 2012) . Moreover, hepatic TG accumulation in control, likely because of 
inadequate liver carnitine availability, and higher oxidation and lower esterification of palmitate 
for the liver slice from C200 at d 10 than C100 and  control (Carlson et al 2007) are in support to 
our FGF 21 mediated regulation carnitine metabolism in response to different metabolic 
condition. 
Prepartal energy and LPS challenge alter FGF21 expression 
The overfed cows used in this study were in positive energy balance and had greater BCS 
prepartum than controls, but were in more NEB early postpartum and before the LPS challenge 
(Graugnard et al., 2013).  Soon after the LPS challenge, however, there was an increase in 
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NEFA, a decrease in BHBA, and an increase in liver TAG only in the OVE:Y group (Graugnard 
et al., 2013). OVE:Y in the present study, the observed increase in FGF21 expression due to 
feeding OVE was associated with high NEFA level in these cows after parturition. However, the 
lack of significant effect on the expression of PPARA due to LPS or diet suggests the existence 
of another PPAR-independent mechanism for the observed increase in FGF21 during 
inflammation or feeding OVE. The lack of PPARA response to high NEFA in early lactation 
cows further supports our observation (Carriquiry et al., 2009, van Dorland et al., 2009).  Palin 
and Petit (2004) observed no change in the hepatic expression of PPARα in response more than 
100% of prepartum energy requirement and different sources of fat (Palin, 2004). Moreover, 
Carriquiry and colleagues (2009) speculated that the lack of increase in PPARA postpartum in 
response to diets provided with 8% more fat than typically fed to dairy cows and enriched with 
PUFA (n-6 and n-3: activators of PPARA (Clarke, 2004)) could be related with a hepatic 
inflammatory response induced by prepartal high energy intake. These all observations 
encourage to suggest a PPARA independent model for FGF21 regulation in dairy cows with 
high prepartal energy intake and inflammatory conditions. 
Recently, it was observed that a circadian protein E4BP4 (NIFL3) regulates the hepatic 
expression of FGF21 during a circadian cycle and upon food intake (Tong et al., 2010). This 
protein suppressed BMAL1 (ARNTL) -CLOCK activated FGF21 expression and also abolished 
PPARA activated FGF21 expression (Tong et al., 2010). This supports to speculate that LPS 
along with the interaction of effect of diet and days relative parturition induced the expression of 
NIFIL3 (T×D×L <0.01) that may lead to the observed down regulation of the hepatic PPARA 
(T×D×L <0.01), and ARNTL (L <0.01), CLOCK ((T×D×L <0.01), which have been identified as 
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ligand activators of FGF21 (Tong et al., 2010). These observations may further support the 
existence of another regulatory mechanism for FGF21 expression under inflammatory condition. 
The marked decrease in hepatic expression of STAT5B and SOCS2 in OVE:Y between d 
7 and 14 relative to parturition (Graugnard et al., 2013) suggests uncoupling of GH/IGF-1 axis 
(Lucy, 2008) and argues against the possibility of GH-mediated activation of FGF21 via 
JAK2/STAT5 signaling (Yu et al., 2012). It has been recognized recently in monogastrics that 
glucagon increases the hepatic expression of FGF21 either via PPAR mediated activation or 
directly via PKA (Berglund et al., 2010, Uebanso et al., 2011).  Glucagon is an important 
hormone secreted by the pancreas in response to low glucose level or other physiologic and 
metabolic stresses (Jones et al., 2012).  Calving increases the concentration of glucagon (Deboer 
et al., 1985) as part of the homeorhetic mechanism to coordinate lactation. The regulation of 
glucagon around calving (Deboer et al., 1985) and negative energy balance at d7 (Graugnard et 
al., 2013) may lead to the activation of PKA, further supported , by a very recent study that 
observed increase in both expression and secretion of FGF21 in response to  both native 
glucagon and glucagon receptors (GcgR) agonist in rodents and humans, and demonstrated that 
glucagon achieves its long-term effects on energy and lipid and glucose metabolism at least in 
part via FGF21-dependent pathways (Habegger et al., 2013). 
 We speculate the existence of a glucagon-mediated activation of FGF21 via PKA under 
the current scenario (Figure 2.5); in this way glucagon mediates its lipid metabolic function via 
FGF21;   however, further studies are required to demonstrate such role.   It has been previously 
reported that  both intravenous and intramuscular injection of glucagon can alleviate fatty liver in 
dairy cows, possibly by increasing the rate of NEFA re-esterification in the adipose tissues 
(Hippen et al., 1999, Nafikov et al., 2006). It is notable that none of these earlier work has 
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examined the FGF21 expression under glucagon injection; the long term effect of glucagon 
could be mediated through FGF21, supported by the earlier reported lipolysis inhibitory role of 
FGF21 (Li et al., 2009). Therefore, based on these discussions we suggest that glucagon induced 
hepatic expression of FGF21 in order to achieve its lipolysis inhibitory effect, glucose and 
energy metabolism functions  in the cows under study (Figure 2.5), supported by both  
biochemical and gene expression data (Graugnard et al., 2013). 
The increase in plasma concentration (Figure 2.2) of FGF21 with LPS challenge agrees 
with the greater mRNA expression in the liver, which is the main contributor of plasma FGF21 
in dairy cows (Schoenberg et al., 2011); however, induced expression of FGF21 with LPS 
suggests glucagon independent mechanism.  In bovine, another PPAR isotyp called PPARδ was 
suggested to regulate the expression of ANGPTL4 and other hepatokines during acute 
inflammation (Bionaz et al., 2013), as reported in non-ruminants (Staiger et al., 2009).  
Moreover, in the cows under study, the LPS challenged induced the hepatic expression of 
PPARδ (LPS p=0.05) and genes associated with inflammation and stress (Graugnard et al., 
2013). Furthermore, the parallel increase of ANGPLTL4 expression with LPS (L, P <0.01: Table 
2.3), which  has recently been reported as a positive acute phase protein in mice challenged with 
LPS (Lu et al., 2010), supports to speculate that LPS induced the hepatic expression of both  
hepatokin ANGPTL4 and FGF21 via PPARδ (Figure 2.5). 
 The increase in plasma FGF21 with LPS injection in mouse also supports our 
observations (Feingold et al., 2012); however, contradictory to our results, Feingold and 
colleagues demonstrated the adipose tissue as a major contributor of serum concentration of 
FGF21 in LPS response. Previous work from our group (Ji et al., 2012) failed to detect FGF21 
mRNA expression in subcutaneous adipose tissue and parturition casting doubt on the 
 
 
60 
 
contribution of this tissue to peripheral FGF21 concentration.  Furthermore, shecnonberge and 
colleagues observed little or no contribution from WAT, skeletal muscle, and mammary gland to 
the plasma FGF21 level as compared to liver (Schoenberg et al., 2011). However, as discussed in 
the previous sections, β-Klotho (FGF21 co-receptor) determines the target specificity of FGF21 
action; the down regulation of hepatic KLB with LPS (Table 2.3) suggests the extra hepatic role 
of FGF21 in under LPS challenge. Therefore, we speculate that LPS induced FGF21 targets 
adipose tissue to suppress lipolysis in order to prevent NEFA flow to liver and prevents fatty 
liver. The lack of FGF21 expression in subcutaneous adipose tissue and parturition (Ji et al., 
2012)  and the observation of Schoengberg et al (2011) support our results, that adipose tissue is 
not main contributor of FGF21 but, as reported, is the second major target tissue after liver in 
dairy cows: the meaningful expression of the KLB and its subset of interacting FGF receptors 
was restricted to liver and WAT in a survey of 15 tissues that included the mammary gland and 
modestly affected by the transition from LP to EL in liver but not in WAT (Schoenberg et al., 
2011).  
CONCLUSIONS 
In dairy cows, change in metabolic, inflammatory, and physiological conditions regulates 
hepatic expression of FGF21. Ketosis induced hepatic FGF21 expression and its serum 
concentration, which acts as paracrine/autocrine to increase ketogenesis and beta oxidation of 
NEFA, and down regulate the hepatic expression of IGF-1. High dietary L-carnitine 
supplementation down regulates the hepatic FGF21expression. Furthermore, prepartal high 
energy level and intra mammary LPS challenged induced FGF21 though PPARA independent 
mechanism. Moreover, inhibition of KLB with LPS suggests extra hepatic role of FGF21 in LPS 
challenged cows.  Like other mammals, FGF21 is regulated by different mechanism depending 
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on metabolic and physiological state of the animal. Further studies are required to delineate the 
precise mechanistic basis underlying central FGF21 mediated physiology. 
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TABLES AND FIGURES 
 
Table 2.1. Hepatic expression of FGF21 and genes associated with tissue specificity, circadian 
rhythm and insulin signaling in healthy and ketotic transition dairy cows.  
 
Genes Treatment Relative mRNA SEM P value 
FGF21 Healthy 1.70a 1.40 <0.01 
 Ketotic 7.06b   
KLB Healthy 2.99a 0.49 0.02 
 Ketotic 4.67b   
ARNTL Healthy 0.57 0.34 0.26 
 Ketotic 1.11   
CLOCK Healthy -1.42 0.34 0.20 
 Ketotic -0.80   
NFIL3 Ketotic -0.86 0.34 0.39 
 Healthy -0.44   
AKT1 Healthy -1.24 0.20 0.86 
 Ketotic -1.19   
 
ab indicate  significant difference (P≤ 0.05) due to main effect of health status.  
  
 
 
71 
 
Table 2.2. Hepatic expression of FGF21 and genes associated with regulation and tissue 
specificity, circadian rhythm and insulin signaling in control and dietary L-carnitine 
supplemented transition dairy cows.  
   
Gene Days Treatment  P value 
     Con1 C1002 C2003 SEM Diet (T) Day (D) T × D 
FGF21 2 -0.17 -1.65 -0.68a 0.83 0.21 0.85 0.03 
 10 0.42• -0.98•* -2.13b*   
PPARA 2 0.22  0.09a 0.15 0.16 0.08 0.68 0.02 
 10 0.30• 0.41 b • 0.06*     
KLB 2 0.11 -0.11 0.08a 0.2 <0.01 0.46 <0.01 
 10 0.09• 0.03• -0.53b*  
CPT1A 2 <0.01 -0.13a 0.09 0.17 0.81 0.39 0.05 
 10 0.18 0.15b -0.15     
ANGPTL4 2 -0.45a• 0.30• 0.33a* 0.23 0.23 <0.01 <0.01 
 10 0.07b• 0.01* -0.92b*     
ARNTL 2 -1.42 • -2.05 * -1.74a•* 0.39 0.37 0.41 <0.05 
 10 -1.61 • -1.59 • -2.56 b*     
CLOCK 2 -0.45• -3.55a* -0.11• 0.79 0.06 0.02 0.06 
 10 -0.40  -1.48 b 0.07      
NFIL3 2 -0.03a• 0.42a*$ 0.27$ 0.18 <0.01 0.14 0.03 
 10 0.43b•* 0.78b* 0.27 •     
AKT1 2 -3.06 -2.95 -2.63 0.19 0.33 0.49 0.26 
 10 -2.89 -2.81 -2.73     
abc Indicate  an interaction  effect (T×D×L,  P ≤0.05) in specific treatments between time points  
•*$ Indicate an interaction effect (T×D×L, P ≤0.05) at the specific time point between treatments. 
1Control  
2L-Carnitine infused 100mg/day 
3L-Carnitine infused 200mg/day 
 
 
72 
 
Table 2.3. Hepatic expression of FGF21 and genes involved in the regulation and target tissue specificity, circadian rhythm and 
insulin signaling in prepartum moderate energy without (OVE:N) / with (OVE:Y) LPS challenge , and control without (CON:N) /with 
(CON:Y) LPS challenge transition cows. 
Gene Day  Treatment    P value 
  OVE:N OVE:Y CON:N  CON: 
Y 
SEM Diet 
(T) 
Day 
(D) 
LPS 
(L) 
T×D T×L D×L T×D×L 
FGF21 7 -0.30  0.35a -2.02a -0.28 0.87 <0.01 0.04 0.07 0.11 0.07 0.56 <0.01 
 14 -0.20• -0.87b• -4.11 b* -0.60•         
PPARA 7 -0.37 a• -0.30• 0.18α * -0.21a•* 0.22 0.06 <0.01 0.42 0.43 0.68 0.82 <0.01 
 14 0.01b -0.02 0.33 0.27b         
CPT1A 7 0.14 0.08 -0.17 0.02 0.14 0.16 0.53 0.85 0.74 0.16 0.27 0.27 
 14 0.19 -0.04 -0.18 0.01         
ANGPTL4 7 0.35 1.13 -0.96  1.18 0.45 0.06 <0.01 0.21 0.66 0.16 <0.01 0.17 
 14 -0.06 -0.93 -1.13  -1.35         
KLB 7 0.18 -2.08  0.08 -2.73 0.97 0.82 0.32 <0.01 0.32 0.77 0.30 0.83 
 14 0.04 -2.69 0.23 -2.89         
ARNTL 7 0.45 -4.91 -0.08 -5.42  0.84 0.71 0.67 <0.01 0.19 0.73 <0.01 0.26 
 14 -0.27 -4.89 -0.73 -4.41          
CLOCK 7 -0.08• -2.86 *β 0.06 • -3.18 * 0.87 0.63 0.1 <0.01 0.2 0.75 0.02 0.01 
 14 -0.08 • -4.64 *β 0.03 • -3.16 *         
NFIL3 7 0.13* 2.01a• 0.31a* 2.23 a• 0.26 0.25 <0.01 0.38 0.10 0.26 <0.01 0.02 
 14 0.11 * -1.09b• 0.76b* -0.78b•$         
AKT1 7 0.42  -1.22  0.30  -1.37  0.23 0.77 0.07 <0.01 0.02 0.69 <0.01 0.44 
 14 0.34  -1.82  0.72  -1.72         
  
abc indicate  an interaction  effect (T×D×L,  P ≤0.05) in specific treatments between time points  
•*$  Indicate an interaction effect (T×D×L, P ≤0.05) at the specific time point between treatments. 
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Figure 2.2. Serum concentration of FGF21 in prepartum moderate energy without (OVE:N) / 
with (OVE:Y) LPS challenge , and control without (CON:N) /with (CON:Y) LPS challenge 
transition cows  (a-b Indicate  an interaction  effect (T×D×L,  P ≤0.05) in specific treatments 
between time points; *$ Indicate an interaction effect (T×D×L, P ≤0.05) at the specific time point 
between treatments). 
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CHAPTER 3: Dietary lipid during late-pregnancy and early-lactation to manipulate metabolic 
and inflammatory gene network expression in dairy cattle liver with a focus on PPARs  
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ABSTRACT 
Polyunsaturated (PUFA) than saturated long-chain fatty acids (LCFA) are more potent in 
eliciting molecular and tissue functional changes in monogastrics. From -21 through 10 days 
relative to parturition dairy cows were fed no supplemental LCFA (control), saturated LCFA 
(SFAT; mainly 16:0 and 18:0), or fish oil (FISH; high-PUFA). Twenty-seven genes were 
measured via quantitative RT-PCR in liver tissue on day -14 and 10. Expression of nuclear 
receptor co-activators (CARM1, MED1), LCFA metabolism (ACSL1, SCD, ACOX1), and 
inflammation (IL6, TBK1, IKBKE) genes was lower with SFAT than control on day -14. 
Expression of SCD, however, was markedly lower with FISH than control or SFAT on both -14 
and 10 days. FISH led to further decreases in expression on day 10 of LCFA metabolism (CD36, 
PLIN2, ACSL1, ACOX1), intracellular energy (UCP2, STK11, PRKAA1), de novo cholesterol 
synthesis (SREBF2), inflammation (IL6, TBK1, IKBKE), and nuclear receptor signaling genes 
(PPARD, MED1, NRIP1). No change in expression was observed for PPARA and RXRA. The 
increase of DGAT2, PLIN2, ACSL1, and ACOX1 on day 10 versus -14 in cows fed SFAT 
suggested upregulation of both beta-oxidation and lipid droplet (LD) formation. However, liver 
triacylglycerol concentration was similar among treatments. The hepatokine FGF21 and the 
gluconeogenic genes PC and PCK1 increased markedly on day 10 versus -14 only in controls. At 
the levels supplemented the change in the profile of metabolic genes after parturition in cows fed 
saturated fat suggested a greater capacity for uptake of fatty acids and intracellular handling 
without excessive storage of LD. 
Key words: dairy cows, fat supplementation, hepatic gene network 
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INTRODUCTION 
The liver plays a pivotal role in whole-body lipid hemostasis and responds rapidly to 
changes in dietary fat composition in both rodents (Jump, 2008) and ruminants (Douglas et al., 
2007). Previous data with peripartal dairy cattle have underscored the potential for dietary lipid 
supplementation as a useful nutritional strategy to prepare (Andersen et al., 2008) and facilitate 
the hepatic metabolism of non-esterified fatty acids (NEFA) (Carriquiry et al., 2009) released in 
high amounts from adipose tissue during early lactation (Loor, 2010). However, there have been 
contrasting results  with respect to type of dietary lipid and the response in blood 
hydroxybutyrate (BHBA), liver lipid content, dry matter intake (DMI), milk yield, and changes 
in body weight and body condition score (Andersen et al., 2008, Carriquiry et al., 2009, Douglas 
et al., 2007, Grum et al., 1996). It is likely that differences across studies are partly due to the 
specific type (e.g. saturated vs. unsaturated) and quantity of lipid supplemented.  
In rodent liver long-chain fatty acids (LCFA) can bind directly to various nuclear 
receptors (PPAR, LXR) leading to changes in their transcriptional activity, which alters the 
function of pathways in proportion to changes in the mRNA expression of target genes (Pegorier 
et al., 2004, Postic et al., 2007). Pathways associated with LCFA oxidation, inflammation, and 
ketogenesis were recently evaluated in bovine cells leading to the recognition that saturated 
LCFA, e.g. 16:0 and 18:0, and the fish oil-enriched 20:5n-3 were the most-potent at upregulating 
genes associated with PPARα activity (Bionaz et al., 2011, 2012). The response to saturated 
LCFA likely is a ruminant evolutionary adaptation of PPAR to metabolize the saturated LCFA 
which are found in large amounts in the circulation due to extensive ruminal hydrogenation 
(Bionaz et al., 2011, 2012).  
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There is in vivo and in vitro evidence suggesting that the PPARα gene network might be 
responsive to dietary lipid and could be used to monitor the functional changes that might occur 
in liver during the transition period (Bionaz et al., 2012, Carriquiry et al., 2009, Loor et al., 2005, 
Loor et al., 2006). From that perspective, it is important to evaluate if those responses also are 
observed during the transition period in cows receiving supplemental lipid enriched in one or 
more of the main dietary LCFA. The objective of the current study was to evaluate the 
expression of several genes associated with the PPARα transcriptional network in liver tissue 
harvested from cows fed supplemental saturated fat or fish oil during the transition period.  
 
MATERIALS AND METHODS 
Experimental design 
 The present study involved the same subset of multiparous Holstein cows used by 
Schmitt et al. (Schmitt et al., 2011). Briefly, a completely random subset of 5 multiparous cows 
(2nd and 3rd lactation) that were fed no supplemental LCFA (control, n = 12 cows total) or 
supplemental LCFA from either Energy Booster (SFAT; Milk Specialties Co., Dundee, IL, USA; 
n = 15) or fish oil (FISH; Omega Proteins, Houston, TX, USA; n = 15) were used for hepatic 
phospholipid (PL) and triacylglycerol (TAG) LCFA analysis and gene expression profiling. The 
cows from control, FISH, and SFAT diets were fed the respective diets from -25 (± 4), -24 (± 3), 
and -26 (± 7) d, respectively, until 10 days post parturition.  
Biopsies 
The liver tissue was harvested via percutaneous biopsy (Ballou et al., 2009). The average 
gap between the start of feeding and the first biopsy was 11 ± 3 days. Prepartal liver biopsies 
were harvested at -14 ± 4, -13 ± 3, and -16 ± 6 days in cows fed control, FISH, and SFAT, 
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respectively. Postpartal biopsies were harvested at 7 ± 4 days in all the groups. Biopsied tissue (1 
to 2 g) was weighed and stored in liquid N2 prior to RNA extraction. A portion of liver tissue 
collected (0.8 to 1.0 g) was used for analysis of PL and TAG fatty acid concentrations as 
described by Ballou et al. (Ballou et al., 2009). 
RNA extraction and real-time quantitative PCR (qPCR) 
 Complete details of the procedure for RNA extraction can be found in Schmitt et al. 
(2011). Briefly, approximately 0.2-0.3 g of liver tissue was weighted and immediately placed in 
ice-cold TRIzol reagent for homogenization. Genomic DNA was removed from RNA with 
RNase-free DNase, using RNeasy Mini Kit columns. RNA concentration was measured with 
NanoDrop ND-1000 spectrophotometer, while the RNA quality was assessed using the Agilent 
Bioanalyzer system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA). 
The average RNA integrity number (RIN) value for adipose samples was 8  0.4. Protocols for 
primer design, testing, selection of internal control genes (ICG) for normalization were as 
previously described (Schmitt et al., 2011). Briefly, genes selected as suitable ICG based on 
geNorm analysis included EDC4, SHPRH, EIF3K, UXT, ACTB and MRPL39. The geometric 
mean of these genes was used to normalize gene expression data in the present study.  
Genes selected for transcript profiling in this study are associated with fatty acid uptake 
and transport (FABP1, CD36), esterification, desaturation and lipid droplet formation (DGAT2, 
SCD, PLIN2,  PLIN4), fatty acid oxidation (ACSL1, ACOX1, CPT1A, FGF21), gluconeogenesis 
(PC, PCK1), and intracellular energy (UCP2, PRKAA1, STK11). Of particular importance was 
the study of transcription regulators (PPARA, RXRA, PPARD, SREBF2), nuclear receptor co-
activators (CARM1, MED1), nuclear receptor co-repressors (NCOR2, NRIP1), inflammation 
related (IL6, TBK1, IKBKE) and apoptosis/signaling related genes (CIDEB, STK1). Primer pairs 
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for target genes and ICG and sequencing results of primer products not shown in Table 3.1 and 
table 3.2 were reported previously (Graugnard et al., 2009, Schmitt et al., 2011).  
Fatty acid analysis 
 Details of these procedures were already published by Ballou et al. (Ballou et al., 2009). 
Briefly, a 100 mg liver sample was used to separate both PL and TAG via thin-layer 
chromatography using hexane-diethyl etheracetic acid (90:30:1, vol/vol/vol) as the elution phase. 
Methyl esters of FA were prepared by incubation with 2 M potassium hydroxide in methanol for 
15 min at room temperature. The ester mixture was separated using a Hewlett Packard 5890 gas 
chromatograph (Hewlett Packard, Avondale, PA, USA) equipped with a flame-ionization 
detector and a Supelco 2560 100-m capillary column (Supelco, Bellefonte, PA, USA) (Ballou et 
al., 2009). 
Statistical analysis 
 After normalization with the geometric mean of the ICG, the qPCR data from all 
treatments (prepartum and postpartum) were log-2 transformed prior to statistical analysis 
(Schmitt et al., 2011). A repeated measures model was fitted to gene expression, fatty acid, 
NEFA, and DMI data using Proc MIXED in SAS. The model consisted of time, treatment, and 
time × treatment interaction as fixed effects, as well as cow as the random effect. An 
autoregressive covariate structure was used. All means were compared using the PDIFF 
statement of SAS. 
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RESULTS 
Dry matter intake and blood NEFA 
The DMI was significantly (P <0.05) affected by the interaction of diet and day. 
Supplementing FISH led to lower peripartal DMI compared to SFAT and control cows; the 
maximum decrease was observed close to parturition. A postpartal increase in DMI was 
observed in all the groups but cows supplement with FISH still had lower DMI than the other 
two groups by the end of the supplementation period (Figure 3.1A). The plasma NEFA 
concentration was not affected significantly by diet (P<0.05). Irrespective of lipid type, NEFA 
increased at calving and remained elevated for the subsequent 10 days (Figure 3.1B). Cows 
supplemented with FISH had comparatively lower postpartal NEFA relative to controls or 
SFAT, which agreed with the lower DMI during that time-frame. 
Hepatic fatty acid composition 
Phospholipids. Mean concentration of palmitic acid (16:0) increased (P < 0.05) after 
parturition in all groups including control. The hepatic PL fatty acid content of stearic acid (18:0) 
decreased (diet × day P < 0.05) after parturition in CON and SFAT but increased with FISH and 
remained elevated by day 11 (Table 3.3). Supplementing FISH increased (diet × day P < 0.05) 
the proportion of trans-18:1 isomers, with a maximal concentration on day -10 followed by a 
gradualdecrease by day 11 (Table 3.3 and Appendix–B Suppl. Table B.1). Concomitantly, FISH 
led to lower (diet × day P < 0.05) prepartal linoleic acid (18:2n-6) content at -10 days followed 
by a steady increase after parturition. By day 11, there were no differences in 18:2n-6 among 
diets.  Overall concentration of 18:1trans11 was greatest (P < 0.05) in FISH compared with 
control or SFAT from -10 through 11 days. In contrast, conjugated linoleic acid (CLA) 
concentration was lower (diet P <0.05) in lipid-supplemented than control cows. However, CLA 
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concentration peaked in all the groups (day P <0.05) at parturition (1 day) followed by a gradual 
decrease by day 11. The concentrations of other 18:1trans isomers were little affected by 
supplemental lipid (Appendix–B Suppl. Table B.1). 
SFAT and FISH-supplemented cows had greater (diet × day P < 0.05) α-linolenic acid 
(18:3n-3) content at -21 days compared with controls, while a lower concentration was observed 
at -10 days in the same groups (Table 3.3). As compared with SFAT and control, the FISH-
supplemented cows had a lower (diet × day P < 0.05) proportion of γ-linolenic acid (18:3n-6) at -
10 days but a gradual increase was observed at 1 and 11 days (Appendix–B Suppl. Table B.1).  
As expected, the concentration of eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid 
(22:6n-3) was greatest with FISH compared with control or SFAT from -10 days through 11 
days. However, arachidonic acid (20:4n-6) decreased markedly with FISH and SFAT after 
parturition as compared with control (Table 3.3). 
Triacylglycerol. Concentration of 16:0 was greatest (P < 0.05) overall in cows fed SFAT, 
but 18:0 was not affected by diet (Table 3.4). A postpartal increase (day P <0.05) in 16:0 and a 
decrease (day P<0.05) in stearic acid was observed (Table 3.4). Similar to the PL fatty acid 
fraction, FISH-supplemented cows had a tendency (diet × day P = 0.06) for a postpartal increase 
in TAG concentration of trans-vaccenic acid (18:1trans11) as compared with control and SFAT 
(Table 3.4). Overall, however, concentration of 18:1trans11 was greatest (P < 0.05) for cows fed 
FISH than SFAT or control. Similar to PL, the CLA concentration of hepatic TAG also increased 
soon after calving and remained elevated compared with prepartal concentrations. A postpartal 
increase (day P < 0.05) was observed in the concentration of 18:2n-6 regardless of diet. The 
concentrations of other 18:1trans isomers were little affected by supplemental lipid (Appendix–B 
Suppl. Table B.1). 
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Compared with the PL fraction, supplementing lipid was not effective (diet P >0.05) in 
altering the 18:3n-3 and 20:4n-6 concentration of the hepatic TAG fraction. However, a 
postpartal increase (day P <0.05) in 18:3n-3 and a concomitant decrease in 20:4n-6 concentration 
was observed regardless of diet (Table 3.4).  Similar to PL, there was an increase (diet × day P < 
0.05) in the proportion of all n-3 fatty acids in the TAG fraction of FISH-supplemented cows; 
20:5n-3, 22:5n-3, and 22:6n-3 had a steady increase in concentration by day 1 followed by still 
greater concentrations relative to the prepartum levels. Overall, the postpartal concentration of 
20:5n-3, 22:5n-3 and 22:6n-3 was markedly lower in SFAT and control than FISH (Table 3.4). A 
postpartal increase (diet × day P < 0.05) was observed in the proportion of 18:3n-6, namely due 
to the response in the control group. The overall increase, however, was of a lower magnitude in 
FISH as compared with SFAT (Appendix–B Suppl. Table B.2). 
Hepatic gene expression 
Fatty acid transport and lipid droplet formation. The expression of genes involved in 
fatty acid uptake/transport, storage and oxidation changed in a different fashion with lipid as 
compared to control. The expression of the LCFA-uptake protein CD36 in the prepartal period 
was lower (diet × day P < 0.05) with SFAT than FISH and control, and was markedly down 
regulated after parturition in response to FISH. In contrast, an increase (diet × day P < 0.05) in 
FABP1 expression postpartum was observed in cows fed SFAT and controls at which point 
expression was greater in those cows compared with FISH (Table 3.5). 
Feeding SFAT led to lower (diet × day P < 0.05) DGAT2 prepartum compared with 
control or FISH, but feeding that diet resulted in an increase in expression postpartum at which 
point expression of DGAT2 was similar between control and FISH. Quite remarkably, the 
expression of SCD was lowest (diet P < 0.05) for SFAT and FISH than controls during the 
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prepartal period. However, its expression decreased markedly after parturition in control cows 
but not in lipid-supplemented cows. The lipid droplet-associated proteins PLIN2 (formerly 
known as adipophilin) and PLIN4 (formerly known as S3-12) did not differ in expression among 
groups in the prepartal period. However, there was a decrease in expression of PLIN2 in cows 
fed FISH while an increase was observed in cows fed SFAT (diet × day P < 0.05). The overall 
result was that PLIN2 expression postpartum was similar between SFAT and controls and lower 
with FISH. 
Fatty acid oxidation. The expression of ACSL1 and ACOX1 in the prepartal period was 
greater in cows fed FISH than SFAT, but after parturition cows fed FISH had lower expression 
and cows fed SFAT greater expression of both genes resulting in an overall interaction effect 
(diet × day P < 0.05). Cows fed control also had an increase in ACSL1 expression after 
parturition, in fact resulting in greater overall expression than SFAT and FISH. Whereas 
expression of the PPARα target CPT1A did not differ due to treatment or day, the expression of 
FGF21 which is another PPARα target increased to the greatest extent (diet × day P < 0.05) 
postpartum in controls. Thus, in the postpartal period FGF21 expression was greatest in controls 
relative to FISH and SFAT. 
Genes involved in gluconeogenesis and intracellular energy sensing. There was no 
interaction (diet × day P > 0.05) in the prepartal period for the expression of PC and PCK1; 
however, expression of both genes increased (diet × day P < 0.05) markedly postpartum in 
controls at which point cows fed FISH and SFAT had lower overall expression largely due to a 
lack of change in expression from the prepartal period. In a similar fashion, there was no 
significant prepartal interaction effect on the expression of UCP2, PRKAA1, and STK11, which 
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are involved in intracellular sensing of ATP and signaling via the AMPK pathway. However, 
cows fed FISH had a marked decrease (diet × day P < 0.05) in expression of these three genes in 
the postpartal period leading to a lower overall PRKAA1 expression postpartum. 
 Transcription regulators and nuclear co-activators and repressors. No obvious pre and 
postpartal differences were observed in the expression of PPARA, while RXRA had an overall 
downregulation after parturition (time P = 0.06) due namely to feeding control and FISH (Table 
3.6). Feeding SFAT resulted in lower (diet × day P < 0.05) SREBF2 prepartum compared with 
controls, but unlike FISH it did not elicit a decrease in expression in the postpartum period. 
Thus, overall SREBF2 expression postpartum was similar in controls and SFAT and lower in 
FISH. Similar to SREBF2, feeding FISH led to lower (diet × day P < 0.05) expression of PPARD 
between the pre and postpartal period at which point cows fed both FISH and SFAT had lower 
(diet × day P < 0.05) expression than controls. 
Feeding FISH and SFAT vs. control led to lower expression in the prepartal period of the 
nuclear receptor co-regulators CARM1, NCOR2, MED1, and RIP1 (diet × day P < 0.05). 
Expression of all these genes decreased (diet × day P < 0.05) in the postpartum period 
exclusively in cows fed FISH such that control cows still had greater overall expression followed 
by cows fed SFAT. 
Inflammation and apoptosis. The expression of IL6, TBK1, and IKBKE in the prepartal 
period was lowest (diet × day P < 0.05) in cows fed SFAT than control or FISH (Table 3.7). 
However, cows fed FISH experienced a decrease (diet × day P < 0.05) in postpartal expression 
of these genes while expression in SFAT-fed or control cows remained unchanged. Except for 
TBK1 and IKBKE, expression of IL6 was lower (diet × day P < 0.05) overall postpartum in cows 
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fed SFAT and FISH. Cows fed FISH also had a decrease (diet × day P < 0.05) in CIDEB 
expression postpartum at which point expression was lower compared with controls and SFAT.  
 
DISCUSSION 
Hepatic PL and TAG fatty acid composition 
Changes observed in the hepatic fatty acid profiles of PL and TAG were likely driven by 
a combination of 1) alterations in LCFA composition of adipose tissue induced by feeding, 2) 
mobilization of LCFA postpartum in response to lipolytic signals, and 3) biohydrogenation of 
PUFA in the rumen leading to increases in trans fatty acids. The contribution of adipose tissue 
LCFA to the PL and TAG fraction of lipid in dairy cattle liver has been demonstrated previously 
(Douglas et al., 2007, Rukkwamsuk et al., 2000). Schmitt et al. (Schmitt et al., 2011) using the 
same cows from this study reported that all groups had an increase in liver TAG after parturition, 
which is a typical response observed due to the increase in circulating NEFA (i.e. from 
mobilization of adipose tissue) (Figure 3.1B). Although not measured in these cows, it is likely 
that the pool of LCFA stored in adipose tissue TAG and also in liver PL during the prepartal 
period in particular contributed to the observed changes in gene expression profiles. This idea is 
supported by the fact that both FISH and SFAT (Schmitt et al., 2011) upregulated several genes 
associated with lipid metabolism and the PPAR pathway namely in the prepartal period. 
Dietary fat supplementation often produces a pronounced effect on hepatic PL 
composition (Douglas et al., 2007). In the present study, the postpartal decrease in the 
concentration of 18:0 and the increase in 18:1trans isomers (particularly trans11) with FISH was 
consistent with greater biohydrogenation of dietary PUFA (Ballou et al., 2009). The postpartal 
increase in 16:0 and 18:2n-6 regardless of diet likely was associated with increased adipose 
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tissue lipolysis and subsequent transport and storage in the liver (Rukkwamsuk et al., 2000). The 
observed decrease in the PL concentration of γ linolenic acid (18:3n-6) might have been due to 
allosteric inhibition or transcriptional regulation of the elongases as well as the Δ5- and Δ6-
desaturases, or to competition between n-6 and n-3 substrates for incorporation into PL (Shimano 
et al., 2002). 
The observed increase in the hepatic PL and TAG content of α linolenic acid (18:3n-3) 
likely accounted for the increase in content of 20:5n-3, 22:5n-3 and 22:6n-3 at calving (Douglas 
et al., 2007); α linoleic acid can be desaturated and elongated to 20:5n-3 and 22:6n-3. The 
decrease in dihomo-γ-linoleic acid (20:3n-6) and arachidonic acid (20:4n-6) with FISH and 
SFAT after parturition as compared with control (Table 3.3) might have been due to a low 
baseline concentration of linoleic acid (18:2n-6) in hepatic PL (Ballou et al., 2009), because 
linoleic acid is desaturated and elongated to 20:3n-6 and subsequently to 20:4n-6 (Douglas et al., 
2007). Another possibility is that greater supply of 18:2 resulted in competition and displacement 
of other long chain PUFA for esterification into PL (Douglas et al., 2007). Similarly, increased 
tissue content may inhibit elongation and desaturation of 18:2 and 18:3 as observed in calves 
(Jenkins, 1988). The lower level of γ linolenic acid in FISH could have affected the 
concentration of arachidonic acid, because γ linolenic acid is the intermediate in the conversion 
of linoleic acid to arachidonic acid (Laho et al., 2011). 
Intracellular metabolism and long-chain fatty acids in bovine 
The metabolism of specific LCFA has been studied previously in vitro using hepatocytes 
isolated from neonatal calves (Mashek et al., 2002, Mashek and Grummer, 2003). Despite the 
inherent difficulties in comparing in vitro and in vivo studies, in the context of our study, data 
generated with incubations of 16:0 alone or in combination with 18:0, 18:1, 20:5n-3, or 22:6n-3 
 
 
91 
 
are of interest. For instance, greater total oxidation (CO2 and acid-soluble products) of 14C-16:0 
were observed with incubations of 1 mM 16:0 plus 1 mM 20:5n-3 and 18:1 compared with 
incubation of 1 mM 16:0 alone (Mashek et al., 2002). In contrast, the incubation containing 
20:5n-3 did not increase use of 14C-palmitic acid for cellular TAG synthesis but 18:1 did. 
Palmitate plus 22:6n-3 did not affect total oxidation of 14C-palmitic acid or its esterification to 
TAG (Mashek et al., 2002). Results from that initial study clearly underscored the differential 
utilization of LCFA for esterification or fatty acid oxidation in liver cells. Although there were 
no data on mRNA or protein expression of lipid metabolism enzymes, it would not be 
unreasonable to suspect (based on data from model organisms) that changes in expression would 
have been partly responsible for the changes observed. For instance, 18:1 either from exogenous 
sources or synthesized from 18:0 via SCD is central for cellular TAG synthesis and LD 
formation (Coleman and Mashek, 2011), and in liver probably an essential step in VLDL 
synthesis. 
A second study confirmed the response of 18:1 only in terms of enhancing the use of 16:0 
for esterification but did not confirm the effect of 20:5n-3 on ketone body formation from 16:0 
(Mashek and Grummer, 2003). Furthermore, there was an increase in cellular TAG with 
incubations of 22:6n-3. However, contrary to the first study incubation of 1 mM 16:0 plus 1 mM 
18:0 resulted in greater BHBA concentration in culture media as a result of greater oxidation rate 
of 14C-16:0 (Mashek and Grummer, 2003). Although we did not detect statistical differences in 
blood BHBA due to lipid supplementation (Schmitt et al., 2011), the likely fluctuations in BHBA 
metabolism during lactation compared with in vitro systems would make it difficult to use this 
marker to discern physiological effects in vivo. 
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Additional analyses from this second study included rate of gluconeogenesis and 
concentration of cellular glycogen. Linolenic acid plus 16:0 resulted in the highest rates of 
gluconeogenesis from 14C-propionic acid and greatest amounts of intracellular glycogen, along 
with reduced TAG production (Mashek and Grummer, 2003). An interesting finding was that 
22:6n-3 plus 16:0 incubation or both plus 20:5n-3 increased cellular TAG content and 
incorporation of 14C-palmitic acid into cellular TAG. In addition, 22:6n-3 plus 16:0 decreased 
metabolism of 14C-propionic acid to glucose in the medium or to cellular glycogen (Mashek and 
Grummer, 2003). 
The in vitro work with hepatocytes has, by necessity, been short-term compared with the 
longer-term feeding studies. Furthermore, the above studies used supra-physiological 
concentrations of each LCFA and their expected concentration in the circulation of the cow after 
parturition is unlikely to reach the 1 mM level. In fact, unless the cow is under a ketotic situation, 
the peak total NEFA concentration after parturition is rarely greater than 1.5 mM (Drackley, 
1999). Although the resulting data from these in vitro studies have helped expand our knowledge 
of the metabolic effects of specific LCFA, the observed results are challenging to place in the in 
vivo context. Thus, gene expression data obtained over a longer time-frame from cows in field 
conditions may provide a more physiologically-relevant view of the likely mechanistic effects of 
enriching diets with specific LCFA.  
Hepatic gene expression 
Fatty acid transport and metabolism. The expression of FABP1 in dairy cows has been 
previously characterized as increasing between parturition and 14 days postpartum, a response 
which was proposed to denote downstream activation of PPARα via NEFA metabolism (Loor, 
2010). However, in the present study, even with the increase in NEFA postpartum (Figure 3.1B) 
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the FABP1 expression remained stable in cows fed SFAT and FISH while it was upregulated in 
controls. That response suggests that irrespective of the type of fat supplemented this intra-
cellular transporter could be modulated without the influence of the rising NEFA postpartum.  
On the other hand, the pronounced down-regulation of CD36 after parturition in cows fed FISH 
(Table 3.5) suggested a possible biological role of PUFA in the control of the intracellular flux of 
LCFA. Such a response would be contradictory with non-ruminant data, i.e. upregulation of 
CD36 with PUFA, indicating an intra-species difference in the response of liver cells to 
supplementation with PUFA as already proposed in bovine kidney cells (Bionaz et al., 2012). 
The contrasting response between liver tissue in the present study and bovine kidney cells 
(Bionaz et al., 2012) in the same species is not surprising and obviously is likely related with the 
different types of cells studied but also the endocrine and metabolic environment. The 
complexity of the LCFA pool that hepatocytes are exposed to also has shown to influence the 
degree of PPAR gene network activation in rodent liver (Berger et al., 2006, Pawar and Jump, 
2003, Shearer et al., 2012). As stated before, feeding FISH led to a large difference in the 
concentration of 18:1trans11, 18:1trans12, 22:6n-3, and 20:5n-3, all of which could potentially 
play a role in the activation of the PPARα gene network at least judging from in vitro data (Ide, 
2005). 
Esterification, desaturation, and lipid droplet formation. The enzyme SCD is 
responsible for biosynthesis of monounsaturated fatty acids (18:1 and 16:1) from 16:0 and 18:0, 
which are substrates for de novo synthesis of PL, cholesterol esters, and TAG (Hofacer et al., 
2012, Paton and Ntambi, 2009). Our results with SCD agree with reports from other animal 
species where both omega-3 and omega-6 PUFA decreased SCD expression partly by decreasing 
mRNA stability (Hofacer et al., 2012, Landschulz et al., 1994, Ntambi, 1999, Sessler et al., 1996, 
 
 
94 
 
Velliquette et al., 2009). On the other hand, the SCD down-regulation with SFAT is contrary to 
in vitro reports with bovine kidney cells (Bionaz et al., 2012) in which SCD was upregulated by 
exogenous 16:0 and 18:0, the main LCFA in the blood of ruminants. However, the 
downregulation of CD36 could partly explain the lower SCD if in fact there was less 18:0 and 
16:0 taken up from blood, hence, leading to reduced substrate availability. 
In rodents, the SCD and DGAT2 are located adjacently in the outer endoplasmic 
reticulum membrane (Man et al., 2006) and it has been proposed that SCD influences indirectly 
the activity of DGAT2 by supplying substrates (16:1 and 18:1) for synthesis of TAG (Paton and 
Ntambi, 2009). Our data revealed a similar pattern of expression response for SCD and DGAT2 
across diets, namely postpartum. The DGAT2 enzyme plays a key role in the cytosolic 
accumulation of TAG (Monetti et al., 2007, Yamazaki et al., 2005, Yen et al., 2008), which 
could in the post-absorptive state provide LCFA for lipoprotein synthesis. The lower expression 
of this gene postpartum with FISH than control and the lack of difference between FISH and 
SFAT could be taken as an indication of decreased use of LCFA for TAG synthesis. Such 
response would have channeled LCFA towards PL and/or cholesterol ester synthesis, VLDL 
synthesis, or oxidation (Coleman and Mashek, 2011). 
The lower SCD expression also could have been associated with the response observed 
for PLIN2, another enzyme linked with liver TAG accumulation and size of lipid droplets (LD) 
(Chang and Chan, 2007). Studies in vitro with different non-ruminant cell lines (Dalen et al., 
2006, Tobin et al., 2006) demonstrated that ADFP is upregulated by PUFA, which obviously 
FISH did not induce.  The increase of PLIN2 expression postpartum we observed with SFAT 
agrees with previous data from rodent hepatocytes (Dalen et al., 2006), and underscores the fact 
that the increase in NEFA alone is not the sole mechanism for activating transcription of this 
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gene. Hepatic TAG accumulation typically follows the rise in NEFA postpartum (Drackley, 
1999, Schmitt et al., 2011). As an integral LD protein, PLIN2 may serve more critical roles in 
managing the turnover of neutral lipid stores to facilitate the coordinated release of LCFA into 
lipoproteins in response to changes in metabolic state (Coleman and Mashek, 2011). 
Unlike PLIN2, PLIN4 is an exchangeable cytosolic LD protein that facilitates rapid 
protein association with the immature LD (Brasaemle, 2007, Loor, 2010). Generally in the liver 
the PLIN4 is associated with smaller and peripheral LD and is stimulated by high concentrations 
of LCFA; while, PLIN2 is associated with bigger and more mature LD (Ducharme and Bickel, 
2008). The observed changes postpartum for PLIN2 in cows fed SFAT (upregulation) and FISH 
(downregulation) seem to suggest a difference in potency of LCFA, or alternatively in the case of 
FISH, a protective mechanism of the cell to buffer from excessive LCFA influx.   
 Fatty acid oxidation. In the liver, ACSL1 is central for the synthesis of LCFA-acyl-CoA, 
which can then be channeled towards β-oxidation (Li et al., 2009). The regulation of expression 
of this enzyme by PPARα activation in rodents is well-established (Frederiksen et al., 2004, Li et 
al., 2009, Schoonjans et al., 1993), and recent work demonstrated a similar response in bovine  
(Bionaz et al., 2012, Thering et al., 2009). Previous work with peripartal dairy cows fed diets 
without supplemental lipid revealed that ACSL1 increases expression between -14 to 1 day 
postpartum after which it remains unchanged through 14 days, a response that could help in the 
metabolism of incoming NEFA, thus, channeling them towards β-oxidation (Bionaz et al., 2007, 
Loor, 2010). We observed a similar response in cows fed control and SFAT; thus, the down 
regulation of ACSL1 in cows fed with FISH, along with CD36 in particular, would agree with the 
concept of different LCFA eliciting opposite effects on transcription of ASCL1 and CD36. It 
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could be envisioned that such a response would prevent excessive influx of LCFA but also serve 
to control their use for esterification or oxidation. 
The lack of difference for ACOX1 expression postpartum between control and SFAT 
suggested that, on the one hand, enhanced dietary LCFA flux into liver did not alter peroxisomal 
oxidation, i.e. at a greater availability of LCFA the liver from SFAT-fed cows might have been 
capable of oxidizing a greater fraction, and on the other hand, that not enough dietary LCFA 
reached liver to cause an effect. The latter case is likely because of the mammary gland’s 
preference for taking up LCFA from the circulation, and in a way buffering other tissues (Ballou 
et al., 2009). The effect of fish oil on ACOX1 expression has been evaluated in several rodent 
studies, which demonstrated that PUFA are potent activators (Berger et al., 2006, Fan et al., 
1996, Ide et al., 2000, Leclercq et al., 2008). Mechanistically such response makes sense because 
it is the first and rate-limiting enzyme of the peroxisomal fatty acid β-oxidation pathway 
(Vluggens et al., 2010), which is quite important in peripartal liver lipid metabolism (Grum et al., 
1996). The prepartal response with FISH vs. SFAT appeared to be in line with rodent data. 
However, the postpartal decrease in ACOX1 with FISH coupled with the increase with SFAT 
suggested that saturated LCFA were more potent in activating ACOX1, which agrees with in 
vitro data (Bionaz et al., 2012). These results highlight that in peripartal cows, feeding FISH (at 
least at the levels of this study) might not be effective in enhancing LCFA oxidative capacity. 
In our analysis of adipose tissue gene expression form these cows, we found some 
evidence that lipid supplementation could influence the production of adipokines by adipose 
tissue, hence, influence indirectly the hepatic capacity of β-oxidation (Schmitt et al., 2011). It has 
been proposed in rodents, that adiponectin binding to its hepatic receptor (ADIPOR2) leads to 
activation of both AMPK and PPAR signaling pathways, and consequently ACOX1 activation 
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(Kadowaki et al., 2006, Loor, 2010). We observed that FISH led to lower postpartal expression 
of ADIPOR2 and ADIPOQ in the adipose, and lower ADIPOR2 in liver tissue (Schmitt et al., 
2011). In contrast, ADIPOR2 expression in liver and ADIPOQ in adipose tissue were the same in 
the control and SFAT. Such responses could be mechanistically related with the lower postpartal 
ACOX1 and a potential overall reduction in β-oxidation when FISH was fed. 
Recently, it was reported that FISH inhibits de novo lipogenesis and β-oxidation and 
decreases insulin resistance in non-ruminants. The improvement in insulin sensitivity is mediated 
by down regulating the PPARG network, ChREBP, and SREBF1. Furthermore, FISH also 
increases adiponectin (powerful insulin-sensitizing agent) production in adipose (Masterton et 
al., 2010). The decrease in DMI (Figure 3.1A) along with the lower milk yield (Schmitt et al., 
2011) and the observed down regulation of SCD and DGAT2 in the present study and in adipose 
tissue (SCD, DGAT2 ChREBP, and SREBF1) in the study of Schmitt et al. (Schmitt et al., 2011) 
suggests that FISH may actually have had a negative impact on genes involved in LCFA 
oxidation. Additional research seems warranted to elucidate the underlying mechanisms and their 
physiological relevance. 
 The peroxisomal oxidation results in the increased production of shorter-chain fatty acyl-
CoA that generally are channeled to be completely oxidized in mitochondria (Loor, 2010). 
Although CPT1A has a key role in this process, the lack of change in expression in our study 
seems to confirm previous data providing evidence that this enzyme is not strongly controlled at 
the transcription level even during periods of severe negative energy balance (Loor et al., 2007). 
Rodent CPT1A is markedly upregulated in response to undernutrition and fasting, thus, 
underscoring additional differences between species in the control of hepatic LCFA oxidation. 
Despite the apparent lack of CPT1A activation, i.e. it is a PPAR target in rodents, the 
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upregulation of FGF21 (another PPAR target) postpartum provided evidence of transcriptional 
adaptations that could have been driven via PPAR. 
In rodents PPARα protein is required for the normal activation of hepatic LCFA 
oxidation, TAG clearance, and ketogenesis (Badman et al., 2007). Despite obvious biological 
variation in its expression across treatments, the pattern of FGF21 expression that was observed 
in this study seemed to confirm that this protein is important in coordinating hepatic adaptations 
to undernutrition in ruminants as in rodents. However, the lack of postpartal increase in cows fed 
SFAT or FISH could indicate that excess LCFA influx into liver actually might feedback-inhibit 
the transcriptional activation of FGF21 and more potently when feeding PUFA (e.g. FISH) than 
saturated LCFA. From a mechanistic standpoint, the attenuation of FGF21 did not seem to 
curtail LCFA oxidation in cows fed SFAT, i.e. ACOX1 expression increased, and blood BHBA 
was similar among treatments (Schmitt et al., 2011). Overall, the present and previous data 
(Carriquiry et al., 2009) suggest that FGF21 in cows is associated with negative energetic 
balance. 
Genes involved in gluconeogenesis and intracellular energy sensing. The predominant 
glucose precursors in dairy cows are propionate and lactate, although the contribution of alanine 
and glycerol becomes quantitatively more important during conditions of propionate deficit (i.e. 
the early postpartal period) (Overton et al., 1999, Reynolds et al., 2003). Partitioning of lactate 
and alanine towards gluconeogenesis is under the control of PC, the expression of which 
increases sharply after parturition (Greenfield et al., 2000, Loor et al., 2006), feed restriction 
(Velez and Donkin, 2005), and experimentally-induced glucose deficit (Bradford and Allen, 
2005) to facilitate flux of alanine and lactate toward oxaloacetate rather than acetyl-CoA. 
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The upregulation of PC at calving is linked with increased concentrations of NEFA in 
plasma. This is not surprising as several metabolic reactions are regulated by LCFA at the level 
of the activation of genes that encode key regulatory enzymes (Jump et al., 2005, White et al., 
2011), including gluconeogenesis and fatty acid metabolism. The observed increase in linoleic 
acid concentration in PL after calving in controls (and comparatively lower in FISH) seems to 
support in vitro data demonstrating that linoleic acid could serve to activate PC and enhance the 
capacity for fatty acid oxidation and glucose synthesis (White et al., 2011). Furthermore, there is 
evidence that greater supply of linoleic acid can enhance the rate of gluconeogenesis in bovine 
hepatocytes (Mashek and Grummer, 2003). Cellular-membrane bound linoleic acid also can 
serve as ligand for NR that regulate gene expression, e.g. in hepatocyte cultures this LCFA 
increased the PCK1 mRNA level in a dose-dependent manner (Suh et al., 2008).  
The exogenous LCFA can enhance the rates of hepatic mitochondrial oxidation by 
uncoupling oxidation from ATP production (Loor, 2010). The uncoupling proteins (UCP) are 
key players in mitochondrial oxidation the activity of which can be induced by LCFA. 
Monounsaturated and PUFA appear more effective than saturated LCFA in activating the liver 
specific isoform UCP2 (Armstrong and Towle, 2001). UCP2 is a demonstrated non-ruminant 
PPAR target in vivo, and has been proposed to play a role in lipid metabolism, insulin 
resistance, glucose utilization, regulation of reactive oxygen species, and macrophage-mediated 
immunity (Arsenijevic et al., 2000, Ricquier and Bouillaud, 2000).  
Armstrong and Towle (2001) reported induced expression of hepatic UCP2 with high 
concentrations of LCFA (Armstrong and Towle, 2001). To some extent that effect lends support 
to the observed lower postpartal UCP2 expression in cows fed FISH vs. SFAT because they had 
numerically-lower blood NEFA (Figure 3.1B).  Insulin (Yonezawa et al., 2008) and aspirin 
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(Armstrong and Towle, 2001) significantly reduced the expression of UCP2 mRNA in rodent 
liver. Because the high NEFA concentration postpartum seems to impair directly the ability of 
the pancreas to secrete insulin in pospartal dairy cows (Bossaert et al., 2008), it is unlikely that in 
the present study insulin had a mechanistic role on the expression of UCP2. In contrast, the fact 
that aspirin reduced UCP2 in rodent liver despite high concentrations of LCFA could indicate 
that in our study the prostaglandin pathway might have been physiologically relevant.  That idea 
is supported by the lower hepatic PL concentration of 20:4n-6 (the immediate precursor of 
prostaglandins) in cows fed FISH compared with SFAT. 
Nuclear receptor co-activators and co-repressors. The co-activator-associated arginine 
methyltransferase I (CARM1) is a critical component of glucose metabolism in rodent 
hepatocytes (Krones-Herzig et al., 2006), where it physically interacts with cAMP-responsive 
element binding factor CREB before both being recruited to the PCK1 and glucose-6-
phosphatase promoters in a cAMP-dependent manner particularly during periods of dietary 
glucose short-falls (e.g. undernutrition, starvation, negative energy balance) (Jiang and Zhang, 
2003). CARM1 regulates gene expression by multiple mechanisms including methylation of 
histones and co-activation of steroid receptor transcription (Bai et al., 2011). The observed 
postpartal decrease of CARM1 with FISH agrees with the lower expression of PCK1 (Table 3.5).  
In addition, it is possible that differences in intracellular cAMP concentration also might have 
played a role in both CARM1 and PCK1 upregulation. We speculate that because of the lower 
rate of milk production and DMI in response to FISH, the intracellular levels of cAMP (driven 
by the increase in glucagon after parturition (Herbein et al., 1985)) would have been lower in 
those cows. The lower DMI due to feeding FISH was clearly a long-term response which 
preceded parturition; thus, cows likely were adapted by the time of parturition in a way that the 
 
 
101 
 
lower rate of milk production was driven by a level of DMI that was appropriate to meet the 
energy demands of the mammary gland. 
Mediator 1 (MED1) is required for high-fat diet– induced hepatic steatosis via PPARγ , 
and loss of MED1 protects rodents against fatty liver (Bai et al., 2011). A biologically-similar 
role for PPARG in ruminant liver is unlikely because this isoform is substantially lower in 
abundance than PPARA or PPARD (data not shown). In fact, in this study the expression of 
PPARD and not PPARA was affected by the onset of lactation and by the type of lipid fed. Our 
data seem to suggest a mechanistic link between PPARD, CARM1, and MED1, particularly 
postpartum when the responses due to diet for the three genes were the same. That suggestion is 
supported by the observed responses in the expression of the co-repressors NCOR2 and NRIP1.  
Nuclear receptor co-repressor 2 (NCOR2) in tandem with specific NR and different DNA 
binding transcription factors represses the transcription of target genes (Jepsen et al., 2000). In 
non-ruminants NRIP1 seems to play dual roles in metabolic tissues but the precise mechanisms 
driving its co-activator role remain elusive (Fritah et al., 2010). What seems evident from 
previous rodent studies is that NRIP1 is required for expression of genes associated with energy 
metabolism (e.g., UCP1, CPT1A) partly under control of β-adrenergic stimulation and PPARα 
and PPARδ (Leonardsson et al., 2004).  
Transcription regulators of lipid metabolism. In non-ruminants, sterol regulatory 
element binding proteins (SREBF1 and SREBF2) act as a central hub to control the transcription 
of genes required for cholesterol, fatty acid, TAG, and PL (Espenshade, 2006, Horton et al., 
2003). In the liver, SREBF1 preferentially regulates genes involved in fatty acid synthesis and 
SREBF2 genes associated with cholesterol biosynthesis (Bommer and MacDougald, 2011, Li et 
al., 2010). The activation of SREBF2 in the liver is mediated by SREBF cleavage binding 
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protein (SCAP); whereas, CIDEB controls cholesterol biosynthesis by regulating the levels of 
SCAP at the transcriptional level (Li et al., 2010). In the present study, the postpartal decrease in 
SREBF2 with FISH (Table 3.6) could have been a consequence of lower CIDEB expression 
(Table 3.7), which may have decreased abundance of SCAP and, thus, reduced the transport and 
activation of SREBF2. From a physiological perspective, such decrease in SREBF2 expression 
could have resulted in lower endogenous synthesis of cholesterol, which is an important process 
in liver as a part of the pathway of lipoprotein synthesis. 
Inflammation and apoptosis. Dietary LCFA can impact immunity through the 
production of cytokines and molecules involved in the regulation of immune responses (Lessard 
et al., 2003). Omega- 3 and omega-6 PUFA are important immunomodulators (Miles and Calder, 
1998).The transcription factors interferon regulatory factor 3 (IRF3) and NFkB are the central 
points of an integrated network of genes involved in the innate immune response; whereas, 
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (IKBKE) and 
TANK-binding kinase (TBK1) play a pivotal role in coordinating the activation of both those 
genes (Fitzgerald et al., 2003). The decrease in expression of IL6, TBK1 and IKBKE postpartum 
in cows fed FISH could have been associated with lower concentration of 20:4n-6 in PL; this 
fatty acid is the major substrate for prostaglandins and a key link between PUFA and 
inflammation (Calder, 2006, Lessard et al., 2003). 
The observed postpartal increase in 20:5n-3 and 22:6n-3 in PL of cows fed FISH likely 
inhibited 20:4n-6 metabolism, directly via substrate competition or indirectly by altering the 
expression of inflammatory genes through effects on transcription factor activation (Calder, 
2006). Feeding plant or fish oil rich in omega-3 PUFA generally reduces inflammatory reactions 
and production of interleukin (IL)-1, IL-6, MMP-3 (STR1), and tumor necrosis factor (Curtis et 
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al., 2006, Curtis et al., 1994). Such type of effect might be less pronounced in dairy cattle 
because of the substantial degree of biohydrogenation of PUFA in the rumen and also because of 
the substantial uptake of LCFA by the mammary gland during lactation. However, the data 
provides strong evidence that the enrichment of omega-3 PUFA in liver PL due to feeding FISH 
likely was important in lowering the expression of inflammatory genes. A possible mechanism 
for such an effect could have encompassed PPAR, which was recently shown to be activated in 
dairy cattle liver during inflammation (Graugnard et al., 2013). 
The cell death-inducing DFFA-like effector b (CIDEB) protein has a high level of 
expression in non-ruminant liver, and its deficiency affects energy expenditure, plasma TAG 
levels (Li et al., 2007) and also alters the expression of genes involved in various metabolic and 
signaling networks (Li et al., 2010). The CIDEB protein is localized to the LD, endoplasmic 
reticulum, Golgi apparatus and facilitates VLDL lipidation and maturation in the liver by 
interacting with ApoB (Li et al., 2010). In the present study the decrease in CIDEB expression 
with FISH may have led to reduced expression of SREBF2, de novo cholesterol biosynthesis, and 
potentially an augmentation of the cellular inflammatory status. 
CONCLUSIONS 
The present study revealed that type of dietary fatty acid affects the hepatic fatty acid 
profile of PL and TAG. At the levels supplemented the change in the profile of metabolic genes 
after parturition in cows fed saturated fat suggested a greater capacity for uptake of fatty acids 
and intracellular handling without excessive storage of LD. The lack of difference in liver TAG 
concentration between lipid-supplemented groups and the downregulation of metabolic genes 
after parturition in cows fed fish oil suggested that it might not be effective in enhancing 
oxidative capacity of LCFA. Such response contrasts the effect of very-long chain PUFA in 
 
 
104 
 
monogastric species. The results highlighted that both saturated and very-long chain PUFA 
seemed equally effective at helping decrease inflammatory gene expression but FISH had a more 
potent effect after parturition. Based on the combined data from this study additional studies to 
better delineate the effective doses of saturated and very-long chain PUFA to feed around 
parturition seem warranted. 
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TABLES AND FIGURES 
 
Table 3.1. GenBank accession number, gene symbol, hybridization position, sequence and 
amplicon size of primers. 
Accession # Gene Primers1 Primers (5’-3’)2 bp3 
XM_002695200.1 FGF21 F.223 
R.328 
CAGAGCCCCGAAAGTCTCTTG
AAAGTGCAGCGATCCGTACAG 
106 
NM_001034036.1 PPARA F.729 
R.830 
CATAACGCGATTCGTTTTGGA 
CGCGGTTTCGGAATCTTCT 
102 
NM_001083636.1 PPARD F.460 
R.559 
TGTGGCAGCCTCAATATGGA 
GACGGAAGAAGCCCTTGCA 
100 
NM_001035289.2 
 
ACOX1 F.180 
R.279 
ACCCAGACTTCCAGCATGAGA 
TTCCTCATCTTCTGCACCATGA 
100 
NM_173980.2 PLIN2 F.1607 
R.1706 
TTTATGGCCTCATGCTTTTGC 
CTCAGAGCAGACCCCAATTCA 
100 
FJ415874.1 CPT1A F.141 
R.240 
TCGCGATGGACTTGCTGTATA 
CGGTCCAGTTTGCGTCTGTA 
100 
BC111622 FABP1 F.183 
R.283 
GTTCATCATCACCGCTGGCT 
CCACTGCCTTGATCTTCTCCC 
101 
1Primer direction (F – forward; R – reverse) and hybridization position on the sequence. 
2Exon-exon junctions are underlined. 
3Amplicon size in base pairs (bp). 
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Table 3.2. Sequencing results of PCR primer products. Best hits using BLASTN 
(http://www.ncbi.nlm.nih.gov) are shown.  
Gene Sequence 
FGF21 CGAGATCTGAAGCAAATTGAGGCAGAAATCCTTACGTGTGAGCATGACCTA
GAAGATTCCGAAACCGCGA 
PPARA CGAGATCTGAAGCAAATTGAGGCAGAAATCCTTACGTGTGAGCATGACCTA
GAAGATTCCGAAACCGCGA 
PPARD GCATGGGGACGGCGTCGGGCTCACTACGGCGTTCACGCTTGTGAGGGATGC
AAGGGCTTCTTCCGTCCACAAA 
ACOX1 ATCCTCGTATCCGCGTTCAGGGTGCGTTTAAGAAGAGTGCCATCATGGTGCA
GAAGATGAGGAAATCCCC 
PLIN2 ACGTGCGTCGTCGTTCGTATAAAACACCTTCATGTAGGCTGTTGTATGAATT
GGGGTCCGCTCTGAGAC 
CPT1A GGACTATGAAGGTAAACCAGGCCCGGGACGCCCTTCGTACAGGCCTCTCGC
TCCAGCTGGCTCATTACAAGGGACCA 
FABP1 GAGGGAGGAGTGTGAGATGGAGTTCATGACTGGGAGAGAAGATCAAGGCA
GTGGA 
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Table 3.3. Percentage of long-chain fatty acids in liver phospholipids during the peripartal 
period in cows fed (n = 5/treatment) control, fish oil (FISH), or saturated lipid (SFAT).    
Fatty acid1 Treatment 
Day 
SEM 
P value 
-21 -10 1 11 Diet Day Diet × day 
16:0 CON 9.47 11.28 12.86 12.90 0.96 0.34 <0.01 0.39 
 SFAT 10.58 10.98 12.55 12.12     
 FISH  12.55 10.32 13.25 13.33     
18:0 CON 30.58α 30.07aα 27.34abβ 27.01γ 1.11 0.62 <0.01 <0.01 
SFAT 31.08α 31.01aα 26.80aβ 27.65β 
FISH  30.03α 25.59bβ 29.68bαγ 28.44 αγ 
18:1cis9 CON 0.57 0.82 0.90 0.78 0.11 0.21 <0.01 0.73 
 SFAT 0.75 0.81 0.88 0.88     
 FISH  0.43 0.70 0.83 0.84     
18:1trans11 CON 0.76a 0.91a 0.87a 0.79ab 0.14 <0.01 <0.01 <0.01 
 SFAT 0.74a 0.56a 0.86a 0.54a     
 FISH   0.37bα 4.95bβ 1.50bγ 0.97bδ     
18:2c9t11 CON 0.16 0.20 0.27 0.22 0.02 <0.01 <0.01 0.23 
 SFAT 0.14 0.13 0.28 0.16     
 FISH   0.07 0.13 0.21 0.17     
18:2n-6 CON 9.64α 10.35aα 13.16aβ 13.15β 0.88 <0.01 <0.01 0.03 
 SFAT 9.62α 9.87aα 13.25aβ 13.45β     
 FISH   10.29α 7.09bβ 9.46bα 13.16γ     
18:3n-3 CON 0.93bα 0.95α 1.37abβ 1.24α 0.12 0.49 <0.01 0.03 
 SFAT 1.12abα 0.89α 1.64aβ 1.17α     
 FISH   1.26aα 0.79β 1.14bα 1.28α     
20:4n-6 CON 11.76αβ 10.60α 10.92bα 12.29aβγ 0.53 <0.01 <0.01 0.02 
 SFAT 11.29α 10.45αβ 9.87abβ 11.42aα     
 FISH   11.24α 10.34αβ 9.01aβγ 8.82bγ     
20:5n-3 CON 1.43 1.43a 1.44a 1.69a 0.21 <0.01 <0.01 <0.01 
 SFAT 1.59α 1.51aα 1.52aα 2.21aβ     
 FISH   1.30α 4.03bβ 4.33bβ 3.94bβ     
22:5n-3 CON 0.71 0.68 0.43 0.36 0.07 0.01 <0.01 0.10 
 SFAT 0.64 0.65 0.41 0.28     
 FISH   0.70 0.93 0.65 0.27     
22:6n-3 CON 0.94 0.92a 0.92a 0.89a 0.29 <0.01 <0.01 <0.01 
 SFAT 0.97 0.84a 0.83a 0.76a     
 FISH   0.90α 7.72bβ 7.97bβ 6.58bγ     
a-c Difference (P< 0.05) between diets on the same day. 
αβγδ Significant interactions (P<0.05) within a diet and between days.  
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 Table 3.4. Percentage of long-chain fatty acids in liver triacylglycerol during the peripartal  
period in cows fed (n = 5/treatment) control, fish oil (FISH), or saturated lipid (SFAT). 
Fatty acid Treatment 
Day 
SEM 
P value 
-21 -10 1 11 Diet Day Diet × day 
16:0 CON 32.21 33.23 38.76 39.37 1.80 0.03 <0.01 0.87 
 SFAT 35.10 36.70 39.14 40.42     
 FISH  33.05 33.03 35.46 37.10     
18:0 CON 20.59 18.00 6.87 7.56 1.93 0.18 <0.01 0.82 
 SFAT 18.11 18.87 9.37 6.27     
 FISH   16.86 15.56 6.59 5.77     
18:1cis9 CON 14.28 13.82 20.90 20.72 2.63 0.92 <0.01 0.21 
 SFAT 14.35 12.81 21.16 19.57     
 FISH   20.04 14.00 14.92 21.69     
18:1trans11 CON 0.85 0.99 1.07 0.72 0.24 0.04 0.01 0.06 
 SFAT 0.84 0.66 1.22 0.86     
 FISH   0.41 1.47 1.76 1.43     
18:2c9t11 CON 0.07 0.12 0.26 0.26 0.04 0.85 <0.01 0.33 
 SFAT 0.12 0.08 0.26 0.20     
 FISH   0.11 0.04 0.29 0.28     
18:2n-6 CON 4.48 4.88 6.45 7.75 0.60 0.14 <0.01 0.80 
 SFAT 4.29 4.36 5.52 6.42     
 FISH   3.68 4.01 6.22 7.31     
18:3n-3 CON 0.50 0.73 1.36 1.34 0.20 0.33 <0.01 0.19 
 SFAT 0.89 0.46 1.54 1.16     
 FISH   0.62 0.54 1.74 1.74     
20:4n-6 CON 2.24 2.77 0.60 0.81 0.59 0.90 <0.01 0.44 
 SFAT 2.92 2.42 0.45 0.51     
 FISH   1.81 3.93 0.66 0.57     
20:5n-3 CON 0.06α 0.24β 0.07aα 0.11aαβ 0.06 <0.01 0.23 0.04 
 SFAT 0.15 0.11 0.06a 0.10a     
 FISH 0.09α 0.25αβ 0.36bβγ 0.29bβγ     
22:5n-3 CON 0.62α 1.30bβ 0.62aα 0.61aα 0.20 <0.01 0.02 <0.01 
 SFAT 0.52 0.69a 0.61a 0.56a     
 FISH   0.47α 0.84abα 1.61bβ 1.57bβ     
22:6n-3 CON 0.04b 0.27ab 0.04a 0.06a 0.10 <0.01 <0.01 <0.01 
 SFAT 0.35aα 0.04aβ 0.06aβ 0.04aβ     
 FISH   0.09abα 0.46bβ 1.26bγ 1.01bγ     
a-c Difference (P< 0.05) between diets on the same day. 
αβγδ Significant interactions (P<0.05) within a diet and between days.  
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Table 3.5. Relative expression (treatment means, log-2 scale) of genes involved in fatty acid uptake, esterification, desaturation, lipid 
droplet formation, fatty acid oxidation, gluconeogenesis and cellular energy during the peripartal period in cows fed (n = 5/treatment) 
control, fish oil (FISH), or saturated lipid (SFAT). 
 Prepartum Postpartum  P value 
Gene Control FISH SFAT Control FISH SFAT SEM Diet Time D × T
Fatty acid uptake/transport 
CD36 -0.02a -0.59ab* -1.48b 0.12a -1.91b* -1.07ab 0.43 0.06 0.18 <0.01 
FABP1 1.34* 1.39 0.99* 1.99a* 0.99b 1.50ab* 0.24 0.20 0.13 <0.01 
Esterification, desaturation, lipid droplet formation 
DGAT2 1.49a 0.96ab 0.33b* 2.09a 1.00b 1.52ab* 0.34 0.13 <0.01 <0.05 
SCD -0.43a* -4.11c -2.02b -1.69a* -4.21b -1.72a 0.38 <0.01 0.22 0.09 
PLIN2 2.59 1.97* 1.42* 3.21a 0.97b* 2.29a* 0.41 <0.05 0.43 <0.01 
PLIN4 -2.57 -2.38 -2.71 -1.90 -3.38 -3.12 0.51 0.45 0.33 0.09 
Fatty acid oxidation          
ACSL1 3.95a* 2.88ab* 2.72b* 4.76a* 2.12*c 3.40*b 0.41 <0.01 0.21 0.02 
ACOX1 2.71a 2.24a* 1.22b* 2.24ab 1.36b* 2.48a* 0.33 0.10 0.9 <0.01 
CPT1A 3.08 2.92 2.20 3.54 1.76 2.20 0.71 0.20 0.54 0.14 
FGF21 -0.51* -0.06 1.07 5.55a* 2.10b 1.08b 1.09 0.33 <0.01 <0.01 
Gluconeogenesis 
PC 3.57* 3.25 2.83 5.73a* 2.95b 3.54b 0.53 0.06 <0.01 <0.01 
PCK1 3.76* 3.72 3.49 5.13a* 3.10b 3.21b 0.51 0.17 0.56 0.04 
Intracellular energy  
UCP2 2.98 2.76* 1.60 1.96 0.76* 1.62 0.67 0.33 0.04 0.04 
PRKAA1 3.80 3.59* 2.90 4.19ab 2.36b* 2.90ab 0.50 0.22 0.16 0.01 
STK11 4.09 3.78* 2.96 3.57 2.39* 2.81 0.44 0.21 <0.01 0.04 
 a-c Difference (D × T, P < 0.05) between diets at prepartum or postpartum times. 
 *Difference (D × T, P < 0.05) prepartum vs. postpartum within diet.    
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Table 3.6. Relative expression (treatment means, log-2 scale) of genes encoding transcription regulators, nuclear receptor co-
activators and co-repressors during the peripartal period in cows fed (n = 5/treatment) control, fish oil (FISH), or saturated lipid 
(SFAT).   
 Prepartum Postpartum  P value 
Gene Control FISH SFAT Control FISH SFAT SEM Diet Time D × T
Transcription regulators 
PPARA 0.24 0.24 0.24 0.24 0.23 0.24 0.24 0.54 0.31 0.88 
RXRA 3.17 2.85 2.31 2.60 1.36 2.24 0.57 0.30 0.07 0.77 
PPARD 3.18 2.86* 1.93 3.72a 1.19b* 2.22b 0.45 0.04 0.18 <0.01 
SREBF2 4.43a 3.74ab* 3.18b 3.72a 2.59b* 3.74a 0.36 0.01 0.66 0.02 
Nuclear receptor co-activators 
CARM1 4.20a 3.48b* 2.84b 4.04a 2.10b* 3.24ab 0.37 0.03 0.08 <0.01 
MED1 4.30a 3.57b* 2.89b 4.21a 2.15c* 3.37b 0.38 0.02 0.12 <0.01 
Nuclear receptor co-repressors          
NCOR2 3.67a 3.00ab* 2.35b 3.69a 1.91b* 2.73b 0.33 0.01 0.30 0.04 
NRIP1 3.60a 2.78b* 2.40b 3.48a 1.64b* 2.72b 0.36 0.03 0.14 0.03 
 a-c Difference (D × T, P < 0.05) between diets at the prepartum or postpartum times. 
 *Difference (D × T, P < 0.05) prepartum vs. postpartum within diet. 
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Table 3.7. Relative expression (treatment means, log-2 scale) of genes involved in inflammation and cell growth during the peripartal 
period in cows fed (n = 5/treatment) control, fish oil (FISH), or saturated lipid (SFAT). 
 Prepartum Postpartum  P value 
Gene Control FISH SFAT Control FISH SFAT SEM Diet Time D × T
Inflammation related genes 
IL6 3.04a 2.11a* 1.06b 2.32a 0.90b* 1.48b 0.35 0.01 0.03 0.02 
TBK1 4.37a 3.68a* 2.78b 4.04a 1.98b* 3.44a 0.38 0.03 0.05 <0.01 
IKBKE 3.58a 3.28a* 2.17b 3.34a 1.39b* 2.76a 0.37 0.05 0.03 <0.01 
Apoptosis           
CIDEB 5.38 4.40* 4.18 5.63a 3.52b* 4.82a 0.40 0.02 0.99 0.04 
 a-c Difference (D × T, P < 0.05) between diets at the prepartum or postpartum times. 
 *Difference (D × T, P < 0.05) prepartum vs. postpartum within diet.  
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CHAPTER 4: Postpartal subclinical endometritis alters transcriptome profiles in liver and 
adipose tissue of dairy cows 
Haji Akbar1, Felipe C. Cardoso1, Susanne Meier2, Christopher Burke2, Scott McDougall3, 
Murray Mitchell4,5, Caroline Walker2, Sandra L. Rodriguez-Zas1, Robin E. Everts1, Harris A. 
Lewin1, John R. Roche2, and Juan J. Loor1,6* 
 
 
 
 
 
 
 
This study has been published in its complete information   in gene regulation and system 
biology and cited in this chapter of dissertation as “Akbar et al 2014”. Akbar, H., F. C. Cardoso, 
S. Meier, C. Burke, S. McDougall, M. Mitchell, C. Walker, S. L. Rodriguez-Zas, R. E. Everts, H. 
A. Lewin, J. R. Roche, and J. J. Loor. 2014. Postpartal subclinical endometritis alters 
transcriptome profiles in liver and adipose tissue of dairy cows. Bioinform Biol Insights 8:45-
63." Available at 
http://www.ncbi.nlm.nih.gov/pubmed/?term=Postpartal+Subclinical+Endometritis+Alters+Trans
criptome+Profiles+in+Liver+and+Adipose+Tissue+of+Dairy+Cows and using DOI: 
10.4137/BBI.S13735  
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ABSTRACT 
Transcriptome alterations in liver and adipose tissue of cows with subclinical 
endometritis (SCE) at 29 d postpartum were evaluated. Bioinformatics analysis was performed 
using the Dynamic Impact Approach by means of KEGG and DAVID databases. Milk 
production, blood metabolites (non-esterified fatty acids, magnesium), and disease biomarkers 
(albumin, aspartate aminotransferase) did not differ greatly between healthy and SCE cows. In 
liver tissue of cows with SCE, alterations in gene expression revealed an activation of 
complement and coagulation cascade, steroid hormone biosynthesis, apoptosis, inflammation, 
oxidative stress, MAPK signaling, and the formation of fibrinogen complex. Bioinformatics 
analysis also revealed an inhibition of vitamin B3 and B6 metabolism with SCE. In adipose, the 
most activated pathways by SCE were nicotinate and nicotinamide metabolism, long-chain fatty 
acid transport, oxidative phosphorylation, inflammation, T cell and B cell receptor signaling, and 
mTOR signaling. Results indicate that SCE in dairy cattle during early lactation induces 
molecular alterations in liver and adipose tissue indicative of immune activation and cellular 
stress. 
Key Words: uterine infection, liver, adipose, cow genomics. 
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INTRODUCTION 
Endometritis is an inflammation of the uterine internal lining that develops in many cows 
soon after parturition (“calving”) (Sheldon et al., 2009). Clinical endometritis is characterized by 
the presence of a purulent uterine discharge (>50% pus) in the first 21 days postpartum or 
mucupurulent discharge (50% pus, 50% mucus) after 26 days postpartum (Sheldon et al., 2006). 
It affects approximately 20% of lactating dairy cows, with a prevalence varying from 5% to 
>30% in certain herds (Galvao et al., 2009, LeBlanc et al., 2002). Subclinical endometritis (SCE) 
is typically defined as an elevated percentage of polymorphonuclear (PMN) cells in the uterus 
(Hammon et al., 2006, Kasimanickam et al., 2004). The SCE is characterized by the presence of  
>18% PMN in uterine cytology samples collected at 21 to 33 days postpartum, or >10% PMN in 
samples collected at 34 to 47 days postpartum (Sheldon et al., 2006). The incidence of SCE is the 
most prevalent of all uterine pathologies, affecting approximately 30% of lactating dairy cows, 
with a prevalence varying from 11% to > 70% in certain herds (Cheong et al., 2011, Galvao et 
al., 2009a, Gilbert et al., 2005). During the endometritis process, dairy cows experience a 
decrease in blood PMN function when compared with healthy cows (Hammon et al., 2006). 
Furthermore, cows afflicted with endometritis have reduced fertility (McDougall et al., 2007, 
Pleticha et al., 2009) and may have an impairment of both the innate and adaptive immune 
system(Bondurant, 1999, Levkut et al., 2002) rendering them more susceptible to other diseases. 
Elevated non-esterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA) and lower 
glucose and calcium plasma concentrations are some of the biomarkers often associated with 
periparturient immune function suppression and uterine health disorders (Galvao et al., 2010, 
Hammon et al., 2006, Rukkwamsuk et al., 1999). However, in a recent study with grazing cows, 
no change was observed in plasma concentrations of NEFA, BHBA, and glucose in cows with 
signs of SCE, whereas, a lower albumin plasma concentration indicated impaired liver function 
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(Burke et al., 2010). Consistent with this, other studies have reported an association between 
higher plasma concentrations of positive acute-phase proteins and clinical endometritis (Bertoni 
et al., 2008, Sheldon et al., 2004), suggesting a pro-inflammatory response involving the liver in 
affected cows. 
In addition to the liver, recent research on the immune role of adipose depots confirmed 
that the tissue (and resident immune cells) is capable of synthesizing and releasing adipokines, 
chemokines, cytokines and inflammatory mediators upon exposure to an inflammatory condition 
(Ingvartsen and Boisclair, 2001, Mukesh et al., 2010). This peculiarity of the adipose tissue 
might be relevant during early lactation when there is extensive mobilization of all fat depots 
(Butlerhogg et al., 1985) Therefore, knowledge of both hepatic and adipocyte responses to a pro-
inflammatory condition, such as SCE, might be important in understanding the cow’s systemic 
adaptations to the disease. It is noteworthy that a recent study demonstrated that SCE leads to 
alterations in gene expression profiles of both endometrium and embryo, hence, underscoring the 
potential for localized uterine inflammation to affect other tissues or cells.(Hoelker et al., 2012) 
Previous work focusing on specific target genes associated with inflammation in dairy 
cows has demonstrated the relevance of the molecular approach in helping uncover the cellular 
processes induced by endometritis (Gabler et al., 2010). However, large-scale gene expression 
profiling (i.e. transcriptomics) coupled with bioinformatics are better suited for integrating host-
tissue responses to changes in disease state (Loor et al., 2011). Therefore, in addition to blood 
metabolites and enzymes, we sought to study transcriptome-wide changes in liver and 
subcutaneous adipose tissue using a bovine microarray and bioinformatics analysis. 
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MATERIALS AND METHODS 
Animal experimental design 
All animal procedures were approved by the Ruakura Animal Ethics Committee 
(Hamilton, New Zealand). Cows grazed pasture, managed in an intensive rotational manner 
(Roche and Berry, 2006). Uterine sampling was undertaken twice a week between 22 and 25 
days postpartum for evaluation of polymorphonuclear cells (PMN) and uterine bacteriology. 
Cows with calving difficulties, retained placenta, or those treated with antibiotics during the first 
30 days postpartum were excluded from the study. 
Selection of cows 
The criterion for cow selection was based on the percentage of PMN in the uterine swab. 
Cows with no PMN or macrophages identified were classified as no uterine infection (NUI) 
whereas, cows with >18% PMN with an absence of macrophages were classified as SCE. Cows 
were paired (a NUI and a SCE cow), ensuring a balance (as best as possible) for calving date, 
breed, and age (Kasimanickam et al., 2004). 
Body condition score (BCS) and milk yield 
Body condition was measured on the New Zealand 1 to 10 scale, where 1 was emaciated 
and 10 obese (Roche et al., 2004). Individual body condition and body weight were measured 
weekly pre- and post-calving. Individual milk yields (kg/d) were recorded using the DeLaval 
Harmony & ALPRO® milking system with milking point controller (MPC™) at each bail 
recording for each cow. 
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Blood metabolites  
Blood was collected by jugular venipuncture into multiple evacuated blood tubes (EDTA, 
heparin, clot-activator; Becton & Dickinson, New York, USA) on the day of slaughter and 
immediately placed in iced water. After collection, samples were centrifuged within 30 min (12 
min at 1,500 × g) and the aspirated plasma and serum fractions were stored at -20 °C until further 
analysis. Plasma samples were analyzed for concentrations of NEFA (WAKO, Osaka, Japan), 
Mg (xlidyl blue reaction), albumin (bromocresol green reaction at pH 4.1), and total protein 
(Biuret reaction method), with globulin calculated by subtracting albumin from total protein. 
Glutamate dehydrogenase (GDH, IU/L; catalyzing activity of NADH-dependent conversion of α-
ketoglutarate to glutamate), and aspartate aminotransferase (AST, IU/L; catalyzing activity of 
transamination of L-aspartate to oxaloacetate) were also analyzed. All assays were colorimetric, 
and performed at 37oC using a Roche Modular P800 analyzer (Roche Diagnostics, Indianapolis, 
IN) by Gribbles Veterinary Pathology Ltd (Hamilton, New Zealand). The inter-assay and intra-
assay CV for all assays were ≤11% and ≤2%, respectively. 
Tissues collection and RNA extraction 
Animals (6 in each NUI and SCE) were slaughtered at a commercial abattoir 
(AgResearch Abattoir, Hamilton, New Zealand) at 29 days postpartum (range of 27-31 days). 
Samples of liver and subcutaneous adipose tissue from the shoulder (~1.0 g) were stored in 2 mL 
cryo-vials and placed in liquid nitrogen. All tissue samples were subsequently stored at -80oC 
within 30 to 50 min after exsanguination. RNA was extracted from frozen tissue using 
established protocols in our laboratory (Loor et al., 2007). Briefly, tissue was weighed (~0.3-0.5 
g) and placed in a 15 mL centrifuge tube (Corning Inc. ®, Cat. No. 430052, Corning, NY, USA) 
containing 1 µL linear acrylamide (Ambion® Cat. No. 9520, Austin, TX, USA) as a co-
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precipitant, and 5 mL of ice-cold Trizol reagent (Invitrogen Corp., Carlsbad, CA, USA). Samples 
were homogenized using a hand-held polytron homogenizer. This extraction procedure also 
utilizes acid-phenol chloroform (Ambion® Cat. No. 9720, TX, USA), which removes residual 
DNA. Any residual genomic DNA was removed from RNA with DNase using RNeasy Mini Kit 
columns (Qiagen, Hilden, Germany). The RNA concentration was measured using a Nano-Drop 
ND-1000 spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA). The purity of 
RNA (A260/A280) for all samples was above 1.81. The quality of RNA was evaluated using the 
Agilent Bioanalyzer system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, 
USA). The average RNA integrity number for samples was 8.0  0.4.  
Microarrays 
Transcript profiling was conducted using a bovine oligonucleotide microarray containing 
~13,000 unique elements described elsewhere (Loor et al., 2007). The methods used for 
hybridization and scanning were consistent with those of Loor et al.(Loor et al., 2007) 
Annotation was based on similarity searches using BLASTN and TBLASTX against human and 
mouse UniGene databases and the human genome. Briefly, cDNA was labeled with Cy3 and 
Cy5 fluorescent dyes (Amersham, Piscataway, NJ). A dye-swap loop microarray design was 
used; briefly, the Cy3 labeled cDNA (T1) from SCE was co-hybridized with Cy5 labeled cDNA 
(C1) from NUI liver samples to generate fluorescence ratios as a measurement of relative 
expression across the treatments. Moreover, in the next microarray slide the Cy3-labeled cDNA 
(C1) of the same NUI sample was co-hybridized with another Cy5-labeled (T2) SCE sample to 
form a loop (Appendix–C Suppl. Figure C.1). 
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Quantitative PCR  
Quantitative real-time PCR (qPCR) was performed to verify microarray results and 
analyze other genes of interest. Protocols for primer design, primer testing, selection of internal 
control genes (ICG) for normalization, and details of the qPCR analysis were as previously 
described (Akbar et al., 2013a). Detailed information of the primers is provided in Appendix–C 
suppl. tables (C.1 and C.2). Briefly, for liver tissue the genes analyzed by qPCR included 
transcription regulators (PPARA, RXRA, NFIL3), genes associated with fatty acid oxidation 
(ACOX1, CPT1A), ketogenesis (HMGCS2), growth hormones/IGF-1-axis (total GHR, IGF1), 
cytokines /inflammatory mediators (IL10, IL1B, TNF, STAT3, SOCS2, STAT5B), acute-phase 
proteins (ORM1, HP, SAA, PON1), oxidative stress (SOD1, GPX1), hepatokines (ANGPTL4, 
FGF21) and insulin signaling (AKT1). These targets are central components of the pathways 
under study (Loor, 2010). The final data were normalized using the geometric mean (V2/3 = 
0.20; geNorm) of ubiquitously-expressed transcript (UXT), glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), and ribosomal protein S9 (RPS9), detailed information of qPCR 
efficiency and % relative RNA abundance can be found in Appendix–C Suppl. table C.3. 
For subcutaneous adipose tissue the genes analyzed by qPCR included transcription 
regulators (RXRA, PPARG, SREBF1, TP53, NFIL3), lipogenic enzymes (LP1N2, SCD, FASN), 
lipolysis (ABHD5, LIPE, PNPLA2), insulin signaling pathway (GHR, SLC2A4, IRS), adipokines 
(ADIPOQ, ANGPTL4, CCL5, BCL2, CCL2), cytokines/inflammatory mediators (IL6, HP, SAA, 
NFKB1, STAT3) and oxidative stress (SOD2). These targets are central components of the 
pathways under study and some have been reported to respond to inflammatory stimuli.(Ji et al., 
2012a, Mukesh et al., 2010) The final data were normalized using the geometric mean (V2/3 = 
0.20; geNorm) of FUN14 domain containing 2 (FUNDC2), secretion regulating guanine 
nucleotide exchange factor (SERGEF), solute carrier family 35 (adenosine 3'-phospho 5'-
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phosphosulfate transporter), member B2 (SLC35B2), and prokineticin receptor 1 (PROKR1). The 
detailed information for qPCR efficiency and % relative RNA abundance of the measured genes 
is provided in Appendix–C Suppl. table C.4. 
Statistical analysis  
Data from a total of 12 microarrays were normalized for dye and microarray effects (i.e., 
Lowess normalization and microarray centering) and used for statistical analysis (Loor et al., 
2007). Data were analyzed using the Proc MIXED procedure of SAS (SAS, SAS Inst. Inc., Cary, 
NC). Fixed effects were treatment (SCE = infection and NUI = control), and random effects 
included cow and microarray. Quantitative PCR data normalized relative to the internal control 
genes were first log2-transformed prior to statistical analysis. Differentially expressed genes were 
determined as reported recently (Piantoni et al., 2012) using a cutoff of P < 0.05 and a fold-
change greater or lower than 1.5 in the comparison of SCE versus NUI. Validation for this 
approach (which does not take into account multiple testing corrections) was reported previously 
(Guo et al., 2006, Shi et al., 2008).  
Bioinformatics 
The entire microarray data set with associated statistical P-values was imported into the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang et al., 2009) 
analyses tools (http://david.abcc.ncifcrf.gov) and Kyoto Encyclopedia of Genes and Genomes 
(KEGG) software to obtain significant gene ontology (GO) terms in different categories 
(molecular functions, biological pathways and cellular components). The whole annotated 
microarray was used as the reference dataset (i.e., background) for pathway analysis, i.e. only 
pathways represented by the genes on the microarray platform were used for the bioinformatics 
analysis. 
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Functional enrichment analysis   
The functional enrichment analysis was performed using the Dynamic Impact Approach 
(DIA) (Bionaz et al., 2012). The DIA is a novel functional analysis tool that allows visualizing 
the impact and the direction of the impact of DEG on several annotation databases included GO 
and KEGG pathways. The DIA has been described in detail previously (Bionaz et al., 2012); 
briefly, the alterations in expression of proteins in a metabolic or signaling pathway determine 
the flux (or overall direction, i.e. activation/up-regulation, inhibition/down-regulation, or no 
change) of the respective pathway, whereas, the extent of the impact on a pathway is directly 
depicted by the number of proteins affected by a particular treatment. The cumulative flux of 
pathways is determined by total number of up-regulated and down-regulated proteins involved in 
a pathway. If the ratio of up-regulated/down-regulated = 1, the flux can be taken as unchanged 
overall, regardless of the fact that the treatment had a large impact on the pathway.(Morandini, 
2009) The impact and the flux for KEGG pathways were calculated for only those terms which 
were represented by at least 30% in the microarray compared with the whole annotated bovine 
genome.  
RESULTS 
Body condition score (BCS), milk production and blood metabolites   
There was a postpartum (P < 0.01) decrease in BCS, but no effect of health status was 
observed (P = 0.45) (Figure 4.1). There were no health status  week relative to parturition 
interactions (P = 0.76) for BCS. Irrespective of health status (P = 0.78), milk yield increased 
between day 1 and 29 postpartum (P = 0.07). However, there was a trend (P = 0.07) for an 
interaction of health status  week for daily milk yield due to healthy cows producing more milk 
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through the first 3 weeks postpartum (Figure 4.1). There was no effect (P = 0.11 to 0.70) of 
health status on the concentration of blood biomarkers measured (Table 4.1). 
Differential expression of genes using microarrays 
The analysis of microarray data revealed a total of 97 differentially expressed genes 
(DEG; P < 0.05, fold-change cut off ≥1.5 or ≤1/1.5 SCE vs. NUI) in liver (35 down-regulated, 
62 up-regulated) (Table 4.2). The primary up-regulated DEG included genes involved in steroid 
biosynthesis (CYP11A1), acute-phase and pro-inflammatory proteins synthesis (IL1RAP), 
GTPase activity and leukemogenesis (RGS2),  beta component of fibrinogen (FGB), lipid 
uptake, transport and metabolism (FABP5, APOC4), oxidative phosphorylation (ATP5A1, 
ATP5G3) and cell growth (GRN) and complement system (C1QA). Whereas, the primary down-
regulated DEG included genes involved in peptide hormone binding (NPR3), immune system 
and inflammation (IFITM3, CCR4, AOX1), breakdown of extracellular matrix (MMP7), ATP 
binding (CKM), and fatty acid catabolism (ACOT7) (Table 4.2). 
Microarray analysis of adipose uncovered 144 DEG (P < 0.05, fold-change cut off ≥1.5 
or ≤1/1.5 SCE vs. NUI) (82 down-regulated, 62 up-regulated) (Table 4.3). The primary up-
regulated DEG included genes involved in endogenous cholesterol synthesis (SREBF2), NAD 
metabolism (NUDT12, UGDH), cytokine-mediated signaling (IRF2), oxidative phosphorylation 
(NDUFS6), and insulin signaling (AKT2). Whereas, the primary down-regulated DEG included 
genes involved in golgi complex morphology and function (CORO7), cytokine-mediated 
signaling (IFITM3), calcium ion binding (ANXA6), oxidative phosphorylation (NDUFS7), and 
apoptosis (HIC1) (Table 4.3). 
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Differential expression of genes by qPCR 
Expression analysis by qPCR in liver tissue revealed a significant up-regulation of total 
GHR (somatotropic axis), HP (acute-phase protein), SOD2 and GPX1 (oxidative stress), and 
RXRA (fatty acid oxidation) in cows with SCE (Table 4.4). In subcutaneous adipose tissue, 
infection was associated with up-regulation of TP53 (transcription factor), IL6 and CCL2 
(adipokines), and tended (P = 0.16) to increase STAT3 (inflammation). The expression of the 
lipid droplet-associated gene PLIN2, SLC2A4 and IRS1 (insulin signaling), and SOD2 (oxidative 
stress) in adipose was down-regulated in SCE (Table 4.5).  
Functional analysis of KEGG pathways using DIA  
Liver. A functional analysis of DEG (P < 0.05, fold-change cut off ≥1.5 or ≤1/1.5 SCE 
vs. NUI) was undertaken with DIA using the KEGG pathway database. In liver, the metabolic 
pathways and organismal systems categories were the most impacted due to SCE; whereas, 
environmental information processing, genetic information processing and cellular processes 
were the least impacted categories (Figure 4.2). Among the top metabolism subcategories 
affected by SCE, there was an overall inhibition of vitamin B6 metabolism, nicotinate and 
nicotinamide metabolism (metabolism of cofactors and vitamins), and arginine and proline 
metabolism (amino acid metabolism) (Figure 4.3). Biosynthesis of unsaturated fatty acids (lipid 
metabolism), tyrosine metabolism, tryptophan metabolism, and drug metabolism – cytochrome 
P450 also were among the top 50 inhibited metabolism subcategories (Akbar et al 2014; 
Additional file 1, KEGG Liver sheet). The analysis further uncovered that steroid hormone 
biosynthesis (lipid metabolism), pentose inter-conversion (carbohydrate metabolism), 
glycosaminoglycan biosynthesis–keratan sulfate (glycan biosynthesis and metabolism), and 
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oxidative phosphorylation (energy metabolism) were the most activated subcategories (Figure 
4.3; Akbar et al 2014; Additional file 1, KEGG Liver sheet).  
Among the top subcategories within hepatic organismal system that were highly-
impacted and activated with SCE were complement and coagulation cascades and chemokine 
signaling pathway (immune system), aldosterone-regulated sodium reabsorption (excretory 
system), and PPAR signaling pathway (endocrine system) (Figure 4.3). Another activated 
subcategory with a role in the immune response was cytokine-cytokine receptor interaction 
within the environmental information processing category (Akbar et al 2014; Additional file 1: 
KEGG Liver Sheet). Within cellular processes, the most induced pathways included regulation 
of autophagy, lysosome and endocytosis (transport and catabolism), and apoptosis (cellular 
growth and death) (Akbar et al 2014; Additional file 1: KEGG Liver Sheet). Within the genetic 
information processing category, transcription, translational and protein export were the most 
activated and the SNARE interactions in vesicular transport was the most inhibited pathway 
(Figure 4.3). Subclinical endometritis also was associated with induction of calcium signaling 
pathway, GnRH signaling pathway, and hedgehog signaling pathway among the top 50 
subcategories (Akbar et al 2014; Additional file 1: KEGG Liver Sheet).  
Adipose. Functional analysis of the adipose microarray data revealed that metabolism, 
genetic information processing, and organismal system categories were the most impacted; 
whereas, cellular processes and environmental information processing were the least impacted 
categories (Figure 4.4). Within the metabolism category, the most activated terms in the top 20 
subcategories affected (Figure 4.5) include nicotinate and nicotinamide metabolism (metabolism 
of cofactors and vitamins), pentose and glucuronate interconversions, starch and sucrose 
metabolism, ascorbate and aldarate metabolism (carbohydrate metabolism), amino sugar and 
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nucleotide sugar metabolism, and oxidative phosphorylation (energy metabolism) (Figure 4.5). 
The DIA also uncovered an inhibition of fructose and mannose metabolism among the top 20 
affected subcategories (Figure 4.5).  
In addition, galactose metabolism (carbohydrate metabolism), cysteine and methionine 
metabolism, (amino acid metabolism), glycosaminoglycan biosynthesis - keratan sulfate, N-
glycan biosynthesis, and glycosphingolipid biosynthesis - lacto and neolacto series (Glycan 
biosynthesis and metabolism) were among the top 50 metabolism subcategories affected (Akbar 
et al 2014; Additional file 1: KEGG Adipose Sheet).  Within the top 20 genetic information 
processing subcategories affected, the RNA degradation and basal transcription factor were the 
most impacted and activated, while RNA polymerase, protein export and sulfur-relay system 
were the most impacted and inhibited pathways (Figure 4.5).  
Among the top 20 affected subcategories, the peroxisome (cellular process) was the 
second most affected and along with spliceosome were overall activated (Figure 4.5). Within 
adipose organismal system and among the top 50 affected subcategories the most impacted and 
activated pathways include T cell and B cell receptors signaling and Fc gamma R-mediated 
phagocytosis (immune system) (Akbar et al 2014; Additional file 1: KEGG Adipose sheet); 
whereas, aldosterone-regulated sodium reabsorption (excretory system) and circadian rhythm 
(environmental adaptation) were the most impacted and inhibited pathways among the top 20 
affected subcategories (Figure 4.5). Among the top 20 affected subcategories, extracellular 
matrix (ECM)-receptor interaction (signaling and molecular interaction) was overall activated 
(Figure 4.5). Among the top 50 affected subcategories, SCE was associated with an overall 
activation of mTOR signaling and VEGF signaling (Akbar et al 2014; Additional file 1: KEGG 
Adipose sheet).  
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Gene ontology (GO) functional categories affected by subclinical endometritis as uncovered by 
the DIA  
We used the DIA to uncover the impact and direction (flux) of the pathways within the 
terms obtained from DAVID (Akbar et al 2014; Additional file 1: DAVID Liver Up and Down 
sheets) as it relates to GO Biological Process (GOTERM_BP_FAT), Molecular Function 
(GOTERM_MF_FAT), Cellular Components (GOTERM_CC_FAT), KEGG_PATHWAY, and 
SP_PIR_KEYWORDS. A cutoff of the mean plus 1 standard deviation was used to obtain the 
top impacted pathways in each term. Detailed results from DIA are reported in Akbar et al 2014; 
additional file 1 (Liver DIA sheet).  
The functional enrichment analysis of GO biological process (GOTERM_BP_FAT) with 
DIA revealed that the top 10 most impacted and activated pathways in this category were 
biosynthesis and production of interleukin-2, response to progesterone stimulus, gas 
homeostasis, nitric oxide homeostasis, negative regulation of tyrosine phosphorylation of STAT 
protein, negative regulation of peptidyl-tyrosine phosphorylation, positive regulation of 
sequestering of triglyceride, post-embryonic body morphogenesis, and vitamin D metabolic 
process (Figure 4.6; Akbar et al 2014; Additional file 1, Liver DIA sheet). Other pathways 
among the top 20 with important roles in metabolism included positive regulation of lipid 
storage, negative regulation of nitric oxide biosynthetic process, negative regulation of JAK-
STAT cascade, and positive regulation of lipid storage (Figure 4.6; Akbar et al 2014; Additional 
file 1, Liver DIA sheet).  
The functional enrichment analysis of GO cellular component (GOTERM_CC_FAT) 
with DIA revealed that the top 10 most impacted and activated pathways by SCE in this category 
were autophagic vacuole membrane, fibrinogen complex, smooth endoplasmic reticulum, 
perikaryon, integral to membrane of membrane fraction, very-low-density lipoprotein particle, 
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triglyceride-rich lipoprotein particle, proton-transporting ATP synthase complex, coupling factor 
F(o), high-density lipoprotein particle, and autophagic vacuole (Figure 4.6; Akbar et al 2014; 
Additional file 1, Liver DIA sheet).  
The functional enrichment analysis of GO molecular functions (GOTERM_MF_FAT) 
with DIA revealed that the top 10 most impacted and activated pathways by SCE in this category 
were nitric-oxide synthase binding, interleukin-1 receptor activity, GABA receptor binding, 
cholesterol monooxygenase (side-chain-cleaving) activity, prenylcysteine oxidase activity, 
interleukin-1 binding, L-xylulose reductase (NADP+) activity, formate transmembrane 
transporter activity, N-acylneuraminate cytidylyltransferase activity, and adenosylmetathionine 
decarboxylase activity (Figure 4.6; Akbar et al 2014; Additional file 1, liver DIA sheet). 
Adipose. Among the relevant GO biological process (GOTERM_BP_FAT) that were 
among the top 20 most impacted and activated pathways in this category were positive regulation 
of activin receptor signaling pathway, muscarinic acetylcholine receptor signaling pathway, 
long-chain fatty acid transport, and negative regulation of myoblast differentiation (Figure 4.6; 
Akbar et al 2014; Additional file 1, Adipose DIA sheet). Although with a much lower impact, 
defense response to virus, neuroprotection, and calcium-dependent cell-cell adhesion were 
among the top 50 pathways and were inhibited (Akbar et al 2014; Additional file 1: Adipose DIA 
sheet). Among the top 10 most impacted and activated terms within cellular components 
(GOTERM_CC_FAT) were mitochondrial crista, transcription factor TFIIE complex, collagen 
type I, peroxisome, and lipid particle (Figure 4.6; Akbar et al 2014; Additional file 1, Adipose 
DIA Sheet).  
Within the molecular function (GOTERM_MF-FAT) category, among the top ten 
impacted pathways were NAD+ diphosphatase activity and nucleotide diphosphatase activity 
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which were activated (Figure 4.6). In contrast, carbonate dehydratase activity was among the top 
10 inhibited pathways, and retinoic acid receptor activity among the top 25 inhibited pathways.   
DISCUSSION 
Despite the marked differences in uterine swab PMN percentage, neither the BCS nor the 
blood concentrations of most biomarkers differed between healthy cows and those with SCE. 
However, those responses contrast with the lower milk production (Figure 4.1) during the first 
three weeks of lactation, numerically greater plasma globulin concentration, and changes in gene 
expression in the subcutaneous adipose and liver tissue of cows with SCE. The bioinformatics 
analyses of affected genes revealed alterations in several pathways encompassing nutrient 
metabolism, cell signaling, inflammation, and oxidative stress, among others.  Furthermore, the 
up-regulation of total GHR without a change in IGF1 expression in liver suggested a further or 
more persistent uncoupling of the somatotropic axis in the SCE cows. Molecular data from this 
study are among the first to demonstrate a response in peripheral tissues to the onset of 
subclinical inflammation of the uterine tissue. 
Body condition score (BCS), blood metabolites, and subclinical endometritis 
In the current study, despite the small number of animals, the lack of a health status effect 
on BCS pre or postpartum suggests that loss of BCS due to onset of lactation, per se, is not a 
major risk factor for developing SCE. The lack of differences in concentration of NEFA in the 
present study agrees with previous similar studies (Burke et al., 2010, Dubuc et al., 2010, Senosy 
et al., 2012, Valergakis et al., 2011). Overall, the observations from the present study seem to 
confirm the suggestion of Burke et al. that energy status per se is not a risk factor for SCE (Burke 
et al., 2010).  
 
 
141 
 
Serum globulin concentrations can provide an indication of an animal’s humoral immune 
status or response (Chorfi et al., 2004); a high concentration of globulin and globulin:albumin 
ratio is suggestive of lymphocyte proliferation and greater levels of circulating antibodies (Chorfi 
et al., 2004). The numerically greater concentration of globulin (Table 4.1) is in accordance with 
previous data from cows with endometritis (Burke et al., 2010, Green, 2009), and is indicative of 
an activation of adaptive immune responses. 
The lack of clear differences in concentrations of Mg, AST, and GDH between groups is 
opposite to previous reports of lower Mg concentrations in cows with liver dysfunction (Bertoni 
et al., 2008); whereas, Burke et al.(Burke et al., 2010) reported greater concentrations of AST 
and GDH and lower Mg concentration in cows with SCE. Therefore, in the current study the 
onset of SCE did not seem to cause a severe impairment in liver function and likely explains the 
similar BCS after calving and the small difference in milk production between groups.  
Molecular links between adipose and liver tissue during subclinical endometritis 
Subclinical endometritis induced a state of local inflammation and oxidative stress in 
adipose tissue as indicated by the greater expression of CCL2 and IL6 and the lower expression 
of metabolic-related genes such as PLIN2, SLC2A4, and IRS1 (Table 4.5). At the molecular level 
such changes would have resulted in sustained adipose tissue lipolysis leading to activation of 
long-chain fatty acid transport (Figure 4.6), either for efflux into the blood or as a means to 
recycle fatty acids within the adipose tissue (Nye et al., 2008). Despite the lack of statistical 
difference in the expression of lipogenic genes (SCD, FASN) and transcription regulators 
(SREBF1), the lack of difference in blood NEFA could be taken as indication of greater 
recycling of long-chain fatty acids within adipose tissue. Alternatively, the lack of increase in 
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blood NEFA of cows with SCE resulted from metabolism in liver and/or mammary gland to 
prevent excessive buildup in the circulation.  
The greater hepatic expression of RXRA and the overall activation and high impact of the 
PPAR signaling pathway (Figure 4.4) in SCE cows provides some evidence of greater NEFA 
utilization in liver despite the fact that expression of genes associated with fatty acid oxidation 
(ACOX1, CPT1A) and ketogenesis (HMGCS2) did not differ (Table 4.4). Together with most of 
the blood data, e.g. the lack of change in AST and GDH, which are markers of liver 
function(Bertoni et al., 2008), it appears that SCE did not cause long-term negative effects on 
metabolic activity of liver.  
The tumor suppressor TP53 is a transcription factor that preserves genomic stability and 
prevents oncogenesis. Various genotoxic stresses such as DNA damage, oxidative stress, 
hypoxia, and heat shock can activate TP53, causing changes in the expression of its target genes 
(Oren, 1999). In non-ruminants, in addition to maintaining genomic integrity, TP53 can induce 
proinflammatory cytokines in adipose and cause insulin resistance (Minamino et al., 2009, 
Yahagi et al., 2003). In dairy cows, negative energy balance and inflammatory conditions were 
reported to induce TP53 expression and its signaling in various tissues, e.g. liver, adipose, and 
spleen (Loor et al., 2006, McCabe et al., 2012, Morris et al., 2009, Mukesh et al., 2010). In 
addition to eliciting effects on other genes, TP53 can affect glucose metabolism in insulin-
sensitive tissues by repressing the expression of SLC2A4 (Schwartzenberg-Bar-Yoseph et al., 
2004), which is the insulin-sensitive glucose transporter. The up-regulation of TP53 expression 
(Table 4.5) in adipose tissue and the lower milk production in cows with SCE suggests that the 
availability of glucose for the immune system might have increased at least in part by limiting 
the intracellular glucose transport via direct repression of glucose uptake (Table 4.5, Figure 4.7) 
(Maddocks and Vousden, 2011, Schwartzenberg-Bar-Yoseph et al., 2004). The expression of 
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SLC2A4 in dairy cattle adipose tissue can be up-regulated by feeding diets with greater non-
structural carbohydrate, hence, allowing for greater glucose uptake for lipogenesis (Ji et al., 
2012). 
A recent study also did not find differences in glucose concentration between healthy and 
endometritic cows (Burke et al., 2010). In contrast, Senosy et al. reported that low blood glucose 
is a risk factor in cows diagnosed with endometritis (Senosy et al., 2012).	The difference in the 
response of glucose to endometritis among different studies could be due to the time of sampling, 
e.g.  Senosy et al.(Senosy et al., 2012) observed differences in glucose concentration at 28 days 
postpartum in cows diagnosed with endometritis at 42 days postpartum but in the present study 
the SCE was evaluated at 22 or 25 days postpartum. 
Subclinical endometritis and cholesterol metabolism 
Cholesterol and its derivatives are essential for vital functions in the body; the 
intracellular quantity of cholesterol and its distribution to subcellular compartments (e.g. ER , 
Golgi) are two key regulatory points that help maintain an optimal concentration of cholesterol at 
the cellular level (Storch and Xu, 2009). As in other mammals, the cow achieves cholesterol 
homeostasis through the endogenous synthesis of cholesterol and regulating its turn over via 
lipoprotein metabolism; hepatic gene expression is an important part of the control mechanisms 
involved in this process (Cummins et al., 2006, Viturro et al., 2009)  
Transcriptomic data from liver in the present study indicate that SCE induced 
intracellular cholesterol homeostasis and transport, at least in part, by up-regulating the 
expression of CAV1 and NPC2 (Table 4.2); both genes are involved in intracellular cholesterol 
flux and have important roles in the regulation of intracellular cholesterol homeostasis (Frank et 
al., 2006, Smart et al., 1996, Storch and Xu, 2009). Subclinical endometritis increased hepatic 
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RXRA (Table 4.4), which in addition to enhancing long-chain fatty acid oxidation leads to an 
increase in CAV1 expression (cholesterol homeostasis) (Llaverias et al., 2004). Similar to a 
previous study (Gargalovic and Dory, 2003), the overall activation of apoptosis (Figure 4.4) in 
liver also could have partly mediated the observed change in cholesterol homeostasis and the up-
regulation of CAV1. Although we did not measure it in the study, such response might have 
increased hepatic lipid accumulation.  
Cholesterol is the precursor for steroid hormone synthesis, and the process is initiated by 
cleavage of cholesterol to produce pregnenolone. The observed induction in cholesterol 
monooxygenase activity (the key enzyme) and MAPK activity (Akbar et al 2014; Additional file 
1: Liver DIA sheet) in cows with SCE are noteworthy. The MAPK proteins are known to be 
involved in the regulation of steroid production by different mechanisms; among those, the 
induction of expression of CYP11A1 is very prominent (Singh et al., 1999) Subclinical 
endometritis induced hepatic CYP11A1 (Table 4.2), which catalyzes the conversion of 
cholesterol to pregnenolone, the first and rate-limiting step in the synthesis of the steroid 
hormones. Therefore, MAPK appears to play a role in regulating cholesterol homeostasis in liver 
during endometritis (Go and Mani, 2012). The expression data support observations from a 
recent study, which reported lower cholesterol at wk 4 postpartum in cows diagnosed with 
endometritis at wk 5 (Senosy et al., 2012). Taking into account that samples in our study were 
harvested on day 29 postpartum, we speculate that the decrease in cholesterol at wk 4 in the 
study of Senosy et al.(Senosy et al., 2012) could have been associated with greater cleavage of 
cholesterol to steroids. 
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Molecular signatures of inflammation 
The activation of local and systemic host defense mechanisms requires interactions 
between numerous types of immune cells and inflammatory mediators, such as nitric oxide 
(NO), prostaglandins, and cytokines (Sordillo et al., 2009). Signal transduction occurs via several 
intracellular pathways, including the Janus kinase (JAK)–STAT pathway, the phosphoinositide 
3-kinase (PI3K)–AKT pathway and the MAPK pathway (Boyman and Sprent, 2012). Moreover, 
the complement and coagulation cascades are the first line of defense that helps the host against 
injurious stimuli and inflammation (Amara et al., 2008, Choi G et al., 2006). 
During pathophysiological situations, the activation of these cascades (both complement 
and coagulation cascades) occurs simultaneously and is intended to act locally; however, 
systemic activation of these pathways has been reported in situations when the relevant control 
mechanism at the site of infection fail to respond (Markiewski et al., 2007). Therefore it is 
speculated that the increase in the hepatic expression of genes associated with complement and 
coagulation cascades in SCE cows (Figure 4.3; Akbar et al 2014; Additional file 1, Liver DIA) 
could have been associated with a failure of control mechanisms within the endometrium. This 
idea seems to be supported by previous data demonstrating a decrease in PMN function 
(Hammon et al., 2006) and potential modifications of both the innate and adaptive immune 
systems in cows with endometritis (Bondurant, 1999, Levkut et al., 2002). 
Cytokines play an important role in a wide range of reproductive-related processes via 
regulation of a complex metabolic network (Orsi and Tribe, 2008). The activation of pathways 
leading to biosynthesis of IL-2 and activity of IL-1 in cows with SCE indicate an activation of 
both innate and adaptive immune systems (Boyman and Sprent, 2012, Sims and Smith, 2010). 
The decrease in hepatic expression of chemokine (C-C motif) receptor 4 (CCR4) (Table 4.2) 
with SCE could have had a major contribution to the activation of the innate immune 
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system.(Ness et al., 2006) For instance, in CCR4-/- mice receiving LPS (Ness et al., 2006), there 
was a marked induction of the JNK and p38 MAPK pathways, which we also observed in liver 
(Akbar et al 2014; Additional file 1: Liver DIA).  
Nitric oxide is an inflammatory mediator that among other effects mediates 
cytoimmunity and inflammation toxicity (Li et al., 2010). An increase of NO has been reported 
with endometritis in both cows (Li et al., 2010) and mares (Christoffersen et al., 2012). Although 
we did not measure the concentration of NO in tissue or blood, the activation of pathways 
associated with hepatic NO homeostasis and negative regulation of nitric oxide biosynthetic 
process (Akbar et al 2014; Additional file 1: Liver DIA) indicates changes in NO concentrations 
in SCE cows. As such, a local increase in NO within liver tissue could, at least in part, be 
associated with the changes in the expression of inflammatory genes. 
Haptoglobin is an acute-phase protein primarily synthesized in the liver that 
accomplishes its function by acting as an antioxidant, anti-inflammatory agent, bacteriostat, and 
by regulating the maturation and activity of immune cells (Sabedra, 2012). The increase in HP 
expression in liver (Table 4.4) from cows with SCE agrees with previous work reporting greater 
serum concentration of HP in Holstein cows with acute puerperal metritis (Drillich et al., 2007). 
A greater concentration of HP also was observed in cows with retained fetal membranes, which 
is one of the key risk factors associated with uterine infection (Mordak, 2009). From a 
mechanistic standpoint, the numerical up-regulation of SOCS2 (1.5-fold) and STAT3 (~2-fold) 
(Table 4.4) not only suggests an augmentation of cytokine signaling (Nicholson and Hilton, 
1998) with SCE but also a potential impairment of growth hormone signaling (Udy et al., 1997).  
The immune responsive role of adipose depots has been studied previously (Ingvartsen 
and Boisclair, 2001, Mukesh et al., 2010), and data from the present study support this role, e.g. 
there was activation of B cell receptor signaling, cytokine-cytokine receptor interaction, and T 
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cell receptor signaling pathways in subcutaneous adipose from cows with SCE. A novel response 
in this study was the induction of the mTOR signaling pathway in cows with SCE (Akbar et al 
2014; Additional file 1: Adipose DIA); mTOR is a large molecular-weight protein that mediates 
intracellular signaling related to cell growth, proliferation, and differentiation (Kim et al., 2002, 
Rosner et al., 2008). In non-ruminants the increase in mTOR signaling pathway in adipocytes is 
mediated by PI3K-ATK signaling, which is activated by cytokines and ECM (Figure 4.8) (Bhatt 
and Damania, 2012, Friedl and Wolf, 2003). 
In addition to other regulatory mechanisms, PI3K can also be activated by insulin through 
IRS1/2(Insulin receptor substrate-1/2); PI3K then leads to activation of mTOR via Akt (Pirola et 
al., 2003). In adipose tissue, AKT2 is the predominant isoform of Akt (Choi et al., 2010); the 
down-regulation of IRS1 and SLC2A4 (insulin-induced glucose transporter) indicates that the up-
regulation of AKT2 (Table 4.3) might have been mediated by PI3K via the activation of 
cytokines and ECM rather than insulin signaling (Figure 4.8). Increased signaling through AKT2 
then could have regulated mTOR signaling by phosphorylating the AKT1S1 (PPAS40) (Table 
4.3). Moreover, the tendency for greater expression of STAT3 in adipose tissue (Table 4.5) 
suggests that mTOR might have elicited its effect by phosphorylation at Ser727 (Yokogami et 
al., 2000, Zhang et al., 2012) Following phosphorylation, STAT protein translocates to the 
nucleus to regulate transcription or activate the transcription of target genes associated with cell-
cycle progression and apoptosis. As a result, STAT can promote cellular transformation as well 
as abnormal cell proliferation (Hsieh et al., 2005, Seita et al., 2008). In addition to important 
roles in cytokine signaling pathways, STAT3 has been reported to contribute to the phenotypic 
variation in embryonic survival in cattle (Khatib et al., 2009, Kisseleva et al., 2002). 
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Molecular adaptations in vitamin B3 and B6 metabolism 
In the present study,  an activation of genes coding for enzymes associated with oxidative 
phosphorylation in both liver (e.g. ATP5A1) and adipose (e.g. ATP6V1B2, COX6B2, NDUFS6) 
(Table 4.2 and 4.3) was observed. As precursors of the coenzymes nicotinamide-adenine 
dinucleotide (NAD+) and nicotinamide-adenine dinucleotide phosphate (NADP+), both nicotinic 
acid (anionic form: nicotinate) and nicotinamide (amide derivative of nicotinic acid) are essential 
for organisms (Niehoff et al., 2009). Nicotinic acid and nicotinamide are often grouped together 
under the generic term niacin, and are also known as vitamin B3 (Moffett and Namboodiri, 
2003). 
The reduction in flux of nicotinate and nicotinamide metabolism in liver did not seem to 
alter mitochondrial respiration per se because expression of genes associated with fatty acid 
oxidation (CPT1A, ACOX1) did not change. It could be possible that this reduction in flux in 
SCE cows reflected a state of oxidative stress (up-regulated SOD2 and GPX1; Table 4.4), at least 
in part, because of a decrease in niacin availability (Kamanna et al., 2008). In contrast, the 
induction of this pathway in adipose tissue suggests the tissue might have an inherently greater 
ability to counteract oxidative stress compared with liver, potentially as a function of niacin 
accumulation. Additionally, cows in the present study were fed predominately forage diets, with 
potentially greater availability of niacin (Schwab et al., 2006). The amino acid tryptophan is the 
sole substrate for de novo NAD+ and NADP+ synthesis in the absence of nicotinamide or 
nicotinic acid. All species are able to synthesize niacin from tryptophan and quinolinate.(Niehoff 
et al., 2009) The decrease in tryptophan metabolism (Akbar et al 2014; Additional file 1: Liver 
KEGG sheet) in cows with SCE is additional evidence of a state of oxidative stress in the liver.  
Because of its integral involvement in the synthesis of nucleic acid, and consequently in 
mRNA and protein synthesis, vitamin B6 influences acquired and humoral immunity, and the 
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production of cytokines and inflammatory mediators (Friso et al., 2001). The vitamin B3 
metabolite N-methylnicotinamide may exert anti-inflammatory and anti-oxidative stress effects 
(Domagala et al., 2012). The observed inhibition of vitamin B3 and B6 metabolism was 
associated with activation of cytokine and proinflammatory cytokine production (Akbar et al 
2014; Additional file 1: Liver DIA sheet) and oxidative stress (SOD2 and GPX1 up-regulation; 
Table 4.4). In contrast, the activation of vitamin B3 (nicotinamide) metabolism (Figure 4.5) in 
adipose tissue may have served a protective role against oxidative stress (SOD2 up-regulation) 
(Table 4.5) to protect cells against reactive oxygen species (Sauve, 2008). 
Intracellular energy status and oxidative stress   
Mitochondria are responsible for ∼90% of oxygen consumption and ATP production 
(Kelly et al., 2011); however, they are also major sources of intracellular reactive oxygen 
metabolites (ROM) (Wei and Lee, 2002). In dairy cows, excessive production of ROM may lead 
to oxidative stress when the body antioxidant defenses are insufficient, which is a major risk 
factor associated with endometritis (Heidarpour, 2012).  
The protein ATP6V1B2, which transports H+ across the membrane of intracellular 
organelles, also is a component of the B2 subunit of the H+ transporting AT-Pase (VATPase) 
(Dong et al., 2011, Nishi T and M., 2002). Previous studies reported that an increase in V-
ATPase led to the accumulation of ROM (Dong et al., 2011, Migliore and Coppede, 2009). 
Therefore, it could be possible that in the present study the evident changes enhanced oxidative 
phosphorylation and ROM production, which coupled with  the greater hepatic expression of 
SOD2 and GPX1 (Table 4.4), suggests that SCE can enhance the oxidative stress status of 
peripheral tissues.  
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CONCLUSIONS 
The local uterine inflammation appears to induce a marked inflammatory response at the 
level of liver, whereas in adipose, there was a more pronounced response in oxidative stress and 
apoptosis coupled with impaired insulin signaling. The lack of change in BCS, plasma NEFA 
concentration, and gene expression data associated with lipolysis and lipogenesis provides 
additional evidence that energy status of the cow is not a primary risk factor for SCE. Despite the 
observed changes at the molecular level, there were no evident systemic long-term negative 
effects on liver function. 
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TABLES AND FIGURES 
 
Table 4.1. Plasma metabolite concentration on the day of slaughter in healthy 
cows (no uterine infection, NUI) or cows with subclinical endometritis (SCE). 
 Group    
Item SCE NUI SEM  P = 
NEFA, mmol/L 1.50  1.69  0.18   0.46  
Protein 82.1 77.1 2.8  0.23 
Albumin, g/L 36.8 37.5 25.8  0.75 
Globulin, g/L1 45.3 39.6 2.2  0.11 
Albumin/Globulin ratio 0.83 0.95 0.06  0.23 
Mg, mmol/L 0.66 0.70 10.6  0.70 
GDH, IU/L2 24.3 28.3 5.5  0.62 
AST, IU/L3 78.5 87.5 4.6  0.20 
 
1 Globulin is calculated when albumin is subtracted from total protein 
2 GDH = glutamate dehydrogenase 
3 AST = aspartate aminotransferase 
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Table 4.2. List of all genes that were differentially expressed in liver tissue due to subclinical endometritis1. 
  
Gene ID Symbol Expression Ratio SCE/NUI P =  Gene ID Symbol Expression Ratio SCE/NUI P = 
281358 NPR3 0.43 0.001  - KIAA1639 1.54 0.05 
782932 C2orf53 0.46 0.04  282578 ATP5A1 1.54 0.03 
541142 LANCL2 0.48 0.01  526937 DCXR 1.54 0.001 
338074 AOX1 0.52 0.03  504664 NRBP2 1.54 0.001 
286794 MMP7 0.52 0.04  534579 TFDP1 1.55 0.01 
281938 MYOD1 0.52 0.001  534799 TOP1 1.55 0.001 
538785 STAMBPL1 0.53 0.03  514465 SMAP1L 1.56 0.001 
522346 LOC522346 0.55 0.03  767942 GRN 1.56 0.001 
616425 SUPT4H1 0.55 0.01  280815 NPC2 1.56 0.01 
524334 L3MBTL3 0.55 0.001  538975 CNN3 1.57 0.05 
282092 TIMP1 0.55 0.04  511852 ASB11 1.57 0.03 
530184 SSBP3 0.56 0.04  525619 LOC525619 1.57 0.02 
615833 IFITM3 0.56 0.04  535362 GRM7 1.58 0.02 
286822 CKM 0.58 0.02  514514 CELSR3 1.58 0.01 
- CN437645 0.59 0.01  444859 ST3GAL3 1.58 0.03 
768316 NRBF2 0.60 0.03  535258 HSPC148 1.58 0.001 
338074 LOC618565 0.61 0.05  533483 CMAS 1.59 0.03 
282684 CSNK1A1 0.61 0.05  282385 TMSB10 1.60 0.05 
780809 VTI1B 0.61 0.01  522795 KLF10 1.61 0.04 
282100 TRPC1 0.61 0.001  530352 SLC39A1 1.63 0.01 
535232 LOC535232 0.62 0.01  783871 PI3 1.64 0.01 
616676 GALM 0.62 0.03  444874 UBC 1.64 0.02 
524743 LOC524743 0.62 0.01  614936 ILF3 1.65 0.03 
- BF043596 0.62 0.001  536863 MPDZ 1.65 0.04 
574056 TNFRSF8 0.63 0.02  534366 C6orf62 1.65 0.03 
100139141 SHROOM3 0.63 0.01  281040 CAV1 1.66 0.001 
- CN438887 0.63 0.01  286883 MAP2K6 1.66 0.02 
- CN435533 0.64 0.01  100125835 PCYOX1 1.67 0.01 
507060 WBP2 0.64 0.01  280997 AMD1 1.68 0.04 
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Table 4.2. (Cont.) 
1SCE = subclinical uterine infection (endometritis). NUI = no uterine infection. 
  
Gene ID Symbol Expression Ratio SCE/NUI P =  Gene ID Symbol Expression Ratio SCE/NUI P = 
507503 THAP4 0.64 0.03  282711 EPAS1 1.70 0.01 
408019 CCR4 0.64 0.03  282146 ATP2B4 1.72 0.01 
512648 ELL3 0.65 0.01  614280 C7orf23 1.73 0.001 
514788 ACOT7 0.65 0.05  530076 GC 1.76 0.03 
508167 LOC508167 0.66 0.04  327715 GABARAP 1.76 0.001 
319095 ADCYAP1R1 0.66 0.01  510102 RARRES1 1.78 0.001 
- LOC727737 1.50 0.03  767925 RPL13A 1.80 0.02 
505031 C6orf49 1.51 0.001  100298683 FAM43B 1.85 0.02 
533894 LRP1 1.51 0.001  415113 HSPA5 1.91 0.03 
511425 LOC511425 1.51 0.01  618041 APOC4 1.95 0.001 
504506 RNPS1 1.51 0.001  280988 AHSG 2.01 0.04 
506149 C22orf32 1.51 0.03  534961 C1QA 2.07 0.001 
508722 RBM39 1.52 0.04  768005 Slc9a3r2 2.11 0.001 
512841 Crk 1.52 0.01  540176 ATP5G3 2.15 0.001 
- BF045974 1.53 0.001  281760 FABP5 2.31 0.02 
- SLC2A3P1 1.53 0.01  510522 FGB 2.42 0.01 
613930 MGC128212 1.54 0.03  513055 RGS2 2.52 0.001 
540007 FAAH 1.54 0.001  539334 IL1RAP 2.54 0.001 
507107 SLC3A2 1.54 0.001  338048 CYP11A1 2.65 0.04 
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Table 4.3. List of all genes that were differentially expressed in subcutaneous adipose tissue due to subclinical endometritis1. 
Gene ID Symbol Expression Ratio SCE/NUI P =  Gene ID Symbol Expression Ratio SCE/NUI P = 
326334 CA11 0.06 0.001  100140537 POLR3E 0.65 0.01 
506415 RSAD2 0.30 0.01  281187 GDF8 0.65 0.03 
527934 CORO7 0.32 0.001  338079 NDUFS7 0.65 0.01 
281127 DSC1 0.34 0.04  100138153 CNNM3 0.65 0.02 
- 9430053O09Rik 0.41 0.02  281781 B4GALT1 0.65 0.02 
515954 HYI 0.41 0.01  514263 TMEM39B 0.65 0.01 
513765 TRABD 0.43 0.03  519163 KLF16 0.67 0.05 
615833 IFITM3 0.43 0.01  - SCRAMBLE2 1.50 0.04 
507525 VTN 0.44 0.02  527491 SLC38A1 1.50 0.001 
509430 SRP72 0.45 0.01  530401 LOC530401 1.51 0.01 
786644 LOC786644 0.46 0.001  518675 BZRAP1 1.51 0.03 
508527 FAM44A 0.46 0.03  767924 MST150 1.51 0.001 
280830 IVL 0.47 0.01  507707 TOMM70A 1.51 0.05 
531369 TTF2 0.47 0.02  - LOC729867 1.52 0.04 
516232 ZNF653 0.48 0.02  - CN441658 1.52 0.05 
527928 UGT2A1 0.48 0.001  281564 UGDH 1.53 0.01 
510377 SP140 0.49 0.01  503554 COX6B2 1.53 0.01 
529049 MRC2 0.49 0.05  516762 LOC516762 1.53 0.04 
- LOC512590 0.50 0.001  505738 MCOLN1 1.53 0.01 
516866 ALPK3 0.51 0.01  514957 KIAA0020 1.55 0.001 
768005 Slc9a3r2 0.52 0.03  509050 C15orf40 1.55 0.01 
- BM363375 0.52 0.001  508935 SYMPK 1.55 0.04 
527903 LOC653968 0.52 0.03  282524 SLC25A16 1.55 0.03 
614868 KHK 0.53 0.01  613479 MGC133516 1.56 0.02 
- C14orf73 0.53 0.02  281944 NR2E3 1.57 0.01 
533984 SUB1 0.53 0.03  538444 SET 1.59 0.03 
- OAS1 0.53 0.01  540605 CREM 1.59 0.04 
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Table 4.3. (Cont.) 
 
Gene ID Symbol Expression Ratio SCE/NUI P =  Gene ID Symbol Expression Ratio SCE/NUI P = 
512972 HMHA1 0.54 0.001  525040 LOC525040 1.60 0.01 
541100 PLEKHH3 0.55 0.001  281751 EIF4E 1.61 0.05 
504889 GMPPA 0.56 0.04  338082 ATP6V1B2 1.61 0.03 
286850 GNG12 0.56 0.02  536417 SEMA3D 1.62 0.04 
- BF043373 0.56 0.04  613644 CD99L2 1.62 0.001 
516456 MVP 0.56 0.04  614521 Rab35 1.62 0.03 
615501 LOC615501 0.56 0.04  614583 LOC614583 1.62 0.04 
514859 AKT1S1 0.57 0.03  - CN438914 1.63 0.001 
532997 AOF2 0.57 0.04  521854 NID2 1.64 0.02 
615146 SOCS6 0.57 0.03  - TC359671 1.65 0.001 
529131 LOC529131 0.58 0.02  532209 LOC532209 1.65 0.02 
521868 PTPRH 0.58 0.05  505727 NOV 1.66 0.04 
514291 EMILIN2 0.59 0.02  524854 THUMPD1 1.66 0.02 
534280 RARA 0.59 0.03  531535 MGC139383 1.67 0.001 
516318 PER1 0.59 0.04  - CK394167 1.74 0.02 
536731 LOC536731 0.59 0.001  507102 SREBF2 1.75 0.02 
505328 OSBPL2 0.60 0.001  450214 CENPC1 1.76 0.01 
783452 NRG2 0.60 0.05  534923 AKT2 1.76 0.04 
513577 LOC513577 0.60 0.01  768209 5730406M06Rik 1.77 0.02 
512069 MGC137476 0.60 0.02  529149 MGC52110 1.79 0.04 
511254 NRD1 0.60 0.03  540525 GTF2E1 1.79 0.001 
522346 LOC522346 0.60 0.02  504483 BLMH 1.79 0.01 
327685 ANXA6 0.61 0.02  280981 ADFP 1.80 0.05 
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Table 4.3. (Cont.) 
1SCE = subclinical uterine infection (endometritis). NUI = no uterine infection. 
Gene ID Symbol Expression Ratio SCE/NUI P =  Gene ID Symbol Expression Ratio SCE/NUI P = 
507065 RBM19 0.61 0.03  282188 COL1A2 1.80 0.01 
513300 SENP8 0.61 0.03  282484 SLC34A2 1.80 0.02 
518833 CYFIP2 0.61 0.02  782059 SCYL2 1.82 0.01 
786191 HIC1 0.61 0.001  780788 ITGB1BP3 1.85 0.02 
282431 PROKR2 0.62 0.03  617358 ASB1 1.85 0.03 
- CN438353 0.62 0.001  540172 MGC10433 1.91 0.04 
539675 ZNF415 0.62 0.03  505889 PPYR1 1.94 0.04 
- FLJ45422 0.62 0.04  281598 ACVR2A 1.97 0.04 
532645 MAN1A2 0.62 0.02  - NG010008B10D06 1.98 0.02 
280946 TST 0.62 0.01  282127 ZFP36 2.01 0.04 
511691 LOC511691 0.63 0.02  539795 ABHD3 2.04 0.001 
512308 MMRN2 0.63 0.01  525795 AGRN 2.04 0.02 
617894 LOC617894 0.63 0.02  281490 JARID1C 2.06 0.02 
- CR452857 0.63 0.01  - TC345541 2.11 0.01 
505884 KLF6 0.63 0.01  327691 NDUFS6 3.32 0.001 
534394 NIP30 0.63 0.03  614759 LSM3 3.48 0.001 
616482 RANBP3 0.63 0.03  337916 IRF2 4.13 0.001 
535203 NTHL1 0.63 0.01  617720 NUDT12 4.41 0.001 
- BF440371 0.63 0.02  - CR551628 7.15 0.001 
407996 KRIT1 0.64 0.02      
532721 USP42 0.64 0.02      
518458 SEMA6D 0.64 0.02      
539250 KCNJ1 0.64 0.04      
536818 LOC536818 0.64 0.03      
534063 EIF2B3 0.65 0.001      
 
 
168 
 
Table 4.4. Expression of genes associated with inflammation, oxidative stress and 
metabolism in liver tissue from healthy cows (no uterine infection, NUI) or cows with 
subclinical endometritis (SCE). Data were generated via quantitative RT-PCR. 
 Group   
Gene SCE NUI SEM P = 
Transcription regulators         
PPARA -0.19 -0.09 0.24 0.78 
RXRA 0.38 (↑) 0.11 0.10 0.06 
NFIL3 0.60 0.54 0.30 0.87 
Fatty acid oxidation     
ACOX1 0.23 0.32 0.14 0.64 
CPT1A 0.25 0.20 0.17 0.82 
Ketogenesis         
HMGCS2 0.23 0.35 0.24 0.72 
GH/IGF-1 axis         
GHR 0.53 (↑) 0.19 0.16 0.05 
IGF1 0.25 0.24 0.27 0.96 
Cytokines/inflammatory mediators       
IL10 -0.29 0.33 0.51 0.38 
IL1B 0.22 0.32 0.35 0.84 
TNF 0.28 0.57 0.37 0.57 
STAT3 0.50 0.21 0.18 0.25 
SOCS2 0.23 -0.40 0.40 0.27 
STAT5B 0.08 0.13 0.08 0.71 
Acute-phase proteins          
ORM1 0.13 0.10 0.49 0.96 
HP 0.41(↑) -1.03 0.69 0.04 
SAA3 -0.36 -0.75 0.68 0.69 
PON1 0.32 0.10 0.15 0.30 
Oxidative stress         
SOD2 0.42(↑) 0.05 0.13 0.04 
GPX1 0.44(↑) -0.05 0.20 0.08 
Hepatokines         
ANGPTL4 0.11 -0.05 0.35 0.74 
FGF21 -0.65 -0.51 0.92 0.91 
Insulin signaling         
AKT1 -0.63 -0.69 0.11 0.72 
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Table 4.5. Expression of genes associated with inflammation, oxidative stress and 
metabolism in subcutaneous adipose from healthy cows (no uterine infection, NUI) or cows 
with subclinical endometritis (SCE). Data were generated via quantitative RT-PCR.  
 Group    
Gene SCE NUI SEM  P =  
Transcription regulators          
RXRA -1.30 -0.71 0.37 0.28 
PPARG 1.49 1.63 0.18 0.60 
SREBF1 0.80 1.15 0.31 0.44 
TP53 1.23(↑) -0.20 0.44 0.04 
NFIL3 0.68 0.44 0.12 0.20 
Lipogenic enzymes     
LPIN1 -0.15 0.16 0.32 0.50 
SCD -1.21 -0.12 0.80 0.36 
FASN 0.26 0.31 0.33 0.91 
PLIN2 -1.86(↓) 0.20 0.57 0.02 
Lipolytic-related (lipolysis)     
ABHD5 0.09 0.08 0.26 0.98 
LIPE 0.14 -0.10 0.19 0.38 
PNPLA2 0.15 0.45 0.19 0.26 
Insulin signaling     
GHR -0.09 -0.08 0.30 0.98 
SLC2A4 0.82(↓) 1.44 0.21 0.03 
IRS1 -1.69(↓) -1.02 0.13 <0.01 
Adipokines     
ADIPOQ 0.73 0.77 0.68 0.97 
ANGPTL4 -0.07 -0.06 0.27 0.98 
CCL5 -1.23 -1.26 0.52 0.98 
BCL2 -0.70 -0.48 0.31 0.62 
CCL2 -1.34(↑) -3.62 0.46 <0.01 
Oxidative stress     
SOD2 -2.44(↓) 0.99 1.22 0.06 
Cytokines/inflammatory mediators     
IL6 0.36(↑) -2.27 0.33 <0.01 
HP -1.74 -1.20 0.51 0.46 
SAA3 -2.64 -0.68 1.26 0.29 
NFKB1 1.26 0.98 0.28 0.98 
STAT3 1.68 0.96 0.35 0.16 
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Notes: the bar associated with each mean denotes the standard error of the mean. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Body condition score and daily milk yield in healthy cows (no uterine 
infection, NUI) and cows with subclinical endometritis (SCE). Body condition score is 
reported on a 1-10 scale, where 1 is emaciated and 10 obese (Roche et al., 2009) . 
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Category Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
Figure 4.2. Impact and flux of main KEGG pathways categories and sub-categories 
affected by subclinical endometritis constructed from liver differentially expressed genes 
(DEG) as calculated by the Dynamic Impact Approach. Reported are the total impact 
(Blue horizontal bars; larger the bars higher the impact) and the direction of the impact 
(or flux; green bars expanding left denote inhibition and red bars expanding right denote 
activation) of DEG on the categories and subcategories 
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Figure 4.3. Impact and flux of the top 20 KEGG pathways affected by subclinical 
endometritis in liver tissue uncovered by the Dynamic Impact Approach (DIA). Reported 
are the total impact (blue horizontal bars; larger the bars higher the impact) and the 
direction of the impact (or flux; green shade denotes inhibition and red shade denotes 
activation). 
 
KEGG Pathway Impact Flux
Vitamin B6 metabolism
Complement and coagulation cascades
Regulation of autophagy
Pentose and glucuronate interconversions
Aldosterone‐regulated sodium reabsorption
Staphylococcus aureus infection
Glycosaminoglycan biosynthesis ‐ keratan sulfate
Steroid hormone biosynthesis
Pancreatic secretion
Apoptosis
Glutamatergic synapse
Protein export
Bacterial invasion of epithelial cells
Endocrine and other factor‐regulated calcium reabso
Vasopressin‐regulated water reabsorption
Nicotinate and nicotinamide metabolism
Salivary secretion
PPAR signaling pathway
Arginine and proline metabolism
SNARE interactions in vesicular transport
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Figure 4.4. Impact and flux of main KEGG pathways categories and sub-categories 
affected by subclinical endometritis constructed from adipose differentially expressed 
genes (DEG) as calculated by the Dynamic Impact Approach. Reported are the total 
impact (Blue horizontal bars; larger the bars higher the impact) and the direction of the 
impact (or flux; green bars expanding left denote inhibition and red bars expanding right 
denote activation) of DEG on the categories and subcategories. 
Category Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
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Figure 4.5. Impact and flux of top 20 KEGG pathways affected by subclinical 
endometritis in subcutaneous adipose tissue uncovered by the Dynamic Impact Approach 
(DIA). Reported are the total impact (blue horizontal bars; larger the bars higher the 
impact) and the direction of the impact (or flux; green shade denotes inhibition and red 
shade denotes activation). 
 
KEGG Pathway Impact Flux
Nicotinate and nicotinamide metabolism
Peroxisome
Sulfur relay system
Fructose and mannose metabolism
Ascorbate and aldarate metabolism
Basal transcription factors
RNA degradation
Protein export
Glycosaminoglycan biosynthesis ‐ keratan sulfate
Pentose and glucuronate interconversions
ECM‐receptor interaction
Circadian rhythm ‐ mammal
N‐Glycan biosynthesis
Oxidative phosphorylation
Aldosterone‐regulated sodium reabsorption
Amino sugar and nucleotide sugar metabolism
Collecting duct acid secretion
Starch and sucrose metabolism
Spliceosome
RNA polymerase
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Figure 4.6. Most up- and down-regulated pathways due to subclinical endometritis in the 
Biological process (BP), Cellular components (CC) and Molecular processes (MP) GO 
categories uncovered by DIA using differentially expressed genes in liver and adipose 
tissue. Reported are the impact (blue horizontal bars; the larger the bar the higher the 
impact) and the direction of the impact (or flux; green shade denotes inhibition and red 
shade denotes activation). 
 
Term Liver Impact Flux
GOTERM_BP_FAT GO:0032623~interleukin‐2 production
GOTERM_BP_FAT GO:0042094~interleukin‐2 biosynthetic process
GOTERM_BP_FAT GO:0007518~myoblast cell fate determination
GOTERM_BP_FAT GO:0048625~myoblast cell fate commitment
GOTERM_CC_FAT GO:0000421~autophagic vacuole membrane
GOTERM_CC_FAT GO:0005577~fibrinogen complex
GOTERM_CC_FAT GO:0043034~costamere
GOTERM_CC_FAT GO:0008023~transcription elongation factor complex
GOTERM_MF_FAT GO:0050998~nitric‐oxide synthase binding
GOTERM_MF_FAT GO:0004908~interleukin‐1 receptor activity
GOTERM_MF_FAT GO:0004031~aldehyde oxidase activity
GOTERM_MF_FAT GO:0016623~oxidoreductase activity
Term Adipose Impact Flux
GOTERM_BP_FAT GO:0015909~long‐chain fatty acid transport
GOTERM_BP_FAT GO:0050999~regulation of nitric‐oxide synthase activity
GOTERM_BP_FAT GO:0051607~defense response to virus
GOTERM_BP_FAT GO:0043526~neuroprotection
GOTERM_CC_FAT GO:0030061~mitochondrial crista
GOTERM_CC_FAT GO:0005777~peroxisome
GOTERM_CC_FAT GO:0000299~integral to membrane of membrane fraction
GOTERM_CC_FAT GO:0000138~Golgi trans cisterna
GOTERM_MF_FAT GO:0000210~NAD+ diphosphatase activity
GOTERM_MF_FAT GO:0004551~nucleotide diphosphatase activity
GOTERM_MF_FAT GO:0004089~carbonate dehydratase activity
GOTERM_MF_FAT GO:0016836~hydro‐lyase activity
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CHAPTER 5: Body condition score at calving affects systemic hepatic transcriptome indicators 
of inflammation and nutrient metabolism in grazing dairy cows  
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ABSTRACT 
Calving body condition score (BCS) is an important determinant of early lactation DMI, 
milk yield, and disease incidence. The current study investigated the metabolic and molecular 
changes induced by the change in BCS using blood biomarkers, hepatic triacylglycerol (TAG) 
concentration, and hepatic gene expression profiling. Target BCS at calving were achieved by 
managing feed allowance before dry off. Postpartal cows were allocated pasture and pasture 
silage to appetite. A group of cows of mixed age and breed were managed from the second half 
of the previous lactation to achieve mean group BCS that were high (H, 5.5 BCS, n = 20), 
medium (M, 4.5 BCS, n = 18), or low (L, 3.5 BCS, n = 19) BCS (10-point scale). Blood was 
sampled at wk -4, -3, -2, 1, 3, 5, and 6 relative to parturition to measure biomarkers of energy 
balance, inflammation, and liver function. Liver was biopsied from 10 cows per BCS group on 
wk 1, 3, and 5 relative to parturition, and used for transcript profiling via qPCR. Cows in H and 
M produced more milk and had greater NEFA and BHBA postpartum than L cows. Peak 
concentration of NEFA and BHBA, and greater hepatic TAG concentrations were recorded in H 
at wk 3. Consistent with blood biomarkers, H and M had a greater expression of genes associated 
with fatty acid oxidation (CPT1A, ACOX1), ketogenesis (HMGCS2), and hepatokines (FGF21, 
ANGPTL4), whereas, H had the lowest expression of APOB. High BCS decreased TMLHE and 
increased SLC22A5 expression by wk 3, suggesting muscle-derived carnitine uptake. Greater 
expression of BBOX1 in M and L suggested greater de novo carnitine synthesis. In comparison 
with L, H and M had greater expression of genes associated with gluconeogenesis (PC, PDK4), 
and lower expression of growth hormone/IGF-1 signaling axis (GHR1A, IGF1 and IGFALS), 
which likely contributed to the higher milk production and greater gluconeogenesis. Despite 
greater serum haptoglobin around calving, cows in H and M compared with L had higher blood. 
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Cows in M, however, had lower globulin and a higher albumin:globulin ratio, probably 
indicating a less pronounced inflammatory status and better liver function. The marked decrease 
in expression of NFKB1, STAT3, HP, and SAA3 coupled with the increase in ALB on wk 3 in M 
cows support the blood data. Overall, results suggest that the greater milk production of cows 
with higher calving BCS is associated with a pro-inflammatory response without negatively 
affecting expression of genes related to metabolism and the GH/IGF-1 axis. Results highlight the 
sensitivity of indicators of metabolic health and inflammatory state to subtle changes in calving 
BCS and, collectively, indicate a suboptimal health status in cows calving at either BCS 3.5 or 
5.5 relative to BCS 4.5. The data are consistent with recommended calving BCS targets of 4.5-
5.0 (i.e. 2.75-3.0 in a 5-point system) in grazing dairy cows, to optimize production, while 
reducing liver lipid accumulation and the negative effects of inflammation on liver function. 
Key words: BCS, liver, dairy cows   
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INTRODUCTION 
In dairy management systems, BCS is used as an indicator of body fat content to inform 
on cows’ nutritional status. Nutritional management to achieve appropriate BCS during both the 
important pre and post-calving periods will also reduce risks to animal welfare (Roche et al., 
2009). The BCS at calving may affect early lactation DMI, post-calving BCS loss, milk yield, 
cow immunity, and influences fertility (Roche et al., 2009). In addition, BCS loss due to 
homeorhetic influences around calving and early lactation is associated with the incidence of 
several metabolic disorders, most importantly ketosis (Gillund et al., 2001), milk fever (Roche 
and Berry, 2006), displaced abomasum (Bewley, 2008), and is likely also fatty liver syndrome 
(Drackley, 1999).  
 A cow’s dry matter intake at calving is negatively associated with BCS (Hayirli et al., 
2002, Matthews et al., 2012). Therefore, in general, “fat” animals suffer from a more pronounced 
and more prolonged depression in DMI after calving compared with cows in normal body 
condition, resulting in a deeper negative energy balance (NEB) (Agenas et al., 2003, Hayirli et 
al., 2002). These over conditioned cows have increased mobilization of adipose depots at 
calving, which leads to a more pronounced and persistent increase in blood NEFA (Dann et al., 
2006).  
The NEFA released into the circulation can be utilized as an energy source by other 
tissues, most importantly the liver. However, when NEFA uptake by liver exceeds the normal 
oxidative or export (as VLDL) capacity, partial oxidation will occur, resulting in greater 
production of ketone bodies, including β-hydroxybutyrate (BHBA) (Drackley, 1999). 
Furthermore, if the rate of esterification exceeds the rate of triacylglycerol (TAG) export via 
lipoproteins, fatty liver may develop (Drackley, 1999), thereby increasing susceptibility to other 
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pathologies. An association has been reported between ketosis and early lactation BCS loss 
(Gillund et al., 2001). 
Although a recent review of the literature reported that both over- and under-conditioned 
dairy cows have a greater incidence of diseases than animals with a normal BCS (Roche et al., 
2009), it appears that, there are no reports about whether molecular signaling patterns in hepatic 
tissue vary during early lactation in a manner associated with calving BCS. It was hypothesized 
that calving BCS affects the inflammatory response and liver function partly through alterations 
in gene expression. Thus, the objective of the present study was to profile mRNA expression of 
key metabolic genes associated with fatty acid oxidation, ketogenesis, lipoprotein export, 
carnitine metabolism, gluconeogenesis, inflammation, and oxidative stress in hepatic tissues 
recovered from cows with high (H), medium (M), and low (L) BCS at calving (Roche et al., 
2013). Those data were complemented with liver TAG concentration and concentrations of 
blood biomarkers of energy balance, liver function, and inflammation.  
MATERIALS AND METHODS 
Animals, management, and tissue sampling 
The details of the project management were reported recently (Roche et al., 2013).  
Briefly, a group of 60 cows were allocated to one of three groups that underwent nutritional 
management through late lactation to achieve different BCS targets by the end of lactation [BCS 
targets were 5.0, 4.0, and 3.0, for H, M, and L, respectively: 10-point system, where 1 is 
emaciated and 10 obese; Roche et al., 2004]. During the dry period these cows were fed a ration 
that allowed for fetal growth and for the cows to gain 0.5 BCS unit before calving. The final 
targets for mean calving BCS were 5.5, 4.5, and 3.5, for the H, M, and L groups, respectively.  
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  Blood samples were obtained on -4, -3, and -2 wk pre calving and 1, 3, 5, and 6 wk post 
calving  by coccygeal venipuncture into evacuated tubes that contained heparin, EDTA, or no 
anticoagulant (Vacutainer, Becton Dickinson, Franklin Lakes, NJ). Samples containing heparin 
anticoagulant were placed immediately into iced water then centrifuged within 60 min of 
collection to obtain plasma. Samples without anticoagulant were held at ambient temperature 
following collection for at least 4 h in order for serum to separate. Sera were used to measure 
albumin (ALB), globulin (GLO), creatinine, glucose, BHBA, aspartate aminotransferase (AST), 
glutamate dehydrogenase (GDH), γ-glutamyl transferase (GGT), haptoglobin (HP), and serum 
amyloid A (SAA). Plasma was used to measure NEFA. 
Liver biopsy. Liver samples were collected by biopsy during the wk before calving (-1 
wk), and subsequently on 1, 3, and 5 wk. Briefly, the skin was shaved and disinfected, and the 
area through the skin and body wall, was anesthetized with 7 mL of 2% lignocaine (Lopaine 2%, 
lignocaine hydrochloride 20 mg/mL, Ethical Agents, South Auckland, New Zealand). A stab 
incision was made through the skin in the right 11th intercostal space at the level of the greater 
trochanter through which a 12G  20 cm biopsy needle was inserted into the liver and 
approximately 1 g (wet weight) of liver tissue was collected. Liver samples were snap-frozen in 
liquid nitrogen and stored at -80°C.  
Liver TAG analysis 
Liver TAG content was analyzed in biopsy samples (-1, 1, 3 and 5 wk) by modifying the 
procedure described in Wako LabAssay TM Triglyceride Kit (Wako Chemicals USA Inc., VA). 
Briefly, approximately 100 mg of liver tissue was finely-chopped using a sterile scalpel blade, 
and homogenized in 1 mL 5% Triton-X100 in water. The homogenized tissue was slowly-heated 
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in a water bath (up to 80-100 °C) for 2-5 minutes or until the Triton X-100 appeared cloudy. 
After cooling at room temperature, the heating process was repeated one more time to solubilize 
all TAG into solution. The samples were vortexed and centrifuged at 2,000  g for 5 min to 
remove any insoluble material. The supernatant was collected in sterile 1.5 mL microfuge tubes 
and stored at -80 °C. Approximately 50 µL of sample was diluted 10-fold with distilled water 
before the TAG assay. The TAG analysis was performed using the standard procedure provided 
in the Wako LabAssay TM Triglyceride Kit. 
RNA extraction and real-time quantitative PCR (qPCR) 
 RNA extraction. Complete sets of high-quality RNA from eight cows per group were 
selected for analysis of gene expression. Approximately 40 mg of frozen liver tissue was 
weighed and immediately placed in ice-cold 1 mL Qiazol reagent for homogenization. After 
homogenization, the samples were centrifuged for 10 min at 12,000  g at 4ºC to remove the 
insoluble material. The supernatant was transferred to a collection tube and incubated for 5 min 
on ice. Chloroform (200 L) was added to each tube and the sample incubated at room 
temperature for 3 min. Subsequently, samples were centrifuged for 15 min at 12,000  g at 4ºC, 
and the upper phase was transferred to a new collection tube without disturbing the mid and 
lower phase. A second wash was performed with 100% ethanol; 750 L was added and 
transferred to a miRNeasy Mini Kit columns (Cat. No: 217004, Qiagen).  Genomic DNA was 
removed from RNA samples with RNase-free DNaseI, using the recommended protocol 
provided with the miRNeasy Mini Kit. RNA concentration was measured with a NanoDrop ND-
1000 spectrophotometer, while the RNA quality was assessed using the Agilent Bioanalyzer 
system (Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA). The average 
RNA integrity number (RIN) value for samples was 7  0.4.  
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Primer design and qPCR. Protocols for primer design, primer testing, selection of 
internal control genes (ICG) for normalization, and other protocols for the qPCR analysis were 
as previously described (Graugnard et al., 2013). Briefly, genes selected as suitable ICG based 
on geNorm analysis included UXT, GAPDH, and RPS9. The geometric mean of these genes was 
used to normalize gene expression data.  Genes selected for transcript profiling in this study are 
associated with fatty acid oxidation (PPARA, CPT1A, ACOX1), carnitine metabolism and uptake 
(TMLHE, BBOX1, SLC22A5), growth hormone/IGF-1 axis (IGF1, IGFALS, GHR1A, IGFBP3), 
liver-secreted hepatokines (FGF21, ANGPTL4), ketogenesis (HMGCS2), lipoprotein metabolism 
(MTTP, APOB), gluconeogenesis (PC, PDK4, PCK1), cytokines/inflammatory mediators 
(NFKB1, STAT3), acute-phase proteins (ALB, SAA3, HP), and oxidative stress enzymes (GPX1, 
SOD1). Complete information about primer sequences and amplified products is reported in 
Appendix–D (Suppl. table D.1 and D.2). The detailed information for qPCR efficiency and % 
relative RNA abundance of the measured genes is provided in Appendix–D Suppl. table D.3. 
Statistical Analysis  
After normalization with the geometric mean of the ICG, the qPCR data from all 
treatments (H, M, and L) were log2 transformed prior to statistical analysis. The TAG data were 
not normally distributed and were log10 transformed prior to statistical analysis. A repeated 
measures model was fitted to gene expression, blood biomarkers, and hepatic TAG concentration 
data using the Proc MIXED procedure in SAS.  The model consisted of wk (w), BCS (b), and 
BCS × wk (b × w) as fixed effects, as well as cow as the random effect.  An autoregressive 
covariate structure was used. All means were compared using the PDIFF statement of SAS.  
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RESULTS 
Milk production 
 Milk production was similar for H and M cows and both groups had greater (b, P = 0.01) 
milk production from 1 through 5 wk postpartum than L cows (Figure 5.1). The overall 
significant effect of wk (P < 0.01) was due to increased production between wk 1 and other time 
points for H and M cows, while no difference was evident between wk 2 to 6. Cows in L had a 
gradual increase in milk production from 1 through 6 wk postpartum. 
Blood biomarkers 
Biomarkers of energy balance. There was an interaction (b × w, P < 0.01) for both 
NEFA and BHBA (Figure 5.2); plasma concentration of both parameters increased as early as -2 
wk prepartum across all groups. The NEFA concentration was greater in H and M compared 
with L cows at -2 wk prepartum through 6 wk postpartum. Concentration was even greater in H 
than M cows from wk 3 through 6 postpartum, with a peak concentration recorded at wk3. The 
pattern of BHBA followed a similar pattern to NEFA, but differences between treatments were 
not evident until wk 1 postpartum, when cows in H had greater concentration than M and L, 
which were similar. Concentrations of BHBA increased further in the H group to a peak at wk 3, 
and remained greater than cows in M and L even at wk 6. Cows in M had greater concentration 
of BHBA from wk 3 until wk 6 compared with L. By wk 6, concentration of BHBA in H cows 
was still greater than prepartal values. Plasma concentration of glucose was not affected by 
treatment (Figure 5.2). 
Biomarkers of inflammation. There was no interaction (b × w, P > 0.05) for HP, SAA, 
GLO, ALB, and albumin:globulin ratio (AGR) (Figure 5.3). The concentration of HP and SAA 
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increased between wk -3 and -2 prepartum (Figure 5.3) and increased further postpartum (w, P< 
0.01). In the case of HP, concentration remained higher than prepartum until wk 3 postpartum, 
and for SAA there was a gradual decrease in concentration from wk 1 postpartum to wk 5 
postpartum, at which point concentrations were similar to prepartal levels (Figure 5.3). 
In all groups, the concentration of GLO decreased (w, P < 0.01) after parturition with the 
nadir at 1 and 3 wk followed by a gradual increase in concentration by 5 wk postpartum. Overall, 
cows in the H, L, and M groups had greater (b, P = 0.03), intermediate, and lower 
concentrations, respectively, at all the time points studied (Figure 5.3). The concentration of 
ALB decreased (w, P < 0.01) from -4 to -2 wk prepartum in all groups, but after calving the 
concentrations increased and remained steady for the remaining 5 wk in H and M cows 
compared with L, which had comparatively lower concentration (b, P <0.01) of ALB during the 
study. There was an overall increase (w, P < 0.01) in the AGR from -2 wk to 3 wk relative to 
parturition. However, cows in M had greater (b, P = 0.05) overall AGR compared with those in 
L and H (Figure 5.3). 
Biomarkers of liver function. There was no interaction (b × w, P > 0.05) for AST, GGT, 
and GDH concentrations (Figure 5.4). However, in all groups there was an overall increase (w, P 
< 0.01) in their concentrations between prepartum and postpartum. For instance, concentration of 
AST and GGT increased markedly between -2 wk and 1 wk postpartum. The concentration of 
AST remained at its peak by 2 wk postpartum then decreased by 3 wk postpartum. In contrast, 
the concentration of GGT remained elevated through 6 wk postpartum. There was an interaction 
(b × w, P < 0.01) for creatinine concentration; with greater concentrations of creatinine in M and 
L cows compared with H from -4 and -2 wks. Between -2 and 3 wk around parturition 
concentration decreased only for cows in M and L such that concentrations on 1 and 3 wk were 
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similar for all groups. Between 3 and 5 wk postpartum there was a decrease in concentration for 
all groups; this was more pronounced for cows in L, such that cows in H and M had greater 
concentrations than L at wk 5 (Figure 5.4).   
Hepatic TAG concentration 
There was an interaction (b × w, P < 0.01) for the hepatic concentration of TAG (Figure 
5.5). Although concentrations were similar prepartum, there was an increase between -1 and 1 
wk for cows in the M and H groups, resulting in greater values compared with cows in L. Cows 
in H had a further increase in concentration by wk 3, but concentration decreased in M cows to 
values similar to those evident in L. At 5 wk postpartum, concentration of TAG had decreased in 
H cows to levels similar to cows in M; but, in both groups, the concentration was greater than in 
L.            
Hepatic gene expression 
PPAR targets: fatty acid oxidation, ketogenesis, and IGFBP. There was an interaction 
(b × w, P < 0.05) for the expression of PPARA due to a decrease in H cows between 1 and 3 wk 
followed by an increase at 5 wk (Figure 5.6). Among the PPAR target genes evaluated, there 
were b  w effects (P < 0.01) for HMGCS2, ACOX1, and IGFBP1. The expression of HMGCS2 
was greater on wk 1 and 3 for cows in H compared with L and M. However, cows in M also had 
greater (b × w P < 0.01) expression on wk 3 compared with cows in L (Figure 5.6). Expression 
decreased by wk 5 in H and M cows, at which point there was no difference in expression 
between groups. The expression of ACOX1 was greater (b × w, P < 0.01) on wk 3 and 5 in M 
and H cows. Furthermore, cows in H had greater expression of ACOX1 on wk 5 compared with 
M (Figure 5.6). The overall temporal trend was for an increase (w, P < 0.01) in expression in H 
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and M cows (at least by wk 3) while cows in L had the same expression between 1 to 3 wk 
followed by a decrease at wk5. There was no interaction (P = 0.13) for the expression of CPT1A 
(Figure 5.6). There was an overall effect of BCS and wk (P < 0.05) for CPT1A such that 
expression was greater in M and H despite the fact that expression decreased from wk 1 to 5. The 
pattern of expression of IGFBP1 revealed that on wk 1 cows in M had greater (b × w, P < 0.05) 
expression than L. For both H and M, however, expression decreased (b × w, P < 0.05) by wk 3 
and remained unchanged by wk 5. Cows in L had no difference in expression over time. 
VLDL synthesis and secretion. There were interactions (b × w, P < 0.05) for the 
expression of MTTP and APOB (Figure 5.7). In the case of MTTP, the interaction was primarily 
driven by the decrease in expression from wk 1 to 5 for cows in L and M compared with cows in 
H, which had nearly same expression, and at wk 5 had greater expression than cows in L and M 
(Figure 5.7). In contrast, the interaction effect for the expression of APOB was primarily due to 
the steady increase from wk 1 to 5 for cows in L and M. However expression of APOB did not 
change from wk 1 to 3 in H cows and they had lower (b × w, P < 0.05) expression of APOB on 
wk 1 and wk 3 compared with M. By wk 5 expression of APOB in H cows increased and were 
similar across groups (Figure 5.7). 
Growth hormone/IGF-1 Axis. There was an interaction (b × w, P < 0.05) for the 
expression of IGF1, IGFALS, GHR1A, and IGFBP3 (Figure 5.8). For IGFALS and GHR1A, 
expression on wk 1 was lower for cows in M compared with H and L; there was no difference in 
expression of IGFALS in both H and L whereas, GHR1A expression was greater and 
intermediate for H and L, respectively. Expression of IGFALS from 1 to 3 wk decreased in H 
cows, increased in M cows and remained unchanged in L cows (Figure 5.8). In contrast, 
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expression of IGFALS increased in cows in H and L from wk 3 to 5 and remained similar in M 
cows, resulting in no BCS effect at wk 5. Although all the groups had increased expression of 
GHR1A on wk 3 compared with wk 1, there was a greater increase was observed in M and L 
cows. This effect resulted in similar expression across the groups at wk 3 and 5 (Figure 5.8). 
It is noteworthy that expression of IGF1 and IGFBP3 on wk 1 was greatest for cows in L 
compared with M (IGF1) and H (IGFBP3). As a whole, cows in H and M had the same 
expression pattern for IGF1 and IGFBP3 from 1 to 5 except wk 3, where lower expression of 
IGF1 was measured in cows with high BCS. Interestingly, the expression of IGFBP3 for cows in 
L increased by wk 3 and that of IGF1 reached peak expression by wk 5. Despite the changes in 
expression pattern over time, the expression of IGF1 and IGFBP3 on wk 5 did not differ among 
groups.  
Hepatokines.  The expression of FGF21 and ANGPTL4 was affected by the interaction 
of BCS and wk (b × w, P < 0.01; Figure 5.9). The expression of both genes decreased over time 
(w, P < 0.01) and was generally greater in H compared with L cows. In addition, cows in M also 
had greater expression of ANGPTL4 and FGF21 at wk 3 and 5 than L cows. The expression of 
ANGPTL4 remained unchanged in cows in H from wk 1 to 3, unlike cows in L and M; however, 
they decreased more severely from wk 3 to 5 and had similar expression with M at wk 5. In 
contrast, expression of FGF21 decreased in all cows from wk 1 to 3; however, in cows in M and 
L expression remained similar between wk 3 - 5 compared with a significant decrease in H 
(Figure 5.9).  
Carnitine synthesis and uptake. The expression of BBOX1, TMLHE, and SLC22A5 was 
affected by the interaction of BCS and wk (Figure 5.10). For instance, cows in H had lower 
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expression of BBOX1 on wk 1 compared with M and L and, despite an increase by wk 3, 
expression was still lower than M and L. The expression of BBOX1 continued to increase in H 
cows from wk 3 to 5, while expression decreased in cows in M and L. In contrast, expression of 
TMLHE did not differ among groups at wk 1, but cows in H had a decrease by wk 3, at which 
point expression was lower than cows in L. The expression pattern of this gene across groups 
indicated that the overall interaction effect was due to changes in H cows. It was noteworthy that 
the overall expression pattern of BBOX1 and SLC22A5 changed over time (w, P < 0.01), such 
that SLC22A5 expression decreased gradually from wk 1 to 5 in cows in M and L; however, in H 
cows, expression increased from wk 1 to 3 before decreasing at wk 5. In comparison, there was a 
clear increase in all treatments in BBOX1 between wk 1 and wk 3, followed by further increase 
in H at wk 5 but a return to wk 1 values in M and L. 
Gluconeogenesis and carbohydrate metabolism. The expression of PC, PCK1, and 
PDK4 was affected by the interaction of BCS and wk (b × w, P < 0.05; Figure 11). There was a 
gradual decrease in PC expression over time, and cows in H and M had greater expression of PC 
on wk 1 through 5 (Figure 5.11) compared with L. In addition, the expression of PC at wk 3 was 
greater for cows in H compared with M. The expression of PDK4 also was greater in cows in H 
compared with cows in L at all weeks, whereas, compared with M, cows in H had higher 
expression at wk 1 and 3 but a similar expression at wk 5. Furthermore, the PDK4 expression in 
M cows was similar as cows in L at wk 1, but was higher at wk 3 and 5. In contrast to the effect 
of high BCS on PC and PDK4, the expression of PCK1 in H cows increased (b × w, P < 0.05) 
between wk 3 and 5 compared with L cows, which followed the opposite trend. The expression 
of PCK1 for cows in M increased from wk 1 to 3, and did not change from wk 3 to 5.       
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Acute-phase proteins and inflammation. In contrast with ALB,  the recorded interaction 
(b × w, P < 0.05) in the expression of HP, SAA3, NFKB1, and STAT3 on wk 1 was due to a 
greater change in expression for cows in M compared with H (Figure 5.12 and 5.13). Cows in L 
had intermediate expression of these genes. The expression of HP, SAA3, NFKB1, and STAT3 
decreased (b × w, P < 0.05) more markedly between wk 1 and 3 in M and H cows compared 
with L. Despite that, the expression of SAA3 on wk 3 and 5 was lower (b × w, P < 0.05) for cows 
in H compared with L. The interaction (b × w, P < 0.05) on wk 3 and 5 for the expression of ALB 
was due to a lower expression for cows in H compared with L and M. Peak expression of ALB 
occurred for cows in M on wk 3 and on wk 5 for cows in L (Figure 5.12). Cows in H had the 
lowest expression of ALB on wk 3 and on wk 5 expression was the same in wk 1. 
Oxidative stress. There was no interaction for the expression of GPX1; however, there 
was an overall effect of time (w, P < 0.01) due to the increased expression between wk 1 and 5, 
with numerically lower expression in H compared with L and M (Figure 5.12). In contrast, there 
was an interaction (b × w, P < 0.05) for the expression of SOD1, due to the lower expression on 
wk 1 for cows in M and H compared with L. Expression increased for H cows, peaking on wk 3; 
but, for cows in M, the peak expression occurred on wk 5. There was no change in expression 
over time for cows in L (Figure 5.14).  
DISCUSSION 
The findings from the current study revealed that a higher BCS at calving benefits milk 
production, despite blood and liver tissue biomarkers indicating those cows are in greater NEB 
for several weeks after calving. Consistent with metabolic biomarkers, the hepatic gene 
expression profiling revealed that a higher BCS at calving increased the capacity of the liver for 
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fatty acid oxidation and ketogenesis. It was noteworthy that blood biomarkers of liver function 
were not affected by the high BCS at calving, despite the greater and more prolonged hepatic 
lipidosis. In addition, irrespective of calving BCS, all cows underwent a peripartal inflammatory 
response that was most evident after calving. Circulating concentrations and expression profiles 
of genes associated with inflammation decreased with time, with the rate of decline being 
greatest in cows with medium BCS, and least in those with high BCS.  Although cows with a 
low BCS had the lowest concentrations of acute phase proteins, their lower ALB (supported by 
gene expression data) provided some evidence of liver dysfunction.  
Overall, the collective measures of milk production, blood inflammation and metabolism 
biomarkers, and gene expression profiles suggest that cows calving at BCS 4.5 in the current 
study were in a more “optimal” health and productivity state than cows in either of the other two 
treatments. The results are, therefore, consistent with the recommendations by Roche et al. 
(2009) that of 5.0 as an optimal calving BCS target (10-point system; 3.0 in 5-point system). 
While this is important information for producers to understand, of much greater significance is 
this demonstration that relatively subtle changes in calving BCS are associated with significant 
changes in hepatic metabolism and inflammatory state.  
BCS at calving and metabolic and molecular adaptations in energy metabolism 
General. The pattern of milk production (Figure 5.1) and the concentrations of NEFA 
and BHBA in blood post-calving (Figure 5.2) in the H and M groups were indicative of a linear 
relationship between calving BCS and NEB. Such an effect of calving BCS on post-partum 
energy balance is consistent with previous findings (Bernabucci et al., 2005, Busato et al., 2002, 
Hayirli et al., 2002). However, two things are particularly evident in the present study: 1) the 
longer duration of the NEB state (i.e. elevated NEFA and BHBA) with increasing calving BCS; 
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high BCS cows continued to have high NEFA and BHBA concentrations after M cows had 
begun to decline (Figure 5.2).  These data are consistent with the increase in liver TAG in H 
cows on wk 3 post-calving (Figure 5.5). 2) The relatively high plasma glucose concentrations in 
M cows during this period compared with the H and L cows (Figure 5.2). The overall 
associations between BCS and concentrations of these key plasma metabolites where higher BCS 
links to higher BHBA and lower glucose concentrations while lower BCS links to lower NEFA 
and glucose concentrations, imply the existence of an optimum calving BCS to protect liver 
function. What is particularly interesting, however, is that these effects are evident over subtle 
changes in calving BCS (i.e. ± 1.0 BCS units on a 10-point scale; approximately 0.5 BCS units 
on a 5-point scale).  
The effect of calving BCS on NEFA and BHBA is supported by the reported increased 
expression of genes associated with fatty acid oxidation and ketogenesis, in both H and M cows 
relative to the L cows, particularly during wk 1-3 post-calving    Despite the marked increase in 
the serum NEFA concentration as early as 2 wk pre-calving in the L cows, the liver TAG 
concentration remained unchanged throughout the study (Figure 5.5). Such response agrees with 
previous reports in TMR-fed cows, in which nutritional management to avoid sudden and drastic 
changes in BCS around calving did not alter liver TAG significantly (Dann et al., 2006). Cows in 
the L group maintained consistent BCS and consistent liver TAG concentrations after calving, so 
are unlikely to have experienced the hepatotoxic effects of lipid accumulation. 
GH and IGF-1 axis. The lowest expression of GHR1A, IGF1, and IGFALS at wk 1 
postpartum in cows in the M group potentially indicates a more uncoupled somatotropic axis in 
this treatment. An uncoupled axis is also characterized by increased plasma GH, and decreased 
plasma IGF-1 concentrations (Lucy et al., 1998) which act to enhance lipolysis of stored adipose 
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reserves (Renaville et al., 2002). The greater plasma NEFA concentrations at wk 1 in cows in M 
relative to cows in L support the idea these cows had a more uncoupled somatotropic axis. 
Despite the lack of a difference in GHR1A expression from wk 3 onwards, the greater expression 
of IGF1, IGFALS, and IGFBP3 in cows in L, compared with cows in H, indicates greater 
production and more stable transport of IGF1 (Boisclair et al., 2001). IGF-1 binds to receptors 
that promote tissue growth (Nakae et al., 2001), which may limit the availability of nutrients for 
milk production; therefore, greater expression of these genes at wk 3 may contribute to the low 
milk production in cows in L.     
Fatty acid oxidation and ketogenesis. In non-ruminants, long-chain fatty acid (LCFA) 
oxidation and ketogenesis can be controlled at the transcription level (i.e. via changes in mRNA 
expression), hormonal level (e.g. ratio of insulin to glucagon), and/or through the availability of 
substrate and carnitine (Eaton, 2002, Nakamura et al., 2013). These pathways are likely to 
operate in a similar manner in ruminants. From a molecular standpoint, greater expression of 
CPT1A and HMGCS2 at wk 1 and 3, and of ACOX1 at wk 3 in the H compared with L group, 
reflect an increase in hepatic LCFA oxidation and ketogenesis in response to the higher influx of 
NEFA. This latter point is of particular interest since previous work with peripartal dairy cattle 
has provided evidence that peroxisomal LCFA oxidation provides an important pathway for 
hepatic processing of NEFA in the post-calving period (Grum et al., 1996). In the case of cows in 
H and M, the longitudinal response in ACOX1 and HMGCS2 along with the patterns of 
circulating NEFA and BHBA indicate an early transcriptional response to increase the amount of 
enzyme protein, after which the availability of substrate and flux through the pathway might 
have driven the reactions. However, the data for liver TAG and the expression profile of MTTP 
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and APOB indicate that molecular adaptations after calving were insufficient to prevent 
intracellular buildup of LCFA and their subsequent esterification, particularly in H cows.  
In some studies, the increased NEFA concentration after parturition has been associated 
with greater expression of CPT1A (Loor et al., 2005, Schlegel et al., 2012a, van Dorland et al., 
2009). In the present study, the higher expression of CPT1A at 1 wk postpartum in M and H 
groups suggests greater transport of cytosolic LCFA to mitochondria for fatty acid oxidation, 
whereas the lower expression in the low BCS group supports the view that lower circulating 
NEFA concentrations are limiting LCFA production (Figure 5.2).  The gradual decrease of 
CPT1A expression with time relative to parturition indicated an association with lower 
concentration of mobilized NEFA and subsequent reduction in hepatic oxidation, as reported 
recently (Litherland et al., 2011).  
Fatty acid oxidation and carnitine availability. In the context of CPT1A enzyme activity 
around calving, the role of hepatic carnitine availability for LCFA transport into mitochondria 
has received greater attention in recent years. Both TMLHE and BBOX1 encode key enzymes for 
carnitine synthesis (Bremer, 1983), while SLC22A5 encodes a transporter to promote carnitine 
uptake from the circulation. The protein encoded by BBOX1 catalyzes the final step to form 
carnitine from gamma-butyrobetaine (Bremer, 1983). These genes are PPAR targets in non-
ruminants (Wen et al., 2011, Wen et al., 2012).  Previous work with sheep revealed that 
ruminants primarily synthesize carnitine from endogenous sources of methionine and lysine 
rather than from dietary sources (Erfle et al., 1974, Snoswell and McIntosh, 1974). Overall, the 
present results reveal a negative association between BCS and the level of expression of genes 
involved in endogenous carnitine synthesis (TMLHE and BBOX1), although at wk 3 post-calving 
there was a positive association between BCS and hepatic ability to take up carnitine from 
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circulation (SLC22A5). It has recently been demonstrated that TMLHE, BBOX1, and SLC22A5 
are more highly expressed at 1 wk post-calving than at 3 wk prepartum (Schlegel et al., 2012a).  
The changes in expression over time observed in the present data would result in 
increased intracellular carnitine content, as reported by (Schlegel et al., 2012a).  Whether from 
de novo synthesis (TMLHE, BBOX1) or greater uptake (SLC22A5). There was sustained up-
regulation of BBOX1 after calving while expression of both TMLHE and SLC22A5 decreased 
between 1 and 5 wk post-calving (Schlegel et al., 2012a).  This suggests that hepatic synthesis of 
carnitine is an important adaptation of the tissue to cope with the influx of NEFA during the 
post-calving period.   
The greater prepartal serum creatinine concentration for M and L compared with H is 
suggestive of greater skeletal muscle breakdown. This could reflect mobilization of muscle tissue 
to meet energetic or other requirements due to their lower BCS status and, therefore, adipose 
reserves. As such, it is likely that availability of carnitine and/or amino acids needed for carnitine 
synthesis in liver (lysine and methionine) (Bremer, 1983) were increased. Such a requirement 
would partly explain the similar expression of SLC22A5 and TMLHE among groups on wk 1.  
Although the concentration of serum creatinine remained unchanged between wk 1 and 3 for all 
groups, the fact that TMLHE decreased markedly in the H group while SLC22A5 increased by 
wk 3 may indicate that those cows relied more on muscle-derived carnitine uptake while cows in 
M and L relied more on de novo synthesis via greater BBOX1 expression. This hypothesis is 
supported by a greater concentration of liver carnitine after calving coupled with lower skeletal 
muscle carnitine (Carlson et al., 2007). Although data on amino acid uptake by liver around 
parturition are scarce, there is evidence that net liver removal of methionine and lysine, sources 
for carnitine synthesis, after calving decreases in favor of their use by the mammary gland for 
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milk protein synthesis (Doepel et al., 2009).  Therefore, hepatic uptake after calving appears to 
be the major source of intracellular carnitine. 
Role of PPARα in molecular adaptations. The data from non-ruminant studies clearly 
demonstrated that NEFA taken up by the liver bind and activate the PPARߙ signaling pathway 
(Kersten et al., 1999); PPAR is a transcription regulator that plays a central role in the metabolic 
adaptations to dietary energy deficiency. Moreover, the agonistic role of LCFA in bovine cells 
and a recent review of the literature in ruminants has led to the hypothesis that up-regulation of 
PPARA and its target genes (ACOX1, CPT1A, HMGCS2, ACADVL) when circulating NEFA 
concentrations increase will help to coordinate LCFA oxidation and ketogenesis (Bionaz et al., 
2013). Although PPARA expression did not differ between wk 1 and 3 among treatments, the 
differences in the expression pattern of target genes such as HMGCS2 and ACOX1 (which are 
transcriptionally-regulated) in H and M cows, along with circulating NEFA and BHBA levels, 
provide some evidence that they may work through LCFA activation of PPAR. Changes in the 
expression of PPARA in liver around calving have not always been recorded (Bionaz et al., 
2013). One study even reported no change in PPARA expression  in liver of cows with ketosis 
and high plasma NEFA, and when cows were fed LCFA beginning in the dry period  (Carriquiry 
et al., 2009).  The longitudinal decrease in expression of CPT1A and IGFBP1, both well-
established PPAR targets in non-ruminants (Bionaz et al., 2013), indicates that they are not 
strict PPAR targets or that alternate mechanisms play a role in controlling their expression in 
ruminants (e.g. intracellular malonyl-CoA, hepatic insulin sensitivity). Future work in this area is 
warranted.    
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Lipoprotein synthesis. The pattern of MTTP and APOB expression agrees with previous 
data (Bernabucci et al., 2004, Gruffat et al., 1997, Schlegel et al., 2012b), although this may not 
necessarily reflect the level of protein expression resulting from these two genes Expression of 
APOB protein increased progressively from wk 1 through 12 post-calving without changes in 
mRNA (Gruffat et al., 1997). The discrepancy results from the tight control of both synthesis and 
degradation of APOB mRNA (Adeli et al., 1995).  The control of MTTP appears more complex. 
Data derived in vitro using calf hepatocytes reported no association between NEFA 
concentration and activity of the enzyme, but intracellular TAG increased as NEFA 
concentration increased (Bremmer et al., 2000). Other enzymes in the pathway of TAG synthesis 
(e.g. DGAT1, AGPAT, GPAM, PLIN2) may limit the ability of bovine hepatocytes to synthesize 
VLDL. Reduced hepatic insulin sensitivity in the post-calving period might also be associated 
with lower mRNA expression/enzyme activity of MTTP (Tietge et al., 1999). 
Gluconeogenesis. Lactate and alanine are utilized for gluconeogenesis under the control 
of PC, and hepatic activity of this enzyme increases markedly after calving (Reynolds et al., 
2003, White et al., 2012). Greater PC mRNA expression and enzyme activity in periods of NEB 
allow pyruvate carbon to be channeled through oxaloacetate to maintain hepatic glucose output 
(Reynolds et al., 2003). Expression of PC is increased during the transition to lactation and 
during feed restriction (Greenfield et al., 2000, Loor et al., 2006, Velez and Donkin, 2005). In 
addition to the role of PC in gluconeogenesis, the higher expression of PDK4 after calving 
ensures that flux of pyruvate through the TCA cycle is affected because this kinase 
phosphorylates pyruvate dehydrogenase and prevents pyruvate oxidation (Sugden and Holness, 
2003). Thus, the fact that cows in H and M had greater PC and PDK4 during the first 3 wk post-
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calving is indicative of an adaptation to support greater rates of gluconeogenesis for the higher 
milk production in those cows.  
BCS at calving and hepatokine expression as metabolic stress signals 
Fibroblast growth factor 21 (FGF21) is a secreted protein produced primarily by the liver 
and in non-ruminants seems to have important roles in regulating glucose and lipid metabolism 
(Inagaki et al., 2007). Angiopoietin–like 4 (ANGPTL4) is another hepatokine identified as a 
target of PPAR in non-ruminants. It is strongly up-regulated in liver by fasting (Kersten et al., 
2000) and during nutrition-induced ketosis in early post-calving cows (Loor et al., 2007). The 
induction of hepatic FGF21 expression stimulates hepatic oxidation of LCFA and 
gluconeogenesis in response to fasting and during consumption of a ketogenic diet 
(Domouzoglou and Maratos-Flier, 2011). In TMR-fed cows, Schoenberg et al. (2011) reported a 
positive relationship between energy deficit and plasma FGF21 concentration, coupled with 
greater hepatic mRNA expression. Calving increases circulating concentration of growth 
hormone and glucagon as part of the homeorhetic adaptations to lactation, and both have been 
recognized as regulating hepatic expression of FGF21, either via direct activation or, indirectly, 
via the activation of PPAR by NEFA (Uebanso et al., 2011). Both H and M showed changes 
over time in FGF21 and ANGPTL4, another hepatokine controlled by PPAR (Kersten et al., 
2000), that were similar to those of PC and PDK4, reflecting a concerted mechanistic adaptation 
linking LCFA oxidation and gluconeogenesis.  
The fact that FGF21 and ANGPTL4 expression was greater in the H cows emphasizes 
their more pronounced NEB status (Roche et al., 2013). Both hepatokines could be used as 
biomarkers of energy balance during the peripartal period. Their potential role in regulation of 
adipose tissue lipolysis and insulin sensitivity (Murata et al., 2013, Nakamura et al., 2013), 
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suggests they could also signal the intensity of metabolic stress and be used as a measure of 
susceptibility to metabolic disorders. For example, ANGPTL4 increases both in non-ruminants 
(Lu et al., 2010) and early post-calving cows when challenged with a pro-inflammatory stimulus 
(lipopolysaccharide) (Graugnard et al., 2013). This suggests a possible role as an acute-phase 
protein reflecting metabolic stress, and the application of these proteins as biomarkers should 
undergo further investigation. 
BCS at calving and the Inflammatory and oxidative stress response 
The acute-phase response (APR) is a complex early-defense system, initiated by pro-
inflammatory cytokines released from macrophages and monocytes at the site of infection or 
tissue damage (Bertoni and Trevisi, 2013). Serum albumin generally decreases during the APR 
and, therefore, is considered as a major negative acute-phase protein (Bertoni and Trevisi, 2013). 
Fat infiltration in the liver also may affect the concentration of some blood components, 
including albumin. Albumin concentrations among all groups were greater than levels reported 
to reflect impaired peripartal liver function (Bertoni et al., 2008). Nevertheless the overall pattern 
was suggestive of a lower inflammatory response after calving for the H and M cows than the L 
group (Figure 5.3). The lesser response to the expression of ALB in H compared with M cows 
between 1 and 3 wk was surprising, since post-calving serum albumin levels did not differ 
between these groups and was markedly lower in the L cows. Since low plasma albumin 
concentration is generally considered an indicate of chronic pro-inflammatory liver activation 
(Bertoni and Trevisi, 2013), the ALB mRNA expression patterns suggest that the H and M 
groups differed in their pro-inflammatory status. Such differences could be related to the greater 
influx of NEFA and/or accumulation of TAG in the H group, however, further research is 
warranted. 
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There was no effect of BCS in the concentration of serum haptoglobin and serum 
amyloid A, but their pattern around calving was typical of what is commonly reported in dairy 
cattle (Bertoni and Trevisi, 2013).  The greater expression of HP and SAA3 on wk 1 in the M 
cows compared with H suggests a more pronounced inflammatory state, but the marked decrease 
in expression of both APP by wk 3 postpartum suggests this was limited to a transient adaptation 
associated with parturition and lactogenesis.   
Although not measured in the present study, it also is possible that concentrations of 
eicosanoids and/or reactive oxygen metabolites (ROM) (Reddy and Rao, 2006) were greater in 
liver tissue of H cows. Although the expression of SOD1 increased between wk 1 and 3 in the H 
cows, the cellular anti-inflammatory and anti-oxidant mechanisms in those cows could have been 
impaired. It is noteworthy that the molecular data do not seem to be associated with the temporal 
concentrations of AST, GGT, and GDH, which are commonly used as biomarkers of liver 
function, stress, and overall health (Bertoni and Trevisi, 2013). In contrast, a high concentration 
of globulin, as detected in the H group, would be indicative of poor liver function (Bertoni et al., 
2008); when combined, the albumin to globulin ratio supports the notion that cows in H (and L) 
had compromised liver function compared with M. It must be noted, however, that the post-
calving concentrations of globulin were below those reported for cows with signs of 
inflammation-related liver dysfunction (Bertoni et al., 2008). 
Haptoglobin and SAA are positive APP that can act as antioxidant and anti-inflammatory 
agents, at least in part, by regulating the maturation and activity of immune cells. Their 
expression is regulated by the NFKB-STAT3 signaling pathway (class II acute phase genes) 
(Burgess-Beusse and Darlington, 1998). The greater mRNA expression on wk 1 of NFKB1 and 
STAT3 along with HP and SAA3 in the M group was quite surprising and suggests that a transient 
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inflammatory status within the liver is not necessarily associated with poor liver function (e.g. 
high serum AGR and albumin) and lower milk production. This idea is partly supported by the 
greater expression of NFKB1 and SAA3 on wk 3 in the L cows compared with M. Furthermore, 
accumulation of TAG in liver did not seem to compromise the ability of cows to produce more 
milk or promote a sustained pro-inflammatory response within liver.  
These represent novel findings and seem to confirm that some degree of inflammation is 
part of the homeorhetic mechanisms coordinating the transition into lactation (Bertoni et al., 
2004, Farney et al., 2013). However, as our data also suggest, a sustained pro-inflammatory 
response is not desirable and in the long-term could compromise the ability of the cows to reach 
their potential for milk production (Bertoni et al., 2004). The present data from L cows supports 
this point.  
CONCLUSIONS 
To conclude, the results highlight the effects of differing calving BCS on measures of 
production, inflammatory state, and metabolism. Cows calving at BCS 3.5 or 5.5 were 
compromised relative to cows calving at BCS 4.5 (1-10 scale). Collectively, the results support a 
similar optimum calving BCS for pasture-based dairy cows to that recommended by Roche et al. 
(2009). This optimum calving BCS is approximately BCS 5.0 (i.e. equivalent to BCS 3.0 in a 5-
point scale). 
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TABLES AND FIGURES 
 
 
 
 
 
 
 
 
 
Figure 5.1. The effect of BCS at calving on milk production during the first 6 wk post-calving. 
Cows were managed during the dry period to maintain a high, low, or medium (Med) body 
condition score until calving. The statistical effect of week (w), BCS (b), and BCS  wk (b*w) is 
indicated. 
Week relative to parturition
0 1 2 3 4 5 6 7
kg
/d
16
18
20
22
24
26
High
Med
Low
w    P < 0.01
b      P = 0.01
b x w  P = 0.11
Milk yield
 
 
214 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. The effect of BCS at calving on serum concentration of non-esterified fatty acids 
(NEFA), beta-hydroxybutyric acid (BHBA), and glucose during the last 4 wk prepartum and the 
first 6 wk postpartum.  Cows were managed during the dry period to maintain a high, low, or 
medium (Med) body condition score until calving. The statistical effect of week (w), BCS (b), 
and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 0.05 within a BCS and between wk. α-γ 
BCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.3. The effect of BCS at calving on serum concentration of haptoglobin (HP), serum 
amyloid A (SAA),   globulin (GLO),  albumin (ALB), and albumin:globulin ratio (AGR) during 
the last 4 wk prepartum and the first 6 wk postpartum. Cows were managed during the dry period 
to maintain a high, low, or medium (Med) body condition score until calving. The statistical 
effect of week (w), BCS (b), and BCS  wk (b*w) is indicated. 
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Figure 5.4. The effect of BCS at calving on serum concentration of serum aspartate transferase 
(AST), glutamate dehydrogenase (GDH), Gamma-glutamyltransferase (GGT), and creatinine (D) 
during the last 4 wk prepartum and the first 6 wk postpartum. Cows were managed during the 
dry period to maintain a high, low, or medium (Med) body condition score until calving. The 
statistical effect of week (w), BCS (b), and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 
0.05 within a BCS and between wk. α-γBCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.5. The effect of BCS at calving on concentration of triacylglycerol (TAG) in liver 
tissue on the last wk prepartum and wk 1, 3, and 5 postpartum.  Cows were managed during the 
dry period to maintain a high, low, or medium (Med) body condition score until calving.  The 
statistical effect of week (w), BCS (b), and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 
0.05 within a BCS and between wk. α-BCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.6. The effect of BCS at calving on postpartal expression of genes involved in fatty acid 
oxidation, ketogenesis, and PPAR signaling. Cows were managed during the dry period to 
maintain a high, low, or medium (Med) body condition score until calving. The statistical effect 
of week (w), BCS (b), and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 0.05 within a 
BCS and between wk. α-γBCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.7. The effect of BCS at calving on postpartal expression of genes involved in 
lipoprotein synthesis. Cows were managed during the dry period to maintain a high, low, or 
medium (Med) body condition score until calving.  a-cBCS  wk (b*w) P < 0.05 within a BCS 
and between wk. The statistical effect of week (w), BCS (b), and BCS  wk (b*w) is indicated. α-
BCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.8.  The effect of BCS at calving on postpartal expression of genes involved in the 
growth hormone/IGF-1 signalling axis. Cows were managed during the dry period to maintain a 
high, low, or medium (Med) body condition score until calving. The statistical effect of week 
(w), BCS (b), and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 0.05 within a BCS and 
between wk. α-BCS  wk (b*w) P < 0.05 among BCS at a given wk.  
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Figure 5.9.  The effect of BCS at calving on postpartal expression of liver-secreted hepatokines. 
Cows were managed during the dry period to maintain a high, low, or medium (Med) body 
condition score until calving.  The statistical effect of week (w), BCS (b), and BCS  wk (b*w) 
is indicated. a-bBCS  wk (b*w) P < 0.05 within a BCS and between wk. α-γ BCS  wk (b*w) P < 
0.05 among BCS at a given wk.   
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Figure 5.10.  The effect of BCS at calving on postpartal expression of genes associated with 
carnitine synthesis and uptake. Cows were managed during the dry period to maintain a high, 
low, or medium (Med) body condition score until calving. The statistical effect of week (w), 
BCS (b), and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 0.05 within a BCS and 
between wk. α-BCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.11.  The effect of BCS at calving on postpartal expression of genes associated with 
gluconeogenesis. Cows were managed during the dry period to maintain a high, low, or medium 
(Med) body condition score until calving. The statistical effect of week (w), BCS (b), and BCS  
wk (b*w) is indicated.  a-cBCS  wk (b*w) P < 0.05 within a BCS and between wk. α-γBCS  wk 
(b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.12.  The effect of BCS at calving on postpartal expression of genes encoding acute-
phase proteins. Cows were managed during the dry period to maintain a high, low, or medium 
(Med) body condition score until calving. The statistical effect of week (w), BCS (b), and BCS  
wk (b*w) is indicated.  a-cBCS  wk (b*w) P < 0.05 within a BCS and between wk. α-γBCS  wk 
(b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.13.  The effect of BCS at calving on postpartal expression of genes encoding 
inflammation transcription regulators. Cows were managed during the dry period to maintain a 
high, low, or medium (Med) body condition score until calving. The statistical effect of week 
(w), BCS (b), and BCS  wk (b*w) is indicated. a-cBCS  wk (b*w) P < 0.05 within a BCS and 
between wk. α-BCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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Figure 5.14.  The effect of BCS at calving on postpartal expression of genes encoding 
antioxidant enzymes. Cows were managed during the dry period to maintain a high, low, or 
medium (Med) body condition score until calving. The statistical effect of week (w), BCS (b), 
and BCS  wk (b*w) is indicated.  a-bBCS  wk (b*w) P < 0.05 within a BCS and between wk. α-
BCS  wk (b*w) P < 0.05 among BCS at a given wk. 
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CHAPTER 6: Body condition score at calving alters the hepatic transcriptome in grazing dairy 
cattle 
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ABSTRACT 
In dairy management, the assessment of body-fat contents that a cow possesses is an 
excellent indicator of the nutritional status, and inferred risk to animal welfare. Peripartum BCS 
influenced milk production, reproduction and animal health. The objective of the current study 
was to use transcriptomics and bioinformatics to evaluate alterations in hepatic gene expression 
profiles in cows managed to achieve a high (H, 5.5 BCS), medium (M, 4.5 BCS), or low (L, 3.5 
BCS) BCS (10-point scale). Target BCS at calving were achieved by managing feed allowance 
after dry off. Post-calving cows were allocated pasture and pasture silage. Liver from 8 cows per 
BCS was biopsied on wk 1, 3 and 5 relative to parturition. A whole-transcriptome bovine 
microarray (Agilent) was used. An ANOVA with repeated measures using PROC MIXED 
resulted in 4,325 DEG due to main effect of BCS and 251 differentially expressed genes (DEG; 
False Discovery Rate <0.05) due to interaction effect of BCS  wk. Bioinformatics analysis was 
performed with the Dynamic Impact Approach (DIA) focusing on pathways from the KEGG 
database. The transcription regulator (TR) network analysis was performed with Ingenuity 
Pathway Analysis (IPA). Bioinformatic analysis uncovered carbohydrates, lipid terpenoids and 
polyketides, and vitamin metabolism as the most impact categories affected with change in BCS. 
In comparison, L cows induced the pathways associated with glycolysis / gluconeogenesis, 
synthesis and degradation of ketone bodies, steroid biosynthesis, biosynthesis of unsaturated 
fatty acids, vitamin B 6 metabolism, apoptosis, and lysosomal functions. The comparison of H 
with M revealed down- regulation of pathways included metabolism of propionate and pyruvate, 
glycolysis/gluconeogenesis, vitamin B6 metabolism, fatty acid biosynthesis, and induced the 
regulation of autophagy, and fatty acid elongation in mitochondria. Using the BCS  wk DEG, 
analysis of most-impacted pathways revealed marked differences on wk 1 for H vs. L and M vs. 
L. The pathways associated with the biosynthesis of ‘fatty acid’, ‘unsaturated fatty acids’, and 
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‘steroid’ were among the top 5 highly-impacted pathways when comparing H vs. L and L vs. M. 
However, all were highly-inhibited in H vs. L but highly-activated in L vs. M. The degree of 
impact on pathways observed when comparing H vs. M on wk 1 was quite low, and there were 
little differences in pathway flux (i.e. little change in activation/inhibition). Remarkably, the 
most-impacted pathways in H vs. L on wk 3 were for the most part the same as those observed 
on wk 1. ‘fatty acid biosynthesis’ on wk 3 was the most-impacted pathway and markedly 
inhibited in H vs. M. Data from wk 5 suggests a lesser effect of BCS at calving on the 
transcriptome because impact values regardless of BCS were substantially lower than those in 
wk 1 and 3. However, it is noteworthy that the ‘sulfur relay system’ pathway, key for post-
transcriptional RNA modifications in mammals, was the most impacted and inhibited pathway in 
H vs. M. The TR network analysis uncovered TP53 as a central hub regulating a large spectrum 
of genes altered by BCS. Expression of TP53 was overall greater in H vs. M and L vs. M, but 
lower in H vs L. Among DEG with a BCS  wk effect due to H vs. M or L vs. M on wk 1, 
HNF4A among 10 TR uncovered had the greatest number of targets. Preliminary bioinformatics 
analyses underscored the role of BCS at calving on liver function through alterations of the 
molecular phenotype. 
Key words: Cows, BCS, liver, bioinformatics 
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INTRODUCTION 
The onset of lactation in cows is a very stressful period characterized by an increase in 
lipolysis to meet a high energy demand. However, when the energy demand for milk production 
and maintenance exceeds the energy released by adipose tissue, the negative energy balance 
exposes the cow to many health issues. A body condition score (BCS), which determines the 
energy status of a dairy cow, is importantly used to assess the transition period of a cow 
experiencing a change in metabolism and energy content (Drackley, 1999, Roche et al., 2009). 
Recent research focused on calving BCS management has found that a high BCS, rapid BCS 
loss, or both, are associated with several metabolic and immune disorders and an overall 
decrease in productivity (Roche et al., 2009). 
In obese cows with a high BCS, the NEFA mobilized from adipose tissue is often greater 
than the energy demand for maintenance and lactation (Bobe et al., 2004). This surplus in 
mobilization leads to hepatic metabolic stress and associated health problems including fatty 
liver and uterine infections (Burke et al., 2010, Lacetera et al., 2005). Cows with a low BCS at 
calving have also been associated with an increased risk of hepatic disease (Roche et al., 2009, 
Roche et al., 2013). Functional adaptation in the liver and the liver’s role in dairy metabolic 
dynamics are processes central to changes in a cow’s BCS, but previous research mentioned in a 
recent review has been limited to biochemical analysis and the expression of a few target genes 
(Roche et al., 2009). Large-scale gene expression profiling (i.e. transcriptomics) coupled with 
bioinformatics are methods better suited for linking host-tissue responses to changes in 
metabolism and health status (Loor et al., 2011). The current study is the first to compare large 
scale alterations in the hepatic transcriptome profiles in response to change in calving BCS 
induced with different prepartum energy levels. 
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Analysis of high-throughput microarray data at pathway levels is very appealing for 
gaining insight into the underlying biology of the condition (Khatri et al., 2012). Therefore, 
bioinformatics tools were used in this study to uncover the pathways and functional categories 
most stimulated in response to changes	in calving BCS. Beyond the physiological and nutritional 
condition of the cell, previous studies have recommended evaluating transcription regulators 
those directly control gene expression for the complete understanding of cellular adaptation in 
response to ligands (Blais and Dynlacht, 2005). Therefore, in addition to analyzing functional 
categories and pathways, bioinformatics tools also uncovered the top transcription factors, 
nuclear receptors, and associated networks that differ in expression across the liver transcriptome 
with changes in BCS.  
MATERIALS AND METHODS 
Animals, management, tissue sampling and RNA extraction 
   Liver samples were obtained from a previous set of cows with low, mid and high calving 
BCS (Roche et al., 2013). The details of the management of the animals were reported recently  
(Roche et al., 2013).  Briefly, a group of 60 cows were allocated to three different treatments and 
nutritionally managed through late lactation to create three different post-lactation BCS 
categories [BCS targets were 5.0, 4.0 and 3.0, for high (H), medium (M) and low (L), 
respectively: 10-point system, where 1 is emaciated and 10 is obese (Macdonald, 2004, Roche et 
al., 2009). During the dry period, these cows were fed a ration that allowed for fetal growth and 
for the cows to gain 0.5 BCS units before calving. The final targets for mean calving BCS were 
5.5, 4.5 and 3.5, for the H, M, and L calving BCS treatments respectively. All of the selected 
cows completed the experiment and exhibited no evident signs of clinical conditions. 
 
 
232 
 
Liver biopsy.  Liver samples were collected by biopsy during the week before calving (-1 
wk), and subsequently on weeks 1, 3 and 5 postpartum. A patch of the cow’s skin was shaved 
and disinfected and the area through the skin and body wall were anesthetized with 7 mL of 2% 
lignocaine (Lopaine 2%, lignocaine hydrochloride 20 mg/mL, Ethical Agents, South Auckland, 
New Zealand). A stab incision was made through the skin in the right 11th intercostal space at the 
level of the greater trochanter through which a 12G  20 cm biopsy needle was inserted into the 
liver and approximately 1 g (wet weight) of liver tissue was collected. Liver samples were snap-
frozen in liquid nitrogen and stored at -80°C.  
RNA extraction. Liver biopsy samples from weeks 1, 3, and 5 postpartum were used for 
RNA extraction, using the optimized protocol from our lab. For each sample, approximately 40 
mg of liver tissue was weighted and immediately placed in 1 ml of an ice-cold Qiazol reagent for 
homogenization. After homogenization, the samples were centrifuged for 10 min. at 12,000 g at 
4ºC to remove the insoluble material. The supernatant was transformed to a collection tube and 
incubated for 5 minutes on ice. Chloroform (200ul) was added to each tub and the sample was 
incubated for 3 minutes at room temperature. After incubation, the samples were centrifuged for 
15 min. at 12,000 g at 4ºC, the upper phase was transferred to a new collection tube without 
disturbing the mid and lower phases. A second wash was performed with 100% Ethanol; 750ul 
was added to the samples and were transferred to miRNeasy Mini Kit columns (Cat. No: 
217004) after proper mixing with the pipette. Genomic DNA was removed from the RNA with 
the RNase-free DNaseI using the recommended protocol provided with the miRNeasy Mini Kit. 
The RNA concentration in each sample was measured with the NanoDrop ND-1000 
spectrophotometer, while the RNA quality was assessed using the Agilent Bioanalyzer system 
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(Agilent 2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA, USA). The average RNA 
integrity number (RIN) value for the samples was 8  0.4.  
Microarrays and data analysis 
cRNA synthesis, labeling, and purification.  The RNA samples (RIN 8  0.4) of eight 
cows from each treatment group were randomly selected for hepatic transcriptome analysis. The 
transcript profiling was conducted using the aglint bovine (V2) gene expression microarray, 
~44k unique elements (Agilent Technologies; cat# G2519F-023647; 
http://www.genomics.agilent.com/article.jsp?pageId=1508). The methods used for labeling and 
hybridization were consistent with those defined by Agilent technologies. Briefly, a total of 200 
ng of RNA from each sample were used to generate first-strand cDNA, which was successively 
reverse transcribed to cRNA using a low input quick amp labeling kit (Agilent Technologies; 
Cat#. 5190-2306; http://www.genomics.agilent.com/article.jsp?pageId=1412). The obtained cRNA 
was labeled with either Cy3 or Cy5 fluorescent dye (Agilent Technologies; Cat#. 5190-2306; 
http://www.genomics.agilent.com/article.jsp?pageId=1412, following the manufacturer's instructions.  
Purification of the labeled cRNA product was performed with RNeasy mini spin columns 
(QIAGEN), and subsequent elution in 30 μl of the dnase rnase free water provided (Agilent). The 
eluted labeled cRNA was quantified on a NanoDrop ND-1000 to confirm the manufacturer's 
recommended criteria for yield and specific activity at least  0.825 ug and  ≥ 6 respectively with 
4-pack microarray format. The labeled samples were stored at – 80C until next day 
hybridization. 
Hybridization and slide scanning. The labeled cRNA samples were hybridized with 
respect to our BCS (H, M, L) and time (wk 1, 3, 5) based factorial microarray design without dye 
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swap (Appendix–E: Suppl. Figure E.1). Briefly, the Cy3 labeled cRNA (red) from one group at a 
given time point was co-hybridized with the Cy5 labeled cRNA (green) from another group with 
same time point to generate fluorescence ratios as a measurement of relative expression across 
the different calving BCS. Similarly, within the same BCS, the Cy3-labeled cRNA from wk 1 
was co-hybridized with Cy5-labeled cRNA from wk3 from wk3 to make a factorial design 
without dye swap (Appendix–E: Suppl. Figure E.1).  
The hybridization mixture was loaded onto bovine specific 44K oligo microarray glass 
slides (Agilent Technologies; cat#G2519F-023647) using the Gene Expression Hybridization Kit 
(Agilent Technologies; cat# 5188-5242), and incubated for 17 h at 65°C. The final step involved 
washing the hybridized slides with the Gene Expression Wash Buffer Kit (Agilent technologies; 
Cat#5188-5327). Within two minutes of the wash, the slides were scanned using an Axon 4000B 
scanner and the images were analyzed with GENEPIX software (Agilent Technologies), at the 
Keck center of the University of Illinois Urbana Champaign.  
Statistical analysis 
The entire microarray data set was normalized for dye and microarray effects (ie, Lowess 
normalization and microarray centering) and used for statistical analysis (Loor et al., 2007). Data 
was analyzed using the Proc MIXED procedure of SAS (SAS, SAS Inst. Inc., Cary, NC). 
Differences in relative expression ratios were deemed significant at BCS  time FDR cutoff of P 
≤ 0.05. The number of differentially expressed genes due to the main effect of BCS, time relative 
to parturition (wk) and interaction of BCS × wk is provided in table 6.1. Fixed effects in the 
model were the BCS, time relative to parturition, and the associated interaction. Random effects 
included the cow and the microarray. Significance of the F-test of fixed effects was declared at P 
 
 
235 
 
≤ 0.05. Overall, the differentially expressed gene was declared at FDR cut off <0.05 and p value 
≤ 0.05. 
Gene expression data mining  
The entire data set of DEG uncovered with microarray (FDR cut off <0.05 with 
associated statistical P values) were imported into Ingenuity Pathway Analysis (IPA, 
http://www.ingenuity.com/; Redwood City, CA, USA) and Dynamic Impact Approach (DIA)  
functional analysis tools. In both tools, the complete annotated microarray was used as the 
reference dataset (i.e., background) for enrichment analysis. For IPA analysis, the FDR cutoff of 
<0.05 was applied to the interaction of BCS and time relative parturition, whereas a more 
stringent cutoff (FDR <0.01) was used to analyze the individual effects of BCS due to the limited 
occupancy of genes (≤ 1000) per network in IPA.  
Dynamic Impact Approach (DIA). Functional enrichment analysis was performed using 
a well-known bioinformatics tool called Dynamic Impact Approach (DIA) (Bionaz et al., 2012). 
The DIA allows visualization of the impact and direction of the impact of DEG on 
pathways/biological functions from several annotation databases including GO and KEGG 
pathways. The impact and the direction of the impact for KEGG pathways were calculated only 
for the terms that were represented at least 30% in the microarray compared to the entire 
annotated bovine genome. 
Network analysis. The networks among DEG were developed using IPA. In order to 
uncover the most important transcription factor for the regulation of DEG, all the possible 
transcription regulators (transcription regulators or nuclear-receptors) in the particular data set of 
DEG were added to the network of DEG using IPA knowledge in order to develop connections 
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and relationships. The list of top transcription regulators (TR) and associated regulated genes are 
provided in table 6.4A and 6.4B, whereas, complete informations are shown in Suppl. table E.1 
and E.2: and Suppl. Figure E.2A-2R (Appendix–E). 
RESULTS 
Differentially expressed genes 
 The statistical analysis uncovered a total of 8788 genes (DEG; FDR cut off of < 0.05 and 
raw p value of < 0.05) significantly affected by the main effect of time relative to parturition,  
whereas BCS alone affected the expression of 4325 genes (Table 6.1). The interaction of BCS 
and time relative to parturition, differentially regulated a total of 251genes (FDR cut off and P 
value <0.05), the details of the number of DEG with a particular interaction are given in Table 
3A-B. 
Functional enrichment analysis with DIA  
Main effect of BCS 
Major categories impacted in low BCS cows, in comparison with high and mid BCS. 
The major categories impacted with a change in calving BCS are associated with metabolism, 
genetic information processing (GIP), and Organismal system (OS). In comparison, cows with a 
low BCS had induced expression of the pathways associated with metabolism; the largest 
increase was observed in the metabolism of terpenoids and polyketides, respectively, followed 
by carbohydrates, lipids, and other amino acids (Figure 6.1). Similarly, all functions associated 
with GIP and cellular processing (CP) increased, whereas replication and repair (GIP) and cell 
communication (CP) were observed to be the top impacted in the up regulated category. In major 
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category OS, functions associated with the immune system increased while the sensory system 
decreased in low BCS.  
Pathways affected with the comparison of high vs low BCS. The functional analysis of 
microarray data revealed down regulation of steroid biosynthesis, terpenoid backbone 
biosynthesis, synthesis and degradation of ketone bodies, pentose and glucuronate 
interconversion, and pyruvate metabolism in cows with a high BCS as compared with a low BCS 
(Figure 6.2). In addition, the other down regulated pathways were glycolysis and 
gluconeogenesis, vitamin B 6 metabolism, fatty acid biosynthesis, apoptosis, and lysosomal 
functions . An increase in function was observed in the expression of genes associated 
cyanoamino acid metabolism, fatty acid metabolism, vitamin digestion and absorption, PPAR 
signaling pathway, fat digestion and absorption, nitrogen metabolism, and fatty acid elongation 
and absorption (Figure 6.2). 
Pathways affected with comparison of low and mid BCS. The DIA analysis uncovered 
the most important up regulated pathways were associated with metabolism, including steroid 
biosynthesis, ascorbate and aldarate metabolism, synthesis and metabolism of ketones bodies, 
propanate metabolism, and terpenoid back bone biosynthesis (Figure 6.2). The other induced 
functions in L cows were glycolysis and gluconeogenesis, biosynthesis of unsaturated fatty acids, 
pentose and glucuronate interconversion, pyruvate metabolism, beta alanine metabolism, and 
glutathione metabolism. The most impacted down regulated pathways were associated with 
vitamin digestion and absorption, hedgehog signaling, thiamin metabolism, fat digestion and 
absorption, and fatty acid bio synthesis (Figure 6.2).  
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Major categories impacted in the comparison of High and Mid BCS. In the functional 
analysis of high and mid BCS cows, carbohydrate and glycan biosynthesis were metabolic 
categories that were up and down regulated respectively. In GIP, a mild decrease was observed 
in replication and repair only, while all the other pathways including transcription showed an 
increase (Figure 6.1). In EIP, an increase was only observed in signaling molecules and 
interaction while membrane transport was recorded as the most down regulated pathway. In CP, 
with the exception of cell growth and death, the other three categories increased in High BCS 
cows. In OS, the environmental adaptation, both the endocrine system and sensory system were 
up regulated while down regulation was observed in the categories associated with the immune 
system, and other OS pathways (Figure 6.1). 
Pathways affected with comparison of high and mid BCS. Glycosaminoglycan 
degradation was observed as a top impacted pathway, which has been down regulated in cows 
with high BCS compared with M. The other down regulated pathways included vitamin B6 
metabolism, fatty acid biosynthesis, glycosaminoglycan biosynthesis metabolism of propionate 
and pyruvate, and glycolysis/gluconeogenesis. The top up regulated pathways were associated 
with regulation of autophagy, vitamin digestion and absorption, primary bile acid synthesis, 
butanoate metabolism, and fatty acid elongation in mitochondria (Figure 6.2).  
Major categories and pathways impacted by the interacting effect of BCS and weeks 
relative to parturition uncovered with DIA  
High BCS at different time points 
High BCS at week 3 vs 1. In cows with high BCS, the metabolic activity lipid, terpenoids 
and polyketides metabolism were decreased at wk 3 compared with wk1, whereas, increase was 
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observed in glycan biosynthesis. The GIP was also upregulated with most upregulation recorded 
in folding, sorting and degradation. The EIP associated pathways decreased and signaling 
transduction was the most impacted category. Furthermore, in cows with a high BCS, the 
function associated with immune system also decreased at wk 3 compared with wk 1 (Figure 
6.3).  
The top impacted down regulated pathways uncovered with DIA include notch signaling 
pathway, steroid biosynthesis, synthesis and degradation of ketone bodies and calcium signaling 
(Figure 6.8). Other downregulated terms associated with insulin signaling pathway, MAP 
signaling pathway, and terpenoid backbone biosynthesis. The top up regulated terms were sulfur 
relay systems, glycosphingolipid biosynthesis-lact and neolacto series, adipocytokines signaling 
and mismatch repair (Figure 6.4). 
High BCS at week 5 vs week 1. High BCS cows had induced expression of metabolic 
pathways at week 5 compared with wk1. The most upregulated pathways associated with the 
metabolism of carbohydrates, lipids, amino acids and other amino acids.  The GIP, EIP, CP and 
OS were also induced; in GIP, replication and repair was the most impacted pathway, whereas in 
EIP, signal transduction was induced, whereas, decrease was observed in function associated 
with signaling molecules and interaction (Figure 6.3).  
The comparison of metabolic functions of cows with a high BCS at wk 5 vs  wk1 
uncovered the upregulation of most pathways, which includes biosynthesis of unsaturated fatty 
acids, ascorbate and aldarate metabolism, fatty acid biosynthesis, pentose and glucuronate 
interconversion. The other top impacted up regulated pathways associated with histidine 
metabolism, beta alanine metabolism, PPAR signaling pathway, propanoate metabolism, steroid 
biosynthesis, pyruvate metabolism, and metabolism of arginine and proline, fatty acids, and 
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tryptophan. The top down regulated pathways were associated with axon guidance, cell adhesion 
molecules (CAMs) and olfactory transduction (Figure 6.4). 
High BCS at week 5 vs week 3. The expression of metabolic pathways in high BCS cows 
at wk 5 was also maximum than week 3, except glaycan biosynthesis and metabolism, which has 
been down regulated. The top impacted metabolic processing associated with metabolism of 
lipid, carbohydrate, amino acid and terpenoids and polyketides. The GIP, EIP, CP, and OS, all 
were up regulated. Most importantly, in OS immune and endocrine system were up regulated 
while sensory system was the top down regulated pathway (Figure 6.3).  
Most likely, most of the pathways were also upregulated in high BCS at wk 5 when 
compared with wk 3. The top up regulated pathways were associated with biosynthesis and 
metabolism of fatty acid, unsaturated fatty acid, steroids, and terpenoid backbone, propanoate, 
pyruvate, and tryptophane. Other important upregulated pathways includes synthesis and 
degradation of ketones bodies, pentose and glucuronate inter conversion, lysine degradation, 
valine, lucine and isoleucine degradation, and PPAR signaling. The top down regulated 
pathways were associated with glycosphingolipid biosynthesis-lacto and neolacto series, 
phototransduction, olfactory transduction, and adipocytokines signaling pathways (Figure 6.4). 
Low BCS at different time points   
Low BCS at week 3 vs week 1. In low BCS, the comparison of functional changes at wk 
3 vs wk 1 revealed an increase in glycan biosynthesis and metabolism, however decrease was 
observed in the metabolism of other amino acid and xenobiotics biodegradation and metabolism. 
Moreover, in OS category, immune system and development was down regulated and increase 
was observed in excretory system (Figure 6.5). Furthermore, DIA uncovered decrease in 
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pathways associated with glycolsphingolipid biosynthesis-lacto and neolacto series, cell adhesion 
molecules (CAMs), leukocytes transendothelial migration, and fatty acid metabolism. The 
upregulated pathways included metabolism of xenobiotics by cytochrome P450, drug 
metabolism –cytochrome P450, glutathione metabolism, PPAR signaling, Jak-sta signaling and 
MAPK signaling pathways (Figure 6.6). 
Low BCS at week 5 vs week 1. The metabolic and organismal systems recorded to be the 
most impacted main categories observed at wk 5 compared with wk 1 in cows with low BCS. In 
metabolic category, the metabolism of lipid, xenobiotics biodegradation, and other amino acids 
up regulated, whereas, glycan biosynthesis and metabolism of amino acid were down regulated.  
Mover, in OS, the sub category of immune system was down regulated (Figure 6.5). 
Furthermore, the axon guidance was observed the most impacted pathway that has been down 
regulated. The other down regulated pathways includes glycolsphingolipid biosynthesis-lacto 
and neolacto series, arginine and proline metabolism and endocytosis. The most upregulated 
pathways included those associated with the metabolism of xenobiotics by cytochrome P450, 
biosynthesis of unsaturated fatty acids, drug metabolism –cytochrome P450, glutathione 
metabolism, and leukocytes transendothelial migration. The Wnt signaling pathway and PPAR 
signaling were also induced at wk 5 compared with wk1, in cows with low BCS (Figure 6.6). 
Low BCS at week 5 vs week 3. Analysis showed that both metabolism and GIP were the 
top impacted main categories at wk 5 compared with wk1, in cows with a low BCS. In 
metabolism, the amino acid and lipid metabolism, induced, whereas, decrease was observed in 
the pathways associated with the metabolism of other amino acid and glycan biosynthesis, 
cofactor and vitamins and carbohydrates. In GIP, the most impacted pathways were folding, 
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sorting, and degradation, and replication and repair, both of which were up regulated. In OS, the 
immune system and sensory system were down regulated while endocrine system was the top up 
regulated category (Figure 6.5).  
The DIA further reveled sulfur relay system to be the top most impacted pathway that has 
been induced on wk5 as compared to wk 1, in cows with low BCS. The top up regulated 
pathways included cytein and methionine metabolism, mismatch repair, melanogenesis, 
leukocytes endothelial migration, Wnt signaling and biosynthesis of unsaturated fatty acids. The 
GIP- anchor biosthesis was the second most impacted pathway that has been reduced. The other 
down regulated pathways included ABC transporters, protein digestion and absorption, 
selenoamino acid metabolism, arginine and proline metabolism, pentose phosphate pathway and 
the notch signaling pathway (Figure 6.6). 
Medium (Mid) BCS at different time points 
Mid BCS at week 3 vs week 1. In Mid BCS at week 3 vs 1, the top main impacted 
category include metabolism, OS and EIP. The metabolism was up regulated with top most sub 
categories included lipid metabolism, metabolism of terpenoids and polyketides. The glaycan 
biosynthesis and metabolism down regulated. In GIP, folding, sorting and degradation was 
observed the most impacted that has been down regulated, whereas, in EIP, signaling molecules 
and interaction and membrane transport were recorded the most impacted down regulated 
pathways. In CP, the transport and catabolism was the most impacted down regulated, whereas, 
in OS, immune system showed decrease (Figure 6.7).  
The comparison of wk 3 vs 1 for cows with a mid BCS uncovered fatty acid biosynthesis 
as the top impacted upregulated pathway, the other upregulated pathways were synthesis and 
degradation of ketones bodies, aldosterone regulated sodium reabsorption, biosynthesis of 
 
 
243 
 
unsaturated fatty acids, carbohydrate digestion and absorption, insulin signaling, and steroid 
biosynthesis. The most down regulated pathways include sphingolipid metabolism, sulfer relay 
system, lysosome, GIP-anchor biosynthesis, complement coagulation and cascades, fatty acid 
metabolism, Notch signaling pathway and PPAR signaling pathway (Figure 6.8).  
Mid BCS at week 5 vs week 1. Overall, the main category of metabolism was the most 
impacted up regulated category, followed by GIP. In metabolism, the lipid, carbohydrates, and 
glycan biosynthesis and metabolism were recorded the top impacted up regulated pathways. In 
GIP, the replication and repair was the most impacted up regulated, whereas, in EIP, all the sub 
categories were equally impacted down regulated (Figure 6.7). Furthermore, wk 5, when 
compared with wk1, showed mid BCS cows to have induced functions associated with 
biosynthesis of unsaturated fatty acids, GPI-anchor biosynthesis, fatty acid biosynthesis, steroid 
biosynthesis, sulfer relay system, and synthesis and degradation of ketones bodies. Other 
important upregulated pathways included were PPAR signaling pathways, pentose phosphate 
pathway, pentose and glucuronate inter conversions, steroid hormone biosynthesis, terpenoid 
backbones biosynthesis, pyruvate metabolism and fatty acid metabolism. Moreover, sphingolipid 
metabolism was observed the second most impacted pathway observed, which has been down 
regulated at week, the other down regulated pathways included lysosome, calcium signaling 
pathway, cell adhesion molecules, drug metabolism, axon guidance, abc transporters and jac and 
STAT signaling pathway (Figure 6.8).  
Mid BCS at week 5 vs week 3. In mid BCS at week 5 vs 3, the top impacted main 
category was GIP, followed by OS and then metabolism. In overall, metabolism was up 
regulated and most impacted pathways included down regulation of carbohydrate and lipid 
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metabolism. In GIP, the folding, sorting and degradation, and replication and repair were the top 
up regulated pathways. In EIP, it was the signal transduction, in CP, cell growth and death and 
cell communication was observed the most impacted categories. In OS, the immune system was 
the top up regulated uncovered by DIA (Figure 6.7).  
The impacted pathways uncovered by DIA include up regulation of sulfur relay system, 
mismatch repair, NOD like receptor signaling pathway, biosynthesis of unsaturated fatty acids,  
and pentose phosphate pathway. Other upregulated pathways associated with PPAR signaling, 
insulin signaling, vitamin digestion and absorption, notch signaling pathway, melanogenesis, 
fatty acid metabolism and p53 signaling pathway. The down regulated pathways associated with 
proximal tubule bicarbonate reclamation, calcium-signaling pathway, carbohydrate digestion and 
absorption, bile secretion, mineral absorption, aldosterone-regulated sodium reabsorption, and 
protein digestion and absorption (Figure 6.8). 
Comparison of different BCS at week 1 
Comparison of high and low BCS at wk 1. Functional analysis uncovered metabolism as 
the top impacted category affected in high BCS, in comparison with low BCS, at week 1. The 
top down regulated pathways were associated with the metabolism of lipids, amino acids, glycan 
biosynthesis and terpenoid, and polyketides. Similarly, down regulation was also observed in 
GIP, with the most impacted pathways being the ones associated with replication and repair. 
Cellular processing was also down regulated, with the most down regulation in pathways 
associated with cell growth and death. Conversely, cell communication was up regulated. The 
organismal system (OS) was also down regulated and the top impacted sub categories were 
associated with the endocrine system and excretory system (Figure 6.9).  
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DIA analysis further uncovered the down regulation of pathways associated with fatty 
acid biosynthesis, biosynthesis of unsaturated fatty acids, and steroid biosynthesis. The other 
negatively affected pathways included mismatched repair, ascorbate and aldarate metabolism, 
Glycosylphophatidylinositol (GPI)-anchor biosynthesis, pentose and glucuronate 
interconversions, and metabolism of histidine, propanoate, beta alanine, tryptophan and fatty 
acids.  The top up regulated pathways were hedgehog signaling, melanogenesis, wnt signaling 
adherens junction, ubiquitin mediated proteolysis, and lecukocyte transendothelial migration 
(Figure 6.10). 
Comparison of high with mid at wk 1. The increase in BCS at week 1 induced the 
functional categories of carbohydrate, lipid and terpenoids and polyketides metabolism, whereas 
a decrease was observed in the metabolic activity of glycan biosynthesis and metabolism, 
xenobiotics biodegradation and metabolism. Similarly, the main categories of GIP, EIP, and OS 
were down regulated with increase in BCS at wk 1, as compared to the cows with a mid BCS 
(Figure 6.9). 
The most down regulated pathways included the sulfur relay system, neurotrophin 
signaling, notch signaling, and cysteine and methionine metabolism. Furthermore, a decrease has 
been observed in functions associated with sphigolipid metabolism, O-mannosyl glycan 
biosynthesis and insulin signaling. The top induced pathways included synthesis and degradation 
of ketones bodies, terpenoid backbone biosynthesis, glyoxylate and dicarboxylate metabolism, 
adherens junctions, and butanoate metabolism (Figure 6.10). 
 Comparison of low with mid at wk 1. Metabolism was up regulated overall, and the most 
impacted pathways were associated with metabolism of lipids, energy, terpenoids and 
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polyketides and Glycan biosynthesis and metabolism. The most upregulated pathways include 
fatty acid biosynthesis, synthesis and degradation of ketone bodies, steroid biosynthesis, 
ascarbate and aldarate metabolism, biosynthesis of unsaturated fatty acids, and  propionate 
metabolism (Figure 6.9). Furthermore, an increase has been observed in the pathways of pentose 
and glucuronate interconversion, terpenoid backbone biosynthesis, metabolism of pyruvate, 
tryptophan, beta alanine, GPI-anchor biosynthesis and PPAR signaling pathways. Down 
regulated pathways were associated with sulfur relay system, hedgehog signaling, sphingolipid 
metabolism, Wnt signaling, lysosome, and ABC transporters (Figure 6.10).  
Comparison of different BCS at week 3 
Comparison of high with low at wk 3. Sub categories associated with metabolism 
decreased with high BCS cows in comparison with low at week 3, whereas carbohydrates, lipids 
and terpenoids and polyketide metabolism were observed as the most impacted categories 
(Figure 6.11).  In GIP, with the exception of folding, sorting and degradation, all pathways were 
down regulated. Conversely, most of the pathways in EIP, CP, and OS were wither down 
regulated or no change was observed. 
Similar to wk 1, most of the pathways were also down regulated with high BCS at wk3 
when compared with a low BCS. The most down regulated pathways include fatty aid 
biosynthesis, biosynthesis of unsaturated fatty acids, steroid biosynthesis, and synthesis and 
degradation of ketones bodies (Figure 6.12). Other down regulated pathways include ascorbate 
and aldarate metabolism, pentose and glucuronate interconversion, GPI –anchor biosthesis, fatty 
acid metabolism, p53 signaling, pyruvate metabolism, lysine degradation, PPAR signaling.  The 
top upregulated pathways were those associated with glycosphingolipid biosynthesis, lacto and 
neolacto series, the sulfur relay system, and RNA degradation.  
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Comparison of high with mid at wk 3. In comparison with mid BCS at wk3, high BCS 
down regulates lipid metabolism and xenobiotic biodegradation and metabolism.  The categories 
associated with GIP and OS were up regulated while EIP and CP were down regulated (Figure 
6.11). Functional analysis more specifically uncovered the down regulation of fatty acid 
biosynthesis, the notch signaling pathway, steroid biosynthesis and insulin signaling (Figure 
6.12). Other down regulated pathways were those associated with metabolism of xenobiotics by 
cytochrome P450 and glutathione, hedegehog signaling pathway, biosynthesis of unsaturated 
fatty acids, cysteine and methionine metabolism, calcium signaling pathways, and wnt signaling. 
The top upregulated pathways were the adipocytokine signaling pathway, fatty acid metabolism, 
PPARA signaling, mismatched repair, homologues recombination, NOD like recptor signaling 
pathways, vitamin digestion and absorption, leukocyte transendothelial migration, and pentose 
phosphate pathway. 
Comparison of low with mid at wk 3. A low BCS induced metabolism, and the most 
impacted pathways were associated with metabolism lipid, carbohydrates, amino acid, other 
amino acids and glycane biosynthesis and metabolism. Similarly, GIP, EIP, CP and OS were also 
induced. In GIP, the replication and repair, while in EIP, membrane transport was the top 
impacted pathway. The most impacted pathway in CP was cell growth and death, while in OS it 
was the immune, digestive, and excretory systems (Figure 6.11). 
The most up regulated pathways included GPI-anchor biosynthesis, ascorbate and 
aldarate metabolism, pentose and glucuronate inter conversion, mismatched repair, NOD-like 
receptor signaling pathway and histidine metabolism (Figure 6.12). Other induced pathways 
were those associated with RIG-I-like receptor signaling pathway, P53 signaling, metabolism of 
beta alanine and propanoate, synthesis and degradation of ketones bodies, apoptosis, metabolism 
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of pyruvate and fatty acid, pentose phosphate pathway and toll-like receptor signaling. The top 
down regulated pathways included the hedegehog signaling pathway, cysteine and methionine 
metabolism, WNT signaling, and glycosphingolipid boisythesis-lacto and neolacto series. 
Comparison of different BCS at week 5 
Comparison of high with low at wk 5. In the category of metabolism, a high BCS 
induced amino acid metabolism, whereas a decrease was observed in the functions associated 
with lipid metabolism and glycane biosynthesis and metabolism (Figure 6.13). Most of the 
pathways associated with GIP, EIP and OS were down regulated while in CP most pathways 
were up regulated in high BCS cows compared with low BCS at week 5. Analysis further 
uncovered the down regulation of fatty acid biosynthesis, mismatched repair, glycosphingolipid 
biosynthesis-lacto and neolacto series, biosynthesis of unsaturated fatty acids, notch signaling, 
and MAPK signaling. The top upregulated pathways included arginine and proline metabolism, 
fatty acid metabolism, PPAR signaling   and ubiquitin mediated proteolysis (Figure 6.14). 
Comparison of high with mid at wk 5. The overall metabolic and CP categories were 
induced while GIP, EIP, and CP were down regulated. In the metabolic category, the metabolism 
of carbohydrates, lipids, energy, and amino acids were up regulated while down regulation was 
observed in the pathways associated with glycane biosynthesis and xenobiotic degradation. The 
top impacted pathway in GIP was folding, sorting and degradation, in EIP, membrane transport, 
and, in CP, cell communication. In OS, the immune system and the sensory system were the mos 
down regulated while excretory, circulatory and digestive systems were the most up regulated 
pathways (Figure 6.13). 
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In comparison with a mid BCS at wk5, cows with a high BCS showed down regulation of 
the sulfur relay system, ABC transporters, insulin signaling pathways and pentose phosphate 
pathway (Figure 6.14). The top up regulated pathways included ascorbate and aldarate 
metabolism, pentose and glucuronate interconversion, arginine and proline metabolism, and 
histidine metabolism. The other important down regulated pathways included beta alanine 
metabolism, protein export, leukocytes transendothelial migration, propionate metabolism and 
biosynthesis of unsaturated fatty acids and metabolism of pyruvate. 
Comparison of low with mid at wk 1. In comparison to Mid BCS at wk 5, Low BCS 
induced the metabolism, lipid and carbohydrate metabolism has been observed to be the most 
impacted sub category. In GIP, folding, sorting and degradation were down regulated while 
replication and repair was upregulated. The EIP, induced with signal transduction and signaling 
molecules and interaction being the most impacted pathways. All the pathways upregulated in 
CP, whereas, immune and sensory systems were down regulated while digestive, nerves and 
excretory were up regulated (Figure 6.13). 
The DIA analysis further revealed increased activity in the functions associated with 
biosynthesis of unsaturated fatty acid, fatty acid biosynthesis and synthesis and degradation of 
ketone bodies (Figure 6.14). Other important induced functions were terpenoid backbone 
biosynthesis, ascorbate and aldarate biosynthesis, pentose and glucuronate interconversion, and 
metabolism of propanoate. The top down regulated pathways included sulfur relay system, 
insulin signaling pathways and pentose phosphate pathway (Figure 6.14). 
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Transcription regulators networks 
Transcription regulator networks analysis with IP reveals that TP53 is a central hub 
regulating a wide array of genes with gene in BCS in transition dairy cows. Furthermore, high 
expression of TP53 was observed in high and low BCS as compared to mid BCS, whereas, in L 
the expression was also induced compared with H (Figure 6.15A-6.15C). The top 10% functions 
associated with TP53 network uncovered by DIA are shown Figure 6.16. The other main 
transcription regulators affected with BCS were CTNNB1, SEREBF1, RXRA, STAT1, NFKBB1A 
and YWHAH. The interaction effect BCS with time revealed, HNF4A and MKL1 as the top 
regulatory factors in H vs M, at wk 1; In comparison with L, ATN1 was observed as a hub in 
regulating hepatic gene expression in H (Table 6.4B and Appendix–E: Suppl.  Figure E.2A-
E.2R). At the same time point, HNF4A and MED1 was the main regulator of DEG in L vs M. 
The network analysis suggested TFC3 as the second most important transcription regulator after 
MYC at wk 3, in H vs L and L vs M, whereas, FOXP3 was the top TF in H vs M, at week 3. 
Similarly, at wk 5, the MYC, FOXP3 and TCF3 were the top regulatory factors observed in H vs 
L, H vs M and L vs M, respectively (Table 6.4B and Appendix–E: Suppl. E.2A-E.2R). 
In high BCS cows, the HNF4A and TCF3 were uncovered the main TF at wk 3 vs 1, 
which were respectively down and up regulated, whereas, MYC was observed the top TF with 
reduced expression at wk 5 compared with wk1 in cows with high BCS (Table 6.4A and 
Appendix–E: Suppl. Figure E.2A-E.2R). The comparison of high BCS data at wk 5 vs wk 3 
reveals MYC, FOXP3, and TCF3 had the same number of affected molecules. The transcription 
factor network analysis of low BCS, uncovered MYC is the top TF induced at wk 3 compared 
with wk 1, whereas, in wk 5 vs 3, the top impacted transcription factors include HNF4, MYC, 
FOXP3 and TCF3, in which MYC was down regulated while all the others were induced at wk 5 
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as compared to wk 3. In mid BCS group, the IPA analysis uncovered HNF4A as a top regulated 
transcription factor with high number of regulatory genes in the observed array of DEG with 
time, the expression increased with time and highest expression was observed at wk 5 followed 
by wk3, the expression was lower at wk 1. The other regulatory TFs included FOXP3, ATN1, 
TCF3, MED1 and MKL1 (Table 6.4A and Appendix–E: Suppl E.2A-E.2R). 
DISCUSSION 
Preliminary findings from the current data sets revealed that the pathways most affected 
by a change in calving BCS are associated with metabolism. Hepatic gene expression profiling 
and bioinformatics analysis uncovered that an increase in calving BCS induced the expression of 
genes associated with gluconeogenesis while reducing the pathways associated with glucose 
catabolism. In contrast to carbohydrate metabolism, the biosynthesis of steroids, terpenoid 
backbones, and the synthesis and degradation of ketone bodies decreased in cows with a high 
BCS (H) and increased in those with a low BCS (L). In cows with a mid BCS (M), the 
expression of these pathways was higher than H but lower than L. Compared to M and L, 
glycosamino glycan degradation, vitamin B6 metabolism, and fatty acid biosynthesis were down 
regulated in H. Although all the groups experienced some degree of inflammatory response, L 
and H showed induced expression of functions associated with inflammatory and oxidative stress 
responses, whereas M had faster recovery with time. The network analysis uncovered TP53 and 
HNF4A among the top transcription regulators altered by BCS and interaction with time 
respectively.  Overall, the collective results from the current set of cows suggest an optimum 
calving BCS of ~4.5 for achieving an “optimal” functional welfare status.  
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Carbohydrate metabolism 
In addition to being a source of energy, carbohydrates are the primary precursors of 
lactogenesis in dairy cows (Aschenbach et al., 2010). Analysis reveals a decrease in carbohydrate 
metabolism in H whereas low BCS cows showed higher metabolisms than M (Figure 6.1). Cows 
with a low BCS showed increased levels of pyruvate, glycolysis / gluconeogenesis, and pentose 
phosphate pathway activity (Appendix–E: Suppl. Figure E.3A-C) High and mid BCS cows, on 
the other hand, showed a decrease in catabolism of glucose at week 5 as compared with week 3 
and 1. The decrease in glucose catabolism in cows with high and mid BCS is consistant with 
greater milk production in these cows (Akbar et al., 2014). Furthermore, high BCS cows have 
shown a decrease in DMI, experienced a severe negative energy balance, and increased levels of 
NEFA and BHBA (Roche et al 2013, Akbar et al 2014). In a previous study, a decrease in the 
abundance of proteins associated with glycolysis and an increase in glycolysis inhibiters were 
observed in lactating cows deprived of food (Kuhla et al., 2009). The decrease in glycolysis, 
pyruvate metabolism, and propionate metabolism in H and L suggests a decrease in carbohydrate 
oxidation by preventing the flow of glycolytic products into the tricarboxylic acid cycle. This 
increases the availability of glucose for lactogensis to support the high milk production in these 
cows. 
Gluconeogenesis is a crucial adaptation developed by dairy cows to compensate for an 
insufficient glucose supply during lactogenesis (Reynolds et al., 1988). The short chain fatty acid 
propionate is the predominant glucogenic precursor and major end product of ruminal microbial 
fermentation. Despite the fact that as much as 85% of propionate is used for glucose production 
in lactating cows (Steinhour, 1988), propionate oxidation may play a significant role in the 
regulation of food intake (Bradford et al., 2006).  In early lactation, an increase in food intake 
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does not meet the glucose requirement for higher milk production (Hammon et al., 2009, 
Ingvartsen and Andersen, 2000). Therefore, cows adapt to increase the relative contribution of L 
lactate, glycerol, and alanine as their total glucogenic substrate uptake, and thus the relative 
contribution of propionate decreases in very early lactation (Aschenbach et al., 2010). The 
observed decrease in propanoate metabolism in H and M cows (Appendix–V: Suppl. Figure 
E.3A-C), most importantly at weeks 1 and 3, indicates that a low energy balance and a high lipid 
mobilization increase the contribution of endogenous glucogenic precursors such as glycerol and 
lactate (Lomax and Baird, 1983). The phosphoenolpyruvate carboxykinase enzyme has 
previously been recognized as the rate limiting step for gluconeogenesis and exits both the 
cytosolic (PCK1) and mitochondrial (PCK2) compartments (Hod et al., 1986, Rognstad, 1979). 
The increased expression of these regulatory genes supports an increase in glucnoeigenies 
associated with both lacate and propanoate. The Pyruvate, glycolysis / gluconeogenesis, and 
pentose phosphate pathways indicate a glucose sparing effect for lactoegensis in H cows 
supported by increase in milk production (Akbar et al 2014). The increase in proponate 
metabolism at week 5 in H, due to an increase in ACAT1 and ACAT2, indicates oxidation after 
conversion to acetyl-CoA (Veenhuizen et al., 1988). Furthermore, at week 5, both H and M 
experience increases in glycolysis and gluconeogenesis, pyruvate, pentose and glucuronate 
interconversions, fructose and mannose metabolism, and ascorbate aldarte metabolism. However 
the increase of these in M is suspected to be associated with a decrease in NEFA and a lower 
inflammatory status. Furthermore, the increase in propanoate metabolism with L cows, in 
comparison with the other two groups, indicates a positive energy balance (Veenhuizen et al., 
1988). 
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Fatty acid metabolism 
The liver adapts quickly to a high influx of NEFA in response to an increased lipolysis 
and blood flow (Drackley et al., 2001). Cows with a high BCS had induced fatty acid 
metabolisms and PPAR signaling, whereas unsaturated fatty acid biosynthesis decreased. 
Peroxisomal oxidation, assumed to be an axillary pathway to mitochondrial oxidation, has been 
reported to be induced by a high flux of NEFA (Drackley, 1999). The increase in NEFA in H 
cows induces hepatic oxidation of fatty acids, but the high flux of NEFA overcomes this hepatic 
oxidation and leads to TAG accumulation. (Akbar et al 2014). Furthermore, the increased 
synthesis and degradation of ketone bodies in cows with H, in comparison to M, is associated 
with NEFA levels (Akbar et al 2014). This has been reported to contribute to an increased milk 
yield, particularly for over conditioned cows (Duffield, 2000, Gillund et al., 2001, Roche et al., 
2009). Similarly, the increase at 3 and 5 in both H and M is supported by the biochemical data 
from these cows in response to NEFA (Akbar et al 2014). In contrast to H and M, the increased 
in synthesis and degradation of ketone bodies in L cow (Figure 6.2), supports the speculation of 
using ketone oxidation as the energy source for vital organ (e.g. the brain) in these cows, 
whereas, most the available glucose is partitioned to the mammary gland for lactogenesis (Bell, 
1995, Stipanuk, 2000). 
Biosynthesis of unsaturated fatty acids. Polyunsaturated fatty acids (ω-3 and ω-6) are 
important modulators of immune reactions because PUFA derivatives can initiate and exacerbate 
inflammatory responses (Miles and Calder, 1998). This study uncovered an increase in the 
biosynthesis of unsaturated fatty acids in cows with a low BCS (Figure 6.2), which indicates 
non-dietary adipose derived PUFA substrates for phospholipid synthesis (Contreras et al., 2010, 
Kaplan and Lee, 1965, Van den Top et al., 1996). Moreover, research suggests that the PUFA 
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content of phospholipids influences inflammation through several mechanisms, including 
membrane fluidity, lipid raft formation, and receptor function (Douglas et al., 2007, Simons and 
Toomre, 2001, Yaqoob, 2003). Adipose derived fatty acids are utilized by the liver for ketone 
body biosynthesis as observed in L (Figure 6.2), where carbohydrate ingestion or substrates for 
gluconeogenesis are restricted relative to the requirements for glucose (Kaneko et al., 2008). 
Furthermore, earlier research supports the idea that adipose-derived fatty acids modify the 
composition of phospholipids in vascular endothelial tissue and induce inflammation with lipid 
mediators (Contreras et al., 2012). The increase in the biosynthesis of unsaturated fatty acids in L 
cows (Figure 6.2), and in particular the upregulation of genes associated with arachidonic acid 
(AA), AA metabolites 5-HETE, and 15 HETE (Appendix–E: Suppl. Figure E.4A-C ), indicates 
an inflammatory condition in L cows (Sordillo et al., 2009). Likewise, the increase in genes 
associated with AA metabolites PE2 and 20 HETE indicates the inflammatory status in H 
(Ishizuka et al., 2008). 
Steroid biosynthesis. Steroid hormone biosynthesis occurs mainly in the adrenal glands 
and the gonads, but recent studies confirmed hepatic inhibition of steroid hormone biosynthesis 
in both transition and mid lactating cows with a severe negative energy balance (NEB) (Akbar et 
al., 2013, Grala et al., 2013, McCabe et al., 2012). The marked inhibition of steroid biosynthesis 
in H and M cows seems to be associated with NEB (Akbar et al 2014, Roche et al 2013). The 
down regulation of steroid synthesis (e.g. CYP51A1, SC5DL and DHCR24; Appendix–E: Suppl. 
Figure E.5A-C) and the hepatic inhibition of MAPK signaling in M and H is indicated to be 
associated with steroid biosynthesis (Akbar et al., 2013). The suggested role of MAPK inhibition 
with steroid biosynthesis remains unverified. However, a relationship between MAPK inhibition 
and steroid hormone synthesis has been observed in steroidogenic tissues. The process of steroid 
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hormone synthesis, initiated by the cleavage of a cholesterol side chain to produce pregnenolone, 
requires the steroidogenic enzymes, such as cytochrome p450 aromatase (CYP19A1), 
cytochrome p450 (CYP17A1), and cytochrome P450scc (CYP11A1). Consistent with a lower 
hepatic expression of CYP17A1 (M and < H cows), earlier studies reported a down regulation of 
CYP17A1 expression in sheep with feed restriction (NEB), and increased NEFA and decreased 
plasma concentrations of TG and T3 (Ying et al., 2013). Thus, a high BCS indicates inhibition of 
follicle growth, and could potentially be associated with an early stage reproductive problem. 
Vitamin metabolism and oxidative stress 
Despite being needed by the body in minute quantities, vitamins have a pivotal role in 
hormone signaling, enzymatic reactions, and act as antioxidants.  In this study, both L and H 
cows had decreased expression of pathways associated with vitamin B6 metabolism and 
nicotinate and nicotinamide metabolism. As precursors of the coenzymes nicotinamide-adenine 
dinucleotide (NAD+) and nicotinamide-adenine dinucleotide phosphate (NADP+), both nicotinic 
acid (anionic form: nicotinate) and nicotinamide (amide derivative of nicotinic acid) are essential 
for organisms (Niehoff et al., 2009). Both nicotinic acid and nicotinamide are often grouped 
together under the generic term niacin, or vitamin B3 (Moffett and Namboodiri, 2003). In the 
present study, a decrease in nicotinate and nicotinamide metabolism reflects a state of oxidative 
stress (Akbar et al., 2014), at least in part, due to a decrease in niacin availability (Kamanna et 
al., 2008). Furthermore, the reduction of nicotinate and nicotinamide metabolism in H seems to 
alter mitochondrial respiration, as supported by the observed decrease in the hepatic expression 
of genes associated with oxidative phosphorylation. This supports the speculation of an increase 
in reactive oxygen species (ROS) in these cows. The induction of oxidative phosphorylation in L 
suggests that the cows have interacted with greater oxidative stress, as is evident in the increased 
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expression of antioxidant system (CAT, SOD) and peroxisomal activity, potentially as a function 
of niacin accumulation. The increase in oxidative phosphorylation seems to support the energy 
requirement for metabolic activity and productivity in these cows. However, as compared to H 
and L, M cows showed normal metabolic activity. Additionally, cows in the present study were 
fed diets composed predominantly of forage, potentially providing a greater availability of niacin 
(Schwab et al., 2006). The amino acid tryptophan is the sole substrate for de novo NAD+ and 
NADP+ synthesis in the absence of nicotinamide or nicotinic acid. All species are able to 
synthesize niacin from tryptophan and quinolinate (Niehoff et al., 2009). The decrease in 
tryptophan metabolism in H cows is additional evidence that indicates a state of oxidative stress 
in the liver.  
Because of its integral involvement in the synthesis of nucleic acids, and consequently in 
mRNA and protein synthesis, vitamin B6 influences acquired and humoral immunity and the 
production of cytokines and inflammatory mediators (Friso et al., 2001). The vitamin B3 
metabolite N-methylnicotinamide may exert anti-inflammatory and anti-oxidative stress effects 
(Domagala et al., 2012). The observed inhibition of vitamin B3 and B6 metabolism in H cows 
was associated with the activation of proinflammatory cytokine production and oxidative stress 
(SOD2 and GPX1 up-regulation). In contrast to the activation of vitamin B3 (nicotinamide) 
metabolism, vitamin B6 metabolism in L cows may serve a protective role against oxidative 
stress (antioxidant system up-regulation) (Sauve, 2008). Overall, the current alterations observed 
in vitamin metabolism in both H and L groups support a protective response to oxidative stress in 
these groups.  
Immunes system processing 
The immune system of dairy cows is closely connected with the physiological and 
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hormonal status of the cow (Ohtsuka et al., 2009). In the peripartum period, nutrition plays a key 
role in immune response and difficulty in adaptation to nutritional needs for lactation results in a 
physiological imbalance. This leads to decrease in immune responses, and increase in risks 
associated health problems during the peripartum period (Ingvartsen and Moyes, 2013). 
Furthermore, both calving BCS and the rate of BCS loss after parturition, increase the probability 
of infectious and metabolic diseases. In the present study, in comparison with H and M, cows 
with L BCS have shown an increase expression of functions associated with immune system and 
maximum increase was observed at week 3. In comparison the functions associated with immune 
signature were lower in M and more reduction was observed at week 5 relative parturition. The 
energy balances (EB) for cows under study were not measured (Roche et al., 2013), whereas, the 
observation from the earlier studies reported that low BCS cows experienced more severe 
negative energy balance during early lactation as compared to high BCS and increase exposure 
to the development of infectious diseases (Lacetera et al., 2005, Suriyasathaporn et al., 2000).  
Toll-like receptors (TLRs) represent a family of pathogen recognition receptors (PRRs) 
that play a crucial role in immune response such as sensing endogenous danger signals and the 
induction of immune response (Majewska and Szczepanik, 2006, Tipping, 2006). In dairy cow, 
change in nutrition status has been shown modulate cellular immune function via TLRs, 
primarily on resident macrophages (Ingvartsen and Moyes, 2013). In L cows, the observed 
increase in Toll-like receptor signaling, chemokine signaling, and natural killer cell mediated 
cytotoxicity, indicating a heightened immune system in response to the high milk demand, which 
predispose these cow stress and risk of health and reproductive problem (Ingvartsen and Moyes, 
2013). Likewise, the reported increase in polymorphonucleated cells (PMN) in the uterine 
secretions from L cows at week 3 and 5 relative parturition (Roche et al., 2013), supports the 
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speculation of compromised health status in these cow. Furthermore, Stevens and colleagues 
reported decrease in PMN phagocytosis, chemotaxis and diapedesis for early lactating cows 
experiencing NEB (Stevens et al., 2011). The increase in functions associated with immune 
system in L and H cows supports the speculation of increase demand for lactogenesis results 
metabolic burden and predispose these cows to infectious diseases (Heuer. et al., 1999, 
Hoedemaker et al., 2009). Overall, the collective data from current study endorsed the idea that 
both high and low calving BCS are associated with compromised health in dairy cows (Roche. et 
al., 2013).  
Transcription regulators network 
Gene expression is regulated by joint effects of physiological state and transcription 
factors and other specific molecules (Berthoumieux et al., 2013). The transcription factors are 
adaptor molecules that detect regulatory sequences in the DNA and target the assembly of 
protein complexes that control gene expression (Zaret and Carroll, 2011). The tumor suppressor 
TP53 is a transcription factor ; various genotoxic stresses such as DNA damage, oxidative stress, 
hypoxia, and heat shock can activate TP53, causing changes in the expression of its target genes 
(Oren, 1999). In dairy cows, negative energy balance and inflammatory conditions were reported 
to induce TP53 expression and its signaling in various tissues, e.g. liver, adipose, and spleen 
(McCabe et al., 2012, Morris et al., 2009). The increased expression of Tp53 in H and L cows, 
are associated with the reported severe NEB and inflammatory conditions in these cows (Roche 
et al., 2013, Akbar et al., 2014). In comparison the higher expression in L cows indicates to 
increase the availability of glucose for lactogenesis to support milk production in these cows. 
Another transcription factor, the hepatocyte-nuclear-factor 4-alpha (HNF4A) has been reported 
to widely regulate the hepatic expression of gene associated with metabolism of lipid and 
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glucose, differentiation and morphogenesis. In addition, recent studies suggested the role of this 
regulator in inflammation processes of the liver (Babeu and Boudreau, 2014). The increased 
expression of HNF4A in the cows with high and Low BCS compared at week 1, support the 
evidence that increase NEFA and subsequent haptic uptake induces haptic expression of HNF4A 
(Loor et al., 2005). The expression pattern of HNF4A is also suggestive of an important role for 
this gene in observed increase in gluconeogenesis and marker of inflammation in these cows 
(Loor et al., 2005, Odom et al., 2004).  
CONCLUSIONS 
The change in pathways associated with metabolism of carbohydrates, lipid, vitamins and 
signaling provides an evidence of alteration in the hepatic molecular signature in response to 
change in calving BCS. The increase in BCS induces milk production but also predisposes cows 
to health issues associated with the increase the hepatic influx of NEFA, biosynthesis of 
inflammatory precursors and oxidative stress. Likewise, in L cows, the adaption of glucose 
sparing effect for lactogenesis regulate the pathways associated with the biosynthesis of 
unsaturated fatty acid, antioxidant system, and immune responses. Overall, the collective data 
from the current study suggest that both high and low calving BCS are associated with 
compromised health in dairy cows. 
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TABLES AND FIGURES 
 
Table 6.1. Number of differentially expressed genes (DEG; FDR cut off of < 0.05 and raw p 
value of < 0.05) in response to time relative to parturition, BCS and interaction of time 
with BCS. ↑ indicates up regulated genes, ↓ indicates down regulated genes.  
 
Effect DEG Effect DEG  Effect DEG  
Time 8788 BCS 4325 BCS × Time  251 
Wk3 vs Wk1 3493 High vs Low 2999    
Wk5 vs Wk1 8006 High vs Mid 2383    
Wk5 vs Wk3 6550 Low vs Mid  3531    
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Table 6.2. Number of differentially expressed genes (DEG; FDR cut off of < 0.05 and raw p value of < 0.05) in the comparison of 
different BCS cows, managed during the dry period to maintain a high (H), low (L), or medium (M) body condition score until 
calving. ↑ indicates up regulated genes, ↓ indicates down regulated genes.  
 
 
   
Comparison DEG  ↑↓ Top 10 Up‐regulated  genes Top 10 Down‐ regulated genes 
H vs L  2999 913  ↑ 
2086↓  
LRRC16B, FAM46D, FGF21, SCN2A, G0S2, 
RXRG, GATSL2, EXOC3L4, ZFYVE28, CCRN4L,  
ACSS2, HEYL, ODZ1, GSTA3, FASN, PIK3R3, 
DHCR7,TRIM67, FEM1A, HMGCR
H vs M  2383  1297↑ 
1086↓ 
C7H5orf48, NTM, GATSL2, TMPPE, BPI, ZNF462, 
TOP3A, TNKS, KRT4, OR4D5
ADAMTS18, CLIP3, PIK3R3, IFRD2, BRPF3, 
ZNF280B, ZAR1, HOXC11, KNTC1, DFFB
L vs M  3531  2466↑ 
1065↓ 
TRIM67, GSTA3, NTM, SCD, MID1IP1, TCF21, 
GIPC2, FAM54A, PPME1, SCARA5 
ZNF280B, WDR96, DLL4, ATG7, 
GRAP2,MTCP1NB, FCRL6, TRAPPC6B, 
ADAMTS18, SPP2, SLC9A5
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Table 6.3A. Number of differentially expressed genes (DEG; FDR cut off of < 0.05 and raw p value of < 0.05) in response to the 
interaction of BCS (H, M, L) with time relative to parturition (wk 1, 3, 5). The cows, managed during the dry period to maintain a 
high (H), low (L), or medium (M) body condition score until calving. ↑ indicate up regulated genes, ↓ indicate down regulated genes. 
 
   
Interaction  DEG  ↑↓ Top 10 ↑regulated  genes Top 10 ↓ regulated genes 
BCS Week     
H  3 vs 1 87 45↑ 
42↓ 
RLBP1, MYOZ2, APOBEC3A, RYK, CD101, 
B3GNT4, IL21, CEP85L,  ETV1, TRPM4 
PTGFR, SAMD4A, NCSTN, ATP8A1, CALM3, FKBP5, 
C28H10orf128, ARPM1, HEATR7A, NKRF 
 5 vs 1 83 55↑ 
28↓ 
SCD,  MYOZ2, CD101, MYC, BEND5,  BTBD19, 
ALDH3A2,  CCDC76, SMN1,  CASP8 
ZPBP2, L1CAM, C2H2orf80, MAP4K2, FKBP5, CPNE8, 
FKBP5, SAA4, PDZD4, FAM60A 
 5 vs 3 148 90↑ 
58↓ 
SCD, NCSTN, PTGFR, CASP8, NKRF, HEATR7A, 
FASN, FAM45A, UBR7, MSMO1 
RLBP1, CPNE8, B3GNT4, L1CAM, ZPBP2, C2H2orf80,  
ANKRD60, SKIV2L2, TSPAN4, PRKAG1 
M 3 vs 1 169 84↑ 
85↓ 
RLBP1, HPCAL1, OTOS,  ZPBP2, HEATR7A, 
ARPM1, ATP8A1,  CNTRL, SCD, B3GNT4 
L1CAM, GALC, SIGIRR, MAGED1, MYOZ2, NALCN, 
CRISPLD2, TBC1D9B, TDP1, TPM2 
 5 vs 1 194 117↑ 
87↓ 
SCD, MEST, OR4D11,  HPCAL1, DYRK3, SCARF2, 
DEFB5, GSTT1, PRPS1,  GORASP1 
GALC, MYOZ2, L1CAM, RBM44, IL21, SAMD4A, PTGFR, 
PHKA2, NUFIP1, WNT6 
 5 vs 3 193 112↑ 
81↓ 
OR4D11, SCD, DEFB5, MEST, CREB3L4, CASP8, 
SCARF2, VAPA, SIGIRR, PTCRA 
RLBP1, SAMD4A, PHKA2, SLC6A14, IL21, NUFIP1, 
SDAD1, RAD17, C2H2orf80, ACTL7B 
L  3 vs 1 65 35↑ 
30↓ 
CCDC88A, GSTT1, DEFB5, RGS19, ARPM1, 
DYRK3, KRT6B, BTBD19, CRISPLD2 
SLC6A14, EFNB3, B3GNT4, MAP4K2, TRIM71, MYOZ2, 
MFAP4, HOOK1, IFRD2,  L1CAM 
 5 vs 1 44 28↑ 
16↓ 
RBM44, VCL, ARPM1, DYRK3, WNT6, NALCN, 
GSTT1, RAD17, MEST, MB  
EFNB3, MFAP4, MKL1, IFRD2, MYOZ2, CPNE8, DIMT1 
GIT2, B3GNT4, GPR52 
 5 vs 3 150 82↑ 
68↓ 
SLC6A14, RBM44,  PTGFR, SKIV2L2, MAP4K2, 
SAMD4A, CITED1, ORC2, FKBP5, MGA 
MKL1, CCDC88A, BTBD19, NYNRIN, FAM45A, P4HA2, 
GIT2, KRT6B, GPR52, KRT8 
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Table 6.3B. Number of differentially expressed genes (DEG; FDR cut off of < 0.05 and raw p value of < 0.05) in response to the 
interaction of BCS (H, M, L) with time relative to parturition (wk 1, 3, 5). The cows, managed during the dry period to maintain a 
high (H), low (L), or medium (M) body condition score until calving. ↑ indicate up regulated genes, ↓ indicate down regulated genes. 
 
 
   
Interaction  DEG  ↑↓ Top 10 ↑regulated  genes Top 10 ↓ regulated genes 
BCS Week     
H vs L 1 117 42↑ 
75↓ 
RAD17,  ARPM1, DEFB5,  RBM44, NALCN,ATP8A1, 
WNT6, NYNRIN, RGS19, UBE3B 
EFNB3, SCD, FASN, DIMT1, KRT8, B3GNT4, 
PIGK, RLBP1, NSDHL, CD101 
H vs M  119 48↑ 
71↓ 
OR4D11, RAD17, OTOS, HNF4A, ATP8A1, MEST, 
MFAP4, TMEM184B, VCL, SAMD4A 
MYOZ2, CCDC88A, MAGED1, CBX6, TDP1, 
GALC, L1CAM, MED1, ZFAND6, IL21 
L vs M  144 80↑ 
64↓ 
SCD, B3GNT4, HPCAL1, RLBP1, MFAP4, OR4D11, 
OTOS, MSMO1, FASN, EFNB3, ACAT2 
NALCN, R BM44, L1CAM, WNT6, MKL1, 
CCDC88A,TBC1D9B, TPM2, GALC, MED1 
H vs L 3 119 41↑ 
78↓ 
CPNE8, SLC6A14,  IFRD2, BIN1, CEP85L, MYOZ2, 
B3GNT4, ANKRD60, SKIV2L2, KLF14 
CASP8, SCD, FASN, KRT8, CRISPLD2, 
NKRF, CCDC88A, KRT6B, MSMO1, NCSTN 
H vs M  115 50↑ 
65↓ 
OR4D11,  KLF14, L1CAM,  SIGIRR, CPNE8, 
ZNF688, SCARF2, CPT2, TSPAN17, PTCRA 
PTGFR, ZPBP2, HEATR7A, NCSTN, NKRF, 
FASN, SPATS1, ATP8A1, ARPM1, SAMD4A 
L vs M  152 92↑ 
60↓ 
CRISPLD2, CASP8,  KRT8, OR4D11, MEST, PTCRA, 
PIGK, SLC1A5, METTL5, RYK 
SLC6A14, ZPBP2, APOBEC3A, C2H2orf80, 
ATP8A1, SAMD4A, HEATR7A, SPATS1, MGA, 
HPCAL1 
H vs L 5 75 28↑ 
47↓ 
P4HA2, MYOZ2, MKL1, PGM5, GPR52, CEP120, 
FAM45A, NYNRIN, BTBD19, UBE3B 
ZPBP2, FKBP5, RLBP1, L1CAM, SKIV2L2, 
B3GNT4,  MAP4K2, SLC6A14, ETV1, KRT6B 
H vs M  154 68↑ 
86↓ 
SDAD1,  SAMD4A, TRIM71, MYOZ2, MYO18A, 
SMC5, GRAMD3, PHKA2, VCL, P4HA2 
ZPBP2, CREB3L4, TXNDC8, PDZD4, URM1, 
ETV1, DYRK3, MED1, C2H2orf80, HPCAL1 
L vs M  136 75↑ 
61↓ 
RBM44, SDAD1, IL21, SAMD4A, FKBP5, ELOVL6, 
FKBP5, PTGFR, NUFIP1, SMC5 
FAM45A, MKL1, DEFB5, TXNDC8, SESTD1 
SLC12A5, DYRK3, PGM5,  CREB3L4, TPM2 
 
 
273 
 
Table 6.4A: Top transcription factor and associated regulatory genes in a particular interaction 
of the BCS (H, L, M) and time relative to parturition (wk 1, 3, 5) uncovered with IPA.   
 
Interactions  Transcription  No. of Affected   Regulated Molecules 
BCS Weeks Factor Molecules  
High  3 vs 1 HNF4A 4 STAU2, LIN7C, SSBP1, TRMT13 
  TCF3 3 MSMO1, SSBP1, CHD4 
 5 vs 1 MYC 5 PAM, SSBP1, SCD, CASP8,CHD4 
 5 vs 3 MYC 7 PAM, CIMT1,SSBP1,SCD, TRIM71,CASP8, 
CHD4 
  FOXP3 7 GIT2, CHD4, FASN, ARHGEF6, 
ORC2,SMCHD1,FYB 
  TCF 3 CHD4, SSBP1, MSMO1 
Low 3 vs 1 MYC 5 KRT6A, PAM, SLC1A5, CPT2, TRM71 
 5 vs 1 MKL1 1 VCL 
 5 vs 3 HNF4A 13 FGB, LIN7C, MTR, PRPS1, KRTB, SSBP1, 
GIN1, PRR3, TRMT13, SPAST, RAD17, 
BLOC1S6, PCMT1  
  MYC 9 KRT6A, PAM, DIMT1, SLC1A5, SSBP1, VIM, 
TRIM71, CASP8, CHD4  
  FOXP3 5 GIT2, CHD4, ARHGEF6, ORC2, FYB 
  TCF3 3 CHD4, SSBP1, PTCRA 
  MKL1 3 CASP8, VCL, TPM2 
Mid  3 vs 1 HNF4A 18 BLOC1S6, NARS2, UMP5, PCMT1,FGB, 
LIN7C, MTR, KRT8, CPT2, STAU2, SSBP1, 
SCD, GIN1, PRR3, TRMT13, LAS1L, EMG1, 
RAD17  
  FOXP3 7 GIT2, LAS1L, CHD4, FASN, ADD3, 
ARHGEF6, SMCHD1 
  ATN1 4 HPCAL1, ATP1A1, TRIP6, VIM 
  TCF3 4 CHD4, SSBP1, RPL4, PTCRA 
  MKL1 3 CASP8, VCL, TPM2  
  MED1 3 MB, PCTM1, FASN 
 5 vs 1 HNF4A 17 BLOC1S6, NARS2, UMPS, PCMT1, FGB, 
LIN7C, MTR, PRPS1, GSTZ1, SSBP1, SCD, 
GIN1, SLC35A5, TRMT13, SPAST, NUFIP1, 
RAD17 
  FOXP3 9 GIT2, CHD4, FASN, ADD3, IL21, ARHGEF6, 
ORC2, SMCHD1, FYB,  
  ATN1 3 HPCAL1, TRIP6, VIM 
  TCF3 3 SSBP1, MSMO1, CHD4 
 5 vs 3 HNF4A 19 BLOC1S6, NARS2, FGB, PCMT1, PRPS1, 
GSTZ1, KRTS1, STAU2, SSBP1, SCD, GIN1, 
CPT2, PRR3, SLC35A5, LAS1L, SPAST, 
EMG1, NUFIP1, RAD17  
  FOXP3 6 LAS1L, IL21, ARHGEF6, ADD3, ORC2, FYB 
  TCF3 4 SSBP1, RPL4, MSMO1, PTCRA 
  ATN1 3 ATP1A1, VIM, TRIP6 
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Table 6.4B:  Top transcription factor or nuclear-receptors and associated regulatory genes in a particular interaction of time relative to 
parturition (wk 1, 2, 3) and different BCS (H, L, M) uncovered with IPA.   
Interaction   Transcription No. of Affected   Regulated Molecules 
BCS Week Factor Molecules  
H vs L  1 ATN1 2 HPCAL1, VIM 
H vs M  1 HNF4A 12 UMPS, PCMT1, FGB, LIN7C, GSTZ1, KRT8, SSBP1, GIN1, PRR3, TRMT13, 
SPAST, RAD17 
  MKL1 3 CASP8, VCL, TPM2 
L vs M 1 HNF4A 14 RAD17, PCMT1, BLOC1S6, UMPS, LIN17C, PRPS1, GSTZ1, KRTS, STAU2, 
SSBP1, SCD,  GIN1, SLC35A5, SPAST   
  MED1 3 MB, PCMT1, FASN 
H vs L 3 MYC 9 KRT6A, PAM, SSBP1, SLC1A5, CPT2, PABPC1, SCD, CASP8, LAS1L 
  MED1 2 PCMT1, FASN  
  TCF3 2 SSBP1, MSMO1 
H vs M 3 FOXP3 4 FASN, ADD3, ARHGEF6, SMCHD1 
L vs M 3 MYC 11 KRT6A, PAM, DIMT1, LAS1A, SLC1A5, PABPC1, SSBP1, SCD, VIM, 
TRIM71, CASP8 
  TCF3 3 SSBP1, MSMO1, PTCRA  
H vs L 5 MYC 6 KRT6A, CPT2, PABPC1, SSBP1, TRIM71, LAS1L 
  FOXP3 3 LAS1L, GIT2, FASN, SMCHD1 
H vs M 5 FOXP3 7 LAS1L, CHD4, IL21, ADD3, ARHGEF6, ORC2, FYB 
  ATN1 3 HPCAL1, ATP1A1, TRIP6 
L vs M 5 TCF3 3 SSBP1, RPLA, CHD4 
  ATN1 2 ATP1A1, TRIP6 
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Figure 6.1. Impact and flux of main KEGG categories and sub-categories affected with change 
in BCS, as calculated by the Dynamic Impact Approach. Cows were managed during the dry 
period to maintain a high, low, or medium BCS until calving. Reported are the total impact (Blue 
horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green 
bars expanding left denote inhibition and red bars expanding right denote activation) of DEG on 
the categories and subcategories. 
Category Impact Flux Impact Flux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
Low vs Mid BCSHigh vs Mid BCSHigh vs Low BCS
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Figure 6.2.  Impact and flux of the top 10 KEGG pathways affected with change in BCS, as 
calculated by the Dynamic Impact Approach. Cows were managed during the dry period to 
maintain a high, low, or medium BCS until calving. Reported are the total impact (Blue 
horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green 
bars expanding left denote inhibition and red bars expanding right denote activation) of DEG on 
the categories and subcategories. 
Pathway Impact Flux
Steroid biosynthesis
Terpenoid backbone biosynthesis
Synthesis and degradation of ketone bodies
Pentose and glucuronate interconversions
Ascorbate and aldarate metabolism
Propanoate metabolism
Pyruvate metabolism
Caffeine metabolism
Cyanoamino acid metabolism
Mismatch repair
Pathway Impact Flux
Glycosaminoglycan degradation
Vitamin B6 metabolism
One carbon pool by folate
Regulation of autophagy
Fatty acid biosynthesis
Glycosaminoglycan biosynthesis ‐ heparan sul
Propanoate metabolism
Pyruvate metabolism
Vitamin digestion and absorption
Glycolysis / Gluconeogenesis
Pathway Impact Flux
Vitamin digestion and absorption
Steroid biosynthesis
Ascorbate and aldarate metabolism
Synthesis and degradation of ketone bodies
Propanoate metabolism
Terpenoid backbone biosynthesis
Mismatch repair
Glycolysis / Gluconeogenesis
Biosynthesis of unsaturated fatty acids
beta‐Alanine metabolism
High vs Low BCS
High vs Mid BCS
Low vs Mid BCS
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Figure 6.3. Impact and flux of main KEGG categories and sub-categories affected with relative 
effect of high BCS with time postpartum (wk 1,3, 5), as calculated by the Dynamic Impact 
Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) 
and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Category Impact Flux Impact Flux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
Week 3 vs 1 Week 5 vs 1 Week 5 vs 3
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Figure 6.4.  Impact and flux of the top 10 KEGG pathways affected with relative effect of high 
BCS with time postpartum (wk 1,3, 5), as calculated by the Dynamic Impact Approach. Cows 
were managed during the dry period to maintain a high, low, or medium BCS until calving. 
Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) and the 
direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Pathway Impact Flux
Notch signaling pathway
Phototransduction
Steroid biosynthesis
Synthesis and degradation of ketone bodies
Calcium signaling pathway
Long‐term potentiation
Insulin signaling pathway
Salivary secretion
Melanogenesis
Sulfur relay system
Pathway Impact Flux
Biosynthesis of unsaturated fatty acids
Ascorbate and aldarate metabolism
Fatty acid biosynthesis
Pentose and glucuronate interconversions
Histidine metabolism
beta‐Alanine metabolism
PPAR signaling pathway
Propanoate metabolism
Steroid biosynthesis
Pyruvate metabolism
Pathway Impact Flux
Fatty acid biosynthesis
Biosynthesis of unsaturated fatty acids
Ascorbate and aldarate metabolism
Steroid biosynthesis
Synthesis and degradation of ketone bodies
Pentose and glucuronate interconversions
Glycosphingolipid biosynthesis ‐ lacto and neolacto series
Histidine metabolism
Propanoate metabolism
Notch signaling pathway
Week 3 vs 1
Week 5 vs 1
Week 5 vs 3
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Figure 6.5. Impact and flux of main KEGG categories and sub-categories affected with relative 
effect of low BCS with time postpartum (wk 1,3, 5), as calculated by the Dynamic Impact 
Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) 
and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Category Impact Flux ImpacFlux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
Week 3 vs 1 Week 5 vs 1  Week 5 vs 3
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Figure 6.6.  Impact and flux of the top 10 KEGG pathways affected with relative effect of low 
BCS with time postpartum (wk 1,3, 5), as calculated by the Dynamic Impact Approach. Cows 
were managed during the dry period to maintain a high, low, or medium BCS until calving. 
Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) and the 
direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Pathway Impact Flux
Glycosphingolipid biosynthesis ‐ lacto and neolacto series
Metabolism of xenobiotics by cytochrome P450
Drug metabolism ‐ cytochrome P450
Glutathione metabolism
Vasopressin‐regulated water reabsorption
Cell adhesion molecules (CAMs)
TGF‐beta signaling pathway
ErbB signaling pathway
Axon guidance
ABC transporters
Pathway Impact Flux
Axon guidance
Metabolism of xenobiotics by cytochrome P450
Biosynthesis of unsaturated fatty acids
Drug metabolism ‐ cytochrome P450
Glutathione metabolism
Adherens junction
Vasopressin‐regulated water reabsorption
Hedgehog signaling pathway
Glycosphingolipid biosynthesis ‐ lacto and neolacto series
Leukocyte transendothelial migration
Pathway Impact Flux
Sulfur relay system
Glycosylphosphatidylinositol(GPI)‐anchor biosynthesis
Cysteine and methionine metabolism
ABC transporters
Mismatch repair
Melanogenesis
Protein digestion and absorption
Leukocyte transendothelial migration
Homologous recombination
Long‐term potentiation
Week 3 vs 1
Week 5 vs 1
Week 5 vs 3
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Figure 6.7. Impact and flux of main KEGG categories and sub-categories affected with relative 
effect of medium BCS with time postpartum (wk 1,3, 5), as calculated by the Dynamic Impact 
Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) 
and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Category Impact Flux ImpacFlux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
Week 3 vs 1 Week 5 vs 1 Week 5 vs 3
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Figure 6.8.  Impact and flux of the top 10 KEGG pathways affected with relative effect of 
medium BCS with time postpartum (wk 1,3, 5), as calculated by the Dynamic Impact Approach. 
Cows were managed during the dry period to maintain a high, low, or medium BCS until 
calving. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) 
and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Pathway Impact Flux
Fatty acid biosynthesis
Sphingolipid metabolism
Sulfur relay system
Cardiac muscle contraction
Lysosome
Proximal tubule bicarbonate reclamation
NOD‐like receptor signaling pathway
Synthesis and degradation of ketone bodies
Cell adhesion molecules (CAMs)
Glycosylphosphatidylinositol(GPI)‐anchor biosynthesis
Pathway Impact Flux
Biosynthesis of unsaturated fatty acids
Sphingolipid metabolism
Glycosylphosphatidylinositol(GPI)‐anchor biosynthesis
Fatty acid biosynthesis
Steroid biosynthesis
Sulfur relay system
Mismatch repair
Synthesis and degradation of ketone bodies
PPAR signaling pathway
Homologous recombination
Pathway Impact Flux
Sulfur relay system
Mismatch repair
NOD‐like receptor signaling pathway
Biosynthesis of unsaturated fatty acids
Homologous recombination
DNA replication
Vasopressin‐regulated water reabsorption
Pentose phosphate pathway
Proximal tubule bicarbonate reclamation
Tight junction
Week 3 vs 1
Week 5 vs 1
Week 5 vs 3
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Figure 6.9. Impact and flux of main KEGG categories and sub-categories affected with different 
BCS (H, L, M) at week 1 relative to parturition, as calculated by the Dynamic Impact Approach. 
Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) and the 
direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Category Impact Flux Impact Flux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
High vs Low BCS High vs Mid BCS Low vs Mid BCS
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Figure 6.10.  Impact and flux of the top 10 KEGG pathways affected with different BCS (H, L, 
M) at week 1 relative to parturition, as calculated by the Dynamic Impact Approach. Cows were 
managed during the dry period to maintain a high, low, or medium BCS until calving. Reported 
are the total impact (Blue horizontal bars; larger the bars higher the impact) and the direction of 
the impact (or flux; green bars expanding left denote inhibition and red bars expanding right 
denote activation) of DEG on the categories and subcategories. 
Pathway Impact Flux
Fatty acid biosynthesis
Biosynthesis of unsaturated fatty acids
Steroid biosynthesis
Mismatch repair
Ascorbate and aldarate metabolism
Glycosylphosphatidylinositol(GPI)‐anchor biosynthesis
Homologous recombination
Pentose and glucuronate interconversions
DNA replication
Histidine metabolism
Pathway Impact Flux
Sulfur relay system
Synthesis and degradation of ketone bodies
Neurotrophin signaling pathway
Notch signaling pathway
Cysteine and methionine metabolism
Terpenoid backbone biosynthesis
Glyoxylate and dicarboxylate metabolism
Sphingolipid metabolism
O‐Mannosyl glycan biosynthesis
Adherens junction
Pathway Impact Flux
Fatty acid biosynthesis
Synthesis and degradation of ketone bodies
Steroid biosynthesis
Ascorbate and aldarate metabolism
Biosynthesis of unsaturated fatty acids
Propanoate metabolism
Pentose and glucuronate interconversions
Terpenoid backbone biosynthesis
Glyoxylate and dicarboxylate metabolism
Histidine metabolism
High vs Low BCS
High vs Mid BCS 
Low vs Mid BCS 
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Figure 6.11. Impact and flux of main KEGG categories and sub-categories affected with 
different BCS (H, L, M) at week 3 relative to parturition, as calculated by the Dynamic Impact 
Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) 
and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
  
Category Impact Flux Impact Flux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
High vs Low BCS High vs Mid BCS Low vs Mid BCS
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Figure 6.12.  Impact and flux of the top 10 KEGG pathways affected with different BCS (H, L, 
M) at week 3 relative to parturition, as calculated by the Dynamic Impact Approach. Cows were 
managed during the dry period to maintain a high, low, or medium BCS until calving. Reported 
are the total impact (Blue horizontal bars; larger the bars higher the impact) and the direction of 
the impact (or flux; green bars expanding left denote inhibition and red bars expanding right 
denote activation) of DEG on the categories and subcategories. 
Pathway Impact Flux
Fatty acid biosynthesis
Biosynthesis of unsaturated fatty acids
Steroid biosynthesis
Synthesis and degradation of ketone bodies
Ascorbate and aldarate metabolism
Pentose and glucuronate interconversions
NOD‐like receptor signaling pathway
Propanoate metabolism
Histidine metabolism
Glycosylphosphatidylinositol(GPI)‐anchor biosynthesis
Pathway Impact Flux
Fatty acid biosynthesis
Notch signaling pathway
Steroid biosynthesis
Insulin signaling pathway
Metabolism of xenobiotics by cytochrome P450
Hedgehog signaling pathway
Biosynthesis of unsaturated fatty acids
Drug metabolism ‐ cytochrome P450
Glutathione metabolism
Adipocytokine signaling pathway
Pathway Impact Flux
Glycosylphosphatidylinositol(GPI)‐anchor biosynthesis
Ascorbate and aldarate metabolism
Pentose and glucuronate interconversions
Mismatch repair
NOD‐like receptor signaling pathway
Histidine metabolism
Homologous recombination
RIG‐I‐like receptor signaling pathway
p53 signaling pathway
beta‐Alanine metabolism
High vs Low BCS
High vs Mid BCS
Low vs Mid BCS 
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Figure 6.13. Impact and flux of main KEGG categories and sub-categories affected with 
different BCS (H, L, M) at week 5 relative to parturition, as calculated by the Dynamic Impact 
Approach. Reported are the total impact (Blue horizontal bars; larger the bars higher the impact) 
and the direction of the impact (or flux; green bars expanding left denote inhibition and red bars 
expanding right denote activation) of DEG on the categories and subcategories. 
Category Impact Flux Impact Flux Impact Flux
1. Metabolism
0.1 Metabolic Pathways
1.1 Carbohydrate Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
1.10 Biosynthesis of Other Secondary Metabolites
1.11 Xenobiotics Biodegradation and Metabolism
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
2.4 Replication and Repair
3. Environmental Information Processing
3.1 Membrane transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
Low vs MidHigh vs Low High vs Mid
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Figure 6.14.  Impact and flux of the top 10 KEGG pathways affected with different BCS (H, L, 
M) at week 5 relative to parturition, as calculated by the Dynamic Impact Approach. Cows were 
managed during the dry period to maintain a high, low, or medium BCS until calving. Reported 
are the total impact (Blue horizontal bars; larger the bars higher the impact) and the direction of 
the impact (or flux; green bars expanding left denote inhibition and red bars expanding right 
denote activation) of DEG on the categories and subcategories. 
Pathway Impact Flux
Fatty acid biosynthesis
Arginine and proline metabolism
Mismatch repair
Vasopressin‐regulated water reabsorption
Glycosphingolipid biosynthesis ‐ lacto and neolacto series
Homologous recombination
Biosynthesis of unsaturated fatty acids
DNA replication
RNA degradation
Cell adhesion molecules (CAMs)
Pathway Impact Flux
Sulfur relay system
Ascorbate and aldarate metabolism
Melanogenesis
Vasopressin‐regulated water reabsorption
Pentose and glucuronate interconversions
Arginine and proline metabolism
Histidine metabolism
Phototransduction
Adherens junction
beta‐Alanine metabolism
Pathway Impact Flux
Biosynthesis of unsaturated fatty acids
Sulfur relay system
Fatty acid biosynthesis
Synthesis and degradation of ketone bodies
Phototransduction
Terpenoid backbone biosynthesis
Ascorbate and aldarate metabolism
Vasopressin‐regulated water reabsorption
Glyoxylate and dicarboxylate metabolism
Mismatch repair
High vs Low BCS
High vs Mid
Low vs Mid 
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Figure 6.16: Top 10% KEGG pathways uncovered with Tp53 target genes affected by change in 
calving BCS. Reported are the results of Dynamic Impact Approach (DIA): Impact (blue 
horizontal bars; larger the bars higher the impact) and the direction of the impact (or flux; green 
shade denotes inhibition and red shade denotes activation). 
  
SUB‐CATEGORY PATHWAY
1.3 Lipid Metabolism Fatty acid biosynthesis
1.3 Lipid Metabolism Steroid biosynthesis
1.9 Metabolism of Terpenoids and Polyketides Terpenoid backbone biosynthesis
1.7 Glycan Biosynthesis and Metabolism Glycosaminoglycan biosynthesis ‐ heparan sulfate
1.1 Carbohydrate Metabolism Ascorbate and aldarate metabolism
4.3 Cell Growth and Death Apoptosis
1.5 Amino Acid Metabolism Alanine, aspartate and glutamate metabolism
1.6 Metabolism of Other Amino Acids beta‐Alanine metabolism
1.1 Carbohydrate Metabolism Pentose and glucuronate interconversions
5.1 Immune System RIG‐I‐like receptor signaling pathway
1.1 Carbohydrate Metabolism Starch and sucrose metabolism
1.1 Carbohydrate Metabolism Amino sugar and nucleotide sugar metabolism
1.2 Energy Metabolism Nitrogen metabolism
1.1 Carbohydrate Metabolism Propanoate metabolism
4.4 Cell Communication Tight junction
5.1 Immune System NOD‐like receptor signaling pathway
1.1 Carbohydrate Metabolism Butanoate metabolism
1.1 Carbohydrate Metabolism Fructose and mannose metabolism
5.6 Nervous System Long‐term depression
4.4 Cell Communication Adherens junction
4.3 Cell Growth and Death p53 signaling pathway
High vs Mid Low vs MidHigh vs Low
Flux = ‐50 ‐25 0 25 50 Impact = 0 12.5 25 50 100
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APPENDICES 
 
APPENDIX-A: Chapter 2 Supplementary data 
 
Suppl. Table A.1. Gene ID, GenBank accession number, hybridization position, sequence and amplicon size of 
primers for Bos taurus used to analyze gene expression by qPCR. 
Gene 
ID 
Accession # Symbol Primers1 Primers (5’-3’) bp2 Source 
281992 NM_001034036.1 PPARA F.729 
R.830 
CATAACGCGATTCGTTTTGGA 
CGCGGTTTCGGAATCTTCT 
102 This 
manuscript 
280991 NM_173986.2  AKT1 F.864 
R.963 
GGATTACCTGCACTCGGAAAAG 
TCCGAAGTCGGTGATCTTGAT 
100 This 
manuscript 
506812 FJ415874.1 CPT1A F.141 
R.240 
TCGCGATGGACTTGCTGTATA 
CGGTCCAGTTTGCGTCTGTA 
100 This 
manuscript 
785576 XM_002695200.2 FGF21 F.514 
R.639 
CAGAGCCCCGAAAGTCTCTTG 
AAAGTGCAGCGATCCGTACAG 
125 This 
manuscript 
509963 NM_001046043.2 ANGPTL4 F.28 
R.136 
AGGAAGAGGCTGCCCAAGAT 
CCCTCTCTCCCTCTTCAAACAG 
109 (Loor et al., 
2007) 
281209 
 
NM_001075240.1  NFIL3 F.958  
R.1057 
CAGGTCAACCGATCCTCCAGT 
TGGGAACCTGCTGCTCATCT 
100 This 
manuscript 
508541 NM_001012671.2 STAT3 F.3804 
R.3913 
GGTAGCATGTGGGATGGTCTCT 
GCATCCCTAGAAACTCTGGTCAA 
110 This 
manuscript 
281209 
 
NM_174076.3 
 
GPX1 F.353  
R.452 
AACGCCAAGAACGAGGAGATC 
CATTCACCTCGCACTTTTCGA 
100 This 
manuscript 
1 Primer direction (F – forward; R – reverse) and hybridization position on the sequence. 
2 Amplicon size in base pair (bp). 
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Suppl. Table A.2. Sequencing results of PCR products from primers of genes designed for this 
experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are shown.  
  
Gene Sequence 
PPARA CGAGATCTGAGAAAGCAAAATTGAAGGCAGAAATCCTTACGTGTGAGCATGAC 
CTAGAAGATTCCGAAACCGCGA 
CPT1A GGACTATGAAGGTAAACCAGGCCCGGGACGCCCTTCGTACAGGCCTCTCGCTCC 
AGCTGGCTCATTACAAGGGACCA 
FGF21 GCATCGTAGCAGGCGTCATTCAGATCTTGGGAGTTAAACATCCAGGTTTCTCTG 
CCAGGGGCCAGATGGGAAGCTGTACGGATCGCTGCACTTTTAA 
AKT1 GTGTTGGACTCAGCGTGGACCTCATGCTGGACAAGGGACGGGCACATCAAG 
ATCACCGACCTTTCGGAAAA 
 
 
 
   
 
 
295 
 
 
 
 
Suppl. Table A.3.  qPCR performance among the genes measured in healthy and ketotic 
transition dairy cows 
 
 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls]   for 
each time point and each steer. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
 
  
Gene Median 
Ct1 
Median 
∆Ct2 
Slope3 (R2)4 Efficiency5 
FGF21 25.33 -5.55 -2.84 0.94 2.25 
KLB 24.13 -4.36 -3.3 0.91 2.01 
FGFR3 23.77 -3.99 -1.55 0.96 4.41 
NFIL3 25.07 -5.29 -3.41 0.98 1.96 
CLOCK 25.97 -2.56 -3.25 0.99 2.03 
ARNTL   -3.38 0.94 1.98 
AKT1 26.94 -3.53 -3.35 0.99 1.99 
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Suppl. Table A.4.  qPCR performance among the genes measured in control and dietary L-carnitine 
supplemented transition dairy cows.  
 
 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls]   for 
each time point and each steer. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
 
 
 
  
Gene Median 
Ct1 
Median 
∆Ct2 
Slope3 (R2)4 Efficiency5 
FGF21 26.53 -5.72 -3.43 0.99 1.96 
KLB 22.99 -2.18 -3.22 0.99 2.04 
PPARA 21.64 -0.83 -3.26 0.99 2.03 
CPT1A 18.83 1.98 -3.31 0.99 2.01 
ANGPTL4 24.19 -3.09 -3.39 0.99 1.97 
NFIL3 25.14 -0.83 -3.72 0.98 1.86 
CLOCK 27.33 -3.36 -2.8 0.96 2.28 
ARNTL 31.24 -7.27 -3.34 0.98 1.99 
AKT1 28.07 -4.10 -3.12 0.91 2.09 
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APPENDIX-B: Chapter 3 Supplementary data 
Suppl. Table B.1. Concentration of fatty acids in hepatic phospholipids during the peripartal 
period. 
Fatty acid Diet 
Day 
SEM 
P value 
-21 -10 1 11 Diet Day Diet × day 
14:0 CON1 0.25 0.35 0.20 0.20 0.09 0.71 <0.01 0.22 
SFAT2 0.53 0.31 0.18 0.16 
FISH3 0.52 0.19 0.20 0.17 
14:1trans CON <0.01 0.02 <0.01 <0.01 0.01 0.60 0.17 0.82 
SFAT <0.01 <0.01 <0.01 <0.01 
FISH <0.01 0.01 <0.01 <0.01 
14:1cics CON 0 <0.01 <0.01 <0.01 <0.01 0.43 0.61 0.19 
SFAT 0 0 <0.01 <0.01 
FISH <0.01 <0.01 <0.01 <0.01 
15:0 CON 0.34 0.34 0.22 0.22 0.04 0.76 <0.01 0.45 
SFAT 0.39 0.32 0.19 0.18 
FISH 0.43 0.25 0.19 0.18 
15:1trans CON <0.01 0.04 <0.01 <0.01 0.01 0.44 0.15 0.78 
SFAT <0.01 <0.01 <0.01 <0.01 
FISH <0.01 0.02 <0.01 <0.01 
16:1trans CON 0.29 0.28 0.18 0.22 0.03 0.03 <0.01 0.09 
SFAT 0.27 0.24 0.18 0.16 
FISH 0.28 0.39 0.22 0.17 
16:1cis CON 0.62 0.66 0.70 0.65 0.06 <0.01 0.52 0.85 
SFAT 0.68 0.67 0.73 0.66 
FISH 0.63 0.55 0.59 0.53 
17:0 CON 1.35 1.27 0.83 0.82 0.10 0.95 <0.01 0.37 
SFAT 1.39 1.30 0.75 0.81 
FISH 1.12 1.43 0.84 0.80 
17:1trans CON 0.09 0.12 0.04 0.05 0.02 0.01 <0.01 0.67 
SFAT 0.11 0.09 0.06 0.04 
FISH 0.04 0.09 0.01 <0.01 
18:1trans5 CON <0.01 0 <0.01 <0.01 0.03 0.10 0.56 0.55 
SFAT <0.01 <0.01 <0.01 <0.01     
FISH 0.10 0.06 0.01 <0.01     
18:1trans7 CON <0.01 <0.01a <0.01 <0.01 <0.01 0.21 0.09 <0.01 
SFAT 0.01 <0.01a <0.01 0.01     
FISH <0.01α 0.03bβ <0.01α <0.01α     
18:1trans8 CON 0.08bα <0.01cβ <0.01β <0.01bcβ 0.03 0.78 0.25 <0.01 
SFAT <0.01aα <0.01abα <0.01 α 0.11aβ     
FISH <0.01aα 0.07bβ <0.01α <0.01bα     
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Suppl. Table B.1. (Cont.) 
Fatty acid Diet 
Day 
SEM 
P value 
-21 -10 1 11 Diet Day Diet × day 
18:1trans9 CON1 0.09 0.11 0.09 0.08 0.05 0.84 0.16 0.39 
 SFAT2 0.09 0.10 0.16 0.03     
 FISH3 0.09 0.17 0.03 0.02     
18:1trans10 CON 0.17 <0.01 <0.01 0.02 0.07 0.91 0.59 0.12 
 SFAT <0.01 <0.01 <0.01 <0.01     
 FISH <0.01 0.16 <0.01 0.04     
18:1trans12 CON 0.39αβ 0.17aα 0.53abαβ 0.63β 0.15 <0.01 0.01 <0.01 
 SFAT 0.35 0.38a 0.50a 0.49     
 FISH 0.18α 1.24bβ 0.90bβγ 0.71γ     
18:1t13-14 CON <0.01 <0.01 <0.01 2.86 0.93 0.39 0.41 0.45 
 SFAT <0.01 0 0 <0.01     
 FISH <0.01 <0.01 <0.01 <0.01     
18:1cis11 CON 0.57 0.82 0.90 0.78 0.11 0.21 <0.01 0.73 
 SFAT 0.75 0.81 0.88 0.88     
 FISH 0.43 0.70 0.83 0.84     
18:1cis12 CON 0.29 0.19 0.26 0.24 0.07 0.74 0.99 0.22 
 SFAT 0.23 0.22 0.26 0.13     
 FISH 0.14 0.29 0.17 0.30     
18:1cis13 CON 0.05 0.01 0.04 0.04 0.02 0.57 0.63 0.42 
 SFAT <0.01 0.01 0.04 0.02     
 FISH 0 0.06 0.03 0.03     
18:1cis16 CON 0.04 0.10 0.14 0.13 0.03 0.38 0.01 0.11 
 SFAT 0.09 0.09 0.13 0.06     
 FISH 0.05 0.16 0.12 0.16     
20:0 CON 0.08 0.10 0.06 0.06 0.03 0.02 <0.01 0.11 
 SFAT 0.08 0.07 0.05 0.04     
 FISH 0.21 0.12 0.07 0.05     
18:3n-6 CON 0.40 0.42a 0.39a 0.38a 0.08 <0.01 0.34 0.04 
 SFAT 0.34αβ 0.48aαβ 0.33aα 0.53aβ     
 FISH 0.39α 0.08bβ 0.11bβ 0.15bβ     
18:2alltrans CON 0.13 0.14 0.07 0.06 0.02 <0.01 <0.01 0.38 
 SFAT 0.14 0.16 0.08 0.10     
 FISH 0.08 0.03 0.01 0.01     
20:3n-3 CON 6.55 6.75 4.53 4.27 0.59 <0.01 <0.01 0.14 
 SFAT 5.92 6.86 4.00 4.38     
 FISH 5.54 3.26 2.14 2.38     
22:1 CON 0.01 0.01 0.01 0.02 0.10 0.39 0.46 0.48 
 SFAT <0.01 0.01 0.01 0.01     
 FISH 0.30 0.03 <0.01 -<0.01     
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Suppl. Table B.1. (Cont.) 
Fatty acid Diet 
Day 
SEM 
P value 
-21 -10 1 11 Diet Day Diet × day 
22:2n-6 CON1 0.01 0.01 <0.01 <0.01 0.12 0.07 0.59 0.75 
 SFAT2 <0.01 <0.01 <0.01 <0.01     
 FISH3 0.35 0.14 0.07 0.04     
22:3n-3 CON <0.01 0.01 0 0.11 0.07 0.92 0.72 0.25 
 SFAT 0.02 0.03 0.09 0.01     
 FISH 0.18 <0.01 <0.01 <0.01     
22:4n-6 CON 2.71 2.58 1.60 1.27 0.22 <0.01 <0.01 0.08 
 SFAT 2.36 2.45 1.59 1.10     
 FISH 2.07 0.93 0.36 0.26     
Unknown CON 5.33 3.89 2.04 2.60 0.80 0.92 <0.01 0.10 
 SFAT 3.93 3.81 1.70 2.74     
 FISH 3.30 6.00 1.71 2.26     
a-c Difference (P< 0.05) between different diet at same day. 
αβγδ Denote significant interactions (P<0.05) within a same diet at different days.  
1 Control diet containing no supplemental lipid. 
2 Supplemental lipid from Energy Booster. 
3 Supplemented with fish oil. 
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Suppl. Table B.2: Concentration of fatty acids in hepatic triacylglycerol during the peripartal 
period. 
Fatty acid Diet 
Day
SEM 
P value
-21 -10 1 11 Diet Day Diet × day
14:0 CON1 3.94 5.34 5.06 3.98 0.53 0.06 0.08 0.62 
SFAT2 5.24 5.30 5.17 5.15 
FISH3 4.00 5.39 4.17 4.16 
14:1trans CON <0.01b <0.01 <0.01 <0.01 0.07 0.11 0.08 0.04 
SFAT 0.33aα <0.01β <0.01β <0.01β 
FISH <0.01b <0.01 <0.01 <0.01 
14:1cis CON 0.06aα 0.14α 0.43β 0.35β 0.06 0.16 0.01 0.03 
SFAT 0.05aα 0.08α 0.34β 0.34β 
FISH 0.32bα <0.01β 0.39α 0.43α 
15:0 CON 1.50 1.58 1.22 1.24 0.24 0.37 0.01 0.72 
SFAT 2.00 1.50 1.11 1.19 
FISH 1.35 1.53 2.00 1.06 
15:1trans CON <0.01b <0.01 <0.01 <0.01 0.64 0.11 0.08 0.04 
SFAT 0.31aα <0.01β <0.01β <0.01β 
FISH <0.01b <0.01 <0.01 <0.01 
16:1trans CON 0.65ab 0.68 0.64a 0.66 0.11 0.02 0.36 0.02 
SFAT 0.90a 0.58 0.74a 0.60 
FISH 0.58bα 0.85αβ 1.12bβ 0.88β 
16:1cis 
 
CON 1.70 2.01 4.03 3.30 0.42 0.05 <0.01 0.11 
SFAT 1.87 1.74 2.64 3.80 
FISH 2.44 3.03 3.90 3.41 
17:0 CON 1.87 1.77 0.84 1.04 0.25 0.83 <0.01 0.98 
SFAT 1.73 1.79 0.98 0.84 
FISH 1.59 1.70 0.91 0.91 
17:1trans CON <0.01 <0.01 0.05 0.05 0.02 0.40 <0.01 0.71 
SFAT 0.04 <0.01 0.07 0.09 
FISH 0.03 <0.01 0.06 0.06 
17:1cis CON <0.01 <0.01 0.12 <0.01 0.08 0.58 0.32 0.55 
SFAT 0.07 <0.01 <0.01 0.10 
FISH <0.01 <0.01 0.13 0.20 
18:1trans5 CON <0.01 <0.01 <0.01 <0.01 0.10 0.37 0.63 0.48 
SFAT 0.28 <0.01 0.07 0.01     
FISH <0.01 <0.01 <0.01 0.09     
18:1trans7 CON <0.01 <0.01 <0.01 0.01 0.11 0.40 0.45 0.48 
SFAT 0.32 <0.01 0.01 0.01     
FISH <0.01 <0.01 <0.01 <0.01     
18:1trans68 CON 0.04 <0.01 <0.01 0.11 0.34 0.55 <0.01 0.71 
 SFAT <0.01 0.04 0.09 0.11     
 FISH <0.01 <0.01 0.04 0.06     
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Suppl. Table B.2. (Cont.) 
  Day   P value
Fatty acid Diet -21 -10 1 11 SEM Diet Day Diet × day
18:1trans9 CON1 <0.01 0.07 0.12 0.02 0.05 0.67 0.03 0.52 
 SFAT2 <0.01 0.04 0.12 0.15     
 FISH3 0.03 0.04 0.09 0.09     
18:1trans10 CON <0.01 <0.01 0.06 0.20 0.07 0.61 0.66 0.53 
 SFAT <0.01 0.07 <0.01 <0.01     
 FISH 0.05 0.04 0.04 0.04     
18:1trans12 CON <0.01 0.04 0.27 0.21 0.12 0.36 <0.01 0.89 
 SFAT 0.14 <0.01 0.39 0.28     
 FISH 0.20 <0.01 0.34 0.40     
18:1t13-14 CON 1.21 1.30 0.49 0.35 0.38 0.51 <0.01 0.71 
 SFAT 1.68 1.92 0.14 0.43     
 FISH 1.16 1.32 0.56 <0.01     
18:1trans15 CON <0.01 <0.01 <0.01 0.20 2.07 0.42 0.44 0.47 
 SFAT <0.01 <0.01 <0.01 <0.01     
 FISH <0.01 <0.01 6.27 <0.01     
18:1cis11 CON 0.53 0.66 1.03 0.64 0.16 0.55 <0.01 0.36 
 SFAT 0.63 0.53 1.02 1.13     
 FISH 0.666 0.45 0.97 1.06     
18:1cis12 CON 0.19 0.26 0.49 0.40 0.09 0.02 <0.01 0.70 
 SFAT 0.26 0.27 0.49 0.54     
 FISH 0.05 <0.01 0.40 0.44     
18:1cis13 CON <0.01 0.02 0.12 0.14 0.04 0.17 <0.01 0.98 
 SFAT <0.01 0.03 0.15 0.14     
 FISH 0.05 0.09 0.18 0.15     
18:1trans16 CON <0.01 0.03 0.08 0.09 0.03 0.70 <0.01 0.61 
 SFAT <0.01 <0.01 0.12 0.09     
 FISH 0.04 <0.01 0.12 0.09     
18:1alltrans CON 2.07 2.43 2.09 1.92 2.02 0.31 0.36 0.25 
 SFAT 3.26 2.70 2.15 1.94     
 FISH 1.91 2.79 9.23 2.21     
18:1allcis CON 15.00 14.77 22.53 21.90 2.70 0.96 <0.01 0.23 
 SFAT 15.25 13.65 22.83 21.38     
 FISH 20.80 14.55 16.47 23.34     
18:3n-6 CON 0.08α 0.13aαβ 0.21bβγ 0.35aγ 0.03 <0.01 <0.01 0.02 
 SFAT 0.11α 0.10aα 0.12abα 0.37aβ     
 FISH 0.08αβ 0.01bα 0.11aαβ 0.13bβ     
18:2alltrans CON 0.05 0.06 0.09 0.11 0.02 <0.01 <0.01 0.08 
 SFAT 0.06 0.07 0.07 0.18     
 FISH 0.03 0.02 0.06 0.04     
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Suppl. Table B.2. (Cont.) 
  Day   P value 
Fatty acid Diet -21 -10 1 11 SEM Diet Day Diet × day
20:3n-3 CON1 0.93 1.15 0.57 0.51 0.18 0.08 0.01 0.91 
 SFAT2 0.66 0.89 0.50 0.53     
 FISH3 0.66 0.65 0.41 0.34     
22:1 CON <0.01 <0.01 <0.01 0.01 0.01 0.08 0.33 0.42 
 SFAT <0.01 0.03 <0.01 0.02     
 FISH <0.01 <0.01 <0.01 <0.01     
22:2n-6 CON 0.36 0.18 <0.01 0.02 0.10 0.14 0.22 0.46 
 SFAT 0.01 <0.01 <0.01 0.01     
 FISH 0.08 0.13 0.04 0.02     
22:3n-3 CON <0.01 <0.01b <0.01 0.26 0.12 0.06 0.10 0.04 
 SFAT <0.01α 0.61aβ 0.05α 0.14α     
 FISH <0.01 <0.01b <0.01 0.02     
24:1 CON <0.01b <0.01 <0.01 <0.01 0.01 0.39 0.33 0.04 
 SFAT 0.04aα <0.01β <0.01β <0.01β     
 FISH <0.01b <0.01 0.01 0.02     
22:4n-6 CON 0.51 0.48 0.22 0.19 0.21 0.31 0.01 0.15 
 SFAT 0.19 1.12 0.20 0.17     
 FISH 0.33 0.34 0.12 0.13     
22:5n-6 CON 0.14 0.12 0.06 0.04 0.11 0.10 0.17 0.07 
 SFAT 0.08 0.49 0.06 0.04     
 FISH 0.08 0.24 0.41 0.28     
Unknown CON 9.53 6.28 6.44 5.63 1.70 0.08 0.86 0.30 
 SFAT 3.72 4.26 5.54 7.09     
 FISH 8.44 8.61 690 6.38     
a-c Difference (P< 0.05) between different diet at same day. 
αβγδ Denote significant interactions (P<0.05) within a same diet at different days.  
1 Control diet containing no supplemental lipid. 
2 Supplemental lipid from Energy Booster. 
3 Supplemented with fish oil. 
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APPENDIX-C: Chapter 4 Supplementary data 
Suppl. Table C.1. Gene ID, GenBank accession number, hybridization position, sequence and amplicon size of 
primers for Bos taurus used to analyze gene expression by qPCR. 
Gene ID Accession # Symbol Primers
1 
Primers (5’-3’) bp2 
513996 NM_001035289.2 
 
ACOX1 F.180 
R.279 
ACCCAGACTTCCAGCATGAGA 
TTCCTCATCTTCTGCACCATGA 
100 
280991 NM_173986.2 AKT1 F.864 
R.963 
GGATTACCTGCACTCGGAAAAG 
TCCGAAGTCGGTGATCTTGAT 
100 
509963 NM_001046043.2 ANGPTL4 F.28 
R.136 
AGGAAGAGGCTGCCCAAGAT 
CCCTCTCTCCCTCTTCAAACAG 
109 
615342 BC110012 BCL2 F.442 
R.531 
GCTCCCAGTCCGAGGAAGAC 
TGGACCAATCCCAAATCCA 
90 
281043 BC142093 CCL2 F.175 
R .272 
TCAACAGTAAGAAGATCTCCATGCA 
CAGGACGGTCTTGAAAATCACA 
98 
327712 BC102064 CCL5 F.155 
R.255 
CCCTGCTGCTTTGCCTATATCT  
ATAAAGACAACTGCTGCCATGGA 
101 
506812 FJ415874.1 CPT1A F.141 
R.240 
TCGCGATGGACTTGCTGTATA 
CGGTCCAGTTTGCGTCTGTA 
100 
785576 XM_002695200.2 FGF21 F.514 
R.639 
CAGAGCCCCGAAAGTCTCTTG 
AAAGTGCAGCGATCCGTACAG 
125 
281813 BC109698 FUNDC2 F.424 
R.527 
AGCGTGTAGAGAAGGACATGAAGA 
CGACACCACCTCCTCTGCTT 
104 
280805 NM_176608.1 
 
GHR F.1350 
R.1459 
CTAGCCAGCAGCCCAGTGTTA 
TGGATTGCTGAGCTGTGTATGG 
110 
281209 
 
NM_174076.3 
 
GPX1 F.353  
R.452 
AACGCCAAGAACGAGGAGATC 
CATTCACCTCGCACTTTTCGA 
100 
503684 NM_001045883.1 HMGCS2 F.837 
R.936 
TTACGGGCCCTGGACAAAT 
GCACATCATCGAGAGTGAAAGG 
100 
280692 NM_001040470.1 HP F.1210 
R.1310 
GGTTCGGAAAACCATCGCTA 
CACTCGTGTCCCCTCCACTC 
101 
281239 NM_001077828.1 IGF1 F.288 
R.330 
CCAATTCATTTCCAGACTTTGCA 
CACCTGCTTCAAGAAATCACAAAA 
103 
281251 NM_174093.1 IL1B F.453 
R.552 
TCCACCTCCTCTCACAGGAAA 
TACCCAAGGCCACAGGAA 
100 
280826 BC123577 IL6 F.290 
R.390 
TGAGTGTGAAAGCAGCAAGGA 
TCGCCTGATTGAACCCAGAT 
101 
537224 NM_001206156.1 LPIN1 F.2119 
R.2219 
TGGCCACCAGAATAAAGCATG 
GCTGACGCTGGACAACAGG 
101 
281209 
 
NM_001075240.1 NFIL3 F.958  
R.1057 
CAGGTCAACCGATCCTCCAGT 
TGGGAACCTGCTGCTCATCT 
100 
616115 NM_001076409.1 
 
NFKB1 F.172 
R.266 
TTCAACCGGAGATGCCACTAC 
ACACACGTAACGGAAACGAAATC 
95 
497200 NM_001040502.1 
 
ORM1 F.370 
R.469 
TCGGACAGAGAACACTTTGTTGA 
AGGACACCCCCACGTTCTTT 
100 
508493 NM_001046005.1 PNPLA2 F.765 
R.866 
CACCAGCATCCAGTTCAACCT 
CTGTAGCCCTGTTTGCACATCT 
102 
523798 NM_001046269.1 
 
PON1 F.1088 
R.1187 
ATCCGTACCCCTACCCTGACA 
GGGTCAGCGTTCACTGTTGA 
100 
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Suppl. Table C.1. (Cont.) 
1 Primer direction (F – forward; R – reverse) and hybridization position on the sequence. 
2 Amplicon size in base pair (bp). 
  
Gene ID Accession # Symbol Primers1 Primers (5’-3’) bp2 
281992 NM_001034036.1 PPARA F.729 
R.830 
CATAACGCGATTCGTTTTGGA 
CGCGGTTTCGGAATCTTCT 
102 
281800 AY089972 PROKR1 F.198 
R.292 
CATGGCGCTGGTGGGTAT 
TGGTGAGGTTGCGTAGCTTCT 
95 
281474 AF540564 SAA3 F.50 
R.155 
GGGCATCATTTTCTGCTTCCT 
TTGGTAAGCTCTCCACATGTCTTTAG 
106 
280924 AY241933 SCD F.665 
R.765 
TCCTGTTGTTGTGCTTCATCC 
GGCATAACGGAATAAGGTGGC 
101 
534377 BC104610 SERGEF F.406 
R.503 
CCTCATGGGCCTCGAAGAT 
GCAGCTAAAGCATGCCTCAGT 
98 
767848 BC103464 SLC35B2 F.836 
R.930 
ACATTGCTTTCGACAGCTTCAC 
GAAGAGATTGACCCCAAACATCA 
98 
281496 NM_201527.2 
 
SOD2 F.620 
R.714 
TGTGGGAGCATGCTTATTACCTT 
TGCAGTTACATTCTCCCAGTTGA 
95 
338437 NM_177523.2 SOCS2 F.995 
R.1094 
CGGCACTGTTCACCTTTATCTG 
GACGGTGCTGGTACACTTGTTAAT 
100 
539361 XM_001790600.1 SREBF1 F.1638 
R.1743 
GTGCTGAGGGCAGAGATGGT 
ACAAAGAGAAGTGCCAAGGAGAA 
106 
508541 NM_001012671.2 
 
STAT3 F.3804 
R.3913 
GGTAGCATGTGGGATGGTCTCT 
GCATCCCTAGAAACTCTGGTCAA 
110 
282376 NM_174617.3 STAT5B F.130 
R.234 
TCATCAGATGCAAGCGCTGTA 
TTATCAAGATCTATTGAGTCCCAAGCT 
105 
281536 AB056444 TLR4 F.1630 
R.1754 
CACTCGCTCCGGATCCTAGA 
CAAACACAAGCAAATGCATTCTG 
125 
280943 EU276079.1 TNF F.437 
R.536 
TCTCAAGCCTCAAGTAACAAGCC 
CCATGAGGGCATTGGCATAC 
100 
281542 BC102440 TP53 F.939 
R.1041 
TGTTTGTGCCTGTCCTGGG 
TGCTCGCTTAGTGCTCCTAGG 
103 
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Suppl. Table C.2. Sequencing results of PCR products from primers of genes designed for this 
experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are shown.   
Gene Sequence 
ACOX1 ATCCTCGTATCCGCGTTCAGGGTGCGTTTAAGAAGAGTGCCATCATGGTGCA 
GAAGATGAGGAAATCCCC 
AKT1 GTGTTGGACTCAGCGTGGACCTCATGCTGGACAAGGGACGGGCACATCAAG 
ATCACCGACCTTTCGGAAAA 
CPT1A GGACTATGAAGGTAAACCAGGCCCGGGACGCCCTTCGTACAGGCCTCTCGC 
TCCAGCTGGCTCATTACAAGGGACCA 
FGF21 GCATCGTAGCAGGCGTCATTCAGATCTTGGGAGTTAAACATCCAGGTTTCTC 
TGCCAGGGGCCAGATGGGAAGCTGTACGGATCGCTGCACTTTTAA 
GHR CGATACAACAGACACTTCTCATGTGGTGACTGAGTCAACTCATCAAGCTGTCC 
ATACACAGCTCAGCAATCCAAAAAT 
GPX1 GTAAATCGTCGACAGGCGGCGGGTTCGAGCCCAACTTTATGCTCTTCGCAAAA 
GTGCGAGGTGAAGGAAA 
HMGCS2 CACTAGCCAGATCGAGAACAGGTGAAGCAAGCTGGCATCGAATCGGCCTTTC 
ACTCTCGATGAATGTGCAAAACCC 
IGF1 CCGGTACAGGGAATCAGCAGTCTTCCACCCAATTATTTAAGTGCTGCTTTTGT 
GATTTCTTGAAGCAGGGGTGAAAA 
IL1B CCACCTCCTCTCACAGGAAATGAACCGAGAAGTGGTGTTCTGCATGAGCTTTG 
TGCAAGGAGAGGAA 
LPIN1 GATCATCTAGTGATGAGGAGCATGCAGCCGCCAAGCCGTCCAGCACAAGCCA 
CCTCCCCCTGTTGTCCAGCAGTCAGCAA 
ORM1 CCGTGTCTCCCTTCGGACTTCATGCTTGCTGCCTCCTGGAATGGCACAAAGAA 
CGTGGGGGTGTCCTTACAA 
PNPLA2 GCCTCGCCTTCAGGCCTGTTCCGCCCGAGCCCTGGTNCTTCGAGAGATGTGCA 
AACAGGGCTACAGAACCC 
PON1 GATAACTCATATCACGTCTGTCCACATCTGTGGGGGCCACAGTGATCTCATCT 
CAACAGTGAACGCTGACCCAA 
SCD AGACTGTGCATGGTATCTGTGGGATGAAACGTTTCAAAACAGCCTGTTTTTTG 
CCACCTTATTCCGTATATAGCCAG 
SOSC2 GACATACTATCAGCACACCCGTGCAGCATCTCTGTAGACTCACCATTAACAAG 
TGTACCAGCACCGTCAAA 
SOD2 GCATGTTTGGCCGATTATCTGAGGCCATTTTGGAATGTGATCAACTGGGAGAA 
TGTAACTGCAATAC 
SREBF1 CAGTCCTGTCGGCTTGTGGCAGTGGAGGGAGCACAGATGTGCCCATGGAGGGC 
ATGAAGCCAGAGGTGGATCGACAA 
STAT3 GCATCCCTCTACGAGCACGGCTAGATGTGGTCGGCTACAGCCATCTTGTCTCAG 
TTGACCAGAGTTTCTAGGGATGCAA 
STAT5B GCCATCATGTAGGGTCGCCATTACTTATCCCAGGTGATTGAAGGGCCAAGCTTG 
GGGACTCAATAGATCTTGATAAAAAACCCC 
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Suppl. Table C.3.  qPCR performance and % relative abundance of genes measured in liver 
tissue. 
Gene  Median Ct Median ∆Cta Slope R2b Efficiencyc Relative % mRNA abundance 
ACOX1 20.55 -2.71 -3.24 0.99 2.04 3.06 
AKT1 25.62 2.35 -3.34 0.99 1.99 0.07 
ANGPTL4 20.55 -2.59 -3.17 0.99 2.07 2.34 
CPT1A 22.53 -0.71 -3.25 0.99 2.03 0.22 
FGF21 25.79 2.04 -3.00 0.99 2.15 0.07 
GHR 21.55 -1.54 -3.07 0.99 2.11 1.68 
GPX1 22.27 -1.00 -3.20 0.99 2.15 0.77 
HMGCS2 18.07 -5.14 -3.14 0.99 2.08 13.59 
HP 20.34 -2.66 -3.20 0.99 2.05 2.42 
IGF1 27.45 4.38 -3.22 0.99 2.04 0.01 
IL1B 27.41 3.97 -2.91 0.99 2.12 0.018 
NFIL3 24.49 1.36 -3.75 0.99 1.85 0.13 
ORM1 16.43 -6.79 -3.01 0.99 2.15 56.51 
PON1 17.91 -5.18 -3.14 0.99 2.05 14.95 
PPARA 21.50 -1.68 -3.12 0.99 2.09 1.23 
RXRA 24.69 0.82 -3.14 0.99 2.08 0.65 
SAA3 25.80 2.03 -3.02 0.99 2.08 0.08 
SOCS2 27.46 4.09 -3.69 0.99 1.86 0.01 
SOD2 22.58 -0.57 -3.30 0.99 2.14 0.55 
STAT3 21.31 -1.87 -3.00 0.99 2.15 1.49 
STAT5B 25.05 1.40 -3.43 0.98 1.96 0.14 
a The median ∆Ct was calculated as [Ct gene – geometric mean of Ct internal controls] for each 
sample. 
b R2 = coefficient of determination of the standard curve. 
c Efficiency is calculated as [10(-1 / Slope)]. 
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Suppl. Table C.4.  qPCR performance and % relative abundance of the measured gene from 
subcutaneous adipose tissue samples. 
Gene  Median Ct Median 
∆Cta 
Slope R2b Efficiency
c 
Relative % mRNA 
abundance 
ABHD5 25.51 -3.10 -3.25 0.92 2.03 0.59 
ADIPOQ 20.36 -8.58 -2.93 0.98 2.19 54.87 
ANGPTL4 25.01 -3.73 -3.13 0.96 2.09 1.02 
BCL2 24.20 -4.60 -2.95 0.94 2.18 3.09 
CCL2 29.41 0.89 -3.52 0.95 1.92 0.04 
CCL5 29.90 1.02 -2.95 0.96 2.18 0.03 
FASN 25.98 -2.72 -3.05 0.98 2.13 0.51 
GHR 24.64 -4.12 -2.91 0.96 2.21 1.89 
HP 28.65 -0.08 -2.95 0.98 2.18 0.07 
IL6 31.60 2.81 -3.10 0.99 2.10 0.03 
IRS1 29.06 0.24 -3.06 0.98 2.12 0.05 
LIPE 22.24 -6.23 -3.12 0.98 2.09 6.43 
LPIN1 22.47 -6.38 -2.92 0.96 2.20 14.58 
NFIL3 24.87 -3.96 -2.92 0.96 2.20 1.48 
NFKB1 26.63 -1.95 -2.93 0.99 2.19 0.49 
PLIN2 27.44 -1.61 -3.64 0.97 1.84 0.27 
PNPLA2 24.01 -4.99 -3.06 0.98 2.12 2.81 
PPARG 24.02 -4.73 -2.70 0.93 2.21 3.66 
RXRA 26.48 -2.06 -3.15 0.95 2.08 0.29 
SAA3 28.55 0.03 -2.91 0.96 2.21 0.06 
SCD 24.93 -3.63 -2.92 0.96 2.20 1.26 
SLC2A4 27.91 -0.70 -2.93 0.91 2.19 0.13 
SOD2 24.58 -4.09 -2.74 0.97 2.19 2.03 
SREBF1 24.68 -4.02 -2.90 0.98 2.21 1.60 
STAT3 24.25 -4.48 -2.94 0.96 2.19 2.20 
TP53 27.44 -1.11 -2.96 0.97 2.18 0.18 
a The median ∆Ct was calculated as [Ct gene – geometric mean of Ct internal controls] for each 
sample. 
b R2 = coefficient of determination of the standard curve. 
c Efficiency is calculated as [10(-1 / Slope)]. 
Relative mRNA abundance between measured transcripts. The relative % mRNA abundance 
between transcripts was calculated as previously reported using the median ∆Ct (∆Ct = Ct of the 
gene – geometrical mean Ct of internal control genes) corrected by efficiency (E), where % 
relative mRNA abundance = [1/E∆Ct]/Σ[1/E∆Ct] all measures genes  100. 
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APPENDIX-D: Chapter 5 Supplementary data 
Suppl. Table D.1. Gene ID, GenBank accession number, hybridization position, sequence and amplicon size of 
primers for Bos taurus used to analyze gene expression by qPCR. 
Gene 
ID 
Accession # Symbol Primers1 Primers (5’-3’) bp2 Source 
281992 NM_001034036.1 PPARA F.729 
R.830 
CATAACGCGATTCGTTTTGGA 
CGCGGTTTCGGAATCTTCT 
102 This 
manuscript 
506812 FJ415874.1 CPT1A F.141 
R.240 
TCGCGATGGACTTGCTGTATA 
CGGTCCAGTTTGCGTCTGTA 
100 This 
manuscript 
513996 NM_001035289.2 ACOX1 F.180 
R.279 
ACCCAGACTTCCAGCATGAGA 
TTCCTCATCTTCTGCACCATGA 
100 This 
manuscript 
785576 XM_002695200.2 FGF21 F.514 
R.639 
CAGAGCCCCGAAAGTCTCTTG 
AAAGTGCAGCGATCCGTACAG 
125 This 
manuscript 
509963 NM_001046043.2 ANGPTL4 F.28 
R.136 
AGGAAGAGGCTGCCCAAGAT 
CCCTCTCTCCCTCTTCAAACAG 
109 (Loor et al., 
2007) 
503684 NM_001045883.1 HMGCS2 F.837 
R.936 
TTACGGGCCCTGGACAAAT 
GCACATCATCGAGAGTGAAAGG 
100 This 
manuscript 
280868 
 
NM_001101834.1 MTTP F.617 
R.716 
ACCAGGCTCATCAAGACAAAGTG 
GTGACACCCAAGACCTGATGTG 
100 This 
manuscript 
494004 XM_002691511.2 APOB100 F.2244 
R.2348 
CAAGGCTTTGTACTGGGTTAAGG 
ACCATGTCCTGCTCATGTTTATCA 
105 This 
manuscript 
338471 
 
NM_177946 
 
PC F.3217 
R.3296 
CCTGCAGGGACCCAAGATT 
TGGCCAAGGCTTTGATGTG 
80 (Loor et al., 
2006) 
507367 NM_001101883 PDK4 F.942 
R.1006 
ATGTTCCATCTCACCTTCACCAT 
AACTGTGGCCCTCATTGCAT 
65 (Akbar et al., 
2013) 
282855  NM_174737 PCK1 F.447 
R.555 
GCCCATCCCCAAAAACG  
CATGGTGCGACCCTTCATG 
109 (Akbar et al., 
2013) 
535630 NM_001076064.1 HTMLE F.910 
R.1132 
TGGCAGGACACTGCTAGTTG 
GACAGCCCGGTCATAGTTGT 
222 (Schlegel et 
al., 2012) 
507159 
 
BC102355.1 BBPX1 F.380 
R.673 
TCCAGCTGCCTACTCTGGAT 
AGCTGAACCTTACCCCAGGT 
294 (Schlegel et 
al., 2012) 
541266 NM_001046502.2 SLC22A5 F.1545 
R.1743 
CACAGTGGTCAGGAACATGG 
AATGGTGTCTGGGAGTGGAG 
181 (Schlegel et 
al., 2012) 
280692 NM_001040470.1 HP F.1210 
R.1310 
GGTTCGGAAAACCATCGCTA 
CACTCGTGTCCCCTCCACTC 
101 (Loor et al., 
2007) 
281474 AF540564 SAA3 F.50 
R.155 
GGGCATCATTTTCTGCTTCCT 
TTGGTAAGCTCTCCACATGTCTTTAG 
106 (Mukesh et 
al., 2010) 
280717 M73993.1 ALB F.1548 
R.1627 
AGTGCTGCACAGAGTCATTGGT 
GGCTTTGGGTACATATGTTTCATCA 
80 This 
manuscript 
616115 NM_001076409.1 NFKB1 F.172 
R.266 
TTCAACCGGAGATGCCACTAC 
ACACACGTAACGGAAACGAAATC 
95 (Osorio et 
al., 2012) 
508541 NM_001012671.2 STAT3 F.3804 
R.3913 
GGTAGCATGTGGGATGGTCTCT 
GCATCCCTAGAAACTCTGGTCAA 
110 This 
manuscript 
281209 
 
NM_174076.3 
 
GPX1 F.353  
R.452 
AACGCCAAGAACGAGGAGATC 
CATTCACCTCGCACTTTTCGA 
100 This 
manuscript 
1 Primer direction (F – forward; R – reverse) and hybridization position on the sequence. 
2 Amplicon size in base pair (bp). 
 
 
310 
 
Suppl. Table D.2. Sequencing results of PCR products from primers of genes designed for this 
experiment. Best hits using BLASTN (http://www.ncbi.nlm.nih.gov) are shown.  
  
Gene Sequence 
PPARA CGAGATCTGAGAAAGCAAAATTGAAGGCAGAAATCCTTACGTGTGAGCATGAC 
CTAGAAGATTCCGAAACCGCGA 
CPT1A GGACTATGAAGGTAAACCAGGCCCGGGACGCCCTTCGTACAGGCCTCTCGCTCC 
AGCTGGCTCATTACAAGGGACCA 
ACOX1 ATCCTCGTATCCGCGTTCAGGGTGCGTTTAAGAAGAGTGCCATCATGGTGCAGA 
AGATGAGGAAATCCCC 
MTTP GCACTGCCCCCTCTATTTTTCAGTTAATCCAAAGCCCTTTAATTTTTGGTCACTT 
TGTCTTGATGAGCCCTGAGGAATATCAAA 
FGF21 GCATCGTAGCAGGCGTCATTCAGATCTTGGGAGTTAAACATCCAGGTTTCTCTG 
CCAGGGGCCAGATGGGAAGCTGTACGGATCGCTGCACTTTTAA 
HMGCS2 CACTAGCCAGATCGAGAACAGGTGAAGCAAGCTGGCATCGAATCGGCCTTTC 
ACTCTCGATGAATGTGCAAAACCC 
ALB GCGATCAGTTTCTTCGTCTCGTACACCTGATGAACATATGTACCCAAAGCCAC 
ACAATGACTCTGGGCAGCACTAACC 
STAT3 GCATCCCTCTACGAGCACGGCTAGATGTGGTCGGCTACAGCCATCTTGTCTCAG 
TTGACCAGAGTTTCTAGGGATGCAA 
GPX1 GTAAATCGTCGACAGGCGGCGGGTTCGAGCCCAACTTTATGCTCTTCGCAAAAG 
TGCGAGGTGAAGGAAA 
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Suppl. Table D.3.  qPCR performance and % relative abundance of the measured gene in cows 
managed to maintain a Low (L), Medium (M), or High (H) body condition score (BCS) during 
the dry period.   
Gene  Median Ct Median ∆Cta Slope R2b Efficiency c Relative % 
mRNA 
Abundance 
PPARA 24.31 1.33 -2.87 0.99 2.232 0.67 
CPT1A 22.99 0.01 -3.07 0.99 2.116 1.95 
ACOX1 22.26 -0.72 -2.92 0.99 2.197 3.44 
FGF21 26.04 3.09 -3.11 0.98 2.094 0.20 
ANGPTL4 25.59 2.46 -3.18 0.99 2.064 0.33 
HMGCS2 19.42 -3.64 -2.92 0.99 2.201 34.45 
MTTP 25.85 2.89 -3.06 0.99 2.124 0.22 
APOB100 19.85 -3.14 -3.05 0.99 2.128 20.94 
PC 21.21 -1.79 -2.84 0.99 2.252 8.35 
PCK1 20.33 -2.73 -3.08 0.99 2.111 15.03 
PDK4 25.85 2.67 -3.00 0.99 2.154 0.25 
HTMLE 28.94 5.86 -3.24 0.97 2.03 0.0 
BBOX1 30.26 7.33 -2.89 0.94 2.22 0.01 
SLC22A5 29.84 6.90 -2.92 0.94 2.92 0.01 
HP 22.09 -1.21 -3.08 0.99 2.113 4.81 
SAA3 27.83 4.95 -3.04 0.99 2.134 0.05 
GPX1 24.32 1.33 -2.92 0.99 2.198 0.68 
SOD1 21.47 -1.54 -2.94 0.99 2.186 6.51 
NFKB1 26.31 3.35 -2.99 0.99 2.160 0.12 
STAT3 22.89 -0.01 -2.99 0.99 2.156 1.95 
a The median ∆Ct was calculated as [Ct gene – geometric mean of Ct internal controls] for each 
sample. 
b R2 represents the coefficient of determination of the standard curve. 
c Efficiency is calculated as [10(-1 / Slope)]. 
 
Relative mRNA abundance between measured transcripts. The relative % mRNA abundance 
between transcripts was calculated as previously reported using the median ∆Ct (∆Ct = Ct of the 
gene – geometrical mean Ct of internal control genes) corrected by efficiency (E), where % 
relative mRNA abundance = [1/E∆Ct]/Σ[1/E∆Ct] all measures genes  100. 
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APPENDIX-E: Chapter 6 Supplementary data 
Suppl. Table E.1. Number of differentially expressed genes (DEG; FDR cut off of < 0.05 and 
raw p value of < 0.05) and top ten transcription regulators (TR) in response change  BCS (H, M, 
L),  and to the interaction of BCS with time relative to parturition (wk 1, 3, 5). The cows, 
managed during the dry period to maintain a high (H), low (L), or medium (M) body condition 
score until calving. 
  
Effect DEG  TR*  Top 10 TR** 
BCS 4325 300 E2F1, CTNNB1, SEREBF1, RXRA, STAT1, TP53,  NFE2L2, 
NFKBB1A, YWHAH, RELA,  
BCS × Time  251 24 ATN1, ETV1, FOXP3, HNF4A, MAGED1, MED1, MKL1, 
MYC, NKRF, TCF3,  
* Transcription regulators 
* * The TR with bold fonts had the highest number of targets. 
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Suppl. Table E.2. Top transcription regulators (TR) in response to the interaction of BCS with 
time relative to parturition (wk 1, 3, 5). The cows, managed during the dry period to maintain a 
high (H), low (L), or medium (M) body condition score until calving.  
Interaction    Target genes present** 
BCS  Week  TR*   
High vs Low 1 ATN1 HPCAL1, VIM 
High vs Mid 1 HNF4A UMPS, PCMT1, FGB, LIN7C, GSTZ1, KRT8, SSBP1, GIN1, 
PRR3, TRMT13, SPAST, RAD17 
Low vs Mid 1 HNF4A RAD17, PCMT1, BLOC1S6, UMPS, LIN17C, PRPS1, GSTZ1, 
KRTS, STAU2, SSBP1, SCD, GIN1, SLC35A5, SPAST   
High vs Low 3 MYC KRT6A, PAM, SSBP1, SLC1A5, CPT2, PABPC1, SCD, CASP8, 
LAS1L 
High vs Mid 3 FOXP3 FASN, ADD3, ARHGEF6, SMCHD1 
Low vs Mid 3 MYC KRT6A, PAM, DIMT1, LAS1A, SLC1A5, PABPC1, SSBP1, 
SCD, VIM, TRIM71, CASP8 
High vs Low 5 MYC KRT6A, CPT2, PABPC1, SSBP1, TRIM71, LAS1L 
High vs Mid   FOXP3 LAS1L, CHD4, IL21, ADD3, ARHGEF6, ORC2, FYB 
Low vs Mid 5 TCF3 SSBP1, RPLA, CHD4 
* Transcription regulators; TR with bold font size indicates upregulation while the normal font 
represents down regulation in response to the interaction of BCS with time relative to parturition 
* * The target genes with bold font size indicate upregulation while the normal font represents 
down regulation in response to the interaction of BCS with time relative to parturition. 
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Suppl. Figure E.2A. Interaction: High BCS at Week 3 vs 1; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E. 2 (Cont.) 
 
 
 
Suppl. Figure E.2B. Interaction: High BCS at Week 5 vs 1; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
  
 
Suppl. Figure E.2C. Interaction: High BCS at Week 5 vs 3; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
 
Suppl. Figure E.2D. Interaction: Low BCS at Week 3 vs 1; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
  
 
Suppl. Figure E.2E. Interaction: Low BCS at Week 5 vs 1; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
   
Suppl. Figure E.2F. Interaction: Low BCS at Week 5 vs 3; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
 
Suppl. Figure E.2G. Interaction: Mid BCS at Week 3 vs 1; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
  
Suppl. Figure E.2H. Interaction: Mid BCS at Week 5 vs 1; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
          
Suppl. Figure E.2I. Interaction: Mid BCS at Week 5 vs 3; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.)  
  
Suppl. Figure E.2J. Interaction: High vs Low BCS at Week 1; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
  
Suppl. Figure E.2K. Interaction: High vs Mid BCS at Week 1; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
  
Suppl. Figure E.2L. Interaction: Low vs Mid BCS at Week 1; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
  
Suppl. Figure E.2M. Interaction: High vs Low BCS at Week 3; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study.   
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Suppl. Figure E.2 (Cont.) 
 
  
Suppl. Figure E.2N. Interaction: High vs Mid BCS at Week 3; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
 
 
Suppl. Figure E.2O. Interaction: Low vs Mid BCS at Week 3; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
  
Suppl. Figure E.2P. Interaction: High vs Low BCS at Week 5; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
  
Suppl. Figure E.2Q. Interaction: High vs Mid BCS at Week 5; Regulation of transcription regulator 
and associated target genes networks uncovered with IPA in the data set of DEG due to the 
particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.2 (Cont.) 
  
Suppl. Figure E.2R. Interaction: Low vs Mid BCS at Week 5; Regulation of transcription 
regulator and associated target genes networks uncovered with IPA in the data set of DEG due to 
the particular interaction of BCS (high, mid and low) and time relative to parturition (wk 1, 3, 5). 
Reported networks are IPA knowledge based: red color indicates upregulation, green down 
regulation and gray color represents the genes with no change but were differentially regulated 
by other interactions in the study. 
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Suppl. Figure E.3A. Glycolysis /gluconeogenesis KEGG pathway in comparison of high and 
low BCS. Green shade denotes down-regulation while red/yellow tones denote upregulation of 
genes.  
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Suppl. Figure E.3 (Cont.) 
 
  
Suppl. Figure E.3B. Glycolysis /gluconeogenesis KEGG pathway in comparison of high and 
medium BCS. Green shade denotes down-regulation while red/yellow tones denote upregulation 
of genes.  
 335 
 
Suppl. Figure E.3 (Cont.) 
 
 
 
Suppl. Figure E.3C. Glycolysis /gluconeogenesis KEGG pathway in comparison of low and 
medium BCS. Green shade denotes down-regulation while red/yellow tones denote upregulation 
of genes. 
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Suppl. Figure E.4A. Arachidonic acid (AA) metabolism KEGG pathway in comparison of high 
and low BCS. Green shade denotes down-regulation while red/yellow tones denote upregulation 
of genes. 
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Suppl. Figure E.4 (Cont.) 
 
 
  
Suppl. Figure E.4B. Arachidonic acid (AA) metabolism  KEGG pathway in comparison of high 
and medium BCS. Green shade denotes down-regulation while red/yellow tones denote 
upregulation of genes. 
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Suppl. Figure E.4 (Cont.) 
 
 
  
Suppl. Figure E.4C. Arachidonic acid (AA) metabolism KEGG pathway in comparison of  low 
and medium BCS. Green shade denotes down-regulation while red/yellow tones denote 
upregulation of genes. 
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Suppl. Figure E.5A. Steroid biosynthesis KEGG pathway in comparison of high and low BCS. 
Green shade denotes down-regulation while red/yellow tones denote upregulation of genes. 
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Suppl. Figure E.5 (Cont.) 
 
 
 
 
Suppl. Figure E.5B. Steroid biosynthesis KEGG pathway in comparison of high and medium 
BCS. Green shade denotes down-regulation while red/yellow tones denote upregulation of genes. 
  
 341 
 
Suppl. Figure E.5 (Cont.) 
 
 
 
 
Suppl. Figure E.5C. Steroid biosynthesis KEGG pathway in comparison of low and medium 
BCS. Green shade denotes down-regulation while red/yellow tones denote upregulation of genes. 
 
